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During the last decades, research focused on the preparation of highly selective and smart 
materials has increased considerably. For instances, it has been possible to achieve intelligent drug 
nano-carriers, biomolecular sensors, platforms to promote cell growth and differentiation among 
many other striking applications. Two mentionable factors that helped such development are the 
incorporation of biological moieties onto this interfaces to gain specificity and the combination of 
more than one material in order to get a synergistic effect between the different components (i.e. 
conducting polymers suffer from poor mechanical strength, therefore, its combination with 
polyesters can reduce their fragility). 
This thesis has been devoted to the design and development of high performance polymeric 
materials for multiple functions related to the biomedical field, such as passive ion transport 
membranes, drug delivery systems and the addition of selectivity in different surfaces. The work 
gives special emphasis to the characterization of these platforms, like its surface chemistry, 
topology, biocompatibility or its mechanical strength. Besides, these systems have been synthetized 
in a large variety of shapes, from free-standing nanomembranes to polymeric nanoparticles.  
The Thesis is divided in three parts: 
The first encloses all the studies realized for the generation of hybrid nanoperforated 
membranes in order to achieve controlled ion diffusion. Specifically, an outer membrane protein, 
Omp2a, was considered for these studies. Primarily, the protein was purified, folded and 
characterized in an ambient resembling to the one encountered in nature, its mechanical forces and 
conductivity were analysed. The project was followed by the immobilization of Omp2a into silicon 
microcantillevers to acquire greater knowledge of its folding and unfolding processes upon thermal 
stress. Next, artificial polymeric membranes containing nanofeatures were developed with the final 
purpose to immobilize Omp2a via protein confinement. Then, the conductivity of the membrane 
with different electrolyte media solutions was tested.  
The second part describes the state-of-the-art of drug delivery systems prepared with 
intrinsically conducting polymers to achieve controlled drug release upon electrical stimuli. 
Furthermore, two systems based on poly(3,4-ethylenedioxythiophene) (PEDOT) nanoparticles are 
described. Particularly, curcumin was employed as a model neutral drug and incorporated within 
the PEDOT nanoparticles. The oxidation state of the PEDOT chains regulated the drug release. Later 
on, a similar system was generated with polyester microfibers loaded with curcumin and 
nanoparticles. The driving force for the later drug release was the actuation of the PEDOT 
nanoparticles.  
Lastly, the third part reports the immobilization of a pentapeptide called CREKA and its analog 





selectivity of those interfaces towards clotted plasma proteins such as fibrin and fibrinogen. PEDOT-
peptide material allowed the electrochemical detection of the proteins by an increase in membrane 
resistance and these interactions were evaluated with microcantilevers by measuring the difference 
on weight when they were incubated with different protein concentrations. 
Overall, the compilation of the studies presented in this Thesis offer a comprehensive view on 
how modifying and generating hybrid materials is possible to optimize and exploit their capabilities 
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CHAPTER 1:  




















1.1.  Motivation of the Thesis Research  
Human development goes together with the necessity to resolve problems and take 
advantage of different resources to build up new and useful gadgets. A clear example is 
when we check our surroundings and find plenty of utensils that make our life easy. 
When the generation of new tools is inspirited by nature, like plane from birds or 
liposomes from lipid vesicles, it is known as biomimetics. This concept takes advantage 
of millions of years of evolution which has led to the generation of unique, marvellous 
and functional natural materials using minimal resources and efforts. Living organisms 
excel with fascinating elegance the production of all sorts of materials with a quite variety 
of shapes and organizations.   
In other words, biomimetics is an interdisciplinary field that makes use of the 
knowledge coming from engineers, chemists, physicits and biologists applied on the 
synthesis of materials, systems or machines with functions that reassemble those 
encountered in nature. Within this context, chemistry plays a crucial role because of the 
necessity to generate synthetic analogues of biomacromolecular structures. Of particular 
scientific and technological interest are biomimetic membranes that are inspired by 
natural membrane compartments and organelles but avoid their drawbacks, such as 
membrane instability and limited control over cargo transport across the boundaries. 
The research to build chemically controlled bioinspired structures is mainly focused on 
more complex and hybrid systems. For instance, an ambitious target is to create 
membranes that regulate the ion or molecule exchange between one side and the other. 
The approach followed to achieve this can be fully synthetic or hybrid when combines 
macromolecules found in nature with artificial materials.  
Biomimetics is a relative recent field of investigation and it has become possible due 
to the many advances on the different research areas. We have to take into account that, 
before to start producing biomimetic materials, it is important to study, characterize and 
understand biological systems. Herein, we want to take profit of biological membranes to 
prepare hybrid artificial layers able to facilitate ion transport. For that reason, firstly the 
focus has been deposited on the study of Omp2a structure, size and thermal properties. 




encountered in nature and, finally, on the generation of hybrid membranes containing 
this protein. Therefore, we can have membranes able to facilitate ion transport with more 
robustness, specificity and simplicity. Thus, a combination of natural and artificial 
products will let to obtain outstanding materials with the advantages of each component.  
Particularly, Part A of this thesis has been focused on describing the biological role 
of lipid bilayers and specific transmembrane proteins, in more detail Omp2a, and its 
functional, structural properties when are embed onto a polymeric artificial membrane 
made of a biodegradable polyester.  
On the other hand, when this need is related to clinical diagnosis, treatment and 
tissue repair and it is in direct contact with the body the employment of biomaterials as a 
concept arose. Interestingly, B. M. Holzapfel et al.1 defined this concept as: 
 
‘‘A biomaterial is a substance that has been engineered to take a form which, alone or 
as part of a complex system, is used to direct, by control of interactions with components 
of living systems, the course of any therapeutic or diagnostic procedure, in human or 
veterinary medicine.’’  
 
However, the name can lead to misinterpretation of its significance. The use of the 
term “bio” could make us think as materials that are made by living organisms such as 
chitin, collagen or bone. For that reason, maybe it would have been easier the name 
biomedical materials instead of biomaterials.2 Strictly, as it is defined by the 
International Union of Pure and Applied Chemistry (IUPAC), a biomaterial is any 
material exploited in contact with living tissues, organism or microorganism.3 
Biomaterials are used in a wide range of applications which include limb replacements, 
artificial arteries, contact lenses, artificial teeth and drug delivery systems. Surprisingly, 
this is not a particular new field; it has been studied and employed for many years. In 
literature there is some controversy regarding which was the first produced biomaterial 
due to it goes back to the beginning of the civilizations. However, it is thought that one of 
the first biomaterials used were gold and ivory for replacements of cranial defects and 
was done by Egyptians and Romans. Later on, celluloid was the first plastic used for 
cranial defects and polymethyl methacrylate (PMMA) was one of the first polymers 
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accepted since World War II. Out of curiosity, during Second World War aviators 
returning from combat were occasionally and tragically injured by plastic shards 
penetrating in their eyes.4 Interestingly, these plastic pieces could remain on pilot’s eyes 
for many years without generating local inflammation. Starting from this material, 
Harold Ridley studied its use for implants. He was a pioneer in the field of intraocular 
lenses using PMMA due to its characteristics; rigid, non-foldable and hydrophobic (water 
content < 1%).5 
Part B and C will be devoted to the design of drug delivery systems (DDSs) made of 
conducting and biodegradable polymers and the preparation of peptide modified 
interfaces for biomedical purposes.  
 
1.2  Biomaterials, evolution and prospective 
During the 1st generation of biomaterials (1960s-1970s) almost all materials used in 
the body were made of one single material and the most important characteristic was its 
biological inertness.6 The vast majority of implants were made of already existing 
materials but with a higher level of purity, the effort being deposited on the elimination 
of toxic by-products and reducing the corrosion levels. There is no cellular adhesion 
between the bioinert material and its host tissue.  
Subsequently, the 2nd generation of biomaterials (1980s-1990s) begun. The 
research started to be more focus on materials that were better at reassembling the 
mechanical and chemical properties of the host tissue. The community was no longer 
interested in bioinert materials but instead on the opposite, bioactive materials able to 
modulate and trigger a cellular response. For instances, within this period it is possible to 
find materials able to release active proteins, growth factors or other molecules of 
interest promoting the desired therapeutic effect. Additionally, a new concept was born: 
biodegradable and resorbable biomaterials. These materials would be breakdown and 
replaced by regenerating tissue leading to an ultimately no noticeable difference between 
the implant and the host tissue.  
The 3rd generation (2000s and onwards) is trying to combine both previously 




specific responses are being demanded. In the case of tissue engineering, for instance, 
progenitor cells are being seeded inside the resorbable scaffold prior to be implanted. 
These scaffolds are degradable and will be ideally replaced by the host tissue. Another 
resulting approach from this period is the genetic control of cellular response. Some of 
these materials are also thought to upregulate or down regulate the expression of some 
specific genes.  
Nowadays, there is no clear separation between the employments of the different 
materials because no longer classic materials alone are being used. More and more 
biomaterials get a complex and greater structure that uses not only primary interatomic 
and intermolecular bonds, but also includes different concepts from nanotechnology and 
the self-assembly phenomena encountered in nature.7 However, there is an important 
issue by over-complicating devices and making them too expensive for the materials 
market. Thus, the main challenge is to provide materials sophisticated enough to 
influence cell behaviour maintaining the maximum simplicity.8 Evolution of the 
biomaterials field is represented in Figure 1.1. Concretely, it is necessary to find the 
minimal cues that would make a difference in resolving a clinical problem. This is now a 
grown and mature field, which is very present in the market area.  Therefore, the 
ambitious approach to replace entire organs has been divided to smaller and more 
attainable aims, such as focusing just on valves off the heard instead of the entire organ. 
Figure 1.1. Evolution of biomaterials. From left to right: classical bioinert materials, followed 
by the appearance of bioactive and biodegradable materials, which leaded to the preparation of 
biomaterials able to mimic biological systems and besides be bioactive and biodegradable. 




The demand grows towards materials able to stimulate tissue growth and repair rather to 
replacement, like living systems do. For example, when a bit more than half of human 
liver is excised, it has the ability to regrow to its original size.  
The biomaterials industry in 2016 was worthy 70.90$ Billions and with a 16% growth 
a year it is expected to reach 149.17$ Bilions by 2021. This huge marked is progressively 
increasing due to the world-wide governments trying to promote the implantable device 
market through an increase on funding’s and research grants. Not forgetting the 
booming number of hip and knee replacements, plastic surgeries and the rising number 
of elders in society (www.marketsandmarkets.com).  
Polymers are very convenient for biomedical applications because it’s many 
outstanding properties regarding mechanical strength, easier processability, cheapness 
and tailorable properties. In this thesis we are just going to focus on two groups of 
synthetic polymers (biodegradable polyesters and intrinsically conductive polymers); a 
few characteristics are going to be mentioned. Both present different but interesting 
qualities. 
The main interest in the biomedical field of polyesters is their possibility to be 
temporary devices, meaning that the material itself is broken down and excreted or 
reabsorbed without any surgical operation. These are linear aliphatic polyesters, 
generally hydrophobic, that present tuneable physical and mechanical characteristics 
which allowed a high development of these materials for biomedical purposes. Examples 
of different medical applications include inert medical meshes, drug vehicles or physical 
fixation supports.9 For many striking applications such as biosensors, controlled drug 
delivery systems or tissue electrical stimulation, conducting biomaterials based on 
graphene, metallic particles, carbon nanotubes or nanowires have been studied. 
Nevertheless, there are some drawbacks to take into account like non-biodegradability, 
long-term in vivo toxicity or inhomogeneous distribution of the conducting material. 
Instead, intrinsically conducting polymers (ICPs) are organic materials with soft nature 
that provide better mechanical compatibility with host tissues. More importantly ICPs, 
are not only biocompatible but also bioactive, they can induce a cellular response 
including promotion of cell adhesion, migration or differentiation by electrical 




drug delivery systems directed to cancer therapy would be discussed as well as the 
preparation of artificial materials taking advantages of biomolecules to increase its 
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CHAPTER 2:  


























The results of this Thesis have been organized in three blocks (visualized in a scheme 
form in Figure 2.1) as a function of the objectives set in this section. 
The first part is devoted to study biomimetic membranes prepared using the Omp2a 
outer membrane protein. Although the main aim of this block, which has been entitled 
“Biomimetic membranes based on Omp2a transmembrane protein”, was to prepare 
polymer-based artificial free-standing nanomembranes for effective ion separation, 
fulfilment of a number of specific objectives was necessary for complete understanding 
and successful achievement of such bioinspired devices. The specific objectives 
addressed in this block can be summarized as follows: 
1) Examine the response of Omp2a protein in an artificial configuration closer to 
the one encountered in nature than to that found in biomimetic polymer-based 
nanomembranes. For this purpose, the molecular forces and function of the 
Omp2a protein supported in a lipid bilayer, which consists in planar in vitro 
assemblies of lipids sitting on a solid support, have been studied using a variety 
of surface sensitive atomic force microscopy and electrochemical techniques, 
respectively.  
2) Investigate the hierarchical organization and response of the Omp2a protein in 
synthetic environments as a function of the temperature. For this, the thermal 
transitions of such protein have been identified by combining microcantilever 
deflection technologies with other techniques, such as FTIR spectroscopy, 
circular dichroism (CD), dynamic light scattering (DLS), wide angle X-ray 
diffraction (WAXD), X-ray photoelectron spectroscopy (XPS) and atomic force 
microscopy (AFM).  
3) Design and develop an approach to fabricate polymeric free-standing 
nanomembranes, preferably using biocompatible poly(lactic acid), with a 
homogeneous distribution of nanopores of controlled diameter crossing the 
entire ultra-thin film thickness (i.e. nanoperforations). 
4) Immobilize the Omp2a porin into the nanoperforation of poly(lactic acid) free-




transport. Check the benefits associated to the immobilization of Omp2a inside 
the nanoperforations with respect to the immobilization at the surface by 
comparing the electrochemical impedance response towards different 
electrolytic media.  
The second part of this Thesis is devoted to the utilization of intrinsic conducting 
polymers as smart drug delivery systems. Two different systems suitable for the 
controlled release upon electrostimulation have been designed, prepared and 
characterized. Moreover, the regulated drug release from the smart drug dosage systems 
developed in this chapter, which has been entitled “Design of intrinsically controlled 
polymers for drug delivery systems”, is based on very different driving forces. The 
specific objectives afforded in this block are: 
5) Develop conducting polymer nanoparticles for the encapsulation and controlled 
release of hydrophobic drugs. Release of the loaded drug from the nanoparticles 
is expected to be externally regulated by modulating the drug – polymer 
interactions through the application of an electric field. 
6) Prepare a new electrosensitive bioplatform combining a hydrophobic drug, 
conducting polymer nanoparticles and electrospun polyester fibers. Release of 
the loaded drug is expected to be regulated by altering the porosity of the 
polyester fibers using as driving force the isotropic actuation principle of the 
conducting polymer nanoparticles upon electrostimulation. 
Finally, the third and last part, “Surface functionalization with CREKA”, presents a 
detailed study about the interaction of CREKA (Cys-Arg-Glu-Lys-Ala) and CR(NMe)EKA 
(Cys-Arg-N-methyl-Glu-Lys-Ala), two linear peptide that recognize clotted plasma 
proteins and selectively home to tumors, with a well-known conducting polymer when 
prepared as polymer-CREKA and polymer-CR(NMe)EKA biocomposites.  Moreover, the 
biological implications of these interactions have been examined by analysing the 
fibrinogen thrombin–catalyzed polymerization, the fibrin-adsorption capacity and the 
attachment of metastatic and normal cells. The specific objectives examined in this block 
are: 
7) Prepare and characterize biocomposites based on the combination of an intrinsic 
conducting polymer and CREKA or CR(NMe)EKA, and analyse how the 
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replacement of Glu by noncoded N-methyl-Glu in the peptide affects the 
biocomposite···fibrin interactions and the differentiation between normal and 
tumor cells.  
8) Explore the biorecognition event between CR(NMe)EKA and clotted-plasma 
proteins (fibrin and fibrinogen) by nanomechanical detection. For this purpose, 
the development of a suitable experimental protocol for the functionalization of 






































 PART A 
Biomimetic membranes based on 





















































Molecular sensing, water purification and desalination, drug delivery and DNA sequencing are 
some striking applications of biomimetic hybrid membranes. These devices take advantage of 
biomolecules, which have gained excellence on their specificity and efficiency during billions of 
years, and of artificial materials that load the purified biological molecules and provide 
technological properties, such as robustness, scalability and suitable nanofeatures to confine the 
biomolecules. Recent methodological advances allow a more precise control of polymer membranes 
that support the biomacromolecules, which are expected to improve the design of the next 
generation of membranes as well as their applicability. In the first section of this chapter we explain 
the biological relevance of membranes, membrane proteins and the classification used for the latter. 
Furthermore, the most basic concepts of expression, purification and refolding of recombinant 
proteins are briefly discussed. After this, we critically analyse the different approaches employed for 
the production of highly selective hybrid membranes, focusing on novel materials made of self-
assembled block copolymers and nanostructured polymers. Finally, a summary of advantages and 
disadvantages of the different methodologies is presented and the main characteristics of 
biomimetic hybrid membranes are highlighted. 
 
Publications derived from this work: 
Puiggalí-Jou, A.; del Valle, L. J.; and Alemán, C. Biomimicking biological membranes incorporating 
































An ambitious goal of today’s synthetic biology, nanotechnology and bioengineering, is 
to build constructs analogous to natural systems for tuning and manipulating their 
complex physical and biological properties. Within this framework, protein-based 
nanomaterials offer countless potential for biophysical and nanobiomedical applications 
and serve as new tools for investigating essential biological questions.  
Particularly, membrane proteins (MPs) are important key regulators in many 
biological processes, such as ion transportation, generation of energy and transduction of 
signals across cell membranes.1 Besides, MPs constitute about one third of all protein 
coding genes and are the targets of a huge amount of pharmacological agents.2,3 
Although knowledge about their structure and function is crucial for the proper 
interpretation of numerous biologically relevant phenomena, these investigations are 
often very difficult due to the great complexity of cell membranes. Therefore, there is a 
continuously growing interest in the development of model systems able to offer suitable 
platforms to address the above mentioned issues. The most popular models include 
proteoliposomes, lipid monolayers and solid/supported lipid bilayers. Beyond the use of 
natural products, it is also possible to incorporate MPs into artificial materials, such as 
synthetic polymers, which can provide new properties (e.g. easiness of handling, 
robustness and functionalization). Thus, the biological molecules can bring specificity 
and efficiency, while the robustness and the possibility of tailoring materials to improve 
the final functionality can be added by the synthetic polymer. As a result, a wide range of 
applications have been investigated, including, DNA sequencing,4 drug delivery,5 
sensors,6 water desalination,7,8 and bioelectronics.9 
Although in the last decade some general reviews on biomimetic membranes have 
been reported,1,10-13 herein a new perspective is offered. More specifically, in this section 
recent developments and advancements from a processing point of view are discussed. 
Thus, the classification of the different approaches used to incorporate MPs onto 
artificial polymeric supports is the primary focus, also giving special emphasis to the 




3.2 Cell membranes: Description and biological 
relevance 
The structure of biological membranes is mainly driven by the lipid bilayer, even 
though the majority of its particular functions are played by the proteins embedded in it. 
The difference on the amount and type of MPs allow its classification. For instance, the 
protein mass in the myelin membrane, which insulates nerve cell axons, represents less 
than 25% of the whole membrane. In contrast, 75% is protein in membranes involved in 
the ATP production, like the internal membranes of mitochondria and chloroplasts. For 
common plasma membranes, proteins reach approximately 50% of their mass. 
Regarding to the orientation of MPs in lipid bilayers, biological membranes are not 
symmetric since the flux of materials needs to follow one particular direction and the 
recognition events just happen in one side of the membrane.  
Lipid bilayers allow facile and rapid diffusion of small non polar molecules such as O2 
(2.3101 cm/s)14 and CO2 (3.710-1 cm/s),15 and slower diffusion of small polar but not 
charged molecules like H2O (3.710-3 cm/s),16 urea and glycerol (10-6 cm/s).17 On the 
other hand, biological membranes are reluctant to allow the diffusion of charged 
molecules (ions) no mattering how small they are, because of the charge and their 
elevated hydration level. For example, the permeability coefficient of Na+ and K+ is 10-14 
cm/s.18  
Although lipids constitute a great part of the cell membranes, the high efficiency of 
the latter for transporting materials across the bilayers is due the presence of MPs. These 
can be classified into three different groups according to their transport mechanism: 
channels, pumps and transporters. The first group are pores that allow the passive 
diffusion across the membrane of ions and molecules depending on the concentration 
gradient. Their specificity is mainly driven by the size and charge of the solutes. Within 
this group, gap junctions (cell-cell direct communication), porins, water channels 
(aquaporins) and ion channels (which are dependent of voltage, ligands or 
mechanosensitive) are especially relevant. The transport rate of these transmembrane 
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proteins is high since they do not need any conformational change (107-109 
molecules/second).  
The second group, which are known as pumps, move ions or electrons against the 
concentration gradient using chemicals or light as energy power, also described as active 
transport. These MPs have specific binding sites for ions and molecules and they can also 
experience conformational changes that allow the transport. Their principal mechanisms 
include the consumption of energy by adenosine triphosphate (ATP) hydrolysis or by 
photon absorption in the case of photosynthetic pumps. The transport rate is quite slow 
compared to the other transport proteins (100-103 molecules/second). Finally, the third 
and last group involves the transporters. In this case, the ion/molecule transport is 
energy-independent and, therefore, is called passive. This transport comprises several 
steps: molecule recognition, translocation from one side to the other of the plasma 
membrane and the release of the ion/molecule. Hence, the transport rate is also 
moderate (102-104 molecules/sec). They can be classified as uniporters (just allow the 
movement of one solute), symporters (two at the same direction) and antiporters (two 
solutes in opposite directions). 
 
3.3 Expression of membrane proteins  
Analysis of the protein structures deposited in the protein data bank (PDB) reveals 
that, in comparison with soluble proteins, the number of MPs is much lower. This feature 
reflects that investigations on MPs are not going as fast as those on soluble proteins due 
to the extra difficulties related to the purification and refolding process.19 The proteins of 
interest can oddly be purified from its original membrane because usually their 
concentration is not enough.20 For that reason, MPs need to be overexpressed, which is 
performed in different host cells.  
Long-stablished strategies require the transformation (bacteria/yeasts) or 
transfection (mammalian/insect cells) of cells with a DNA vector that contains the gene 
of the protein of interest. Subsequently, cultured cells will transcribe and translate the 




Although both prokaryotic and eukaryotic systems can be employed,21 the choice of the 
system is important for a successful recombinant expression. The right choice depends 
on the type of protein, the needs of post-translational modifications, the effect of toxicity 
on the host cell, and the desired yield. The main advantage of mammalian systems is that 
they provide the highest level of protein processing, even though cell culturing is more 
demanding and expensive. Instead, bacterial cultures are easily scalable and not very 
demanding or expensive.  
There are strategies to overcome the toxicity of the protein overproduction on the 
host cells. For example, the utilization of strains with higher tolerance, such as the E. coli 
strain C43(DE3). It is worth noting that E. coli is one of the most universal system for 
prokaryotic and eukaryotic MPs due to the broad range of commercially available 
molecular biology tools and strains.22 Also, it is possible to add fusion partners to 
improve the expression level of the protein.23 Moreover, the overproduction can take 
place in inclusion bodies within the cytoplasm that would result in an easier purification 
and a lower toxicity but in a greater difficulty to refold the protein afterwards. There are 
many detergents for protein solubilisation, as for example n-dodecyl--D-maltoside 
(DDM), n-octyl--D-gluco-pyranoside (b-OG), and lauryldimethylamine-oxide (LDAO). 
Solubilisation is a demanding step since the correct folding and, consequently, the 
preservation of the protein function depends on it. Finally, the desired protein needs to 
be separated from other MPs present in the solution. For this purpose, chromatographic 
techniques are employed to selectively bind the protein of interest. The most common 
protocol is based on Immobilized Metal Affinity Chromatography (IMAC) and uses 
recombinant ion channels containing His-tag at the C- or N- terminal, which complex 
with transition metals (Zn 2+, Cu2+, Ni2+). Consequently, the protein of interest can be 
efficiently separated and just eluted when a histidine analogue (e.g. imidazole) is added 
to the column. 
The proteins that are currently attracting considerable interest due to their functions 
and easy overproduction are: 
 Water channel MPs, known as aquaporins (Aq), are very attractive because of 
their high water transport rate and selectivity that can be used for water 
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purification and desalination. The structure of Aq monomers consists in six 
transmembrane helices and two short helical segments (Figure 3.1a), which 
surround the cytoplasmic and extracellular regions, connected by a narrow 
aqueous pore.24 When located in the lipid membranes, Aq monomers associate 
into tetramers, each monomer functioning independently. Nevertheless, a few 
unsolved questions still remain: is the protein capable to withstand certain 
conditions (e.g. high salinity pressure)? and how can be increased the size of the 
membranes without any rupturing? In the last five-six years, this field of study 
has increased considerably.25-33 
 -hemolysin (-HL), a protein found in the human pathogen Staphylococcus 
aureus bacterium, acts as a toxin and is used since a long time for translocation of 
single stranded DNA.34,35 This porin is very stable and its functionality prevails at 
temperatures close to 100 ºC.36 Because the interior diameter is similar to the 
diameter of a single nucleic acid strand, the current of ions through the nanopore 
is partially blocked when the translocation occurs (Figure 3.1b). More 
specifically, as each nucleotide produces a different reduction in the ionic 
current,37 the incorporation of -HL to artificial polymer membranes could be 
employed to detect DNA sequences through this signal.38  
 Gramicidin (gA), a hydrophobic pentadecapeptide with a length of 22 Å (Figure 
3.1c),39-41 organizes in an ion channel that is specific for monovalent cations. This 
biomolecule has been extensively used as model to study the organization and 
function of channels-containing membranes.41 
 Outer membrane proteins (OMPs) are typically employed for the fabrication of 
hybrid biomimetic membranes. The outer membrane is a protecting barrier of 
gram-negative bacteria. Unlike the MPs located at other systems, the structure of 
OMPs does not contain -helices but instead anti-parallel -barrels (Figure 
3.1d).42 OMPs allow the unspecific passive diffusion of ions and molecules across 
the membrane. The driving-force is the concentration gradient, whereas the 
limitation lies on the molecular size since the diffused specie needs to be smaller 





Figure 3.1 (a) Membrane topography of the Aq monomer (left) and crystal structure (side 
view, left; top view, right) with four water molcules (red balls) shown in aqueous pore region. 
Helices are labelled H1–H8. Reproduced with permission from reference24. (b) Strand-
sequencing using ionic current blockage. A typical trace of the ionic current amplitude (left) 
through an -HL pore clearly differentiates between an open pore (top right) and one blocked 
by a strand of DNA (bottom right) but cannot distinguish between the ~12 nucleotides that 
simultaneously block the narrow transmembrane channel domain (red bracket). Reproduced 
with permission from reference34. (c) Top view of the gA channel as a space-filling model (color 
code: white, carbon atoms; blue, nitrogen atoms; red, oxygen atoms) using coordinates from 
PDB 1MAG. Note how the alternating L–D arrangement allows all amino acid side chains to 
project outward from the channel lumen and the channel lumen is lined by the peptide 
backbone. (d) Axial and equatorial views of crystallized OmpF, a representative MP. 
Reproduced with permission from reference82. 
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3.4 Incorporation onto polymeric substrates 
Within the field of biomimetic membranes there is a wide range of strategies and 
materials studied until now. The modification of artificial membranes with functional 
molecules within their pores or onto their surfaces, as well as the preparation of artificial 
channels embedded into block copolymers or lipid bilayers, have already been 
extensively reviewed by other researches.10 Here, we focus on the group that involves the 
complete incorporation of proteins into hybrid polymeric systems. Thus, our main 
objective is to illustrate the synthetic processes and the materials used for the 
development of biomimetic hybrid membranes. Table 3.1 summarizes the different 
approaches employed until now that, from the perspective of the employed materials, has 
been categorized as those based on the utilization of amphiphilic copolymers and 
nanostructured polymers and Table 3.2 points out the advantages and disadvantages of 
each system. 
 
3.4.1 Amphiphilic copolymers 
This is the most extensive kind of material employed for manufacturing biomimetic 
hybrid membranes. Amphiphilic block copolymers can act as artificial building blocks for 
the generation of membranes capable of incorporating proteins, as do the lipid bilayers. 
However, the former present other important advantages, such as long-term mechanical 
stability, tailorable structural parameters and versatile chemical functionality. In dilute 
aqueous solution, they self-assemble by hydrophobic driving forces, forming different of 
morphologies, such as spheres, cylinders or lamellas.43 Amphiphilic copolymers are 
mostly prepared as diblock copolymers with one hydrophobic and one hydrophilic block 
or as triblock copolymers with two hydrophilic blocks separated by one hydrophobic, the 
latter being usually named ABA block copolymers. Despite membranes made of 
amphiphilic copolymers present high mechanical and chemical stability, low water and 
gas permeability, and customizable properties (e.g. a wide range of membrane 




dynamics/fluidity of the bilayer, higher thickness, and lower flexibility. Overall, 
amphiphilic copolymers hold great potential over lipids as building blocks.38,44-48  
A large variety of amphiphilic copolymers have been designed using different 
monomers and applying diverse synthetic techniques,48 such as anionic49 and cationic 
polymerizations,50 controlled radical polymerization,51,52 ring-opening polymerization,53 
and “click” chemistry.54,55 Furthermore, advanced individual properties can be added to 
the building blocks, as for example the regulation of hydrophilicity and hydrophobicity of 
the blocks, block lengths and length ratios, the functionalization of polymer block,56 the 
addition of stimuli-responsive polymer blocks,57,58 and the use of biodegradable 
polymers.59 Two of the most interesting modifications reported in the literature are 
based on the addition of: (i) methacrylate units to stabilize the membrane by cross-
linking;60 and (ii) dyes for imaging.61  
In order to mimic cell membranes, block copolymers can be used without any support 
(free-standing or self-supported), spread and non-covalently or covalently tethered onto 
solid supports, spread onto porous solid supports, and bounded as polymer vesicles onto 
a 2D surface. 
 
Free-standing block copolymers 
One of the most straightforward methodologies to study the transport across a 
membrane is having it as separator of two media and to investigate the exchange of 
solutes and ions concentrations between them. The experimental set-up required for 
such studies typically includes free-standing membranes. Although a huge amount of 
studies have been reported, these are mainly based on free-standing lipid bilayers while 
only a few of them involve block copolymer. This has been attributed to their lower 
lateral tension, which could lead to a rapid membrane rupture.62 In an early study, 
artificial and stable giant free-standing monomolecular films of functionalized poly(2-
methyloxazoline)-block-poly(dimethylsiloxane)-block-poly(2-methyloxazoline) triblock 
copolymer, named PMOXA−PDMS−PMOXA, were prepared for the first time.46 These 
copolymer films, which exhibited areas of up to about 1 mm2 and thickness of 10 nm, 
were post-polymerized by UV light using the methacrylate groups found at both chain 
ends. The reconstitution of a porin in the preformed layer was achieved by adding a 
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certain amount of the protein to each side of the chamber and, in particular, the 
incorporation was favoured by applying a potential of 20 mV across the membrane. 
Despite the high thickness of the polymer membrane compared to lipid ones, the protein 
was successfully incorporated, leading to an enhancement of the conductance across the 
layer.63  
More recently, Wong et al.64 used PMOXA−PDMS−PMOXA copolymers to compare 
the voltage gating ability and threshold voltages of OmpG and alamethicin embedded in 
lipid bilayers and polymer membranes, which were used to separate two solutions. The 
molecular properties of the protein (i.e. conductance, voltage gating and mobility) were 
similar for polymer- and lipid-based systems.64 Ho et al.65 studied the effect of the length 
of PMOXA−PDMS−PMOXA on protein insertion at the air/water interface. Wilhelmy 
surface pressure measurements (mN/m) revealed greater OmpF insertion for shorter 
copolymer chains, which was attributed to their enhanced biomimicry of natural lipid-
based membranes.65  
 
Block copolymers immobilized onto solid supports 
Obviously, the use of solid supports for membrane immobilization provides 
mechanical stability at the air/water interface and even in the dry state  monolayers and 
or free-standing membranes.66 The easiest procedure to obtain synthetic solid-supported 
membranes is the fusion and spreading of polymersomes onto the support (i.e. gold or 
glass surfaces). In order to attain stronger fixation on the solid support, surface-initiated 
radical polymerization procedures can be also used.67 
Dorn et al.68 formed polymersomes with poly(butadiene)-b-poly(ethylene oxide), PB-
PEO, which were subsequently spread into glass and gold substrates. For the chemical 
immobilization onto the gold surface, PB-PEO was functionalized with sulfur-containing 
lipoic acid (LA), which binds properly to the gold surface (Figure 3.2a). Covalently 
bound layers were further incubated with polymyxin B, a peptide able to disrupt lipid 
membranes.69 The, resistance of the membranes without and with the peptide, as 
determined by electrochemical impedance spectroscopy (EIS), was 4.4 and 1.2 MΩ·cm2, 
respectively, evidencing that the peptide was successfully embedded. Nevertheless, after 




In comparison to the previous example, Zhang et al. 38 combined two methodologies 
to obtain a defect-free layer onto a gold substrate. More specifically, Langmuir-Blodgett 
(LB) and Langmuir-Schaefer (LS) deposition techniques were applied using different 
terminated polymers: LA functionalized linear PB-PEO (PB-PEO-LA) and hydroxyl-
functionalized linear PB-PEO (PB-PEO-OH), respectively (Figure 3.2b). Both 
techniques enabled a strict control of the layer density by regulating the surface pressure 
of the molecular assembly. Moreover, combination of both methods led to the 
achievement of large-area, homogeneous, defect-free layers, which were closer to cell 
membranes. Again, the protein was added after the layer formation and was monitored 
by measuring the conductance through the PB-PEO layer before and after the addition of 
-haemolysin (HL), at a voltage of 40 mV. A significant increase in conductance was 
observed after 20 min of the protein addition.  
The same two-step methodology was employed by Kowal et al.70 to generate defect-
free layers on solid supports. In this case the PDMS-b-PMOXA di-block copolymer with 
Figure 3.2 LA-functionalized PB-PEO vesicles spread onto a bare gold surface. Reproduced 
with permission from reference68. (b) PB-PEO-OH and PB-PEO-LA were transferred onto gold 
substrates by applying consecutively the LB and LS techniques to form a polymer tethered 
bilayer (left), where the protein was inserted (right). 
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aldehyde ending groups was used to promote the covalent attachment of the polymer 
membrane through formation of an imine bond with an amino modified gold substrate. 
More specifically, such authors studied the effectiveness of bio-beads (BB) (i.e. non-polar 
polystyrene adsorbent material) as facilitators of protein incorporation (Figure 3.3a). 
Changes in the conductance of gold substrates were recorded to examine the effects 
associated with the attachment of the polymer layer and the incorporation of protein and 
bio-beads. Results showed an increase in the substrate conductance when the protein 
was incubated with BB, whereas no significant increase was found when the protein was 
incubated without BB, demonstrating that the latter are necessary to incorporate the 
protein (Figure 3.3b). Thus, bio-beads act as driving force for the insertion of MPs into 
polymer membranes attached to solid substrates. 
 
Figure 3.3 (a) Representation of MP insertion when using BB into solid-supported polymer 
membrane. (b) Conductance measured when a voltage of 40 mV is applied on bare Au, the 
bilayer, the bilayer with the protein incorporated using Bio-Beads (bilayer+MloK1+BB), the 
bilayer with the protein (bilayer+MloK1), and the bilayer with the Bio-Beads (bilayer+BB). 





Block copolymers suspended onto porous solid supports 
Due to the low stability and difficulty of handling of free-standing copolymer 
membranes and to the limitations presented by solid supported layers, the field evolved 
towards copolymer films suspended onto porous solid membranes. In this approach, 
some zones of the membrane are still free-standing, allowing molecular diffusion without 
any disturbance.  
In a pioneering study, Gonzalez-Pérez et al.71 obtained stable triblock copolymer 
membranes using scaffolds containing 64 apertures of 300 m diameter each. The 
membranes showed high stability, which was evidenced by a long life-time when high 
polymer concentrations were used (i.e. it was stable several days). In order to incorporate 
ion channels, GA was reconstituted on these membranes and assembled into dimeric 
channels.  
More recently, Wang et al.25 presented a new strategy to produce planar pore-
spanning biomimetic membranes using proteopolymersomes made of 
PMOXA−PDMS−PMOXA and Aquaporin Z (AqpZ) (Figure 3.4a). Poly(carbonate) 
Figure 3.4 Schematic illustration of pore-spanning membrane on the PCTE: design and 
synthesis. (a) Incorporation of AqpZ in PMOXA−PDMS−PMOXA (ABA copolymer) vesicles. (b) 
Surface modification of the PCTE membrane support in a two-step process: (i) coating with a 
monolayer of cysteamine through chemisorption; and (ii) the primary amine are converted to 
acrylate residues via conjugating with acrylic acid. (c) Pressure-assisted vesicle adsorption on 
the PCTE support. (d) Covalent-conjugation-driven vesicle rupture and pore-spanning 
membrane formation. Reproduced with permission from reference 25. 
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tracked-etched (PCTE) membranes with average pore sizes of 50, 100 or 400 nm were 
modified with a thin gold layer (60 nm thickness). Then, cysteamine was deposited 
through chemisorption over the gold surface and the amine residues were transformed 
into acrylate residues via conjugation of acrylic acid (Figure 3.4b). 
Proteopolymersomes were spanned over the surface (Figure 3.4c) and by covalent-
conjugation-driven the vesicle ruptre occurred (Figure 3.4d). Although all the 
substrates were covered by adapting the pressure to the pore size, membranes with 50 
nm pores had much fewer defects compared to the supports with bigger pores.  
Duong et al.30 spanned polymersomes over porous alumina substrates of different 
pore diameters, 55 and 100 nm, covered with gold. Substrates with pores of 100 nm 
resulted uncovered by the membrane film because the spacing was too large, which 
supported the findings of Wang et al.25 However, authors successfully deposited AqpZ-
containing proteopolymersomes onto the alumina with pores of 55 nm, preserving the 
natural functionality of the protein (Figure 3.5).  
 
Figure 3.5 Field-emission scanning electron microscopy (a-c) and atomic force microscopy 
images (d-f) of the gold coated alumina substrate (a and d), the substrate covered with the 
polymer membrane (b and e), and the substrate covered with the AqpZ-incorporated polymer 





Following this approach but using new materials, planar biomimetic membranes 
consisting of AqpZ embedded into PMOXA−PDMS−PMOXA layers were fabricated upon 
a cellulose acetate (CA) substrate functionalized with methacrylate end groups.72 
Proteopolymersomes were spanned over the CA surface and photocross-linked using UV 
radiation. The resulting bioinspired device consisted on a selective layer upon the 
substrate for nano-filtration (Figure 3.6). Although this technique presents advantages 
over the previous ones, it still shows many limitations, such as poor area coverage, 
membrane defects and difficult scalability to support industrial applications. A similar 
but at the same time different strategy consists on non-proteopolymersomes disruption 
but deposition onto porous substrate. Hence, solutes need to cross the whole vesicle and 
then go through the substrate pore.   
Wang et al.32 constructed a new design based on a PCTE membrane (pore size 50 nm, 
porosity 20%) coated with a 50 nm gold layer by vapour deposition. Then, UV cross-
linked vesicles were dropped onto the PCTE surface under vacuum. This allowed exerting 
certain pressure, facilitating the intrusion of the vesicles. The bare gold surface, which 
was not occupied with protein containing polymersomes, was further functionalized with 
Figure 3.6 Field-emission scanning electron microscopy of (a) CA, (b) silanized CA, and (c) 
AqpZ-containing PMOXA−PDMS−PMOXA triblock copolymer. Reproduced with permission 
from reference 72. 
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a self-assembled monolayer of cysteamine. Later on, vesicles were immobilized on the 
membrane through an optimized layer-by-layer polydopamine (PDA)–histidine (His) 
coating process (Figure 3.7).  
A similar methodology but using CA with an average pore size of approximately 25 
nm as solid support was reported by Xie et al.33 The UV-crosslinked Aqpz-polymer 
vesicles were covalently immobilized onto the CA membrane through an amidation 
Figure 3.7 Schemes of AqpZ-embedded vesicular membrane at the top: (a) AqpZ 
reconstitution into the vesicles formed from ABA block copolymer blends. DDM stands for 
dodecyl-b-D-maltoside, a detergent for protein stabilization; (b) Immobilization of the vesicles 
onto the substrate by pressure; (c) addition of the self-assembled monolayer of cysteamine; and 
(d) PDA-His coating on the top of the membrane. (e-h) Field-emission scanning electron 
microscopy micrographs at the bottom: (e) gold-coated PCTE membrane with a self-assembled 
monolayer of cysteamine (pore size 50 nm); (f) PCTE membrane with 3-cycle coating of PDA–
His on the top of chemisorbed cysteamine (control); and (g) vesicles immobilized on the PCTE 
membrane with 3-cycle coating of PDA–His on top. The micrograph displayed in (h) 





reaction between the amino groups on the CA membrane surface and the carboxyl 
groups on the vesicle surface. Finally, a dense hydrophobic polymer layer was generated 
by in situ “surface imprinting” polymerization (Figure 3.8). This innovative membrane, 
which presented pores smaller than perforated PCTE,32 exhibited good and controlled 
selectivity together with high mechanical strength and stability during the nanofiltration.  
 
Proteopolymersomes covalently bounded to a solid support 
The last methodology reviewed in this section is the covalent attachment of 
proteopolymersomes onto a solid surface, which has also been previously employed for 
lipids.73 In order to obtain nanoreactors that could carry out conversions at a precise 
location for the sensors development, Grzelakowski et al. 61 applied this approach using  
block copolymers. For this purpose, an acid phosphatase was encapsulated and the 
intrusion of the substrate inside the vesicle was provided by the reconstitution of OmpF 
onto the polymersome membrane. The resulting proteopolymersomes were immobilized 
into the substrate (i.e. glass) by employing the receptor–ligand pair, biotin– 
streptavidin.73 The de-phosphorylation of the fluorogenic substrate ELFTM 97 by acid 
phosphatase was monitored. It was observed that the reaction did not occur when OmpF 
Figure 3.8 (1) Aqpz-polymer vesicles, (2) porous CA membrane substrate, (3) Aqpz vesicles 
immobilized on the porous membrane, (4) Aqpz-vesicle-imprinted membrane, and (5) cross-
section of the Aqpz-vesicle-imprinted membrane (a). (b-g) Field-emission scanning electron 
microscopy micrographs displayed the membrane morphologies: (b, c) top surface and cross-
section of the porous substrate CA membrane; (d, e) non-vesicle-imprinted membrane; and (f, 
g) Aqpz-vesicle-imprinted membrane. Adapted with permission from reference 33. 
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was not reconstituted, confirming the importance of the protein for the diffusion of 
certain molecules across the membrane.   
More recently, Zhang et al.75 developed “active surfaces” for selective biosensing of 
sugar alcohols with time and space precision (Figure 3.9). This bioactive platform was 
based on the immobilization of nanoreactors with specific MPs inserted in their 
membranes and sugar alcohol sensitive enzymes encapsulated in their cavities. 
Interestingly, the artificial surrounding within such a copolymer membrane and the high 
membrane thickness did not affect the functionality of the reconstituted glycerol 
facilitator (GlpF), which allowed the selective flux of sugar alcohols into the inner cavity 
of the polymer nanoreactors where the encapsulated enzymes acted as biosensing 
entities. An advantage of encapsulating the enzymes inside polymersomes was their 
protection from a potentially harmful environment, while retaining their catalytic 
activity. Thus, this smart approach prolonged the life-time of the enzymatic biosensor. 
The selective permeability of such interesting protein-polymer nanoreactors offers the 
opportunity of monitoring the concentration of biologically relevant sugar alcohols since 
GlpF is able to conduct other sugar alcohols. 
 
Figure 3.9 (a) GlpF molecular representation (green) together with ribitol, as a model sugar 
alcohol (red). Side (right) and front (left) views are represented. (b) Schematic representation of 
a functionalized surface serving as a sugar alcohol biosensor based on immobilized 
proteopolymersome nanoreactors with selective transport due to the GlpF presence and 






3.4.2 Nanostructured polymers 
Researchers have focused on amphiphilic polymers for mimicking biological 
membranes. However, an inconvenient of amphiphilic polymer membranes is that, 
although the system turns out to be more stable than biological membranes, it is not 
strong enough to endure many practical applications.76 In this section we discuss the use 
of confined biological ion channels prepared by incorporating proteins into pores of 
nanostructured polymers. A common methodology to control the pore size is the track-
etch technique.77 More specifically, polymer membranes are perforated when heavy ions 
go through the film and create damage zones on the latent track. Then, these can be 
converted into a pore by employing the right solution. The size and shape of the pore are 
regulated by varying the chemical etching conditions (e.g. time, temperature and solution 
concentration).  
Balme et al.76,78 developed hybrid nanoporous membranes handling commercial 
track-etched PC films of 5 m thickness covered with poly(vinylpyrrolidone) (PVP). The 
resulting nanopores, which exhibited a diameter of 15 nm, were filled with gA. Protein 
confinement was facilitated by the hydrophobicity of the inner parts of the membrane. 
Later on, the ion flux passing through the resulting hybrid membrane was evaluated by 
placing it between two compartments filled with a given electrolyte and pure water, 
respectively. Although results about the selectivity of the protein were unclear, ion 
diffusion was significantly higher when the protein was loaded inside the nanopores of 
the membrane.  
The effect of the pore size was studied in a more complex system in which 
nanostructured polymer membranes were obtained by track etching 
poly(ethyleneterephthalate) (PET) films. This was followed by the deposition of a 
multilayer of aluminium oxide/zinc oxide to decrease the initial diameter of the pores 
from 36 nm to 10.6, 5.7 and 2 nm on demand (Figure 3.10).79 Results evidenced that 
the relative contribution of the ion transport through gA increases with decreasing pore 
diameter. However, this effect was accompanied by a loss of specificity due to the 
disassembling of the head-head dimer structure. 
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Within this context, an interesting OMP, named Omp2a,80-82 was embedded in a 
supported poly(N-methylpyrrole) (PNMPy) membrane.83 Figure 3.11a illustrates how 
the incorporation of the protein caused significant changes in the surface morphology of 
PNMPy. Thus, scanning electron microscopy (SEM) micrographs of PNMPy−Omp2a 
present elements of both submicrometric and micrometric dimensions with a very 
homogeneous and smooth texture, whereas the nodular outcrops typically found in 
PNMPy films (Figure 3.11b) are not detected. These features, which reflected the 
presence of the protein, were correlated with EIS measurements. It was observed that 
Omp2a promotes preferentially the passive transport of K+ with respect to Na+ in 
solutions with relatively high ionic concentrations. Nevertheless, such system had the 
inconvenience that the PNMPy membrane was electrochemically synthesized onto a solid 
working electrode (i.e. stainless steel), which represented a disadvantage for possible 
future applications.  
More recently, instead of using conducting polymers as support for the protein, 
nanoperforated biodegradable poly(lactic acid) (PLA) nanomembranes were used.85 
These membranes, which were self-standing, were prepared by spin-coating a mixture of 
poly(vinyl alcohol) (PVA) and PLA, which are immiscible polymers.84 Nanoperforations 
with diameter of 5122 nm resulted from the combination of nanophase segregation 
processes and selective solvent etching (Figure 3.11c).85 
Figure 3.10 Procedure scheme for the fabrication of nanoperforated membranes, the 
modification of nanopore size by atomic layer deposition (ALD), the creation of hydrophobic 
pore surfaces by vapour exposure treatment with hexamethyldisilazane (HMDS), and the 





Figure 3.11 Surface morphology of (a) PNMPy−Omp2a, (b) PNMPy and (c) nanoperforated 
PLA membranes: low- and high-magnification SEM micrographs are displayed at the left and 
the right, respectively. Adapted with permission from references 83 and 85. (d) 3D AFM phase 
images of the skin surfaces of nanoperforated PLA nanomembranes before (left) and after 
(right) incubation with a 0.5 mg/mL Omp2a solution. Adapted with permission from 
reference85. 
 
 In order to confine the protein into the nanopores, these membranes were incubated 
in protein solutions and, subsequently, washed many times. Contrast 3D AFM height 
images painted with phase skin surfaces of samples before and after incubation 
confirmed the presence of adsorbed oval protein aggregates around and inside the 
nanopores (Figure 3.11d). Specifically, phase channel allowed to differentiate Omp2a 
domains (i.e. dark purple aggregates with an average diameter 27 ± 5 nm) from the PLA 
substrate (coloured in green) where they are adsorbed onto. Moreover, EIS assays 
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showed an increase of conductivity and selectivity against some ions when the protein 
was confined onto the nanopores.85  
The thermomechanical properties of this OMP had also been characterized by 
immobilizing it on microcantilevers.86 It was found that heat promotes local orientation 
of the immobilized biomolecules. Thus, appropriate thermal treatments could be 
employed to enhance the selective ion transport of the substrate since more proteins 
would be correctly oriented with the required thermal treatment. More interestingly, its 
functionality onto lipid bilayers, which represents an environment closer to the one on its 
biological conditions, had also been characterized.87 The resistance of 40 w/w lipid-to-
protein ratio supported lipid bilayers (1.5 kΩ cm2) was found to be similar to that of 
nanoperforated Omp2a-filled PLA membranes85 (1.9 kΩ cm2) and higher than that of 
PPy-Omp2a83 (243 Ω cm2). As it was expected, the resistance of all systems decreased 
when the protein was incorporated, this effect being more pronounced for KCl 
electrolytic solutions. Besides, the resistance variation and the selective ion diffusion 




Table 3.1 Summary of the most important characteristics (i.e. preparation method, polymer, protein and activity) of biomimetic membranes made of 
polymers.  
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AqpZ Water purification 
Maximum water flux 16.4 ± 
1.5L m − 2 h − 1 (LMH) with a 
salt rejection of 98.8% 
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AqpZ Water purification 
Maximum water flux 34.19 
± 6.90 LMH/bar with a 200 
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ppm NaCl salt rejection of 
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Table 3.2 Summary of the advantages and disadvantages encountered during the preparation and application of the different type of biomimetic 
membranes made of polymers 


























Free standing No influence of the substrate. Direct measure. Low stability. No more than 1 mm2 in area. 
Difficult scalability to support industrial 
applications 
63-65 
Solid supported Increased stability. 
Easy to measure the influence of the protein if 
the substrate is a conductive material. 
Interactions with the substrate can induce the 
denaturation of the protein. Poor area coverage. 
Membrane defects. Difficult scalability to 






The protein is not in direct contact with the 
substrate. There is more than enough space for 
the solutes to cross the membrane. 
The porous substrate normally needs a pre-
treatment to facilitate proteopolymersome 
spanning. Poor area coverage. Membrane 







Easier to cover all the perforations. The protein 
is not in direct contact with the substrate. The 
final material is more selective and sensible 
since the electrolyte needs to cross two times 
the membrane. 





to the surface 
The proteopolymersomes are covalently linked 
to the substrate, providing stability. 
Indirect measurement. Need to encapsulate 































The scalability is higher. There are commercial 
membranes that can be used. The stability is 
higher and can be employed for actual 
applications. 
Fine tune on the pore size realized on the 
membrane is needed. Difficult to control the 





The polymerization can take place at the same 
time that the protein is embedded applying low 
voltages. 
Influence of the polymer on the electrical 
measurements. High roughness and thickness 
which difficult the protein localization on the 
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3.5 Conclusions and outlook 
Biolgical membranes are complex systems with many molecules playing crucial 
interactions, which allow the communication between different compartments or directly 
permit cell-cell contacts. The study of these events is complicated and, therefore, 
artificial model membranes play an important role for unravelling the chemical and 
physical characteristics of the embedded proteins together with their functionality.  
In early studies, phospholipid bilayers deposited onto solid substrates (so-called 
solid-supported membranes) were commonly used as experimental cell-surface models 
to gain insight into immune reactions and cell adhesion.88-95 Eventually, mimicking 
properties of biological elements to prepare functional hybrid materials based on 
polymers started to be an attractive alternative to the use of lipid bilayers. Polymer 
membranes in a variety of conditions (i.e. free standing films, solid-supported 
membranes, membranes spanned over porous supports, and proteopolymersomes 
embedded onto porous substrates) were used to insert membrane proteins not only for 
understanding their biofunctionality in synthetic templates but also for developing active 
surfaces for translational applications, such as water purification, molecules biosensing, 
DNA sequencing, and ion transport. 
Within this context, block copolymers have been frequently used to prepare the 
bilayers supported on a material surface. Such block copolymer-based supramolecular 
assemblies exhibit many interesting properties, as for example stability, robustness and 
tunability.  However, many of the proteins employed for basic biophysical studies or for 
sensor applications are known to protrude from the bilayer. These protruded parts may 
form strong interactions with the substrate, leading to a partial loss of functionality or 
even to a complete denaturation.96 For that reason, different attempts have been done to 
maintain the distance between the substrate and the proteins, such as the use of 
nanoperforations to suspended bilayers, the addition of polymer cushions, or the study of 
proteopolymersomes covalently linked to a solid support.   
The approach based on the confinement of the protein on nanostructured polymers is 
particularly interesting. Polymeric membranes with nanopores and nanoperforation can 




for practical use. However, huge challenges still lie ahead both in terms of “on demand” 
inducing properties whilst the architecture of the membrane is preserved and of multi-
functionality, which can be reached by inserting different MPs or by inserting the MPs at 
specific locations.  
It is worth to mention that in terms of applicability, it is difficult to scale-up the 
production of these membranes because above all the production and folding of ion-
channels is time consuming and expensive. However, over more than three decades the 
production of synthetic ion channels has been growing. Nowadays, there are many 
approaches based on chemical synthesis and supramolecular assembly to biomimick 
macromolecules.97,98 For example, chloride selective channels had been prepared via 
directional assembly of electron-deficient iodine atoms, which create a transmembrane 
pathway for facilitating anion transport,99 potassium ion channels by means of aromatic 
stacking of helical oligomers,100 or even artificial channels sensible to an external 
stimuli.101 
Overall, the integration of biological and synthetic materials is still a promising area 
of research that awaits further developments. There are many different proteins with 
useful and accurate functions that upon incorporation on stable polymer membranes 
could proportionate many unique and beneficial applications.  
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CHAPTER 4:  
Characterization of Omp2a 
   
 





Omp2a β-barrel outer membrane protein has been reconstituted into supported lipid bilayers 
(SLBs) to compare the nanomechanical properties (elastic modulus, adhesion forces, and 
deformation) and functionality of the resulting bioinspired system with those of polymeric 
nanomembranes (NMs). Protein reconstitution into lipid bilayers has been performed using 
different strategies, the most successful one consisting of a detergent-mediated process into 
preformed liposomes. The elastic modulus obtained for the lipid bilayer and Omp2a are ∼19 and 
10.5 ± 1.7 MPa, respectively. Accordingly, the protein is softer than the lipid bilayer, whereas the 
latter exhibits less mechanical strength than polymeric NMs.  
Besides, the thermomechanical response of Omp2a has been characterized using 
microcantilever technology and compared with standard proteins. For this purpose, thermally 
induced transitions involving the conversion of stable trimers to bigger aggregates, local 
reorganizations based on the strengthening or weakening of intermolecular interactions, and 
protein denaturation have been detected by the microcantilever resonance frequency and deflection 
as a function of the temperature. Measurements have been carried out on arrays of 8-
microcantilevers functionalized with proteins (Omp2a, lysozyme and bovine serum albumin). 
Results not only demonstrate the complex behavior of porins, which exhibit multiple local thermal 
transitions before undergoing denaturation at temperatures higher than 105 °C, but also suggest a 
posttreatment to control the orientation of immobilized Omp2a molecules in functionalized 
biomimetic nanomembranes and, thus, increase their efficacy in ion transport. 
 
Publications derived from this work: 
Puiggalí-jou, A.; Pawlowski, J.; del Valle, L. J.; Perpète, E. A.; Sek, S. and Alemán, C. Properties of 
Omp2a-based supported lipid bilayers: comparison with polymeric bioinspired membranes. ACS 
Omega 2018, 3, 9003-9019. 
 
Lopes-Rodrigues*, M.; Puiggalí-Jou, A.*; Martí-Balleste, D.; del Valle, L. J.; Michaux, C.; Perpète, E. 
A. And Alemán, C. Thermomechanical response of a representative porin for biomimetics. ACS 
Omega 2018, 3, 7856-7867. 








Membrane proteins (MPs) play a key role in many biological processes, such as cell 
recognition, signal transmission, enzymatic reactions, and transport of metabolites.1-3 
Their importance is proved by the fact that 50% of medical drugs currently on the 
marked target MPs.2-4 The structure of MPs is restricted to -helix and -barrel due to 
the need to satisfy all hydrogen bonds within the water-excluded native bilayer 
environment. Although -helical MPs are present in most biological membranes, -
barrel MPs are exclusively found in the outer membranes of Gram-negative bacteria5 and 
eukaryotic organelles directly derived from prokaryotic ancestors namely, mitochondria6 
and chloroplasts.7 
Porins are -barrel outer membrane proteins (OMPs) that form water-filled open 
channels and allow the passive penetration of hydrophilic molecules. Due to their 
capacity in exchange of ions and small nutrients (i.e. typically < 667 Da) over the OM, 
porins have been used to fabricate smart biomimetic NMs that could incorporate 
biological functions, such as controlled ion transport.8 
 
4.2 Materials and methods 
Expression, purification and refolding of the Omp2a outer membrane 
protein from Brucella melitensis 
Bacterial strain and growth. Cells of E. coli BL21 (DE3) carrying pLysS and pET2a 
plasmids (containing the gene Omp2a without peptide signal) were grown in Lysogeny 
broth (LB) medium at 37°C with constant shaking. Log cultures (OD 0.6) of 500 mL were 
stimulated with IPTG (0.2 mg mL-1) for 3 h. Cells were then harvested by centrifugation 
at 4,000 g for 30 min, the resulting bacterial pellets being stored at -20°C.  
Overexpression and non-native purification of Omp2a. The bacterial pellets were thawed 
and treated with 8 mL of TEN lysis buffer (50 mM Tris–HCl pH 8, 1 mM EDTA, 17 mM 
NaCl, 125 mM PMSF, 250 mg mL-1 lysozyme) for 20 min at 25°C. Harvested cells were 
further broken by addition of 10 mg of sodium deoxycholate for 60 min at 37°C with 
constant shaking, and 2 mg of DNase I for 60 min at 25°C. The suspension was then 
CHAPTER 4  
64 
 
centrifuged at 14,000 g for 20 min at 4°C. The resulting pellet underwent a washing 
buffer (2 M urea, 20 mM Tris–HCl pH 8, 500 mM NaCl, 2% Triton X-100) and 
centrifuged at 14,000 g for 20 min at 4°C. The inclusion bodies were solubilized with 8 
mL of TEN buffer (50 mM Tris–HCl pH 8, 1 mM EDTA, 17 mM NaCl, 8 M urea). Then, 
the solubilized proteins were applied onto an anion-exchange DEAE column previously 
equilibrated with 25 mL of buffer (50 mM Tris–HCl pH 8, 17 mM NaCl, 8 M urea). 
Omp2a was eluted with a 50 mL linear gradient of NaCl from 17 to 500 mM, whereas the 
protein profile was further analyzed using sodium dodecyl sulfate-polyacrylamide gel 
(SDS–PAGE). Fractions containing 39 kDa proteins were then pooled and stored at 4°C.  
Omp2a refolding in SDS – 2-Methyl-2,4-pentanediol (MPD) system. To refold Omp2a, 
the protein solution (1 mg/mL protein, 250 mM NaCl, 50 mM Tris–HCl pH 8, and 8 M 
urea) was eluted onto a PD-10 column to exchange the buffer (150 mM NaCl, 50 mM 
Tris–HCl pH 8, and 120 mM SDS, which is 15 times the critical micellar concentration). 
SDS-unfolded samples were then diluted 1:1 in a refolding solution (50 mM Tris–HCl pH 
8, 150 mM NaCl, 3 M MPD). The protein solution was then incubated at room 
temperature. The samples were stored at –20°C to stop the refolding reaction. Hereafter, 
Omp2a protein at this procedure stage is named as obtained Omp2a.  
Accepted sequence (triple letter code) of Omp2a protein (367 amino acids): 
Met - Asn - Ile - Lys - Ser - Leu - Leu - Leu - Gly - Ser - Ala - Ala - Ala - Leu - Val - Ala - 
Ala - Ser - Gly - Ala - Gln - Ala - Ala - Asp - Ala - Ile - Val - Ala - Pro - Glu - Pro - Glu - Ala 
- Val - Glu - Tyr - Val - Arg - Val - Cys - Asp - Ala - Tyr - Gly - Ala - Gly - Tyr - Phe - Tyr - 
Ile - Pro - Gly - Thr - Glu - Thr - Cys - Leu - Arg - Val - His - Gly - Tyr - Val - Arg - Tyr - 
Asp - Val - Lys - Gly - Gly - Asp - Asp - Val - Tyr - Ser - Gly - Thr - Asp - Arg - Asn - Gly - 
Trp - Asp - Lys - Gly - Ala - Arg - Phe - Ala - Leu - Met - Phe - Asn - Thr - Asn - Ser - Glu - 
Thr - Glu - Leu - Gly - Thr - Leu - Gly - Thr - Tyr - Thr - Gln - Leu - Arg - Phe - Asn - Tyr - 
Thr - Ser - Asn - Asn - Ser - Arg - His - Asp - Gly - Gln - Tyr - Gly - Asp - Phe - Ser - Asp - 
Asp - Arg - Asp - Val - Ala - Asp - Gly - Gly - Val - Ser - Thr - Gly - Thr - Asp - Leu - Gln - 
Phe - Ala - Tyr - Ile - Thr - Leu - Gly - Gly - Phe - Lys - Val - Gly - Ile - Asp - Glu - Ser - 
Glu - Phe - His - Thr - Phe - Thr - Gly - Tyr - Leu - Gly - Asp - Val - Ile - Asn - Asp - Asp - 
Val - Val - Ala - Ala - Gly - Ser - Tyr - Arg - Thr - Gly - Lys - Ile - Ala - Tyr - Thr - Phe - Thr 
- Gly - Gly - Asn - Gly - Phe - Ser - Ala - Val - Ile - Ala - Leu - Glu - Gln - Gly - Gly - Glu - 
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Asp - Val - Asp - Asn - Asp - Tyr - Thr - Ile - Asp - Gly - Tyr - Met - Pro - His - Val - Val - 
Gly - Gly - Leu - Lys - Tyr - Ala - Gly - Gly - Trp - Gly - Ser - Ile - Ala - Gly - Val - Val - Ala 
- Tyr - Asp - Ser - Val - Ile - Glu - Glu - Trp - Ala - Thr - Lys - Val - Arg - Gly - Asp - Val - 
Asn - Ile - Thr - Asp - Arg - Phe - Ser - Val - Trp - Leu - Gln - Gly - Ala - Tyr - Ser - Ser - 
Ala - Ala - Thr - Pro - Asn - Gln - Asn - Tyr - Gly - Gln - Trp - Gly - Gly - Asp - Trp - Ala - 
Val - Trp - Gly - Gly - Ala - Lys - Phe - Ile - Ala - Pro - Glu - Lys - Ala - Thr - Phe - Asn - 
Leu - Gln - Ala - Ala - His - Asp - Asp - Trp - Gly - Lys - Thr - Ala - Val - Thr - Ala - Asn - 
Val - Ala - Tyr - Gln - Leu - Val - Pro - Gly - Phe - Thr - Ile - Thr - Pro - Glu - Val - Ser - 
Tyr - Thr - Lys - Phe - Gly - Gly - Glu - Trp - Lys - Asp - Thr - Val - Ala - Glu - Asp - Asn - 
Ala - Trp - Gly - Gly - Ile - Val - Arg - Phe - Gln - Arg - Ser - Phe 
 
4.3 Properties of Omp2a-Based Supported Lipid Bilayers 
In this section we focused on the study of this protein in a more native ambient, 
similar to that encountered in nature. Amazingly, until now no effort has been made to 
study Omp2a in a SLB, which consists in a planar in vitro assembly of lipids sitting on a 
solid support. In such configuration, which is closer to the natural system than polymeric 
biomimetic NMs, the structure and properties of the protein have been probed using a 
variety of surface sensitive atomic force microscopy and electrochemical techniques. 
More specifically, mechanical mapping with PeakForce Quantitative Nanomechanical 
Mapping® (QNM) mode, which combines single molecule force spectroscopy with single 
molecule imaging, has provided information about molecular forces. Furthermore, the 
function of Omp2a in the SLB has been examined using electrochemical impedance 
spectroscopy (EIS), and the results have been compared with previous data obtained for 












Liposomes production: The procedure used to prepare liposomes is depicted in 
Figure 4.3.1. Initially, liposomes were generated by dissolving and mixing lipids in 4:1 
chloroform:methanol, which assured an homogeneous mixture (1). After this, the solvent 
was evaporated using argon stream and agitation to yield a thin lipid film (2). The film 
was thoroughly dried to remove residual organic solvent by placing the vial on a vacuum 
pump for 30 min. Then, film-rehydration was performed by adding the adequate buffer 
(3) and sonicated 30 min at 37º (4). Vesicles were stored at 4º C. Liposome solutions 
were diluted 1/5 and deposited over the mica substrate for analyses with the AFM (5). 
Formation of proteoliposomes from preformed liposomes: Shortly, liposomes 
were detergent-destabilized by titration with Triton X-100 and, subsequently, mixed with 
the detergent-solubilized Omp2a transmembrane protein. After this, controlled removal 
of the detergent by polystyrene beads, Bio-Beads (BB), resulted in the formation of 
sealed proteoliposomes. Then, the proteoliposomes were incubated onto the mica 
substrate in order to facilitate their spreading. 
 
Strategy of protein reconstitution by direct incorporation into SLBs: SLBs 
were first incubated 15 min at room temperature in the presence of the detergent (Triton 
X-100 at 0.01%) in order to destabilize the membrane.  After this, they were further 
incubated at the same temperature with detergent-solubilized proteins (10 or 2 µg/mL), 
Figure 4.3.1 Scheme of the liposome fabrication. 
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allowing them to be inserted into the membrane. The excess of detergent and proteins 
was removed by extensive washing with mQ water.  
 
SDS-polyacrylamide gel (SDS-PAGE): Proteoliposomes were pelleted by 
ultracentrifugation (15 min, 10,000 g) and the pellet was re-suspended in 25 µL of 
loading buffer. The protein in the supernatant and pellet (equal volumes) were 
subsequently subjected to glycine SDS–PAGE using 15% acrylamide gels and visualized 
with Comassie Blue.  
 
Dynamic light scattering (DLS): The size distribution of the protein in 1 phosphate 
buffer solution (PBS) pH 7.4 and in 50 mM Tris–HCl pH 8, 150 mM NaCl, 3 M MPD was 
determined using a NanoBrook Omni Zeta Potential Analyzer from Brookheaven 
Instruments Corporation. Particularly, three consecutive runs of 60 seconds each were 
conducted for every sample.  
 
Atomic force microscopy (AFM) measurements: Topography imaging of the 
samples was performed with 5500AFM (Keysight) operating in MAC mode. In this 
intermittent contact mode magnetically coated cantilevers are driven by an oscillating 
magnetic field. This enables elimination of spurious responses generated by cantilever 
holding mechanism or the surrounding fluid. For imaging, we have used MAC Levers VII 
with nominal spring constant of 0.14 N/m, but its exact value was determined for each 
individual tip from thermal tuning. Nanomechanical measurements were carried out 
with Dimension Icon (Bruker) instrument operating in Peak Force QNM mode, which 
enables simultaneous imaging of the topography and mapping of the nanomechanical 
properties of the sample. In this mode, Z-piezo is modulated at the frequency of 2 kHz 
with default peak force amplitude and during each cycle the force-distance curve is 
recorded for every pixel of the scanned area. Based on analysis of the retract curves, it is 
possible to determine the adhesion force (Fadh) and reduced modulus of elasticity (E*) 




𝐸∗√𝑅𝑑3 + 𝐹𝑎𝑑ℎ (Eq. 4.3.1) 
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where Ftip denotes force acting on AFM tip, d defines the distance between said tip and 
the sample surface and R is the tip radius. Modulus of elasticity (Es) for given sample can 
be estimated using equation: 










 (Eq. 4.3.2) 
where t  and s are Poisson’s ratios for the material of the tip and the sample 
respectively, while Et  denotes modulus of elasticity of the tip material. In order to 
calibrate the instrument, determination of modulus of elasticity was evaluated using 
poly(methylsiloxane) test sample (Bruker) with nominal value of modulus of elasticity 
equal 3.5 MPa. All images/maps were acquired in aqueous buffers. We have used Scan 
Asyst Fluid+ cantilevers (Bruker) with nominal spring constant of 0.7 N/m and the 
nominal tip radius of 5 nm. However, the exact value of spring constant for each 
cantilever was obtained from thermal tune method.  
 
Transmission electron microscopy (TEM): The liposomes and proteoliposomes 
were placed on carbon-coated grids and stained with 0.5% uranyl acetate and examined 
by electron microscopy. Solution containing Omp2a (0.34 mg/mL) was dispersed on 
glow-discharged carbon coated copper grids (300 mesh) and negatively stained with 
uranyl acetate (2.0 % w/v). After incubation (30 s), the excess of protein was removed 
with filter paper, and the grids air dried for a further 1-2 s. TEM images were obtained 
with a Philips TECNAI 10 electron microscope operating at 100 kV.  
 
Circular dichroism (CD): CD measurements were performed on a Chirascan-plus 
qCD spectrometer (Applied Photophysics, APL; UK) equipped with a temperature-
controlled cell, using a call path length 10 mm. Spectra were recorded between 180 and 
260 nm. Machine settings were as follows: 1 nm bandwidth, 1 s response, 0.5 nm data 
pitch, 100 nm/min scan speed and cell length of 0.1 cm. All CD spectra presented in this 
work correspond to the average from three independent measurements. 
 
Square-wave voltammetry (SWV): SWV experiments were carried out using glassy 
carbon electrodes (GCE) (2 mm diameter) as anodes. Before conducting any experiment, 
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the GCE was mechanically polished with powder of alumina to produce a mirror-like 
surface. The electrodes were subsequently sonicated to remove adhered alumina 
particles, rinsed with water, and left to dry. Finally, 5 µL of the corresponding sample 
were deposited on the top of the surface 
Electrochemical characterization was carried with an Autolab PGSTAT302N. 
Experiments were conducted in a PBS 0.1 M (pH = 7.4) at room temperature. The initial 
and final potential were 0 V and + 1 V. SWV amplitude: 25 mV, frequency: 20. 
 
EIS: EIS measurements were performed using a conventional three-electrode cell and an 
AUTOLAB-302N potentiostat/galvanostat operating between the frequency range of 
104.5 Hz and 10-2 Hz and 5 mV of amplitude for the sinusoidal voltage. All experiments 
were performed at room temperature with lipid bilayers deposited onto ITO and using 
100 mM KCl. ITO was used as working-electrode and platinum as counter-electrode, 
whereas Ag|AgCl saturated (KCl 3M) was employed as reference electrode. After data 
collection, EIS results were processed and fitted to an electrical equivalent circuit (EEC). 
  







Figure 4.3.2 Scheme of the lipids chemical composition. 
4.3.2 Results and discussion 
Lipid formulations  
The total lipid composition in Brucella melitensis is about 37% of 
phosphatidylcholine (POPC), 33% of phosphatidylethanolamine (POPE), 20% of 
cardiolipine (CL) and 10% of phosphatidylglycerol (POPG).9 Though POPE is the main 
phospholipid in many Gram-negative OMs, POPC is the most present in the OM of 
Brucella melitensis. This particular feature gives to this strain of bacteria high stability in 
the OM in comparison with other Gram-negative bacteria, whereas the content of POPE 
in animal cell total lipid membranes is low. For example in the blood cells, POPE and 
POPG constitute about 6% and 2%, respectively, of all the membrane phospholipids.10 
Indeed, POPC is the major lipid component of the animal cell membranes.10 
Three different lipid compositions, which consisted on mixtures of POPC, POPE, 
POPG and/or CL (Figure 4.3.2), were investigated by AFM, TEM, DLS and Z-potential: 
Mixt-1 composed by 4:3 POPC:POPE; Mixt-2 by 4:3:1 POPC:POPE:POPG; and Mixt-3 by 
4:3:1:2 POPC:POPE:POPG:CL.  
Mixt-1 showed a clear phase separation of the two lipid domains constituted by PE 
and PC.  
Specifically, AFM images show that difference in height of the phases is  ̴ 0.8 nm 
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(Figure 4.3.3a) (the bilayer thickness reported for POPC and POPE is 4.33 and 4.03 
nm, respectively11). Instead, Mixt-2 displayed the most homogenous and flattest surface, 
these characteristics being expected to facilitate the rapid recognition of the protein. 
Consequently, Mixt-2 was selected for further studies with the porin. In this case, the 
thickness of the bilayer was 5.4 nm, which is significantly lower than the protein’s height 
(around 7 nm) (Figure 4.3.3b). Finally, Mixt-3 showed less phase separation than 
Mixt-1 but still the difference between the domains was also clear, with 1.3 nm height 
differences (Figure 4.3.3c). Furthermore, as the AFM tip was prone to go through the 
lipid membrane, consequently disrupting the acquiring image, very low forces were 
needed to achieve its visualization. This feature indicates that the consistency of the lipid 
bilayer is lower for Mixt-3 than for Mixt-1 and Mixt-2, suggesting that CL increases the 
fluidity of the lipid bilayer. This hypothesis is supported by the results reported by Unsay 
et al.12, who found that the fluidity of lipid bilayers increases and its mechanical stability 
decreases by enhancing the CL concentration. Thus, CL apparently decreases the packing 
of the lipid membrane.  
It should be mentioned that results derived from TEM can be limited by the drying of 
the samples, which may cause deformation, or even complete destruction of the sample. 
The deposition of the carbon layer used to support the sample in TEM analyses could 
also alter the scattering of electrons. However, it has been observed that many block 
copolymer based assemblies and synthetic lipid bilayers tend to be rigid and, therefore, 
retain their shape.13-15 TEM images displayed in Figure 4.3.3 show some small 
irregularities in the edges, suggesting that sizes may be slightly affected by the drying 
process.  
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Figure 4.3.3  Topographic AFM images with the corresponding vertical profiles and TEM 
images of SLBs obtained from liposomes composed of: (a) 4:3 POPC:POPE (Mixt-1); (b) 4:3:1 
POPC:POPE:POPG (Mixt-2); and (c) 4:3:1:2 POPC:POPE:POPG:CL (Mixt-3) diluted 1/5 in 1x 
PBS. (d) DLS graph expressing the intensity vs diameter and (d) the ζ -potential (e) of the mixt-
1, mixt-2, and mixt-3. 
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DLS measurements proved that the three mixtures led to several liposome sizes 
(Figure 4.3.3d), with diameters  1075, 555 and 213 nm for Mixt-1, Mixt-2 and Mixt-
3, respectively. Besides, the polydispersity in  varied from sample to sample: 0.38, 0.35 
and 0.19 for Mixt-1, Mixt-2 and Mixt-3, respectively. On the other hand, the Zeta-
potential () reported for pure POPC, POPE, and POPG phospholipids is −2.3±2.0, 
−32.4±3.4, and −56.0±2.2 mV, respectively.16 Interestingly, although POPC and POPE 
are structurally very similar zwitterionic phospholipids, they were found to exhibit 
dramatic differences in terms of accessible surface charge.16 The  values determined in 
neutral water for Mixt-1, Mixt-2 and Mixt-3 were -30±9, -60±9 and -61±8 mV, 
respectively (Figure 4.3.3e). Although POPC and POPE lipids are zwitterions (Figure 
4.3.2), Mixt-1 was found to exhibit a moderate negative surface charge at neutral pH. 
The incorporation of POPG and CL, which contain anionic polar heads (Figure 4.3.2), 
markedly increased the negative- of the liposomes. This behaviour has been attributed 
to the fact that negatively charged phosphate group is not counter-posed by any other 
positively charged group, as occurs in the other two tested lipids (i.e. POPC and POPE).17 
Figure 4.3.4 Shows topographic AFM images of SLB obtained from 4:3:1 
POPC:POPE:POPG liposomes incubated over mica overnight and diluted in 1 PBS at 
1/5, 1/10 and 1/20 ratios. The highest area covered by the lipid bilayer corresponds to the 
1/5 dilution, which was selected for further experiments. The breakthrough force of the 
lipid bilayer was 0.18 nN and the apparent height 3.4 nm (Figure 4.3.5). Clearly, the 
latter value is underestimated compared with equilibrium thickness of the film. This is 
related to the fact that in force spectroscopy experiment AFM tip is pushed against the 
sample surface leading to elastic deformation of the bilayer before breakthrough event. 
Hence the measured thickness corresponds to elastically deformed bilayer. 
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Insertion of Omp2a into lipid bilayers  
The protein was inserted into the lipid bilayer by employing two different methods: a) 
creation of proteoliposomes from detergent-mediated reconstitution of the protein into 
the preformed liposomes; and b) reconstitution directly incorporating the Omp2a 
protein into SLBs. The first methodology consists on the following four steps (Figure 
4.3.6): (1) Liposomes are detergent-destabilized by titration with Triton X-100, a non-
ionic surfactant; (2) Destabilized liposomes are mixed with the detergent-solubilized 
Omp2a; (3) Detergent is removed with BB, resulting in the formation of sealed 
proteoliposomes; and (4) SLB are formed by promoting the fusion of proteoliposomes 
onto hydrophilic mica substrate. The second approach only needed three steps (Figure 
4.3.6b): (1) Spreading of liposomes onto mica substrate; (2) Addition of Triton X-100 to 
destabilize the lipid bilayer; and (3) Protein insertion onto the membrane. Results 
obtained from each of such two approaches are described below. 
Figure 4.3.5 Force-distance curve-based AFM for SLB obtained from 4:3:1 PC:PE:PG 
liposomes incubated onto mica overnight and diluted in 1x PBS at 1/5 ratio. 
Figure 4.3.4 Topographic AFM images of SLB obtained from 4:3:1 PC:PE:PG liposomes 
incubated onto mica overnight and diluted in 1x PBS at (a) 1/5, (b) 1/10 and (c) 1/20 ratios. 
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Proteoliposomes from detergent-mediated reconstitution of the protein into liposomes 
In order to grasp the effect of protein reconstitution onto liposomes, the first 
mentioned method was studied at 40, 80 and 100 w/w lipid-to-protein ratios using 
earlier reported protocols.18-21 In general the diameter of the liposomes was slightly 
affected by protein reconstitution (Figure 4.3.7a), whereas  decreased progressively 
upon the incorporation of either protein or protein buffer into the liposome solution 
(Figure 4.3.7b). On the other hand, comparison of the CD spectra recorded for 
solutions with the free protein and the different lipid-to-proteins suggest that the protein 
structure undergoes some changes inside the lipid membrane (Figure 4.3.7c). 
However, in all cases the spectra contained the minimum and maximum ellipticity near 
220 and  ̴195 nm, respectively, indicating that the -strand rich motives are maintained 
within the proteoliposomes.22 Incubation of Omp2a with anionic unilamellar vesicles 
resulted in the co-sedimentation of a major portion of protein with liposomes after 
centrifugation, even though some protein was lost during the proteoliposomes 
purification step, as shown by SDS-PAGE (Figure 4.3.7d). The ratio of protein in the 
pellet/supernatant was 3, 8 and 4.4 for samples coming from 100, 80 and 40 w/w lipid-
to-protein ratios, respectively. Accordingly, the 80 w/w lipid-to-protein proportion 
allowed the most efficient protein retention. Interestingly, the presence of trimers and 
dimers is higher in proteoliposomes than in solution. Just 2% of the population 
presented a trimer organization in the Omp2a free solution (band at 110 KDa in Figure 
4.3.7d), while increasing to 3.4%, 5.8% and 6.2 % in samples coming from 100, 80 and 
Figure 4.3.6 The protein was inserted on the lipid bilayer using two different methods: (a) 
Formation of proteoliposomes from preformed liposomes; and (b) Insertion of the Omp2a 
protein by direct incorporation the Omp2a protein into SLBs. 
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40 w/w lipid-to-protein ratio. This feature suggests that protein confinement into lipidic 
membranes enhances their reorganization, bringing them to a state closer to the natural 
one. 
TEM images of blank liposomes (control) and proteoliposomes (Figure 4.3.7e and 
4.3.7f, respectively) were obtained following the protocol reported by Opalińsky et al.23 
Micrographs denoted that the samples had some polydispersity, similar results as 
obtained with the DLS, the diameters of liposomes and proteoliposomes varied between 
100 and 350 nm (Figure 4.3.7e) and between 50 and 400 nm (Figure 4.3.7f), 
respectively. The addition of Omp2a to anionic vesicles had some influence on their size 
and, presumably, shape, which is in full agreement with the results derived from DLS. 
Proteoliposomes are clearly bigger than control liposomes. In addition, the formers 
exhibit folds, which may be attributed to the re-organization induced by the protein 
reconstitution inside the lipid bilayer (i.e. sterically-driven re-organization). However, it 
should be mentioned that such folds could be also due to an artifact induced by the dry-
state. Thus, the above mentioned re-organization could result in a weakening of the 
interactions inside the lipid bilayer and, consequently, cause deformation upon drying of 
the sample for TEM observation. On the other hand, the integrity of the membranes was 
found to be intact after conducting the four steps for protein insertion (Figure 4.3.6a).  
  




Figure 4.3.7  DLS results expressed in term of (a) intensity vs diameter, (b) ζ values and (c) CD 
spectra of proteoliposomes prepared from detergent-mediated reconstitution of the protein 
using 40, 80 and 100 w/w lipid-to-protein ratio, control liposomes (i.e. preformed liposomes), 
blank liposomes (i.e. preformed liposomes altered by adding the reconstitution detergent 
medium but without protein) and Omp2a solution. (d) SDS-PAGE gel for the proteoliposomes. 
TEM micrographs of (e) blank liposomes and (f) proteoliposomes prepared using 80 w/w lipid-
to-protein ratio. Histograms showing the diameter distributions are also displayed.  
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SLBs were obtained by spreading the control liposomes and the proteoliposomes 
onto mica substrate. Although the most common procedure to obtain SLBs is the 
Langmuir-Blodgett method, this technique usually becomes far complicated when 
multicomponent membranes, like those including OMPs, are studied. Instead, vesicle 
fusion onto a planar hydrophilic solid support is perfectly suitable for such cases. 
Different theories have been developed to elucidate how these vesicles spread over the 
hydrophilic surface. One of the most accepted models assumes that the vesicles adsorb 
on hydrophilic surface, then undergo substrate-induced deformation which causes their 
rupture on a solid surface.24,25 However, the rupture events can be driven by several 
other factors including fusion between neighbouring vesicles, the high surface density of 
vesicles, and the presence of active edges of already formed bilayer patches. In this work 
the SLB formation was performed in the presence of Ca2+, which favours vesicle 
adsorption onto mica support, especially for those containing negatively charged lipids.26  
Figure 4.3.8 displays AFM images of SLB onto mica substrate obtained after 
spreading the control liposomes and the proteoliposomes. AFM images acquired for the 
liposomes reflect a homogenous and flat surface (Figure 4.3.8a), with an average 
roughness of (0.15  0.01 nm). Representative cross-sectional profiles indicate that the 
treatment for obtaining proteoliposomes does not cause protrusions in the lipid bilayer. 
Instead, small protuberances of 2 nm in height and 25 nm in width appear upon the 
incorporation of Omp2a (Figures 4.3.8b-d). Moreover, AFM images evidence that the 
amount of protuberances decreases with increasing lipid-to-protein ratio, while the size 
of the protuberances increases. More specifically, the amount of protuberances decreases 
25% and 35% when the from the lipid-to-protein ratio increases from 40 w/w to 80 
and 100 w/w, respectively. It is worth noting that large aggregates (4 nm in height and 
100 nm in width) appeared for the highest concentration of protein (Figure 4.3.8d), 
limiting protein nanomechanical studies. 
Magnified AFM images provide improved visualization of the protein’s shape 
(Figures 4.3.8b-d). More specifically, magnification of the SLB derived from 
proteoliposomes obtained using 80 w/w lipid-to-protein ratio reflects structures of 1.5-2 
nm in height and 10 nm in width, with small cavities in the middle. This condition seems 
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Figure 4.3.8 Topographic AFM images (first row) of SLB obtained from (a) 
POPC:POPE:POPG (4:3:1) liposomes or from proteoliposomes achieved using (b) 100, (c) 80 
and (d) 40 w/w lipid-to-protein ratios spread over mica. Data were recorded on buffer solution 
(150 mM KCl, 10 mM Tris-HCl, pH 7.8). The red lines in AFM images indicate where from the 
vertical profile shown below (second row) each image has been extracted. Also, insets of each 
AFM image and profile are shown below (third and fourth rows, respectively). 
to be the ideal in terms of protein’s reconstitution efficiency and visualization. Therefore, 
more insights of this condition are shown in Figure 4.3.9a, where AFM images of 
different patches on this surface are displayed. Comparison with the TEM images of the 
free protein in solution, which are shown in Figure 4.3.9b, suggests that such small 
patches on the membrane correspond to clusters of 5 to 10 monomers laterally 
associated. A membrane surface screening allowed to separate large protein-detergent 
aggregates (> 50 nm, dark blue in Figure 4.3.9d) from small clusters of proteins (<50 
nm, light blue in Figure 4.3.9d). Analysis of the height for the population of small 
clusters indicates an average value of 2.3 ± 0.5 nm (Figure 4.3.9d), which is in 
accordance with the protein and lipids heights.27 




Figure 4.3.9 (a) Representative topographic AFM images of SLB obtained from 
POPC:POPE:POPG (4:3:1) proteoliposomes (80 w/w lipid-to-protein ratio) spread over mica. 
The red lines in the AFM images indicate the region used to extract vertical profile shown next 
to each image. (b) TEM images of Omp2a stained with uranyl acetate (scale bar: 10 nm). (c) 
Representative topographic AFM images of SLB obtained from POPC:POPE:POPG (4:3:1) 
proteoliposomes (80 w/w lipid-to-protein ratio) spread over mica. Particle analyses were 
performed on 22 µm2 images. Light blue regions indicate particles below 45 nm (protein 
oligomers) while dark blue spots correspond to particles above 45 nm (protein aggregates). Data 
were recorded with a buffer solution (150 mM KCl, 10 mM Tris-HCl, pH 7.8). (d) Particle 
dimeter distribution and height distribution of protein oligomers (< 45 nm).  
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Omp2a reconstitution by direct incorporation into the SLB  
The alternative method of incorporation of Omp2a into SLBs, which is schematized 
in Figure 4.3.6b, was followed using AFM analysis at high resolution. The main 
assumption for this approach was deeply investigated by Milhiet et al.,28 and is based on 
the insertion of proteins into the destabilized SLB after its deposition onto the mica 
substrate. In a very recent work Sumino et al.29 directly attached transmembrane 
proteins, which were solubilized with an histidine-tag, to a Ni2+ coated mica surface. 
After this, detergent destabilized liposomes were added in order to fill the space between 
the proteins, achieving an oriented reconstitution.  
In this work, SLBs were disrupted by the addition of Triton-X 100 and, afterwards, 
the protein was incorporated. Figure 4.3.10 displays topographic AFM images of SLB 
obtained from POPC:POPE:POPG (4:3:1) liposomes at the three different steps of the 
reconstitution process. The spread liposomes, where two faces can be visualized, are 
shown in Figure 4.3.10a. After incubation with 0.01% Triton X-100 to destabilize the 
membrane, noticeable changes were observed (Figure 4.3.10b), that is, the surface 
became flatter and more homogeneous. Finally, the bilayer was further incubated in a 
protein refolding solution with 10 µg/mL of Omp2a. At this point, large protrusions from 
the lipid bilayer emerged (Figure 4.3.10c). The width and height of such protrusions 
were 93 and 2.3 nm, as is evidenced by vertical profiles extracted from the AFM images 
(red lines in Figure 4.3.10c). Nevertheless, no single units of protein were detected. 
Instead the bilayer was broken in many sites and agglomerates of protein were found. 
This was attributed to the fact that the concentration of Omp2a used in this process was 
too high. In addition, previous studies suggested that lipid bilayers could be destabilized 
by the detergent used in the refolding solution.30   
 




Figure 4.3.10 Topographic AFM images of: (a) SLB obtained from POPC:POPE:POPG (4:3:1) 
liposomes, (b) after being incubated with 0.01 %Triton X-100, and (c) further incubated in a 
refolding solution with 10 µg/mL of Omp2a. Data were recorded on buffer solution (150 mM KCl, 
10 mM Tris-HCl, pH 7.8). The red lines in the AFM images (a-c) indicate where from the vertical 
profiles shown below have been extracted. 
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In order to overcome the limitation associated to the protein concentration, the latter 
was reduced. As occurred above, the surface of spread liposomes (Figure 4.3.11a) 
became flatter and more homogeneous after incubation with 0.01% Triton X-100 
(Figure 4.3.11b). After incubation in a 2 µg/mL Omp2a refolding solution, some 
breakages and agglomerates were also visualized (Figure 4.3.11c), even though at such 
low concentration single protein’s shape could be identified when higher contrasts were 
 
Figure 4.3.11  Topographic AFM images of: (a) SLB obtained from POPC:POPE:POPG (4:3:1) 
liposomes, (b) after being incubated with 0.01 %Triton X-100, and (c) further incubated in a 
refolding solution with 2 µg/mL of Omp2a. Data were recorded with the buffer solution (150 
mM KCl, 10 mM Tris-HCl, pH 7.8). The red square shows where the inset has been obtained 
from. The red line in the AFM image indicates (c) where from the vertical profile shown below 
has been extracted. Red circles correspond to protein agglomerates. 
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used. The recognized protein was around 10 nm wide and 1.5 nm height, showing a 
deeper part in the middle, as it was expected. 
In summary, although high resolution images of the proteins reconstituted into the 
lipid bilayer were obtained, this strategy is limited by the adverse effects caused by the 
detergent used for the refolding procedure. Thus, the lipid bilayer is still disrupted when 
the protein concentration is reduced from 10 to 2 µg/mL. Due to this drawback, the 
strategy based on detergent-mediated reconstitution of the protein into liposomes 
(Figure 4.3.6a) was used to insert the Omp2a into the lipid bilayer for both 
nanomechanical and functional studies. Specifically, this methodology allows a higher 
control of the process, as is proved by the fact that the substrate surface is 
homogeneously coated by the lipid bilayer and a homogeneous protein distribution into 
the bilayer is observed. 
 
Nanomechanical properties of Omp2-containing SLBs prepared using 
preformed liposomes  
Lateral organization of lipid, carbohydrates and proteins found in biological 
membranes is involved in many cellular events, for example signal transduction or 
membrane fusion.31 Furthermore, structural, physical and chemical properties of 
biomacromolecules can control their activity at different length-scales. In particular, 
nanomechanical properties can affect some biological functions of proteins in processes 
such as cell signalling, membrane signal transduction and immune responses.32-34 For 
example, antibodies need high flexibility to bind to diversified antigens.34 Accordingly, 
deep-end studies on how proteins modify the consistency of lipid bilayers and how soft 
proteins are in comparison with the hosting lipid bilayers are not only attractive but also 
very relevant from a biotechnological point of view. Due to recent advances in AFM 
technologies, it is currently possible to measure mechanical properties of single 
molecules in physiological conditions. Thus, force-distance (FD) curves, which are 
directly obtained from cantilever’s deflection, can be collected at the same time as the 
AFM images are acquired. For each pixel of the topographic image, the AFM records FD 
curves with Ångstrom precision and piconewton sensitivity. More specifically, interaction 
forces between the AFM stylus and the biological sample surface are mapped pixel-by-
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pixel, enabling quantification of the elastic modulus, adhesion forces and deformation of 
the sample simultaneously.35 In this work, the elasticity has been extracted using the 
Derjaguin-Muller-Toporov (DMT) model,36 whereas the adhesion force has been 
acquired from the vertical difference of the minimum force during retraction and the 
zero-force. Lipid bilayers were examined using a soft cantilever (nominal spring constant 
ks= 0.7 N/m) with the set point adjusted to get minimum sample deformation. 
Figure 4.3.12a shows a 2 × 2 µm2 topographic image of Omp2a molecules 
embedded on the lipid membrane over a mica substrate, which was obtained in the peak 
force QNM tapping mode. The peak force set point was adjusted to a force of 544 pN. For 
analysis, a cross-sectional profile of 2 µm length (dashed red line) is plotted next to the 
AFM windows. The DMT modulus map (Figure 4.3.12a) reflects the presence of two 
domains with different constant elasticities, corresponding to the lipid bilayer surface 
and to the Omp2a molecules. Figure 4.3.12b includes the profile of elasticity fitted with 
the DMT modulus. The mean DMT modulus obtained for the lipid bilayer and Omp2a 
are 19 MPa and 10.5 ± 1.7 MPa, respectively, the latter being obtained by selecting 
aggregates smaller than 40 nm. These results are consistent with high resolution 
topographic AFM studies on OmpG reconstituted into native E. coli lipids that evidenced 
that the OMP is softer than the lipid bilayer,35,37 even though no quantitative estimation 
of the elastic modulus was provided. However, studies on other related proteins (i.e. 
bacteriorhodopsin and multiprotein complexes contained in erythrocyte membrane) 
using quantitative mechanical AFM mapping38,39 and micro-second force spectroscopy40 
probed that the stiffness of MPs depends on the environment (e.g. electrolyte identity 
and concentration, pH and substrate), ranging from a few MPa to tens of MPa. Similarly, 
the reported moduli of lipid bilayers ranged from 10 to 500 MPa depending on the 
chemical identity and environment.41,42 However, the modulus of elasticity of ~18 MPa 
was recently reported for the liquid disordered phase of mica-supported bilayer 
composed of lipids extracted from E. coli.43 Moreover, the modulus of polymeric FsNMs 
was reported to increase from 25 to 35 MPa with the thickness (i.e. from 10-20 nm to 
80 nm).44 
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Figure 4.3.12c displays, in one hand, the adhesion map, as obtained from the FD 
curves recorded in each pixel, and, in the other hand, both the profile and histogram of 
the difference between lipid bilayer and protein adhesion. It should be noted that the 
DMT model used in this work is appropriated for weak adhesive forces and tips with a 
small curvature radius.45 The adhesion force of the SLB was around 200 pN, while that of 
Omp2a was 161.9 ± 9 pN. Lipids therefore adhered more to the AFM tip than the protein, 
which should be attributed to the asymmetric distributions of van der Waals forces. 
Consequently, the tip forms stronger interactions with the flat surface of lipids than with 
the curved surface of Omp2a, the latter providing less contact area.46 It is worth noting 
that the adhesion forces determined for the lipid bilayer and the OMP are one order of 
magnitude smaller than those reported for polymeric FsNMs.17 More specifically, the 
adhesion force of polymeric FsNMs were found to be comprised between 5 and 7 nN.44 
Two phases are also observed in the representative deformation map displayed in 
Figure 4.3.12d. Indeed, the corresponding profile and histogram provided deformation 
values of 1 nm and 4.6 ± 0.7 nm for the SLB and Omp2a, respectively. These results 
prove that mechanical properties such as the elasticity or deformation can be imaged at 
high resolution. Strikingly, the contour of single molecules becomes apparent when their 
mechanical properties are studied, even though their recognition becomes easier when 
height images are also considered. Similar analyses were performed for the control SLBs 
(i.e. liposomes treated like the proteoliposomes) onto mica substrate (Figure 4.3.13). 
Results corroborated that nanofeatures previously described were due to the protein 
reconstitution. Thus, no small protrusion was observed in Figure 4.3.13 and, in 
addition, no significant changes in the DMT modulus, adhesion and deformation were 
detected when comparing values obtained for SLBs with and without protein.  
 




Figure 4.3.12   FD-based AFM images of POPC:POPE:POPG (4:3:1) proteoliposomes (80 
w/w lipid-to-protein ratio) spread onto mica: (a) topography, (b) DMT modulus map, (c) 
adhesion map and (d) deformation map. Data were recorded with the buffer solution (150 
mM KCl, 10 mM Tris-HCl, pH 7.8). The red lines in the AFM images (a-d) indicate where 
from the vertical profile shown below or next to each image has been extracted. The 
histograms below the profiles express the percentage of particles below 45 nm in diameter 
(protein oligomers) vs the difference in the indicated parameter with respect to lipid bilayer 
values. 
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Overall, comparison of the results obtained in this section with those reported for 
polymeric NMs44 indicates that immobilization of OMPs inside the nanopores of 
polymer-based FsNMs offers advantages over the lipid bilayer-based approaches. 
Indeed, although synthetic lipid bilayers, like those studied in this work, are more stable 
than pure biological membranes, their mechanical strength is lower than that of 
polymeric NMs. The fragility of lipid bilayers may be a handicap for practical 
applications, while the mechanical flexibility and resistance of polymeric FsNM were 
reported to be enough for this purpose. Thus, in many practical applications, as for 
example those related with molecular filtration, nanofluidics and nanodetection, stable 
Figure 4.3.13   FD-based AFM images of PC:PE:PG (4:3:1) liposomes spread over mica: (a) 
topography, (b) DMT modulus map, (c) adhesion map, and (d) deformation map . Data were 
recorded on buffer solution (150 mM KCl, 10 mM Tris-HCl, pH 7.8). The red lines in the AFM 
images (a-d) indicate where the vertical profile shown below or next to each image has been 
extracted. 
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FsNMs are needed to sustain mechanical stress during the fabrication and operation 
processes. 
 
Electrochemical detection of Omp2a in proteoliposomes 
Electrochemical methods are widely accepted to detect residues with redox properties 
in proteins, such as tyrosine (Tyr) and tryptophan (Trp).47,48 Among the different 
electrochemical strategies (e.g. sweep voltammetry and cyclic voltammetry), SWV stands 
out since high peak resolution is obtained with very low peptide and protein 
concentrations after correcting with an efficient base line.49 In addition, the usage of 
electrochemical method has the advantage that proteins can be easily adsorbed on many 
surfaces facilitating the preparation of protein-modified electrodes.50  
It is well-known that the peak potential of Tyr and Trp depend on the buffer. Thus, 
Vacek et al.51 showed that pH plays a key role on the peak potential, which shifts towards 
less positive values with increasing pH. Furthermore, analysis of the peak potential shifts 
at a given buffer conditions allows to discriminate between native and denatured forms 
of proteins.57 Omp2a contains 22 Tyr and 10 Trp residues which are mainly located in the 
external part of the barrel on the folded protein. Therefore, in proteoliposomes are 
expected to be at the interface between the lipid bilayer and the medium if the protein 
remains stable. In order to prove the stability of the protein native form in the 
proteoliposomes, characterization of the Omp2a Tyr and Trp residues has been 
performed by applying the label-free and sensitive SWV methodology. Specifically, the 
response of the protein when it is alone (control of the native form) and embedded into 
the lipid bilayer has been compared. 
Three negative controls were analysed: bare GCE, GCE covered by MPD-containing 
refolding buffer (GCE+MPD), and GCE covered by the spread liposomes 
(GCE+liposomes). As it can be seen in Figure 4.3.14, none of the mentioned samples 
gave rise to any substantial peak. Instead, when the protein was adsorbed with the 
refolding buffer two peaks can be visualized. These correspond to the oxidation peaks of 
Tyr and Trp (+0.45 V and +0.62 V, respectively). The peak current density is much 
higher for the first than for second, which is fully consistent with the larger quantity of 
Tyr than Trp in the Omp2a sequence. In contrast, a single less intense peak at +0.5 V was 
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found when proteoliposomes were spread onto the glassy carbon surface. This is 
correlated with the lower protein presence on the proteoliposomes since there is not a 
complete protein loading and, therefore, the monitoring of the Trp signal becomes more 
difficult.  
 
Functionality of Omp2a in SLBs 
 The chemical environment is critical to maintain the biological functionality of 
OMPs. Hence, biological nanopores offer precise control over ion selectivity rectification 
and gating as well as outstanding permeability. Molecular recognition is the hallmark of 
biological interactions to enable these functions, especially the ion selectivity, so that 
embedded biochannels often lose their activity upon leaving the biological environment. 
Several strategies have been studied to transfer properties of naturally occurring 
nanopores to supported polymeric NMs. For example, incorporation of lipid bilayer onto 
supported NM,52-54 and functionalization of the nanopores surfaces through ligands55-58 
are considered as the most reliable ones. Nevertheless, the utilization of supported NMs 
drastically limits the practical application of the device and, unfortunately, 
functionalization of nanopores surfaces in polymeric FsNMs is not an easy task. In order 
Figure 4.3.14  Voltammograms of SWV obtained for bare GCE and GCE covered by refolding 
buffer (GCE+MPD), spread liposomes (GCE+liposomes) and spread proteoliposomes 
(GCE+proteoliposomes). 
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to engineer new strategies for the fabrication of more effective bioinspired FsNMs, this 
section is devoted to study the functionality of Omp2a-immobilized inside SLB, and its 
comparison to the results for Omp2a-based PLA FsNMs will be reported in Chapter 5.7 
The EIS method has been employed to measure the current through electrodes 
covered by the systems investigated in this study. This technique exploits the fact that 
lipid bilayers are electrically resistant and behave as insulators, monitoring the 
membrane conductance related to the transport of ions. In this work, the electrode used 
for the functional characterization is indium tin oxide (ITO) supported on glass, which is 
a suitable substrate for the characterization of lipid bilayer membranes and does not 
induce protein denaturation.59-62 The complex EIS signal has been related to the 
electrical properties of each component of the system (i.e. the electrode, the lipid bilayer 
with or without protein, and the electrolyte, KCl), representing them as electrical 
elements on an EEC. Each element contributes at different frequency regime enabling 
the separation of the effects of the components at the interface. The quality of the fitting 
between the experimental data and the ECC has been proved by the evaluating the 
percentage error associated to each circuit element, which is lower than 10% in all cases. 
Consistently with previous works, the EEC (Figure 4.3.15a) obtained for bare ITO 
electrodes shows the electrolyte resistance (RS) connected in series with the constant 
phase element (CPE) of the double layer semiconductor/electrolyte interface, (Qdl). Here, 
lipid bilayer-coated electrodes behave as a circuit in which the RS is followed by the lipid 
membrane CPE element (QM) in parallel with the membrane resistance (RM) and the 
semiconductor/electrolyte interface Qdl element, which arises from lipid bilayer defects 
(i.e. lipid bilayers are dynamic in nature and, therefore, the apparition of changing 
defects and holes is expected to be relatively frequent). Moreover, this EEC is not altered 
by the incorporation of Omp2a inside the bilayer (Figure 4.3.15a). 
Figure 4.3.15b displays the Nyquist plots recorded for the bare ITO substrate and 
four different lipid bilayers (i.e. lipid bilayers using 40, 80 and 100 w/w lipid-to-protein 
ratio and lipid bilayer without protein) using 0.1 M KCl aqueous solution. All four 
bilayers display curves with one semicircle in the high frequency range, and a straight 
ascending line in the low frequency range. The starting point of the curve indicates RS, 
while the diameter of the semicircle corresponds to the charge-transfer resistance, RM. 
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Besides, the conductivity calculated for each system is represented in Figure 4.3.15c. 






  (Eq. 4.3.3) 
where L is the thickness of the membrane (5.510−7 cm), A is the area of the electrode 
(0.5 cm2), and RM is the membrane resistance. As expected, the membrane conductivity 
increases as a function of the protein concentration on the lipid bilayer, being 
significantly higher for the 40 w/w lipid-to-protein ratio. 
Figure 4.3.15d displays the Bode plots obtained for each condition, where both the 
difference of logarithmic impedance vs the logarithm of frequency (log f, where f is 
expressed in Hz) and the change in phase angle vs the logarithm of frequency are 
represented. Bare ITO shows a steady increase of the impedance signal log f below 3, the 
same being observed in the difference of phase angle. Instead, when the electrode was 
covered by the lipid bilayer (with/without protein) a well-defined shoulder appeared at 
the log f regime of 1-3. This is related to the resistance and constant phase element (QM) 
induced by the presence of the lipid bilayer. 
 
 





Figure 4.3.15 (a) Schemes representing the ITO, the lipid bilayer and the lipid bilayer 
containing Omp2a with the corresponding EEC used for fitting the experimental data from EIS 
measurements: RS is the electrolyte resistance; QM and RM are the membrane constant phase 
element and resistance, respectively; and Qdl is the double layer constant phase element for the 
electrode surface. (b) Nyquist plots of ITO (green stars), lipid bilayer (purple triangles), lipid 
bilayer with the reconstituted protein at 100 (blue circles), 80 (red diamonds) and 40 w/w 
(black squares) lipid-to-protein ratio in 0.1 M KCl. Symbols correspond to experimental data, 
while lines are the fitted curves according to EEC. (c) Average conductivity measured for the 
lipid bilayer and those containing the protein at different lipid-to-protein ratios. (d) Bode plots 
of the systems described in (b). 
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The resistance obtained for the lipid bilayer alone (4.2 K·cm2) (Table 4.3.1), is 
close to that reported for single component 1,2-dimyristoyl-sn-glycero-3-phosphocholine 
bilayer,63 and is significantly higher than what was obtained for supported PPy 
membranes (821 ·cm2).64 According to these results, ion diffusion decreases as follows: 
supported PPy > SLB. This relative order can be explained considering PPy is a 
conducting polymer, which facilitates the electron transfer to the electrode surface. As 
expected, the reduction in the resistance of each Omp2a-containing system with respect 
to its corresponding non-functionalized analog evidences that the incorporation of the 
porin channel enhances ion diffusion in all cases.  
The resistance values obtained in this work for lipid bilayers are smaller than those 
previously reported in literature (i.e. > 80 K·cm2).2 This observation could be attributed 
to one of the following two reasons or to the combination of both. First, the ion 
concentration used in this work (i.e. 0.1 M KCl), which was chosen for consistency with 
our previous studies on Omp2a-based PPy bioinspired NMs,64, is one order of magnitude 
higher than the one typically used. It is worth noting that when higher is the electrolyte 
concentration, lower is the membrane resistance.3 Also, the presence of defects in the 
bilayer and the consequent reduction in the packing density of the immobilized lipids can 
explain the low resistances determined in this work, in comparison with those obtained 
in other studies.2 Thus, such imperfections could be due to the difficulty of completely 
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a) The CPE impedances have been expressed as: ZCPE = [Q (j)n ]-1. CPEs represent a capacitor 
and a resistor for n= 1 and n= 0, respectively, while it is associated with a diffusion process 
when n= 0.5. 
 
4.3.3 Conclusions 
The nanomechanical properties and functionality of Omp2a reconstituted into SLBs 
have been evaluated and compared with those of bioinspired Omp2a-polymeric NMs. 
Among the three tested lipid compositions, bilayers made of 4:3:1 POPC:POPE:POPG 
have been found to be the most homogenous and consistent. Besides, reconstitution of 
the OMP into preformed liposomes using detergent as mediator has allowed obtaining 
homogenous and reproducible surfaces. The estimated average DMT moduli, adhesion 
force and deformation of Omp2a is 10.5±1.7 MPa, 161.9±9 pN and 4.6 0.7 nm, 
respectively. These values are clearly distinguishable from the ones determined for the 
lipid bilayer, reflecting the satisfactory incorporation of the OMP. The low stiffness of 
Omp2a and its high deformability compared with the dimensions of the molecule 
(nominal height: 7 nm) reflect a high molecular flexibility. This key property, which is 
related to the conformational adaptability of the protein, could be responsible of an 
Table 4.3.1 R and CPE (a) for each sample, analyzed in KCl 0.1 M solution, obtained from 
fitting parameter with the EECs displayed in Figure 4.3.15a. The percentage error associated 
to each circuit element is included in parentheses. 
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essential aspect of Omp2a biological functionality: it allows the passage of a number of 
molecules with varying sizes and shapes to ensure the nutrition of the bacteria. On the 
other hand, the ion affinity significantly increases with the protein concentration used in 
the proteoliposomes reconstitution, a reduction of 78% being observed between the 
control and the lowest lipid-to-protein ratio. 
In summary, the reconstitution of OMPs into lipid bilayers provides platforms that 
fulfil both the nanometric dimensional requisite for truly mimicking biological attributes, 
and the conditions necessary for exploring their properties. In spite of these advantages, 
the properties Omp2a-based SLBs are less suitable for technological applications than 
those of polymeric FsNMs.  
 
4.4 Thermomechanical response of Omp2a for 
biomimetics  
Recently, there has been a paradigmatic shift in the experimental study of materials 
with applications in biomedicine: new methods have been developed to study 
phenomena associated to single molecules and their small supramolecular / 
nanostructured aggregates when embedded within complex platforms with functional 
interfaces for clinical applications. In particular, micro- and nano-sized mechanical 
techniques based on the principle that variations in electrostatic, van der Waals and 
steric intermolecular interactions on the surface of functionalized cantilever cause 
bending (deflection) of a few nanometers, are playing a fundamental role.65 The 
combination of these miniaturized mechanical systems with electrical and, especially, 
optical displacement sensors has been applied for, among others, chemisorption 
measurements in air at room temperature with up to yoctogram (10-24 g) resolution,66,67 
drug screening,68,69 characterization of the thermomechanical response and the glass 
transition temperatures of macromolecular ultra-thin films,70,71 detection of DNA 
strands,72 observation of the hydration-dehydration (swelling-deswelling) of molecular 
systems,73-75 and identification of biological species through their molecular mass and 
stiffness improving the capabilities of conventional mass spectrometers.76,77 
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In this study, we investigated the organization of -barrel OMPs in synthetic 
environments as a function of the temperature, thereby applying microcantilever 
deflection technologies to hierarchical structured Omp2a (367 residues, 39 kDa). The 
interpretation of these measurements has been carried out with the aid of the results 
obtained using other techniques, such as FTIR spectroscopy, circular dichroism (CD), 
dynamic light scattering (DLS), wide angle X-ray diffraction (WAXD), X-ray 
photoelectron spectroscopy (XPS) and atomic force microscopy (AFM). The distinctive 
thermal transitions identified for Omp2a, which compare with those observed for 
conventional proteins such as lysozyme (LYS; 129 residues, 14.4 kDa) and bovine serum 
albumin (BSA; 583 residues, 66.5 kDa), have been unraveled and their consequences and 
effects analyzed.  
 
4.4.1 Methods 
Materials: Octosensis Microcantilever-Arrays (chips with eight mono crystalline Si 
cantilevers, 500 μm in length) were obtained from Micromotive GmbH (Mainz, 
Germany). The following chemicals were purchased from Sigma-Aldrich and used as 
received without further purification: isopropanol, (3-





L-lysine hydrate (NTA-NH2) (97%), 1-[(3-dimethylamino)propyl]-3-ethylcarbodiimide 
methiodide (EDC), N-hydroxysuccinimide (NHS), 2-(N-morpholino)ethanesulfonic acid 
(MES), 2-amino-2-(hydroxymethyl)-1,3-propanediol (Tris base), carbonate/bicarbonate 
buffer, phosphate buffered saline (PBS, pH7.4) Sodium chloride was purchased from 
Panreac (Spain). Bovine serum albumin (BSA, fraction V) and lysozyme (LYS) were 
purchased from BioLabs (England) and Fluka, respectively. The Omp2a protein was 
expressed, purified, and refolded using a previously reported procedure.78,79 
 
Fourier-transform infrared (FTIR) spectroscopy: FTIR spectra of BSA, LYS and 
Omp2a were recorded on a FTIR 4100 Jasco spectrophotometer. The samples were 
placed in an attenuated total reflection accessory with thermal control and a diamond 
crystal (Specac model MKII Golden Gate Heated Single Reflection Diamond ATR). For 
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each sample 46 scans were performed with a resolution of 2 cm-1. Spectra were recorded 
at 30 ºC and 100 ºC. 
FTIR spectroscopy was used to examine the secondary structure of the proteins. 
Specifically, the number and position of the peaks in the Amide I region, which were 
derived from the second derivative and deconvoluted spectra, provided information 
about the protein conformation. Fourier self-deconvolution was performed with the 
software PeakFit 4 (Jandel Scientific Software, AISN Software Inc.), the resulting profiles 
being fitted to Gaussian functions through the OriginPro 7.5 software.  
 
Circular dichroism (CD): CD measurements of BSA and LYS were performed using a 
1 commercial Dulbecco’s PBS from Gibco with a protein concentration of 0.01 mg/mL, 
whereas a sodium dodecyl sulfate (SDS) – 2-methyl-2,4-pentanediol (MPD) buffer (60 
mM SDS, 1.5 M MPD, 400 mM NaCl, 50 mM Tris-HCl pH 8) with a protein 
concentration of 0.005 mg/mL was used for Omp2a. It should be noted that the different 
buffer selection is due to the fact that the Omp2a structure is protected by amphiphilic 
SDS–MDP detergents.22,23 Spectra were recorded between 190 and 250 nm using a 
Chirascan-plus qCD spectrometer (Applied Photophysics, APL; UK) equipped with a 
temperature-controlled cell. Spectra were obtained using heating (from 5 ºC to 90 ºC) 
and cooling (from 90 ºC to 5 ºC) runs stopping every 5 °C for 5 minutes with a heating 
rate of 5 °C/min. Machine settings were as follows: 1 nm bandwidth, 1 s response, 0.5 nm 
data pitch, 100 nm/min scan speed and cell length of 10 mm. All CD spectra presented in 
this work correspond to the average from three independent measurements. Spectra 
were deconvoluted using the CDSSTR method of the DichroWeb server.80 
 
Dynamic light scattering (DLS): The influence of the temperature in the shape and 
aggregation of BSA, LYS and Omp2a was studied by DLS following the variation of the 
particle effective diameter (Deff) when the temperature increases from 20 to 60 ºC. 
Proteins were dissolved in the buffers described above for CD measurement using the 
same concentrations. Measurements were performed using a NanoBrook Omni Zeta 
Potential Analyzer from Brookheaven Instruments Corporation. Deff values correspond to 
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average values of the corresponding particle size distributions, which were determined in 
steps of 10 ºC (heating/cooling rate 10 ºC/min) stopping for 2 minutes before the 
measurement.  
 
Wide angle X-ray diffraction (WAXD): Time resolved WAXD experiments were 
carried out at the NCD beamline (BL-11) of the Alba synchrotron radiation light facility of 
Cerdanyola del Vallès (Catalunya). The beam was monochromatized to a wavelength of 
1.5406 Å. Samples were confined between Kapton films and then held in a Linkam hot 
stage with temperature control within ±0.1 ºC. WAXD profiles were acquired during 
heating and cooling runs in time frames of 7.5 s and a rate of 4 ºC/min. The WAXD 
detector was calibrated with diffractions of a standard of a Cr2O3 sample. The diffraction 
profiles were normalized to the beam intensity and corrected considering the empty 
sample background. Deconvolution of WAXD peaks was performed with the PeakFit v4 
program by Jandel Scientific Software using a mathematical function known as 
“Gaussian area”. 
 
Functionalization of silicon microcantilever chips: The functionalization 
protocol, which was applied to silicon microcantilever chips previously hydroxylated at 
the surface with a H2O2:H2SO4 (3:1 v/v) mixture, consisted of four steps: 
(i) Silanization. Hydroxylated microcantilevers were silanized with 0.2 % of (3-
glycidyloxypropyl)trimethoxysilane in dry toluene overnight at room temperature 
under nitrogen atmosphere. Afterwards, samples were washed with toluene and 
milli-Q water. 
(ii) Carboxylation. Silanized microcantilevers were incubated into 100 mM Nα,Nα-
bis(carboxymethyl)-L-lysine hydrate (NTA-NH2) solution in 50 mM carbonate 
buffer (pH 9.5) overnight, at room temperature, and under gentle agitation. After 
this, carboxylated substrates were washed with 50 mM carbonate buffer (pH 9.5) 
and milli-Q water. 
(iii) Activation. The carboxyl groups arising from NTA-NH2 at the microcantilever 
surface were activated for direct reaction with primary amines via amide bond 
formation with a mixture of 100 mM EDC and 150 mM NHS, both dissolved in 10 
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mM MES (pH5.5). Samples were incubated for 30 min at 37 °C under gentle 
agitation and, then, extensively rinsed with 10mM MES (pH5.5).  
(iv) Protein immobilization. A solution of 0.1 mg/mL of protein (BSA, LYS or Omp2a) 
was prepared in 10mM MES (pH 5.5). The cantilevers were incubated for 2 h at 
37ºC. After that, samples were washed with 10 mM MES (pH 5.5) and incubated 
for 45 minutes at 37 ºC with 1PBS with 0.3 M NaCl to desorb proteins not 
covalently bonded to the surface. 
 
X-ray photoelectron spectroscopy (XPS): XPS was used to analyze the chemical 
composition at the surface of silicon substrates. The system (SPECS Surface Nano 
Analysis GmbH, Berlin, Germany) was equipped with a non-monochromatic twin anode 
X-ray source XR50 of Mg/Al (1253 eV/1487 eV). Specifically, the Al anode was operated 
at 150 W. Detector pass energy was set at 25 eV and 0.1 eV for the survey and the narrow 
scans (high resolution spectra), respectively, at a pressure below 7.5 × 10−9 mbar. Casa 
XPS software (Version 2.3.16, Casa Software Ltd., Teignmouth, UK) was used to fit and 
perform peak integration of spectra. The C 1s peak was used as an internal reference 
(284.8 eV). High resolution XPS spectra were acquired by Gaussian–Lorentzian curve 
fitting after S-shape background subtraction. 
 
Wettability: Contact angle measurements were conducted using the water drop 
method. 0.5 µL of milliQ water drops were deposited onto the surface of the substrate 
and recorded after stabilization with the equipment OCA 15EC (DataPhysics Instruments 
GmbH, Filderstadt). The SCA20 software was used to measure the contact angle, which 
is shown in this work as the average of at least 10 measures for each sample. 
 
Atomic force microscopy (AFM): AFM was conducted to obtain topographic images 
of the non-functionalized and functionalized surfaces using Si TAP 150-G probes (Budget 
Sensors, Bulgaria) with a frequency of 150 kHz and a force constant of 5N/m. Images 
were obtained with an AFM VEECO Multimode under ambient conditions in tapping 
mode. The row scanning frequency was set between 0.6 and 0.8 Hz. The root-mean-
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square roughness was determined using the statistical application of the NanoScope 
Analysis software (1.20, Veeco). 
 
Resonance frequency measurements and cantilever displacement: Cantilever 
resonance frequency and displacement measurements were carried out by means of the 
SCALA equipment (Scanning Laser Analyzer, from MecWins), a recently developed 
technology for the optical read-out of cantilevers.71,81,82 The readout technique combines 
the optical beam deflection method and the automated two-dimensional scanning of a 
single layer beam by voice-coil actuators. The equipment has been implemented with a 
thermal chamber containing a thermoelectric cooler and a cartridge heater. These 
elements are capable of sweeping the chamber’s temperature from –50 ºC up to 220 ºC 
by flowing thermostatized N2 to the sample. A holder containing multiple thermometer 
probes is placed inside the chamber for a better mapping of the temperature. All 
measurements were performed in nitrogen environment. The temperature control was 
regulated by software created by the MecWins Company. 
Monocrystalline Si microcantilever chips containing arrays of eight cantilevers 
(Micromotive GmbH) were used for the nanomechanical measurements (Figure 
4.4.8a). Specifically, the nominal length, width, and thickness of the cantilevers were 
500, 90±2 and 1 μm, respectively. Resonance frequency measurements were conducted 
in a nitrogen atmosphere at 25 °C. The experimental setup is based on the shift induced 
in the resonance frequency by the added mass onto the cantilever through 
functionalization. The used platform consists in the automated two-dimensional 
scanning with a single laser (1 mW) beam by voice-coil actuators perpendicularly located. 
Displacements over a range of several millimetres at speeds up to 10 mm/s and with an 
accuracy of 100 nm are achieved. Once the laser beam is reflected by the cantilever array, 
the exact position and intensity of the reflected spot is collected by a two-dimensional 
linear position detector. Moreover, TRACKER, which is an algorithm that recognizes 
reflected intensity patterns, locates cantilever sensors in a fully automated process.  
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4.4.2 Results and discussion 
The response of Omp2a to thermal stress has been compared with those of BSA and 
LYS. The latter exhibits an ellipsoidal shape in which both ordered (30% -helix, 27% -
turn and 13% -sheet secondary structures) and unordered (30%) regions coexist,83 
while BSA structure is predominantly -helical with the remaining polypeptide occurring 
in turns and extended or flexible regions (i.e. with no -sheets).84 Before nanomechanical 
measurements, the effects of the heat shift on the secondary structure and aggregation 
tendency of such three proteins have been examined.  
 
Secondary structure and diameter 
Temperature-induced protein denaturation is frequently detected using FTIR 
spectroscopy and CD in various wavelength regimes. The vibrational spectrum is 
selective in the absorption band frequency position, widths, and intensities in response 
to protein structural changes.85 Specifically, the amide I band (1700 – 1600 cm-1), which 
convolutes the major structural domain elements of proteins, including -helix, -sheet, 
-turn and random coil (unstructured), has been used to visualize the response of BSA, 
LYS and Omp2a to heating (Figure 4.4.1 displays the FTIR spectra recorded at 30 and 
100 ºC). At high temperature both BSA and LYS underwent a drastic unfolding, as is 
reflected by the apparition of an intense deconvoluted peak at 1640 cm-1 that has been 
associated to the unstructured protein. In contrast, the resemblance between all spectra 
recorded for Omp2a suggests that the -barrel structure is preserved at the highest 
temperature.  
FTIR observations are fully consistent with the CD spectra (Figure 4.4.2) recorded 
in heating runs from 5 ºC to 90 ºC, which reflect an increment of the disordered motifs 
at temperatures higher than 55 ºC for both BSA and LYS while the content of ordered 
secondary structures, especially -helix, decreases. The melting temperature estimated 
from CD results is 67 ºC and 65 ºC for BSA and LYS.  These results are fully consistent 
with those early reported by different authors for LYS in aqueous solution.86,87 
Specifically, it was concluded that the protein losses a small part of helical structures in 
the -domain below 64 ºC, undergoing irreversible (unless cooling start just after 
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Figure 4.4.1 FTIR spectra in the region of amide I of (a) BSA, (b) LYS and (c) Omp2a at 30 ºC and 





reaching 80 ºC) thermal unfolding of the secondary structures at a temperature close to 
75 ºC. Instead, Omp2a only exhibits slight variations (i.e. thermal stress) in the 
secondary structures, the amount of unstructured protein remaining practically constant 
from 5 ºC to 90 ºC. Moreover, the thermal behavior of the three proteins is reversible, as 
is evidenced from the analyses of the CD spectra recorded in cooling runs (Figure 4.4.3). 
The influence of the temperature in the shape and aggregation of the proteins was 
assessed by DLS. Profiles displaying the variation of the particle Deff with the 
temperature are included in Figure 4.4.2 (both heating and cooling runs).  
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Bimodal distributions were found for BSA at all examined temperatures and, 
therefore, two Deff profiles are displayed in Figure 4.4.2a. In the first one, which 
corresponds to individual BSA the unfolding process is accompanied by an increment of 
 
Figure 4.4.2 CD spectra (left) recorded for (a) BSA, (b) LYS and (c) Omp2a proteins at 
temperatures ranging from 5 ºC to 90 ºC (heating runs). Measurements for BSA and LYS were 
performed using a carbonate buffer, whereas a dodecyl sulfate (SDS) – 2-methyl-2,4-
pentanediol (MPD) buffer was used for Omp2a. The variation of amount of secondary 
structures (in %) against the temperature is also represented (middle). Effective diameter 
(right) derived from DLS measurements at temperatures ranging from 20 ºC to 60 ºC 
(measures for heating and cooling runs are displayed) for (a) BSA, (b) LYS and (c) Omp2a 
proteins. Two profiles are displayed for BSA since a bimodal distribution was found for all 
examined temperatures, while a unimodal histogram was observed for both LYS and Omp2a. 
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the molecular dimension. The Deff values of the second profile are approximately three 
times the values of the first one, indicating that BSA also forms trimers.. In this case, Deff 
increases from 234 nm at 20 ºC to 462 nm at 60 ºC. In contrast, LYS presents 
unimodal distributions, independently of the temperature, with similar Deff values (i.e. 
4.30.2 nm and 4.30.5 nm at 20 and 60 ºC, respectively). Although these results 
suggest that LYS volume is not affected by the unfolding, what actually occurs is that 
unfolding is accompanied by a reduction in the hydration. The latter was proved in early 
X-ray scattering studies at 20 ºC and 80 ºC,86 which showed that the electron density of 
water in LYS crystals decreases with the crystallization temperature and, consequently, 
the radius of gyration remained practically invariant. Thus, we hypothesize that changes 
in protein hydration offset the thermally induced protein motion. Similar observations 
have been found for other proteins,88 negative volume changes being detected in some 
cases.89  
Finally, Omp2a also presents a unimodal distribution, even though Deff increases 
when the 6.10.2 nm at 20 ºC to 12.62.4 nm at 60 ºC. The former value has been 
associated to the trimeric state while the latter corresponds to bigger aggregates. The 
thermal stability observed for Omp2a combined with this significant variation, which is 
even higher in the cooling run (i.e. from 21.65.1 nm at 60 ºC to 6.90.4 nm at 20 ºC), 
indicates that the reversible aggregation of this OMP is notably enhanced by the 
temperature. Thermomechanical assays combined with these DLS results have been used 
to explain the aggregation phenomena of Omp2a in the Discussion section. 
Figure 4.4.3 CD spectra recorded for BSA, LYS and Omp2a proteins at temperatures ranging 
from 90 ºC to 5 ºC (cooling runs). The figure represents the variation of amount of secondary 
structures (in %) against the temperature. Results obtained for the heating run are displayed in 
the main text.  
BSA LYS Omp2a 




Time resolved WAXD data on heating and cooling of lyophilized Omp2a  
Real time WAXD experiments were performed using synchrotron radiation to 
examine the evolution of the -sheets motifs in dried Omp2a during heating and cooling 
processes. Analyses were performed considering both Omp2a and blank samples, which 
were obtained by freeze drying the detergent buffer solution in presence and absence of 
protein, respectively. The one dimensional WAXD profile acquired for Omp2a at room 
temperature exhibits a sharp and intense peak at q= 15.64 nm-1 (Figure 4.4.4a), which 
corresponds to an inter-strand spacing of d= 4.02 Å.90,91 This peak is absent in the 
spectra recorded for blank samples, the broad peak centered at q= 15.40 nm-1 being 
attributed to the salts from the buffer (Figure 4.4.4a, magnification). The presence and 
absence of the reflection associated to the -sheet in the Omp2a and blank samples, 
respectively, is clarified in the representative diffraction patterns showed in Figure 
Figure 4.4.4 (a) 1D scattering patterns of blank (salts from the buffer solution) and Omp2a 
samples as dry powder at room temperature. (b) 2D scattering patters of the blank and Omp2a 
dried samples at room temperature. (c) 1D scattering pattern of Omp2a when a temperature 
ramp (heating) is applied. (d) Intensity of the peak profile for the blank and the Omp2a samples 
at q= 15.6 nm-1 during the temperature ramp.  
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4.4.4b. Figure 4.4.4c displays a three-dimensional representation of the freeze dried 
Omp2a WAXD profiles in the -sheet region (q= 15-16 nm-1) obtained by heating at a rate 
of 5 ºC/min from 25 ºC to 110 ºC, whereas Figure 4.4.4d represents the variation in 
intensity of the peak at q= 15.6 nm-1 that occurs when heating both for Omp2a and blank 
samples. The variation with temperature of this narrow and intense peak has been used 
to monitor the effect of the different thermally-induced structural processes in inter-
strand interactions. First, the intensity experiences a small increment at 50-55 ºC, which 
has been attributed to the reinforcement of neighboring intermolecular connections. 
According to DLS observations, which evidenced the transition from the trimeric form to 
bigger aggregates (Figure 4.4.2c), this result has been interpreted as the formation of 
new -sheets between neighboring protein molecules. After this, from 55 ºC to 75 ºC 
the intensity decreases slowly and, suddenly, grows again at 80 ºC. These changes 
suggest the restructuration of the newly formed aggregates during the heating process. 
Finally, the peak progressively broadened and becomes less intense at higher 
temperatures, evidencing that temperature has some effects in the local stability of the -
sheets. In spite of this, the peak maintains 47% of its initial intensity at 100 ºC, which is 
consistent with the overall stability of the -barrel structure observed above by FTIR 
(Figure 4.4.3c).  
 
Protein immobilization onto the surface of silicon microcantilevers 
The microcantilever-based biosensing technology has been applied in this work to 
monitor the response of OMPs in synthetic environments against the temperature 
change. Analysis of the results has been carried out by comparing their thermal behavior 
with conventional proteins. Among other features, this nanomechanical platform is 
characterized by the high sensitivity, label-free detection, and small sample consumption 
due to the size of the microcantilevers (ca. 1000 m2).92 For successful characterization, 
the first step is the functionalization of silicon microcantilevers to achieve a stable and 
irreversible protein–surface binding.  
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In this work, a recently developed procedure to covalently bind small peptides to 
silicon has been extrapolated and adapted to BSA, LYS and Omp2a proteins (Figure 
4.4.5a).93 This four-step protocol can be summarized as follows: (i) the microcantilever 
surface, previously hydroxylated with acids, is silanized with (3-
glycodyloxypropyl)trimethoxysilane; (ii) epoxy groups are opened with Nα,Nα-
bis(carboxymethyl)-L-lysine hydrate (NTA-NH2) at basic pH; (iii) the carboxylated 
surface derived from (ii) is activated with a mixture of 1-[(3-dimethylamino)propyl]-3-
ethylcarbodiimide methiodide (EDC) and N-hydroxysuccinimide (NHS); and (iv) 
proteins are immobilized by incubating the activated surface in the corresponding 
protein solution. Before conducting any measurement, proteins not covalently bonded to 
the substrate were desorbed by washing with a PBS. Since the three proteins investigated 
contain a relatively large number of amine groups, corresponding to multiple lysine 
Figure 4.4.5  (a) Protein functionalization protocol for silicon substrates. (b) N 1s, C 1s and O 
1s high-resolution XPS spectra for non-functionalized (hydroxylated; Si-OH) and protein 
functionalized (LYS, BSA or Omp2a) silicon substrates. Peaks from deconvolution are also 
displayed.  
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residues, in addition to the N-terminal amine, the study of protein-overhang interactions 
is limited by this immobilization procedure. 
Comparison of the characteristic XPS spectra in the N 1s, C 1s and O 1s regions of 
hydroxylated (non-functionalized) silicon and protein-functionalized substrates (Figure 
4.4.5b) chemically proves the success of the immobilization protocol. The presence of a 
peak in the C 1s region of the non-functionalized silicon spectrum has been attributed to 
the presence of organic contaminants from the environment. Whilst the latter makes 
more difficult the corroboration of the protein incorporation, the carbon content is 
significantly higher when silicon was functionalized with BSA, LYS and Omp2a (Table 
4.4.1), showing a 4.5, 3.0 and 3.2 fold increase, respectively. Moreover, the apparition of 
the N 1s peak, which was not detected for non-functionalized substrates, is an 








Changes in surface properties, as for example the wettability (Figure 4.4.6a) and 
the surface topography (Figure 4.4.6b), provide indirect evidence of the binding 
between the substrate and the protein. Thus, contact angle () measurements using 
deionized water showed that the hydrophilic character of silicon (= 30º5º) decreased 
considerably upon the incorporation of protein (= 70º3º, 47º2 and 49º6º for BSA, 
LYS and Omp2a, respectively). Similarly, 3D topographic AFM images reveal significant 
differences between the bare silicon substrate and the functionalized ones, which affect 
the root-mean-square roughness (Figure 4.4.6c). Moreover, inspection of the cross 
sectional profiles (Figure 4.4.6d) are consistent with the immobilization not only of 
 O 1s C 1s Si 2p N 1s 
Hydroxylated 
silicon 
47.7 13.4 38.9 - 
BSA-silicon 22.5 60.0 10.8 6.7 
LYS-silicon 31.6 40.2 26.7 1.5 
Omp2a-silicon 30.6 43.4 20.7 5.3 
Table 4.4.1 Atomic percent composition (O 1s, C 1s, Si 2p and N 1s) obtained by XPS for non-
functionalized (hydroxylated) and protein functionalized (i.e. with BSA, LYS or Omp2a 
covalently immobilized at the surface) silicon substrates  
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individual protein molecules but also of aggregates, diameter sizes ranging from 40 to 98 
nm.  
 
Thermomechanical response of protein functionalized microcantilevers  
Protein-functionalized silicon chips with arrays of eight cantilevers (i.e. using such 
number of sensors in parallel) were operated in dynamic mode (Figure 4.4.7a). 
Piezoelectric excitation (i.e. an actuator is positioned below the chip base) and their first 
vibration mode were monitored by a scanning laser. After cleaning with isopropanol and 
hydroxylation with a H2O2:H2SO4 (3:1 v/v) mixture, hydroxylated chips (100 m wide, 
500 m long and 1 m thick) displayed a resonance frequency of 5206162 Hz (n= 16) 


































































Figure 4.4.6 (a) Average contact angle of non-functionalized and functionalized silicon 
substrates. Greek letters on the columns refer to significant differences when 1 way ANOVA and 
Tukey’s multiple comparison tests are applied: α vs Si-OH (p < 0.0001) and β vs BSA (p < 
0.0001). (b) Topographic AFM images of non-functionalized and functionalized substrates (500 
 500 nm2). (c) Root-mean-square roughness (Rq) values. δ  vs Si-OH (p<0.05). (d) 
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Figure 4.4.8a shows the resonance frequency shift of at least 16 LYS-, BSA- and 
Omp2a-functionalized cantilevers. As it can be seen, the frequency shift value is 
significantly higher for Omp2a than for BSA and LYS. Provided the molecular weight of 
Omp2a is supramolecular aggregates is clearly evidenced. This feature is corroborated by 
comparing nanomechanical first mode resonances of hydroxylated and functionalized 
cantilevers (Figure 4.4.7c,d and e), which provides a shift of 92, 182 and 313 Hz for 
LYS, BSA and Omp2a, respectively. On the other hand, the standard error of the mean 
calculated for Omp2a is significantly higher than for LYS and BSA. This has been 
attributed to the variability in the size of the Omp2a supramolecular aggregates, which 
induces fluctuations in the measured frequency shift values. However, it should be 
remarked that differences among LYS, BSA and Omp2a are large enough to be 
independent of such uncertainty. The thermal response of proteins have been analyzed 
by plotting the displacement (S) of the reflected laser spot on the position sensitive 
detector (PSD), which originates from the variation of the local slope at the cantilever 
surface with the temperature and depends on the distance (D) between the cantilever 




Figure 4.4.7 (a) Silicon chips with arrays of eight cantilevers used for nanomechanical 
measurements (Micromotive GmbH). (b) Scheme displaying the experimental setup used to 
evaluate the thermal response of LYS, BSA and Omp2a proteins. Nanomechanical resonance 
response of a silicon cantilever functionalized with (c) LYS, (d) BSA and (e) Omp2a. The shift 
with respect to the hydroxylated (non-functionalized) cantilever used as reference is displayed. 




Figure 4.4.8   (a) Nanomechanical response, expressed as resonance frequency shift (f/f), of 
functionalized cantilevers (mean values and standard error of the mean calculated with the data 
of at least 16 different cantilevers). (b) Relative displacement as a function of the temperature of 
a representative hydroxylated (non-functionalized) cantilever. Thermomechanical response of 
cantivelevers functionalized with (c) LYS, (d) BSA and (e) Omp2a proteins. Right: mean relative 
displacement as a function of the temperature (blue, red and green dots in c, d and e, 
respectively) and the corresponding standard error of the mean (thick light-grey lines), both 
calculated with the data of at least 7 different cantilevers, are displayed at the right. Left: 
cartoons schematizing the folded  unfolded transitions in c and d, and the trimer  large 
aggregate and -barrel  unfolded transitions in e. The four regions described in the text are 
labelled in e. 
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It is worth noting that the variation of S with the temperature is analogous to the 
thermally induced cantilever deflection (z). As it was expected, the displacement of non-
functionalized cantilevers increases slowly and progressively with the temperature 
(Figure 4.4.8b), as the deflection of rectangular bare cantilevers of length L grows 
linearly with the change of temperature (T), that is z  L2T.94  
The average displacement curve obtained for LYS (Figure 4.4.8c), which was 
obtained using 16 different microcantilever sensors, reflects a behaviour very different 
from that obtained for non-functionalized cantilevers. The slope of the displacement 
curve in the region comprised from room temperature to 50 ºC is related to the 
deflection produced by the different thermal response of the two materials contained in 
the system (i.e. the silicon substrate and the attached protein). More specifically, protein-
functionalized cantilevers undergo a differential stress due to the thermal expansion 
coefficient difference between the protein and the microcantilever itself, giving rise to the 
cantilever deflection. After this, at 50 ºC the protein starts to unfold, causing a 
redistribution of the molecular mass and reducing the contact between the protein and 
the substrate. This situation enhances the cantilever deflection, as it is reflected by the 
sustained increasing displacement of the profile displayed in Figure 4.4.8c. Thus, the 
melting temperature of LYS, as determined thermomechanically, is approximately 60 ºC, 
which is consistent with the CD data (Figure 4.4.2). At 70 ºC the slope of the 
displacement curve changes and the curve is similar to that observed for the 
hydroxylated silicon cantilevers (Figure 3.4.8b). Thus, once LYS completes the 
conversion towards the unfolding state, the changes induced by the thermal dynamics of 
the random coil are not reflected in the deflection. At this stage the effects associated to 
the mass redistribution and the variation of the protein···surface interactions are 
negligible in average. Overall, the profile displayed in Figure 4.4.8c should be 
considered as the fingerprint to recognize the thermomechanical response of 
conventional proteins, in which the folded  unfolded is the only occurring thermal 
transition.  
Figure 4.4.8d displays the average displacement curve achieved for BSA. From a 
qualitative point of view, the behaviour of the curve is similar to that described above for 
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LYS until 100 ºC, even though the cantilever deflection is smaller for BSA. This has 
been attributed to the higher molecular weight of BSA and its tendency to aggregate, 
both reducing the differences in the stress distribution and the stress gradient between 
the protein and the substrate. Consequently, the impact of the bimetallic effects in the 
bending of the cantilever is relatively small before the protein denaturation at 60 ºC. 
Moreover, the effect of the redistribution of the molecular mass during the unfolding 
process is also smaller than for LYS. As the effect of the unfolding on the cantilever 
displacement is expected to be directly proportional to the amount of protein molecules, 
these results suggest that such amount is lower for cantilevers functionalized with BSA 
than with LYS. Although this could be in apparent contradiction with the 
nanomechanical first mode resonance shift, which is 90 Hz lower for the latter (Figure 
4.4.7c,d and e), it is worth noting that the molecular weight of BSA is four times higher 
than that of LYS.   
In spite of this, the dynamics of the random coil causes a change in the sense of the 
cantilever deflection. Thus, deflection downwards or upwards of the cantilever is mainly 
defined by the response of the protein within the studied temperature range and, as 
mentioned above, the deflection was relatively low before the unfolding. After this, the 
upward profile experiences an abrupt change at 110 ºC, which is not detected for LYS. 
Although this sudden drop in the displacement could be hypothesized as a 
disaggregation of the protein molecules, a simple thermogravimetric analysis (not 
shown) evidenced that it corresponds to the evaporation of water molecules that were 
strongly interacting with the protein. Accordingly, in addition to the molecular unfolding, 
thermomechanical characterization of BSA reveals sharp dehydration process that, 
suddenly, produces a change of sign in the stress gradient.  
The displacement profile recorded for Omp2a (Figure 4.4.8e) exhibits unusual 
complexity. Although bimetallic effect initially affects the cantilever deflection, as in LYS 
and BSA, four regions with distinctive regimes can be distinguished above 40 ºC for 
Omp2a. In the first one, which extends from 40 ºC to 60 ºC, the variation of the 
displacement is practically null, suggesting that the redistribution of the molecular 
masses and the changes in the protein···substrate interactions are minimum (region I in 
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Figure 4.4.8e). From a microscopic point of view, this region has been associated with 
the alteration of intermolecular interactions before the transition from trimers to bigger 
aggregates, which is also consistent with WAXD observations (Figure 4.4.4). While 
initially they seem to become more intense, the step prior to the conversion into bigger 
aggregate is characterized by a weakening of interactions among neighbouring Omp2a 
molecules in trimers. This phase transition is evidenced by the increasing displacement 
(region II in Figure 4.4.8e), which occurs in a relatively wide interval of temperatures 
(i.e. between 60 ºC and 77 ºC). After this (region III in Figure 4.4.8e), the 
displacement experiences small fluctuations, the average deflection increment along the 
whole region being very small. These fluctuations have been associated with local re-
organizations in the newly formed aggregates. Above 105 ºC, the displacement drops 
sharply (region IV in Figure 4.4.8e), suggesting that at such high temperatures the 
thermal stability of the -barrel is finally lost. Therefore, the downward deflection of the 
cantilevers is a consequence of the folded  unfolded transition that alters both the mass 
distribution and the Omp2a···substrate interactions. These observations are fully 
consistent with the WAXD results displayed in Figure 2d. 
 
Discussion 
Although the secondary structure of bacterial OMPs are known to be very sensitive to 
the polarity of the environment, they exhibit an increased thermal stability that has been 
typically attributed not only to the abundant -strands barrel but also to their oligomeric 
architectures.95-98 However, complete understanding of the thermal response of their 
supramolecular oligomeric architectures in synthetic environments, which is essential for 
the utilization of OMPs in the fabrication of bioinspired nanodevices, is an unresolved 
question.99 
Our FTIR and CD results on Omp2a prove that the efficient inter-strand hydrogen 
bond network preserves the protein secondary structure from thermal unfolding even 
outside lipid environments similar to those found in nature. Besides, the heat-induced 
CD response of secondary structural elements in Omp2a has also been compared with 
that of conventional proteins. In folded proteins the -helix is recognized by minima at 
220 and 210 nm, while the -sheet has a minimum at 218 nm and a maximum at 195 
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nm.100 These two structural motifs are detected in the spectra recorded for LYS and 
Omp2a at room temperature, whereas the spectrum of BSA mainly involves the helical 
motif. However, the structural signatures of BSA and LYS significantly change beyond 
55 ºC, evidencing the loss of secondary structure,101 while the CD spectrum of Omp2a 
remains practically unaltered until 90 ºC.  
On the other hand, DLS data reflect that Omp2a self-associates into the typical 
trimeric state found in the outer membranes of bacteria in the detergent buffer at room 
temperature. Thus, the Deff measured by transmission electron microscopy (TEM) for 
Omp2a trimers in dried samples was recently found to be 9.33.0 nm, which is 
consistent with DLS value at 20 ºC (6.10.2 nm). However, the formation of bigger 
aggregates is detected by DLS when the temperature increases above 50 ºC, even though 
they are significantly smaller (Deff= 12.62.4 nm) than those also observed in dried 
samples at room temperature (Deff= 25.94.8 nm) by TEM. Thus, the van der Waals 
interactions between the side groups at the external side of the -barrel are promoted 
through both drying and heating. This feature points out the importance of improving 
the understanding of Omp2a self-association processes in non-native environments, as 
for example those used to fabricate bioinspired NMs for ion transport.  
WAXD experiments indicate that temperature affects the -sheet structure of Omp2a. 
This effect is focused in intermolecular interactions at temperatures lower than 80 ºC 
and in both inter- and intramolecular interactions at higher temperatures. However, the 
amount of -sheets preserved at 110 ºC is still high enough to preserve the -barrel 
structure, which supports FTIR and CD results. Thus, WAXD results corroborate the 
conversion of trimers into bigger aggregates at 50-55 ºC, which after equilibration 
through local reorganizations remain relatively stable until 80 ºC. At higher 
temperatures, inter- and, probably, intramolecular -strands, are affected by the thermal 
stress, these interactions being roughly halved. This interpretation is consistent with the 
well-known increased thermal stability of bacterial porins, which exhibit temperature 
induced unfolding above 100 ºC.95,102 This unusual stability is consequence of their -
barrel structural architecture composed of antiparallel -sheets, in which strands are 
connected by long loops. Thus, the energy required to breakdown the secondary and 
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quaternary structure of bacterial porins is significantly higher than that necessary to 
unfold BSA and LYS. Also, yet porins aggregates are stable, a variety of transitions 
associated to changes in their size (i.e. to dimers, trimers or bigger aggregates) has been 
detected at temperatures significantly lower than their unfolding temperatures but 
comparable to the typical unfolding temperatures of conventional proteins,102-104 which is 
in agreement with the opposite behaviours of Omp2a and BSA. 
The Deff of LYS, which remains at 4.30.2 nm for both 20 and 60 ºC, corresponds to 
the monomer diameter.105,106 Thus, the mass contribution of aggregates, which are 
extremely difficult to avoid completely even with dilute samples, was null in the case of 
LYS. These features combined with CD and FTIR data indicate that the unfolding is the 
only thermally-induced transition for LYS. Finally, BSA displays an intermediate 
situation with two Deff values originated by the bimodal distribution observed at each 
temperature. The lowest value, 8.11.4 nm at 20 ºC, which is consistent with the 
dimensions of the prolate ellipsoid shape proposed for the protein monomer (14  4 
nm),105 increases by 30% with the temperature, due to the unfolding. However, the 
highest value, 234 nm at 20 ºC, grows more than twice when the temperature reaches 
60 ºC. In this case, small aggregates (dimers or trimers) not only experience unfolding 
processes but also incorporate more protein molecules. Accordingly, BSA self-association 
is promoted by the temperature when already formed aggregates act as nuclei. Overall, 
FTIR, CD and DLS results probe that LYS and BSA are suitable controls for the present 
microcantileveler deflection studies due to their different behavior not only with respect 
to Omp2a but also among them.  
Proteins have been covalently linked via an epoxysilane-based protocol to silicon 
microcantilevers that had been efficiently activated by a hydroxylation treatment with a 
H2O2:H2SO4 mixture. The results derived from the different chemical and physical 
characterization techniques performed at each functionalized substrate have confirmed 
directly and indirectly, respectively, the suitability of the protocol to tether 
biomacromolecules onto the silicon surfaces. Moreover, topographic images of protein 
functionalized surfaces, once biomacromolecules non-covalently bonded to the surface 
were eliminated, evidence heights and widths of 2-4 nm and 40-100 nm, respectively, 
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demonstrating the immobilization of aggregates. As expected, the latter aggregates are 
much smaller and less abundant for LYS than for BSA and Omp2a, the former showing 
the flatter profile (root-mean-square roughness of non-functionalized, LYS-, BSA- and 
Omp2a-functionalized substrates is 4.9  2.1, 6.1  2.6, 10.5  5.9 and 10.7  3.0 Å, 
respectively). 
The resonance frequency of non-functionalized cantilevers (), which depends on 
their spring rigidity (k) and effective mass (M), is obtained by the elasticity theory as: 







  (Eq. 4.4.1) 
The constant k is obtained using cantilever Young modulus (E) and dimensions, 
length (L), width (W) and thickness (T):107 




EWTk    (Eq. 4.4.2) 







  (Eq. 4.4.3) 
where  is the resonance frequency contribution due to the tethering of the protein, 
m is the mass of the protein, and   is a function that depends on k and the surface stress 
() induced by protein···silicon surface interactions.108 Particularly, the difference in 
frequency shift (Δ/ x 103) for LYS, BSA and Omp2a was 13.2 ± 4.1, 20.2 ± 1.4 and 43.6 
± 15.6, respectively. These resonance frequency shifts suggest that protein···surface 
interactions predominate over m since the shift is two times higher for Omp2a than for 
BSA, whereas the molecular weight is 1.7 times higher for the latter than for the former. 
Accordingly, protein···surface interactions can be considered as a nanomechanical 
signature sensitive not only to the existence of protein aggregation phenomena but also 
to the distribution of the molecules in such aggregates. 
In addition to the mass redistribution onto the cantilever surface, which causes 
changes in the resonance frequency, and to the bimetallic effect, the main mechanical 
effect in microcantilevers is the surfaces stress () that induces a nanoscale bending.1 
This effect, which occurs if only one of both cantilever sides are coated or, as in this work, 
functionalized, is quantified using the Stoney’s equation:109 
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  (Eq. 4.4.4) 
where L is the microcantilever effective length (450 m), T is the microcantilever 
thickness (1 m), E is the Young modulus of silicon (150 GPa),  is the Poisson ratio of 
silicon (0.17) and z is the deflection of the cantilever. The surface stress is frequently 
associated to intermolecular interactions between molecules anchored onto the 
cantilever surface, such as van der Waals forces, hydrogen bonds, electrostatic 
interactions, steric repulsions, etc. Ideally, protein-functionalized cantilevers should not 
exhibit any static surface stress if the functionalization was identical for both sides. 
However, in practice, the experimental set-ups used during the functionalization process 
do not result in two identical cantilever sides. As a consequence, the surface stress is not 
negligible for protein-functionalized cantivelers (e.g. at 120 ºC, = 0.46  0.12, 0.31  
0.05 and 0.30  0.15 mN/m for LYS, BSA and Omp2a, respectively; Figure 4.4.9a), and 
significantly higher than that measured for hydroxylated non-functionalized ones (e.g. at 
120 ºC, = 0.08  0.012 mN/m). Moreover, the surface stress experiences a significant 
increment when the temperature is higher than 50 ºC for all functionalized cantivelers 
(Figure 4.4.9b).   
Analyses of the displacement curves obtained for protein-functionalized cantilevers 
allowed distinguishing folded  unfolded conformational transitions from phase 
changes related with protein aggregates. Thus, the thermally-induced increment in the 
deflection of protein-functionalized cantilevers is not constant, as occurs for non-
functionalized cantilevers. Proteins are much more sensitive than silicon to the 
temperature and, therefore, the general evolution of the displacement observed at 
relatively low temperatures (< 50 ºC) is mainly due to the differences in both stress 
distribution and stress gradient between the protein and the silicon substrate (i.e. the 
bimetallic effect). In such conditions, the bending of protein-functionalized cantilevers 
depends on the molecular weight and the presence of aggregates.  
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After this, conventional proteins exhibit an abrupt change in the evolution of the 
curve, which is ascribed to their denaturalization process. This folded  unfolded 
transition occurs at temperatures close to 50 ºC and 60 ºC for LYS and BSA, 
respectively, which are lower than those observed in water (60-70 ºC). Consequently, in 
solution the folded structure of these soluble proteins is stabilized by intermolecular 
hydrogen bonds with surrounding water molecules, which are loss upon removal of the 
solvent. This instability induces a lower unfolding temperature.  
Once the denatured protein reaches a stable random coil, the dynamics of this state 
should not affect the thermomechanical response of the cantilever. This is true for LYS- 
and BSA-functionalized substrates, which show a behavior similar to that of non-
functionalized cantilevers when the temperature exceeds 55 and 60 ºC, respectively. 
However, BSA-functionalized cantilevers display another transition at 110 ºC that has 
been ascribed to the evaporation of water molecules strongly interacting with protein 
molecules.  
The thermomechanical response of Omp2a is more complex than those of LYS and 
BSA because of both its intrinsic thermal stability and the tendency to form not only 
trimers but also larger aggregates. The thermal behavior of this porin is characterized by 
Figure 4.4.9 (a) Surface stress determined for hydroxylated (control) and protein-
functionalized cantilevers at 120 ºC. Significant differences are encountered on groups marked 
with the Greek letter α (<0.05) compared to the control group. (b) Variation of the surface 
stress for hydroxylated (control) and protein-functionalized cantilevers against the temperature. 
(a) (b) 
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local re-organizations, which affect the strength of intermolecular interactions among 
neighbouring Omp2a molecules, inducing the transition from trimers to larger 
aggregates. The formation of such larger aggregates is consistent not only with DLS 
results but also with previous TEM investigations, as mentioned in the Results section. 
The latter phase transition is poorly defined, as reflects the continuous increase of the 
displacement in the temperature interval comprised between 60 ºC and 77 ºC. This 
feature should be attributed to the fact that the size and shape of the aggregates formed 
at such temperatures are constrained by the functionalization of the cantilever, which 
defines the tethering position of the protein molecules and gives variability to the 
transition. Such heterogeneity explains the undefined character of the transition that, in 
spite of the monodisperse and precise chemical nature of Omp2a molecules, occurs 
within a wide interval of temperatures rather than at a precise temperature. On the other 
hand, the thermal unfolding of Omp2a is detected at 105 ºC, this temperature 




In summary, thermomechanical measurements at the microscopic level on 
functionalized cantilevers have provided molecular insights that complement the 
information obtained from conventional characterization techniques on ensembles 
formed by a very large number of molecules. A serious limitation of conventional 
techniques is that they provide only a sample average response and are unable to give 
information on specific local features on or within the sample. Within this context, the 
unique thermomechanical response of Omp2a-functionalized cantilevers, which exhibits 
four well-defined regimes above 40 ºC (Figure 4.4.8e), suggests practical approaches 
to improve the efficacy of smart biomimetic NMs with porins immobilized onto the 
surface64,110-112 or confined inside synthetic pores.113-114Specifically, although the 
effectiveness of NMs is regulated by the amount of porin molecules active for the ion 
transport, controlling their orientation once immobilized onto the surface or inside 
nanopores is a challenge that has not been achieved yet. However, the identification of 
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temperature intervals in which protein molecules experience local structural re-
arrangements with an enhancement of intermolecular -sheets, suggests that soft post-
thermal treatments could be very advantageous to improve the efficacy of the NMs. Thus, 
this could be achieved by heating the proteins from their initial assembly state to 
denaturalization and, subsequently, cooling under controlled conditions to maximize 
favourable interactions. The amount of protein molecules contributing to the selective 
ion transport substrate could be substantially increased by enhancing the intermolecular 
-sheets, which requires local orientation of the immobilized biomolecules. 
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First, the production of nanoperforated poly(lactic acid) (PLA) free-standing nanomembranes 
(FsNMs) has been prepared and optimized using a two-step process: (1) spin-coating a mixture of 
immiscible polymers to provoke phase segregation and formation of appropriated nanofeatures (i.e. 
phase separation domains with dimensions similar to the entire film thickness); and (2) selective 
solvent etching to transform such nanofeatures into nanoperforations.  
Later, bioinspired free-standing nanomembranes (FSNMs) for controlled ion transport have 
been tailored by immobilizing the Omp2a β-barrel membrane protein inside nanoperforations 
created in flexible poly (lactic acid) (PLA) nanomembranes. The protein confined inside the 
nanopores of PLA FSNMs preserves the β-barrel structure and organizes in ovoid aggregates. The 
transport properties of Na+, K+, and Ca2+ across non-perforated PLA, nanoperforated PLA, and 
Omp2a-filled nanoperforated PLA have been monitored by measuring the nano- membrane 
resistance with electrochemical impedance spectroscopy (EIS). The incorporation of 
nanoperforations enhances the transport of ions across PLA nanomembranes, whereas the 
functionality of immobilized Omp2a is essential to exhibit effects similar to those observed in 
biological nanomembranes. Indeed, Omp2a-filled nanoperforated PLA nanomembranes exhibit 
stronger affinity towards Na+ and Ca2+ ions than towards K+. In summary, this work provides a 
novel bioinspired strategy to develop mechanically stable and flexible FSNMs with channels for ion 
transport, which are precisely located inside artificial nanoperforations, thus holding great potential 
for applications in biofiltration and biosensing. 
 
Publications derived from this work: 
Puiggalí-Jou, A.; Medina, J.; del Valle L. J. and Alemán, C. Nanoperforations in poly(lactic acid) 
free-standing nanomembranes to promote interactions with cell filopodia. Eur Polym J. 2016, 75, 
552-564. 
 
Puiggalí-Jou, A.; Pérez-Madrigal, M. M.; del Valle, L. J.; Armelin, E.; Casas, M. T.; Michaux, C.; 
Perpète, E. A.; Estrany, F. and Alemán, C. Confinement of a β-barrel protein in nanoperforated free-
standing nanomembranes for ion transport. Nanoscale 2016, 8, 16922-16935. 
 





The term giant nanomembrane was coined by Kunitake et al.1 to denote self-
supporting membranes with thickness (L) from 1 to 100 nm and an aspect ratio of size 
and thickness higher than 106. Besides such characteristics, these free-standing 
nanomembranes (FsNMs) exhibit other special properties, such as easiness of handling, 
low weight, high flexibility, robustness and, in some cases, transparency2. In the last 
decade, polymeric FsNM, have emerged as versatile elements for biomedical applications 
as varied as overlapping therapy, burn wound infection treatment, antimicrobial 
platforms, scaffolds for tissue engineering, drug-loading and delivery systems, 
biosensors, etc., as recently reviewed Pérez-Madrigal et. al 3. 
Among the synthetic polymers used to prepare FsNMs for biomedical applications, 
linear aliphatic polyesters, such as poly(lactic acid) (PLA) and poly(tetramethylene 
succinate) (PE44), have been extensively chosen since their biodegradation rate and 
mechanical properties can be easily controlled through variations in their molecular 
weight3-7. Within the specific case of PLA, Takeoka and co-workers8 developed FsNMs 
with L= 235 nm by spin-coating polymer solutions onto poly(vinyl alcohol) (PVA) 
sacrificial films. The mechanical properties and adhesion strength exhibited by such PLA 
nanosheets, encouraged the analysis of their feasibility as a wound dressing8,9. On the 
other hand, Pensabene et al.10 studied the biocompatibility, adhesion and proliferation 
activity of several cell types onto PLA FsNMs with an average thickness of L= 32027 
nm, which were also prepared by spin-coating. Both, immortalized cell lines and primary 
cell lines cultured on those FsNMs exhibited good morphological and metabolic features 
and the ability to fully differentiate. Moreover, the effect of an underlying substrate on 
the interaction between cells and PLA FsNMs was recently investigated by collecting 
spin-coated nanosheets on both a stainless steel mesh and a SiO2 substrate5. Although 
topological and mechanical properties of PLA FsNMs did not influence cell viability after 
24 h of culturing, cells did geometrically sense the stiffness of the underlying material, 






5.2 Materials and methods 
Materials: PLA, a product of Natureworks (polymer 2002D), was kindly supplied by 
Nupik International (Polinyà, Spain). According to the manufacturer, this PLA has a D 
content of 4.25%, a residual monomer content of 0.3%, density of 1.24 g/cc, glass 
transition temperature (Tg) of 58 ºC and melting point of 153 ºC. The number and weight 
average molecular weights and polydispersity index, as determined by GPC, were Mn= 
98,100 g/mol, Mw= 181,000 g/mol and 1.85, respectively. Polyethylene glycol (PEG) with 
Mw= 35,000 g/mol was purchased from Sigma-Aldrich (Germany). PVA (87-89% 
hydrolysed) with Mw= 13,000 – 23,000 g/mol was purchased from Sigma-Aldrich (USA). 
Dry trichloromethane stabilized with 50 ppm of amylene DS-ACS (99.9%) was purchased 
from Panreac Quimica S.A.U. (Spain). 1,1,1,3,3,3-Hexafluoroisopropanol (HFIP) was 
purchased from Apollo Scientific Limit (UK). SiO2 cover-glasses of 14 mm of diameter 
were acquired to Agar Scientific (France) while the glass cover slips, 2222 mm2 were 
purchased at Menzel-Glässer (Germany). For cell culture experiments, Madin-Darby 
Canine Kidney (MDCK) and African green monkey kidney (Vero) cells were purchased 
from ATCC, USA. Dulbecco’s phosphate buffered saline (PBS) solution without calcium 
chloride and magnesium chloride, Dulbecco’s modified Eagle’s medium (DMEM, with 
4500 mg/L of glucose, 110 mg/L of sodium pyruvate and 2 mM of L-glutamine), 
penicillin–streptomycin, 3-(4,5-dimethylthiazol-2-yl) 2,5-diphenyltetrazolium bromide 
(MTT, 97.5%) and trypsin EDTA solution (0.05% trypsin, 0.02% EDTA) were all 
purchased from Sigma-Aldrich, (USA). Fetal bovine serum (FBS) and trypan blue stain 
(0.4%) were purchased from Gibco, UK. 
 
Preparation of solutions and mixtures: For the fabrication of non-perforated PLA 
FsNMs, 50, 25 and 10 mg/mL polymer solutions in chloroform were prepared. 
Perforated FsNMs were obtained by blending PLA and PEG or PVA. PLA-PEG blends 
with 50:50, 60:40, 80:20 and 90:10 PLA:PEG v/v ratios were prepared by combining 
PLA (10 mg/mL) and PEG (10 mg/mL) chloroform solutions. On the other hand, PLA-
PVA blends with 80:20 and 90:10 PLA:PVA v/v ratios were obtained by mixing PLA (10 
mg/mL) and PVA (10 mg/mL) HFIP solutions. 
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Preparation of nanoperforated free-standing nanomembranes (FSNMs): 
Firstly, a PVA solution in milliQ water (100 mg/mL) was spin-coated onto a clean glass 
slip or ITO substrate at 2500 rpm for 60 s to obtain a sacrificial layer. Before using, 
substrates were cleaned by successive sonication in acetone, ethanol and water (5 min) 
and dried with clean dry air. After this, a PLA:PVA solution with 90:10 or 99:1 v/v ratio, 
which was obtained by mixing PLA (10 mg/mL) and PVA (10 mg/mL) HFIP solutions 
and stirring vigorously (three times at 1000 rpm for 30 s each one using a Vortex-type 
mixer), was spin-coated at 7000 rpm for 60 s. Finally, the substrate coated with the PLA-
PVA NM was immersed into milliQ water for separation of the NM from the substrate 
(i.e. dissolution of the sacrificial layer) as well as for the creation of the nanoperforations 
(i.e. dissolution of PVA phases in PLA-PVA NMs). 
 
5.3 Nanoperforations in poly(lactic acid) free-standing 
nanomembranes  
The aim of this work is to improve the applicability of PLA FsNMs as flexible 
bioactive substrates for cell culture by introducing uniformly distributed 
nanoperforations in a controllable manner. More specifically, cell adhesion and 
spreading have been significantly enhanced by adapting the dimensions of nanopores, 
which might penetrate the entire thickness of the ultra-thin film, to those of cell 
nanofeatures (i.e. promoting cell–substrate interactions). For this purpose, 
nanoperforated FsNMs have been prepared by spin-coating mixtures of PLA and a 
polymer with poor affinity towards such polyester, to develop phase-segregated ultra-
thin films with a thickness comparable to the dimensional scale of the phase separation 
domains. Application of the selective solvent etching technique, which was introduced by 
Walheim et al.11 to illustrate the influence of the relative solubility of polymer blends on 
the structure of the films, to the biphasic nanosheets has resulted in the formation of 
perforated PLA FsNMs. The combination of spin-coating and selective solvent etching 




mechanism of immiscible polystyrene (PS): poly(methyl methacrylate) (PMMA) 
mixtures and to prepare nanoperforated PMMA ultra-thin films.  
In this work, phase-segregated ultra-thin films have been prepared by combining 
PLA with polyethylene glycol (PEG) and PVA. However, surface nanofeatures compatible 
with the fabrication of nanoperforated FsNMs via selective solvent etching were only 
detected in PLA-PVA ultra-thin films. Cell viability assays using non-perforated and 
perforated PLA FsNMs have proved that the behavior of the latter as bioactive substrate 
is much better than that of the former, even though it drastically depends on the 
nanopore dimensions.  
 
5.3.1 Methods 
Preparation of free standing nanomembranes: FsNMs were prepared by applying 
the procedure described by Vendamme and co-workers13, which was successfully used in 
previous works6,7,14. Firstly, a PVA solution in milliQ water (100 mg/mL) was spin-coated 
onto a glass slip, cleaned by successive sonication in acetone, ethanol, and water, at 2500 
rpm for 60 s to obtain a sacrificial layer. After this, PLA, PLA:PEG and PLA:PVA 
solutions were spin-coated at speeds ranging from 2500 to 7000 rpm for 1 min to obtain 
ultra-thin films onto the sacrificial layer. Finally, samples were immersed into milliQ 
water for the separation of the nanomembrane from the substrate (i.e. dissolution of the 
sacrificial layer) as well as for the creation of pores (i.e. dissolution of PEG and PVA 
phases in PLA-PEG and PLA-PVA nanomembranes).    
 
Profilometry: Film thickness measurements were carried out using a Dektak 150 stylus 
profilometer (Veeco, Plainview, NY). Different scratches were intentionally provoked on 
the nanomembranes and measured to allow statistical analysis of data. At least eighteen 
independent measurements were performed for two samples of each examined 
condition. Imaging of the films was conducted using the following optimized settings: tip 
radius= 65.5 m; stylus force= 3.0 mg; scan length= 7 mm; and speed= 100 µm/s. 
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Atomic force microscopy (AFM): The surface morphology and topography of 
nanomembranes supported onto glass slips, before and after application of selective 
solvent etching, were studied by AFM. Images were obtained with a Molecular Imaging 
PicoSPM using a NanoScope IV controller under ambient conditions. The tapping mode 
AFM was operated at constant deflection (i.e. vertical constant force with triangular 
shaped gold-coated silicon nitride). The row scanning frequency was set to 0.87 or 0.68 
Hz, depending on the sample response, and the physical tip sample motion speed was 10 
mm/s. 
RMS roughness (Rq) and profile sections of the images were determined using the 
statistics application and tools of the NanoScope Analysis software version 1.20 (Bruker), 
which calculates the average considering all the values recorded in the topographic image 
with exception of the maximum and the minimum. The scan window sizes were 1010 or 
22 m2.  
 
Scanning electron microscopy (SEM): Detailed inspection of nanomembranes 
before and after application of selective solvent etching was conducted by scanning 
electron microscopy. A Focus Ion Beam Zeiss Neon 40 instrument (Carl Zeiss, Germany) 
equipped with an energy dispersive X-ray (EDX) spectroscopy system and operating at 1 
and 5 kV for characterization of systems without and with cells, was used. 
Nanomembranes supported onto glass slips were mounted on a double-sided adhesive 
carbon disc. FsNMs were, firstly, mounted using silver staining and, after this, were 
sputter-coated with an ultra-thin carbon layer (6-10 nm) to prevent sample charging 
problems. The diameter of the perforations was measured with the SmartTiff software 
from Carl Zeiss SMT Ltd. 
 
Wettability: Static contact angle measurements with the sessile drop method were 
recorded and analysed at room temperature on an OCA-15EC contact angle meter from 
DataPhysics Instruments GmbH with SCA20 software (version 4.3.12 build 1037). The 
solvents, which were used as received, considered for this study were:  




 N,N-dimethyl formamide (DMF; Panreac, ultra-high purity); 
 Ethylene glycol (EG; Merck >99.5%); 
The sessile drop was gently put on the surface of non-perforated and nanoperforated 
PLA using a micrometric syringe with a proper metallic needle (Hamilton 500μL). The 
ellipse method was used to fit a mathematical function to the measured drop contour. 
For each solvent and PLA system, 20 drops were examined. 
 
Cell adhesion and cell proliferation assays: Vero and MDCK  cells were cultured 
in DMEM supplemented with 10% FBS, 1% penicillin and 1% streptomycin at 37ºC in a 
humidified atmosphere of 5% CO2 in air. Culture media were changed every three days. 
For sub-culture, cell monolayers were rinsed with PBS and detached by incubating them 
with 0.25% trypsin/EDTA for 5 min at 37ºC. Finally, cells were resuspended in 5 mL of 
fresh medium and their concentration was determined by counting at the Neubauer 
camera using 0.4% trypan blue as dye vital.  
Perforated PLA nanomembranes were prepared by spin-coating on glass cover slips 
of 14 mm of diameter. Samples were placed in plates of 24 wells and sterilized using UV 
light for 15 min in a laminar flux cabinet. Controls were simultaneously performed by 
culturing cells on the surfaces of SiO2 wafers and non-perforated PLA nanomembranes. 
For adhesion assays, an aliquot of 1 mL containing 6104 cells was deposited on the 
nanomembrane of each well. After 24 h non-attached cells were washed out while 
attached cells were quantified. For proliferations assays, the aliquot deposited on each 
well contained 4104 cells. Quantification of proliferated cells was performed after 7 days 
of culture. 
The percentage of cells adhered and proliferated was calculated through the MTT [3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay. This determines the 
cell viability15. Results were normalized to the non-perforated PLA control and 
represented as relative percentages. Specifically, 50 µL of MTT solution (5 mg/mL in 
PBS) were added to each well. After 2 h of incubation, samples were washed twice with 
PBS and stored in clean wells. In order to dissolve formazan crystals, 200 µL of 
DMSO/methanol/water (70/20/10% v/v) were added. Finally, the absorbance was 
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measured at 570 nm through an ELISA reader (Biochrom, UK). Results were derived 
from the average of four replicates (n= 4). 
After culture, samples were fixed in a 2.5% formaldehyde PBS solution overnight at 4 
ºC. Then, they were dehydrated by washing in an alcohol battery (30º, 40º, 70º, 95º and 
100º) at 4 ºC for 15 min per wash. Finally, samples were air-dried and sputter-coated 
with carbon before SEM observation. 
 
5.3.2 Results and discussion 
Non-perforated PLA free standing nanomembranes 
PLA FsNMs have been extensively studied3,5-10 and, therefore, the aim of this sub-
section is only to establish the influence of spin-coater controllable parameter in their 
most relevant nanofeatures. This information is relevant for the choice of the 
requirements subsequently employed in the preparation of perforated nanofilms.  
In order to adjust the thickness, different PLA solutions in chloroform were spin-
coated onto glass slides for 1 min using different conditions. Table 5.3.1 indicates that 
the thickness of the films, as determined by contact profilometry, is severely affected by 
both the angular speed and the polymer concentration in the solution. Thus, although the 
variation of the thickness is inversely proportional to the speed in all cases, this 
phenomenon is more pronounced for the higher PLA concentrations, especially for the 
50 mg/mL PLA solution. Among the tested conditions, membranes of nanometric 
thickness were only obtained with the lowest polymer concentration (10 mg/mL) and the 
highest spin-coater speed (7000 rpm). Figure 5.3.1a evidences that PLA 
nanomembranes prepared under such conditions are very homogeneous and smooth, the 
roughness being of only Rq= 1.1±0.2 nm.   
After this, PLA ultra-thin films were deposited onto a PVA sacrificial layer of L= 
23843 nm and Rq= 2.60.8 nm using the above selected condition. After coating, 
samples were immersed into water for the separation of the PLA membrane. 
Profilometry and AFM measures indicated that both the thickness (L= 238±43 nm) and 






























































































Figure 5.3.1 Three dimensional height (left) and phase (right) AFM images of different PLA 
and PLA-PEG nanomembranes obtained by mixing PLA (10 mg/mL) : PEG (10 mg/mL) 
chloroform solutions and applying a spin-coater speed of 7000 rpm: (a) PLA (1:0); (b) 50:50 
PLA-PEG; (c) 60:40 PLA-PEG; (d) 80:20 PLA-PEG; and (e) 90:10 PLA-PEG. The AFM image 
windows are 1010 m2 in all cases. 
deposited onto glass slides. Thus, spreading of PLA onto PVA was worse than onto glass, 
which has been attributed to the fact that PLA···PVA interactions are more attractive 
than PLA···glass interactions.  
 
PLA-PEG nanomembranes  
Fabrication of nanoperforated FsNMs using a technique based on the phase-
segregation of two polymers and subsequent elimination of one of them via selective 
solvent etching requires fulfilment of the following conditions:  
 The two polymers must be soluble in a common solvent to facilitate the spin-coating 
process. 
 The two polymers must be immiscible to promote the phase separation.  
 The two polymers should have similar molecular weights to facilitate the formation 
of nanofeatures (i.e. nanopores). 
 The polymer used to fabricate the nanomembrane must remain unaltered by the 
solvent employed to dissolve the less abundant polymer. 
In this work, the first attempt to obtain nanoperforated FsNMs was done using PLA 
and PEG. Both materials are soluble in chloroform, while PLA and PEG are insoluble and 
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soluble in water, respectively. PLA-PEG nanomembranes were prepared by spin-coating 
50:50, 60:40, 80:20 and 90:10 PLA:PEG mixtures as described in the Methods section, 
and applying 7000 rpm for 1 min. Table 5.3.2 lists the thickness and roughness of the 
resulting nanomembranes, which are compared with those achieved for PLA under the 
same conditions, while the corresponding AFM images are displayed in Figure 5.3.1.  
Although the incorporation of PEG affects significantly to both the thickness and 
roughness of PLA nanomembranes, these variations are apparently independent on the 
PEG concentration. Furthermore, no particular nanofeature is detected in the surface 
topography of 50:50, 80:20 and 90:10 PLA-PEG nanofilms, even though small shallow 
cavities are detected at the 60:40 membrane. The characteristics of PLA-PEG ultra-thin 
films are not consistent with a phase separation process and can be attributed to 
different reasons, as for example: (1) the evaporation rate of chloroform is not 
appropriated to produce instabilities at the polymer-polymer interface16; (2) the 
difference between the molecular weights of PLA and PEG is too large for the formation 
of PEG-like pores in the PLA matrix17; and (3) the solubility of PLA and PEG in 
chloroform is too different. Swaminathan et al. 17 studied the physical properties of PLA-
PEG membranes (L= 35±5 µm) prepared by spin solvent-casting using PEG samples with 
different molecular weight.  
 
Membranes were found to be semi-porous, the surface pore size depending on the 
PEG molecular weight. These findings suggested that the PLA:PEG mixtures used in this 
work are not the most appropriated for the fabrication of perforated PLA 
nanomembranes since the dependence on PEG characteristics is too large. 
[PLA] 2500 rpm 4000 rpm 7000 rpm 
50 mg/mL 1616±148 1165±88 - 
25 mg/mL 277±61 237±126 - 
10 mg/mL 190±42 136±19 73±42 
Table 5.3.1 Physical parameters of non-perforated and perforated PLA NMs derived from 
90:10 and 99:1 PLA:PVA mixtures: Average diameter of the nanopores (), root-mean-square 
roughness (Rq) (55 µm2 surface area) and film thickness (L), which also corresponds to the 





PLA-PVA nanomembranes  
In order to overcome the limitations detected in PLA-PEG nanomembranes, PEG was 
replaced by PVA in the spin-coated mixtures. Both PLA and PVA are soluble in HFIP. 
This solvent exhibits a low evaporation temperature (58.2 ºC) and, therefore, a high 
evaporation rate is expected during the spin-coating process. However, it should be 
remarked that the sacrificial layer used to transform the supported PLA-PVA ultra-thin 
films into the PLA FsNM was also made of PVA. Therefore, the sacrificial layer may be 
significantly altered by the dropping of the HFIP solution mixture onto its surface, 
affecting the formation of the PLA-PVA film. In order to evaluate the impact of such 
effect two complementary experiments were performed. 
 First, a PLA solution (10 mg/mL) in HFIP was dropped onto a PVA sacrificial layer 
and spin-coated at 7000 rpm for 1 min. The resulting nanomembrane was characterized 
by AFM before and after being treated with water to eliminate the sacrificial layer 
(Figures 5.3.2a and b, respectively). It is worth noting that both the supported film 
and the FsNM exhibit a porous topography, even though the depth of such pores is 
smaller than the membrane thickness (Figure 5.3.2c). These results clearly indicate the 
HFIP affects the PVA sacrificial layer during the spin-coating process. In spite of this, the 
apparition of nanofeatures (i.e. pores) in the PLA nanomembrane should be considered 
as good result within the context of this work.  
In the second experiment, a droplet of HFIP was deposited onto the PVA sacrificial 
layer (L= 3424 nm and Rq= 0.30.1 nm) and spin-coated at 7000 rpm for 1 min. After 
this, the thickness was not affected by the solvent (L= 34448 nm) while the roughness 
increased considerably (Rq= 0.50.1 nm). This variation, which is fully consistent with 
the apparition of nanofeatures in the previous experiment (Figures 5.3.2a and b), 
suggests that the instabilities created by the addition of a PLA:PVA solution in HFIP onto 
the PVA sacrificial layer could facilitate the fabrication of perforated PLA FsNMs. PLA-
PVA nanombrembranes were fabricated using 80:20 and 90:10 PLA:PVA mixtures in 
HFIP using the process schematically depicted in Figure 5.3.3. AFM topographic and 
phase images are displayed in Figure 5.3.4a and b, respectively. As it can be seen, 
nanofeatures obtained for both compositions are apparently compatible with the 
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formation of PVA nanophases crossing the thickness of the whole PLA nanomembrane 
(Table 5.3.2). 
However, comparison between the 80:20 and 90:10 PLA-PVA films reveals 
important differences related with the frequency and dimensional uniformity of PVA 
nanophases. Thus, 80:20 nanomembranes are not uniform, the dimensions and 
frequency of the nanophases depending on the examined region. In contrast, 90:10 films 
exhibit a relatively homogeneous distribution of PVA nanophases of similar dimensions. 
Such differences remained in the corresponding PLA FsNMs produced by selective water 
etching (Figure 5.3.4b and d). A photograph displaying both a supported 90:10 PLA- 
PVA ultra-thin film and a nanoperforated 90:10 PLA FsNM floating in water is presented 
in Figure 5.3.3b. 
Figure 5.3.2 (a) Three dimensional height (left) and phase (right) AFM images of PLA 
supported nanomembrane prepared using a 10 mg/mL polymer solution in chloroform and a 
spin-coater speed of 7000 rpm. AFM images of PLA (b) the supported nanomembrane and (c) 
the corresponding FsNM prepared using a 10 mg/mL polymer solution in HFIP and a spin-
coater speed of 7000 rpm. The FsNM was obtained after removing the sacrificial layer of the 
supported nanomembrane. The AFM image windows are 1010 m2 in all cases. (d) 
Representative profilometry of supported. The blue, uncoloured and purple regions correspond 




















On the other hand, AFM images indicate that the pores obtained for the two 
compositions penetrate the entire thickness of the film, giving rise to perforations. 
Furthermore, SEM micrographs corroborate that perforations are irregular in terms of 
both distribution and dimensions in the FsNMs derived from the 80:20 PLA:PVA 
composition. Accordingly, regions with many small nanopores coexist in the same 
sample with regions exhibiting relatively large and infrequent pores. In contrast, the 
90:10 composition results in FsNMs with regular distribution of pores.  
a PLA ultra-thin film prepared by spin-coating a 10 mg/mL polymer chloroform solution. b PLA-PEG 
ultra-thin films prepared using by spin-coating PLA (10 mg/mL) : PEG (10 mg/mL) amixtures in 
chloroform. c PLA ultra-thin film prepared by spin-coating polymer (10 mg/mL) HFIP solution. d 
PLA-PVA ultra-thin films prepared using by spin-coating PLA (10 mg/mL) : PVA (10 mg/mL) 
mixtures in HFIP. 
 L (nm) Rq (nm) Nanofeatures 
PLA (chloroform) a 238±43 1.1±0.2 - 
PLA-PEG (50:50) b 45±2 4.0±1.0 - 
PLA-PEG (60:40) b 48±2 1.8±0.1 Shallow surface cavities 
PLA-PEG (80:20) b 48±2 4.6±0.3 - 
PLA-PEG (90:10) b 50±4 6.0±1.3 - 
PLA (HFIP) c 213±20 2.8±0.3 - 
PLA-PVA (80:20) d 74±3 20.46.2 Nanophases penetrating the entire film 
PLA-PVA (90:10) d 62±8 6.72.3 Nanophases penetrating the entire film 
PLA-PVA (90:10) (with 
vigorous stirring) d 
96±2 3.31.2 Nanophases penetrating the entire film 
14 mm
Figure 5.3.3 (a) Schematic representation of the procedure used to prepare perforated PLA 
nanomembranes from PLA-PVA ultra-thin films by the spin-coating technique. (b) 90:10 PLA-
PVA nanomembrane supported onto a SiO2 wafer (blue arrow) and 90:10 PLA FsNM (red 
arrow) floating on ultrapure water. 
(b) 
(a) 
Table 5.3.2 Thickness (L) and RMS roughness (Rq) of PLA, PLA-PEG and PLA-PVA ultra-thin 
films prepared in this work. Observed nanofeatures are also indicated. 
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Characterization of perforated free-standing nanomembranes  
In order to enhance control over the distribution and diameter of nanoperforations 
obtained in FsNMs derived from 90:10 PLA-PVA nanomembranes, the mixing process of 
the two polymer solutions in HFIP was improved by applying vigorous stirring. More 
specifically, the 90:10 PLA:PVA mixture was stirred three times at 1000 rpm for 30 
seconds each one using a Vortex-type mixer. Hereafter, the resulting PVA-PLA 
nanomembranes as well as the corresponding PLA FsNMs have been denoted PLA-
PVA(stir) and PLA(stir) to differentiate them from those obtained without vigorous 
stirring. Figure 5.3.5 displays illustrative AFM images of PLA-PVA(stir) ultrathin films 
and PLA(stir) FsNMs, respectively. The main difference between the supported 90:10 
PLA-PVA and PLA-PVA(stir) nanomembranes (Figure 5.3.4c and Figure 5.3.5a, 
respectively) refers to the dimensions of the segregated nanophases, which are 
significantly smaller for the latter than for the former. After selectively solvent etching, 
the resulting nanoperforations (5.3.5b) exhibit not only a diameter reduction but also 
higher dimensional homogeneity.  
SEM micrographs provided in Figure 5.3.6 display nanometric details on 
nanoperforated PLA and PLA(stir) FsNMs derived from 90:10 mixtures. Figure 5.3.6a 
illustrates the nanopores typically found in perforated 90:10 PLA, while submicrometric 
perforations rarely found in such membranes are shown in Figure 5.3.6b. The 
distribution of homogeneous nanopores in 90:10 PLA(stir) is evidenced in Figures 
5.3.6c and d (low and high magnification, respectively), while details of such pores are 
given in Figure 5.3.6e and f. Finally, Figure 5.3.6g evidences the presence of 
nanopores at the two sides of the same 90:10 PLA(stir) FsNM. This indirectly proves that 

































































































































































400 nm 400 nm
Figure 5.3.4 Three dimensional height (left) and phase (right) AFM images of PLA-PVA supported 
nanomembranes prepared using a (a,b) 80:20 a d (c,d) 90:10 PVA:PLA mixture in HFIP. 
Nanoperforated PLA FsNMs obtained via selective water etching using the (b) 80:20 and (d) 90:10 























Figure 5.3.5 SEM micrographs of nanoperforated (a and b) 90:10 PLA and (c-g) 90:10 
PLA(stir) FsNMs prepared using 90:10 PLA:PVA mixtures in HFIP. Details on a-f are described 
in the text. A folded 90:10 PLA(stir) FsNM showing the presence of nanoperforations at the two 






Figure 5.3.6 Three dimensional height (left) and phase (right) AFM images of (a) PLA-PVA 
supported nanomembranes prepared using a vigorously stirred 90:10 PVA:PLA mixture in 
HFIP and (b) nanoporferated PLA FsNMs obtained via selected water etching using the 
supported nanomembranes displayed in (a). In all cases image windows are 1010 m2 (top) 






































FsNM  (nm) A (nm2) SC (%) Rq (nm) L (nm) 
PLA - - - 1.1±0.2 116±14 
80:20 PLA 841±546 555493±242886 34% 186.925.6 170±14 
90:10 PLA 170±73 22713±4225 6% 93.231.2 127±10 
90:10 PLA(stir) 65±32 3291±795  1% 108.95.7 117±16 
Figure 5.3.7 Pore diameter distribution for (a) 80:20 PLA, (b) 90:10 PLA and (c) 90:10 
PLA(stir) nanomembranes. (d) AFM depth profiles for the 80:20 PLA, 90:10 PLA and 90:10 
PLA(stir) FsNMs. 
 
Table 5.3.3  Average diameter () and area (A) of the pores, surface coverage by pores (SC), 





Quantitative measures of the pores, thickness and roughness were performed for 
perforated FsNMs derived from 80:20 and 90:10 PLA:PVA mixtures. For this purpose, 
five representative SEM images were considered for of each kind of nanomembrane. The 
average diameter and area of the pores ( and A), the surface coverage by the 
perforations (SC), roughness and the thickness of such FsNM are listed in Table 5.3.3. 
As it was stated above, perforations in 80:20 PLA, which are the thickest ones, are 
submicrometric ( 0.80.5 m), representing around 34% of the nanomembrane 
surface. However, inspection of the results obtained for 90:10 PLA indicates that the size 
of the pores (= 17073 nm), the area covered by them (SC= 6%) and the thickness 
decrease with the context of PVA in the mixture. Moreover, such three parameters 
experiences a more drastic reduction when the 90:10 PLA:PVA mixture is submitted to 
vigorous stirring, this feature being particularly important for the diameter of nanopores 
(= 6532 nm). These results are fully consistent with detailed AFM depth profiles and 
monomodal pore diameter distribution displayed in Figure 5.3.7, respectively, which 
provide complementary information about the shape and size of the pores. 
 
Influence of nanoperforations in the PLA wettability  
Wettability, which is related with the surface topography, affects the cellular response 
of materials18, determination of the influence of the perforations introduced in PLA ultra-
thin films being required. For this purpose, the contact angle of milliQ water, DMF and 
EG were determined for non-perforated PLA, 90:10 PLA and 90:10 PLA(stir) 
nanomembranes supported on glass slips. Results, which are displayed in Figure 
5.3.8a, indicate that nanoperforations do not provoke significant changes in the contact 
angle, independently of the solvent polarity. More specifically, the response of the three 
materials to water was very similar, indicating that the PLA hydrophilicity (i.e. contact 
angle < 90º) remains practically unaltered after creating nanopores crossing the entire 
membrane thickness.  
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Surface energies are related with contact angle measurements through the Young’s 
equation19. In this work, surface energies have been modelled using the Owen-Wendt-
Kaelble20,21 (OWK) and Equation-of-State22 (EOS) relationships, results being displayed 
in Figure 5.3.8b. As it can be seen, results provided by the two models are fully 
consistent. Thus, although the surface energies of non-perforated and perforated films do 
not exhibit important difference, those of latter are slightly smaller than that of the 
former for both OWK and EOS models. The fact that the surface energies of 
nanoperforated PLA are intermediate between those of non-perforated PLA and glass 
slip supports that nanopores cross the entire thickness of the nanomembranes. 
Moreover, this behaviour is consistent with the dimensions of the perforations, surface 
energies being slightly smaller for 90:10 PLA than for 90:10 PLA(stir).  
 
Influence of nanoperforations in cell viability 
Cell adhesion and proliferation on ultra-thin films depend on different factors, as for 
example the material used for their fabrication (i.e. chemical composition) and the 
surface topography, which in turn may be altered through the introduction of 
nanofeatures. Thus, the dimensions and distribution of nanofeatures are expected to 
affect the behavior of nanomembranes as bioactive platforms. In this work the response 
Figure 5.3.8  (a) Contact angle determined of milliQ water, DMF and EG. (b) Surface energy 





of perforated 90:10 PLA and 90:10 PLA(stir) nanomembranes to cellular adhesion and 
proliferation have been compared with that of non-perforated PLA considering two 
cellular lines: Vero and MCDK, which are epithelial- like cells. It should be emphasized 
that such three PLA-based systems present identical chemical composition enabling us to 
obtain direct evidences of the influence of both the diameter and distribution of 
nanopores on cell growth. Quantitative results of cellular adhesion assays are displayed 
in Figure 5.3.9a. Results indicate that nanoperforations of  170 nm promote cell 
adhesion with respect to the absence of perforations and, specially, nanoperforations of 
 65 nm. Thus, relative cell viability grows as follows: 90:10 PLA(stir) < non-perforated 
PLA < 90:10 PLA, differences being light more marked for MCDK cells than for Vero 
cells.  
Cell proliferation assays were performed by evaluating the cellular activity on the 
three examined substrates after seven days of culture. Results, which are displayed in 
Figure 5.3.9b, show an appreciable increment in the cellular colonization for the two 
perforated nanomembranes. Evaluation of this increment with respect to the viability of 
adhered cells indicates that the preference of Vero and MCDK cells is higher for 90:10 
PLA(stir) than for non-perforated PLA, evidencing that perforations promote the 
interaction between the polymeric matrix and the cells once these have been adhered. 
However, the most remarkable result refers to perforated 90:10 PLA FsNMs, which 
exhibit cell viabilities 2.6 and 2.2 times higher than those of non-perforated PLA and 
perforated 90:10 PLA(stir), respectively. This marked preference has been attributed to 
the similarity between the diameters of nanoperforations in 90:10 PLA and the filopodia 
filaments in cells.  
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Filopodia are thin, actin-rich structures protruding from the lamellipodial actin 
network23,24. These elements, which are finger-like, sense the extracellular environment 
at their tips using cell surface receptors25, playing an important role in cell migration. 
Thus, contact with an external target promotes the coupling of membrane-bound 
proteins to the backward flow of actin, which in turn produces the pulling forces needed 
for cell migration. This is essential for processes involving proliferation, as for example 
wound healing26. Contact differences between substrates influences the response of 
protruding filopodia. Interestingly, filopodia are 100-200 nm in diameter23 while the 
diameter of the nanoperforations in 90:10 PLA is 17073 nm. Accordingly, 
nanoperforations in 90:10 PLA FsNMs promote cell migration processes, simultaneously 































































































Figure 5.3.9 (a) Cellular adhesion and (b) cellular proliferation on the surface of 
nanoperforated 90:10 PLA and PLA (stir) membranes and non-perforated PLA membranes. 
Vero and MCDK cells were culture during 24 h (adhesion assay) and 7 days (proliferation (c) 
Optical microscopy (left) and SEM (right) images of Vero cells adhered onto perforated  90:10 

























Figure 5.3.9c displays micrographs recorded by optical microscopy and SEM of 
Vero cells adhered onto 90:10 PLA and 90:10 PLA(stir) perforated nanomembranes. As 
it can be seen, cells adhered onto 90:10 PLA exhibit a radial heterogeneous spreading 
with respect to the center of the film (Figure 5.3.9c). This particular distribution, which 
is supported by the elongated morphology of the cells, clearly evidences the interaction 
between cells and 90:10 PLA nanofeatures. In contrast, cells adhered onto 90:10 
PLA(stir) presents a random distribution in which regions without cells coexist with 
areas having a large accumulation of cells (Figure 5.3.9c). Furthermore, the 
morphology of the cells is less elongated than that of cells adhered onto 90:10 PLA. 
Finally, cells adhered onto non-perforated PLA follow a distribution similar to that 
described for 90:10 PLA(stir), where cells present a round-like morphology (data not 
shown). On the other hand, observation of the micrographs displayed in Figure 5.3.9c 
evidences that ultra-thin films frequently exhibit micrometric striation flaws. These 
defects have been attributed to unfavorable capillary forces provoked by changes in 
surface tension during solvent evaporation12,27. This phenomenon, which is called 
“Marangoni instability”, has been largely appreciated in ultra-thin films prepared by 
spin-coating. In this particular study, these tiny thickness undulations have very limited 
influence on the formation of the perforations as well as on cell adhesion and 
proliferation results.   
The overall of these observations are fully consistent with our previous 
interpretation: cell elements interact intensely with nanofeatures of membranes with 
perforations of  170 nm while these interactions become weaker when 
nanoperforations are too small and, especially, when they are non-existent.  
 
5.3.3 Conclusions 
In summary, nanoperforated PLA FsNMs of thickness 120-130 nm have been 
successfully obtained using spin-coating combined with phase segregation processes in 
immiscible 90:10 PLA:PVA mixtures and the subsequent removal of PVA domains via 
selective solvent etching. The diameter of the nanopores, which cross the entire 
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nanomembrane thickness, has been controlled through the conditions applied to the 
preparation of the PLA:PVA mixture. Thus, the dimensional scale of the phase separation 
domain has been found to decrease when the mixing process is performed under 
vigorous stirring conditions. This procedure led to perforated PLA FsNM with nanopores 
of = 170±73 nm (prepared without stirring) and = 65±32 nm (prepared under vigorous 
stirring). The former diameter fits very well to the diameter of protruding finger-like 
filopodia (100-200 nm), which play an important role in cell migration processes. Cell 
proliferation assays considering non-perforated and perforated PLA nanomembranes as 
bioactive platforms indicate that ultra-thin films with nanopores of = 170±73 nm 
exhibit cell viabilities that are 2.2 and 2.6 times higher than those with pores of = 
65±32 nm and non-perforated PLA, respectively. It is clear that this increase is enhanced 
by the better adhesion on such surfaces. Thus, nanopores of  170 nm promote the 
substrate colonization through intense interactions with cell filopodia, as clearly 
demonstrate changes on both cell morphology and cell spreading pattern. Hence, 
nanoperforated FsNMs could be a great promise as novel bioactive platforms and would 





5.4 Confinement of a β-barrel protein in nanoperforated 
free-standing nanomembranes for ion transport  
Biological ion channels, which smartly control the movement of ions and small 
molecules into and out of the cell, have inspired scientists to build materials with 
applications in nanofluidics,28,29 molecule and ion filters,30,31 as well as biosensors.32,33 
Amongst the many approaches addressing selective ion transport, considerable efforts 
have recently been devoted to mimic the principles and functions of channels contained 
in biological nanomembranes (NMs).34-38  
Biological membranes are made of lipid bilayers and embedded proteins sensing and 
subsequently controlling the exchange of substances between the cell and its 
environment. For instance, ion channels are self-assembled proteins that selectively 
transport ions through the cell membrane, while porin proteins are water-filled open 
channels allowing the passive penetration of hydrophilic molecules.39 The latter are 
typically found as monomers or trimers in the outer membranes of Gram-negative 
bacteria, as well as in mitochondria40 and chloroplast41 of eukaryotic cells. Gram-
negative bacteria surround themselves with a second outer membrane (OM) playing the 
role of an effective barrier. That is, this OM is even more hydrophobic than a typical 
phospholipid membrane due to the presence of lipopolysaccharides, whereas the 
translocation of hydrophilic species across OMs is mainly governed by the presence of 
porins.42 
In this work, the attention is focused on the trimeric OM protein Omp2a from 
Brucella melitensis.43 This -barrel protein, which is formed by a sequence of 367 amino 
acids, allows the passive diffusion of small molecular weight hydrophilic materials (< 667 
Da) across the OM (e.g. ions, nutrients, and drugs). It has been previously described that 
Omp2a first refolds under a monomeric form (39 KDa) and then self-associates into a 
trimeric state (115 KDa).44,45 
Supporting biological channels like porins, onto biological or synthetic polymeric 
bilayers presents limitations for practical applications due to their limited mechanical 
strength and stability.46-49 Synthetic solid state membranes offer several advantages over 
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bilayer-based approaches, such as mechanical stability, control over pore dimension and 
shape, and modifiable surfaces for desired functions.35,50 Within this context, we recently 
examined ion diffusion through Omp2a immobilized in a supported poly(N-
methylpyrrol) (PNMPy) membrane.51 Electrical impedance spectroscopy (EIS) studies 
evidenced that Omp2a promotes the passive transport of K+ and Na+ in solutions with 
relatively high ionic concentrations, preferentially favouring the diffusion of hydrated 
Na+ with respect to that of hydrated K+.51 Unfortunately, some drawbacks were also 
identified for such system. For instance, PNMPy membranes electrochemically 
synthesized were not self-standing, a stainless steel support being used to 
electropolymerize PNMPy. Furthermore, the porin immobilization and orientation were 
not well-controlled. In addition, the membrane thickness (219±71 nm) was much higher 
than both the height of the porin (5 nm)39 and the thickness of conventional biological 
lipid bilayers (2-5 nm).52 Consequently, the passive ion transport was not only due to 
Omp2a, but assisted by PNMPy, which is known to be an electrochemically active 
polymer.53,54 
A few studies have reported track-etched polymeric membranes with nanopores as 
solid support of ion channels, despite complex chemical processes were frequently 
involved in the fabrication of such systems.35,55,56 For the selective biomolecular 
recognition through metal···protein specific interactions, Ali et al.35 constructed a 
nanobiosensor based on the immobilization of metal terpyridine complexes inside 
nanopores, which were fabricated in polyethylene terephthalate membranes using 
asymmetric chemical etching. Guo et al.55 also presented a single-pore nanofluidic 
energy-harvesting system that efficiently converts Gibbs free energy in the form of a 
salinity gradient into electricity. Experiments were conducted on ion-track-etched single 
nanopores embedded in polyamide membranes of 12 µm in thickness, which were 
irradiated with a single swift heavy ion and subsequently submitted to chemical etching. 
Balme et al.34 filled nanopores (diameter= 15 nm) of commercial track-etched 
polycarbonate films (thickness= 5 µm) with the ion channel gramicidin A (GA). 
Unfortunately, such membranes did not exhibit the expected properties in terms of ion 




filled with GA, and therefore ions diffused in the “free” electrolyte confined inside the 
nanopore instead of directly interacting with GA. 
Here, we have prepared poly(lactic acid) (PLA) free-standing nanomembranes 
(FsNMs) with nanopores crossing the entire ultra-thin film thickness as solid support, 
then loading the Omp2a porin for selective ion transport. Nanoperforations have been 
obtained using spin-coating combined with phase segregation processes in immiscible 
PLA:poly(vinyl alcohol) (PVA) mixtures, and subsequently removing PVA domains via 
selective solvent etching.56 The immobilization of Omp2a not only at the surface, but also 
inside the nanopores, which has been achieved by incubating nanoperforated PLA NMs 
in protein solutions, has led to important changes in the physical properties of 
nanoperforated PLA NMs, including their electrochemical impedance response towards 
different electrolytic media.  
 
5.4.1 Methods 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE): 
Samples were loaded on 15% acrylamide SDS–PAGE gels without boiling. After 
electrophoresis, the gels were fixed with glacial acetic acid and methanol and stained 
with Coomassie blue.  
 
Dynamic light scattering (DLS): The size distribution of the protein in 1 PBS pH 
7.4 and in 50 mM Tris–HCl pH 8, 150 mM NaCl, 3 M MPD was determined using a 
NanoBrook Omni Zeta Potential Analyzer from Brookheaven Instruments Corporation. 
Particularly, three consecutive runs of 60 seconds each were conducted for every sample.  
 
Circular dichroism (CD): CD spectra were recorded between 190 and 350 nm at 
room temperature using a Jasco J-815 equipment with a protein concentration of 
approximately 125 µg/mL and a 0.1 cm cell path. Spectra were acquired at a scan speed 
of 50 nm min-1 with a 0.2 nm data pitch using a 2 nm bandwidth and a 4 second digital 
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integration time. Spectra were averaged after two accumulations and corrected by 
subtraction of the background spectrum.  
 
Transmission electron microscopy (TEM): TEM images were obtained with a 
Philips TECNAI 10 electron microscope operating at 100 kV. Bright field micrographs 
were taken with an SIS MegaView II digital camera. Solution containing Omp2a (0.34 
mg/mL) was dispersed on glow-discharged carbon coated copper grids (300 mesh) and 
negatively stained with uranyl acetate (2.0 % w/v). After incubation (30 s), the excess of 
protein was removed with filter paper, and the grids air dried for a further 1-2 s. 
 
Omp2a-filled nanoperforated nanomembranes: Nanoperforated PLA 
nanomembranes supported on ITO were placed in a 24-well plate. 500 µL of Omp2a 
solutions (0.5, 0.25 and 0.125 mg/mL) were deposited onto the film surface. After 48 h 
with slight agitation (80 rpm) at room temperature, the nanomembranes surfaces were 
rinsed three times with milliQ water to remove non-immobilized protein residues.  
 
Omp2a-coated non-perforated nanomembranes: Non-perforated PLA NMs were 
incubated in 500 µL of Omp2a solution (0.5 mg/mL) for 48 h with slight agitation (80 
rpm) and at room temperature. After such period of time, samples were rinsed three 
times with milliQ water to remove non-immobilized protein residues. The resulting 
Omp2a-coated non-perforated NMs were used as negative control. 
 
Detection of immobilized protein, Bradford assay: Adsorbed Omp2a was 
removed from the films surfaces by adding 0.2 mL of 0.1 M PBS with nonyl 
phenoxypolyethoxyethanol (NP-40) surfactant (0.5% v/v) and orbital shaking at 50 rpm 
during 30 min and 37ºC. In order to avoid interferences between the NP40 surfactant 
and the Bradford reagent, the former was eliminated by precipitating the Omp2a with 20 
µL of trichloroacetic acid. Next, the precipitate-containing solution was centrifuged for 15 
min at 12000 rpm. The solid (Omp2a) was washed with cold acetone and maintained at 4 
ºC for 1 hour. After this, the solid was centrifuged again during 15 min at 12000 rpm. The 




Standard curves were carried out using protein dilutions, which were prepared using 
buffer solution with concentrations of protein ranging from 0.05 to 1.00 mg/mL. Next, 5 
µL of protein standards and samples were added to a 96-well plate, blank wells being 
filled with 5µL of buffer. After this, Bradford reagent (250 µL) was added into each well 
and plates were subsequently placed on a shaker for mixing (30 s). Samples were 
incubated at room temperature for 15 min. Finally, the absorbance was measured at 595 
nm. 
 
Profilometry: Film thickness measurements were carried out using a Dektak 150 stylus 
profilometer (Veeco, Plainview, NY). Different scratches were intentionally provoked on 
the NMs and measured to allow statistical analysis of data. At least six independent 
measurements were performed for two samples of each examined condition. Imaging of 
the films profile was conducted using the following optimized settings: tip radius= 12.5 
m; stylus force= 3.0 mg; scan length= 3 mm; and speed= 30 µm/s. 
 
Atomic force microscopy (AFM): AFM was conducted to obtain topographic images 
of the films surface using silicon TAP 150-G probes (Budget Sensors, Bulgaria) with a 
frequency of 150 kHz and a force constant of 5 N/m. Images were obtained with an AFM 
Dimension microscope using a NanoScope IV controller under ambient conditions in 
tapping mode. The row scanning frequency was set between 0.6 and 0.8 Hz. The root 
mean square roughness (Rq), which is the average height deviation taken from the mean 
data plane, was determined considering 55 µm2 surface areas and using the statistical 
application of the NanoScope Analysis software (1.20, Veeco). AFM measurements were 
performed on various parts of the films, which produced reproducible images similar to 
those displayed in this work.  
 
Scanning electron microscopy (SEM): SEM micrographs were obtained using a 
Focussed Ion Beam Zeiss Neon 40 scanning electron microscope operating at 1 kV. 
Samples were mounted on a double-side adhesive carbon disc and sputter-coated with a 
thin layer of carbon to prevent sample charging problems.  




Wettability: Contact angle (CA) measurements were conducted using the water drop 
method. 0.5 µL of milliQ water drops were deposited onto the surface of the films and 
recorded after stabilization with the equipment OCA 15EC (DataPhysics Instruments 
GmbH, Filderstadt). The SCA20 software was used to measure the CA, which is shown in 
this work as the average of at least 10 measures for each condition. 
 
Electrochemical impedance spectroscopy (EIS): EIS measurements were 
performed using a conventional three-electrode cell and an AUTOLAB-302N 
potentiostat/galvanostat operating between the frequency range of 104.5 Hz and 10-2 Hz 
and 5 mV of amplitude for the sinusoidal voltage. All experiments were performed at 
room temperature with nanomembranes deposited onto ITO and using different 
electrolyte solutions (NaCl, KCl and CaCl2) at various concentrations (50, 100, 500 and 
1000 mM). ITO was used as working-electrode and platinum as counter-electrode, 
whereas Ag|AgCl saturated (KCl 3M) was employed as reference electrode. After data 
collection, EIS results were then processed and fitted to an electrical equivalent circuit 
(EEC). 
5.4.2 Results  
Protein characterization  
The Omp2a protein was expressed, purified, and refolded using a previously reported 
procedure,44,45 which is briefly described in Chapter 4. The isoelectric point of Omp2a, 
which contains 367 amino acids, is 4.47. The monomeric and trimeric association of 
refolded Omp2a was investigated by SDS-PAGE. Primary and secondary bands were 
observed at 39 and 115 kDa (Figure 5.4.1a), suggesting that the trimeric form was 
less populated than the monomeric species. The competition between 
monomer···monomer and monomer···SDS interactions provides a possible explanation 




DLS measurements reflected that in the buffer solution used to maintain Omp2a 
secondary structure, SDS molecules form small micelles with an effective diameter Deff= 
5.7±0.1 nm (Figure 5.4.1c) that increases to Deff= 6.4±0.4 nm upon the addition of the 
protein. This increment has been associated with the incorporation of the Omp2a 
monomer to the SDS micelles. In contrast, aggregates with Deff= 228±38 nm are 
observed when the protein is diluted in phosphate buffered saline (PBS) solution. The 
formation of these aggregates has been attributed to the de-protection of the 
hydrophobic zones of the protein (trans-membrane), which induces the self-association 
process. According to these results, the SDS-containing buffer medium was not changed 
during protein deposition onto nanoperforated membranes.  
Despite the complete transformation of protein population into trimers has not been 
achieved, the secondary structure of the protein was well-preserved. This is evidenced by 









































Figure 5.4.1 (a) SDS-PAGE of Omp2a. Monomers migrate at 39 kDa while trimers show an 
apparent molecular weight of 115 kDa. (b) CD spectra for the Omp2a protein: as-obtained, after 
4 days of incubation and deposited into the nanoperforations of PLA NMs. (c) DLS results 
showing the volume percentage of particles towards particle diameter for SDS micelles in the 
buffer solution used to maintain the protein, the same solution after incorporate the Omp2a 
protein and a PBS solution with Omp2a. 
(a) (b) 
(c) 
OMP2A ONTO ARTIFICIAL MEMBRANES 
165 
 
scenarios: (i) just after being defrosted (as-obtained), (ii) after four days of incubation (4 
days), and (iii) after being deposited onto the NMs (deposited). In all cases, the spectra 
featured a broad minimum about 217 nm that is typically associated with β-stranded 
proteins.57  
TEM micrographs from Omp2a solutions stained with 2% uranyl acetate enabled us 
to identify not only trimeric units, but also higher hierarchical structures formed by 
around 6-8 trimeric units due to self-association processes (Figure 5.4.2). All these 
structures have been attributed to the hydrophobic interactions promoted by the side 
groups at the external side of the -barrels, consistently with the effective diameter 
Diameter (nm) 
Figure 5.4.2  TEM micrographs of Omp2a trieric units (short red line) and higher aggregates 
(large red line) derived from solutions stained with 2% uranyl acetate. Scale bar of the high 
resolution micrographs: 10 nm. The effective diameter (Deff, in nm) distribution for both Omp2a 




measured by TEM for the trimers (Deff= 9.3±3.0 nm) and such bigger aggregates (Deff= 
25.9±4.8 nm), respectively.  
 
Nanoperforated PLA nanomembrames  
Nanoperforated PLA FSNMs were prepared using an already described two-step 
procedure:56 (1) spin-coating a  mixture of PLA and poly(vinyl alcohol) (PVA), which are 
immiscible polymers but both soluble in 1,1,1,3,3,3-hexafluoroisopropanol (HFIP), onto a 
PVA sacrificial layer to form the appropriated nanofeatures (i.e. phase separation 
domains with dimensions similar to the entire film thickness); and (2) selective solvent 
etching using milliQ water to dissolve both the PVA sacrificial layer and the PVA domains 
of PLA-PVA NMs, consequently transforming such nanofeatures into nanoperforations. 
Perforated FSNMs were initially obtained by considering 90:10 and 99:1 PLA:PVA v/v 
mixtures.  
 
Figure 5.4.3a displays 3D AFM height images coloured with phase skin of NMs 
obtained using 99:1 PLA:PVA mixtures. Briefly, AFM phase imaging registers phase 
signal shifts due to changes in the adhesion force between the tip and the surface, thus 
being sensitive to the surface mechanical and viscoelastic properties (i.e. 
stiffness/softness). Accordingly, AFM phase information allows for the chemical 
mapping of polymer composites.  
Hence, Figure 5.4.3a illustrates how the PVA nanophases, which are clearly 
identified in PLA-PVA NMs as yellow domains, disappear  after selective water etching 
while PLA phase remains (dark purple domain).  
NM  (nm) Rq (nm) L (nm) 
90:10 perforated PLA 6731 1068 11411 
99:1 perforated PLA 5122 213 1107 
Non-perforated PLA - 1.7±0.2 116±14 
Table 5.4.1 Physical parameters of non-perforated and perforated PLA NMs derived from 
90:10 and 99:1 PLA:PVA mixtures: Average diameter of the nanopores (), root-mean-square 
roughness (Rq) (55 µm2 surface area) and film thickness (L), which also corresponds to the 
depth of the pores. 
 





Figure 5.4.3 (a) 3D AFM height images coloured with phase skin: PLA-PVA NM obtained 
using a 99:1 PLA:PVA mixture (left) and nanoperforated PLA NM derived from PLA-PVA via 
selective water etching (right); (b) High magnification SEM micrographs, pore diameter 
distribution, and AFM height images (22 and 0.50.5 m2) with their corresponding phase 





The elimination of PVA in NMs obtained from both 90:10 and 99:1 mixtures was also 
followed by FTIR spectroscopy (Figure 5.4.4). 
For perforated and non-perforated PLA NMs, Table 5.4.1 lists the average diameter 
of the nanopores (), the root-mean-square roughness (Rq) values of 55 µm2 surface 
areas and film thickness (L), which also corresponds to the depth of the pores. It is 
evidenced that Rq increases rapidly with the content of PVA in the polymer mixture. 
Hence, the formation of nanopores provokes drastic topographic alterations with respect 
to the ultra-flat non-perforated PLA NMs. In contrast, L remains almost unchanged for 
perforated and non-perforated NMs, the influence of PVA-induced nanofeatures being 
negligible in this case.  
SEM and AFM micrographs provided in Figure 5.4.3b display nanometric details of 
perforated PLA FsNMs derived from 99:1 PLA:PVA mixture, while micrographs of non-
perforated PLA (used as a control) are displayed in Figure 5.4.5. The diameter of the 
Figure 5.4.4 FTIR  spectra of: (a) individual PLA and PVA membranes; (b) as prepared 
membranes obtained by solvent casting 99:10 and 99:1 PLA:PVA mixtures; (c) membranes of 
(b) after 2 h in milliQ water; and (d) membranes of (b) after one day in milliQ water. 
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nanopores as determined from SEM micrographs is 65±32 nm and 51±22 nm for NMs 
originating from 90:10 and 99:1 mixtures, respectively. As the effective diameter of 
Omp2a aggregates determined by TEM range from 9.3±3.0 nm to 25.9±4.8 nm, PLA 
NMs with the smallest pore diameter have been selected for immobilizing the OM 
protein. Moreover, AFM observations, which recorded simultaneously surface structure 
(height) and material composition (phase data) allow us to verify the presence of PLA 
region only (i.e. no phase contrast), thus indicating complete removal of PVA domains. 
These self-standing ultra-thin films are very flexible and robust, and they can be easily 
folded into small shapes. 
 
Omp2a-filled nanoperforated PLA nanomembrames 
Nanoperforated PLA NMs supported onto ITO and prepared using 99:1 PLA:PVA 
mixtures, were placed on a 24-well plate and incubated with 500 µL of 0.5, 0.25 or 0.125 
mg/mL Omp2a solution for 48 h with slight agitation (80 rpm) at room temperature. 
Then, NMs samples were rinsed three times with milliQ water to remove residues.  The 
incorporation of Omp2a preserving its -barrel structure as proved by CD (Figure 
5.4.1b), induces drastic changes in the physical properties of nanoperforated PLA NMs 
(Figure 5.4.6a). Indeed, the wettability significantly increases upon the incorporation 
of the protein. CA of PLA and nanoperforated PLA (CA= 78º6º and 72º7º, 
respectively) is just below the threshold value that separates hydrophilic and 
hydrophophic surfaces (i.e. CA  90º and CA > 90º, respectively), the CA of Omp2a-filled 
NMs is only 24º14º.  





Figure 5.4.6 (a) Average CA and Rq values (55 µm2 surface area) determined for ITO 
substrate, non-perforated PLA NMs, nanoperforated PLA before and after Omp2a incubation. 
Greek letters on the columns refer to significant differences (p < 0.05) when the 1 way ANOVA 
and Tukey's multiple comparisons test are applied: α vs ITO, β vs non-perforated PLA and δ vs 
nanoperforated-PLA. Images of the drops onto nanoperforated PLA with (bottom) and without 
(top) immobilized Omp2a are also displayed. (b) SEM micrographs of perforated PLA NMs 
after Omp2a immobilization: low and high magnifications at left and right, respectively. Dashed 
arrows illustrate the presence of big protein aggregates. (c) AFM height and their corresponding 
phase images (window: 0.5 × 0.5 μm2) of nanoperforated PLA after Omp2a incubation. Several 
representative cross-sectional profiles showing the topography and dimensions of the 
nanopores (dashed circles) are also displayed. In all samples, incubation was performed 
considering a 0.5 mg/mL Omp2a solution. 
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Similarly, the Rq (55 µm2 surface area) of nanoperforated PLA NMs increases from 
213 nm to 275 nm after Omp2a deposition. In order to explain these physical changes, 
nanoperforated PLA NMs were investigated by SEM (Figure 5.4.6b) and AFM (Figure 
5.4.6c). 
Low and high magnification SEM micrographs, as well as AFM images reveal the 
presence of aggregates at the surface of PLA NMs, which has been attributed to protein 
agglomeration. However, these aggregates are significantly bigger than the pure Omp2a 
assemblies observed by TEM from stained solutions (Figure 5.4.2), precluding an 
unambiguous identification. In opposition, height and phase AFM images (Figure 
5.4.6c and 5.4.7) evidence the presence of aggregates both on the surface and inside the 
pores. Although phase contrast is not as enhanced as in Figure 5.4.3a, topographical 
and texture differences reveal the existence of different phases (Figure 5.4.8a). 
Furthermore, the dimensions of these aggregates are very varied, ranging from some 
hundreds to a few tenths of nanometers. Cross sectional profiles of the interior of the 
pores indicate that their dimensions are suitable to host protein not only as aggregates of 
trimers (Figure 5.4.2), but also as individual trimers and monomers. Furthermore, 
both the roughened topography of the nanopore walls and the hydrophobic character of 
PLA favour the physical immobilization of Omp2a, no chemical treatment being required 
for such purpose. On the other hand, it is worth noting that -barrel porins typically 
present a significant oval shape,58 which is preserved in the aggregates observed by both 
SEM and AFM (Figure 5.4.6c).   
Figure 5.4.7  AFM height and their corresponding phase images (window: 5.0 × 5.0 μm2) of 






Figure 5.4.8 (a) 3D AFM phase images of the skin surfaces of perforated PLA NMs before 
(left) and after (right) incubation with a 0.5 mg/mL Omp2a solution. Oval protein aggregates 
are clearly identified at the surface and inside the nanopores. Diameter (b) and height (c) 
distributions of the protein aggregates observed in (a). (d) Results from Bradford assays for 
non-perforated (incubation with a 0.50 mg/mL Omp2a solution) and perforated (incubation 
with 0.5, 0.25 and 0.125 mg/mL Omp2a solutions). Grey spheres represent the retention 
efficiency (in %) while black bars correspond to the mass of protein entrapped per unit of area 
(µg/cm2). Error bars indicate the standard deviation and greek letters on the columns refer to 
significant differences (p < 0.05) in protein entrapped per unit of area (µg/cm2) when the 1way 
ANOVA and Tukey's multiple comparisons test are applied: α vs non-perforated PLA, β vs 
nanoperforated-PLA incubated with 0.25 mg/mL and δ vs nanoperforated-PLA incubated with 
0.125 mg/mL.  
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Besides, comparison of the 3D AFM height images coloured with phase skin surfaces 
recorded before and after incubation with Omp2a allows confirming the presence of 
adsorbed oval protein aggregates around and inside the nanopores (Figure 5.4.8a). 
Specifically, phase information clearly distinguishes Omp2a domains (i.e. dark purple 
aggregates) from the PLA region they are adsorbed onto, which is coloured in green. The 
average diameter of such immobilized Omp2a aggregates is 27±5 nm (Figure 5.4.8b), 
which is in excellent agreement with the effective diameter measured by TEM for 
aggregates (26±5 nm in Figure 5.4.2). Furthermore, the average height of these 
aggregates is 6±2 nm (Figure 5.4.8c), which is fully consistent with the 6 nm in height 
identified for the majority of -barrel porins studied so far.58 
The Omp2a retention efficiency (RE), expressed as the ratio (in %) between the mass of 
protein entrapped on the nanoperforated PLA substrate and the mass of Omp2a in the 
incubation solution, was evaluated using the Bradford assay. Figure 5.4.8d displays the 
amount of immobilized protein per unit of area and the RE for both perforated and non-
perforated NMs. Results indicate higher the concentration of protein in the incubation 
solution, the greater the amount of immobilized protein. On the contrary, the highest RE 
(5.8±1.0%:) was obtained for the incubation solution with the lowest concentration of 
protein (0.12 mg/mL), while RE values derived after using the 0.5 and 0.25 mg/mL 
protein solutions were practically identical (2.9±0.7% and 2.8±1.3%, respectively). This 
feature indicates that the protein saturation limit is reached at 0.25 mg/mL. 
Interestingly, the amount of immobilized protein and RE are very low (i.e. 0.4±0.3 
µg/cm2 and 0.3±0.2%, respectively) for the non-perforated PLA NMs. This feature 
clearly indicates that, although Bradford assays do not distinguish between proteins 
adsorbed onto the surface of the nanofilm or confined inside the pores, the amount of 
protein immobilized inside the latter is significantly higher. Thus, the adsorption of 
protein onto the surface is difficult because of the smoothness at non-perforated regions 
(i.e. Rq is 1.7±0.2 nm for non-perforated NMs), while the roughness inside the 
nanoperforations (Figure 5.4.6c) is large enough to facilitate the confinement of the 
protein. It is well known that physical immobilization of protein aggregates on ultra-flat 




interpretation of the results because of the imprecision of the Bradford assays mentioned 
above.  
 
Ion diffusion in Omp2a-filled nanoperforated PLA nanomembrames.  
EIS studies were conducted to monitor changes in the resistance and capacitance 
caused by the presence of nanopores filled by Omp2a aggregates. Accordingly, the 
impedance was measured for frequencies ranging from 10-2 to 104.5 Hz for non-
perforated, nanoperforated, and Omp2a-filled nanoperforated PLA NMs using several 
electrolytes. For all assays, such PLA NMs were supported onto ITO semiconductor 
electrodes, which exhibit both a high electron density (1021 e– / cm3) and a good stability 
in aqueous solution for electrochemical applications.60 Stability of bare ITO was essential 
to retain the charged protein inside the induced nanopores during EIS measurements on 
Omp2a-filled PLA NMs. It should be emphasized that no protein was lost during EIS 
measurements on Omp2a-filled PLA NMs. Thus, the concentration of Omp2a 
immobilized in the perforated PLA NMs, which was analysed by the Bradford assay, was 
maintained within the same concentration range before and after EIS studies (4.1±1.0 
and 5.4±1.54 µg·cm2, respectively). The electrolyte concentration interval selected for 
this study was identical to that previously used by Balme et al.61 to examine the ion 
transport through hybrid biological/artificial solid-state nanoporous membrane as a 
function of salt concentration. 
 Figure 5.4.9  displays the Bode and Nyquist plots recorded for ITO substrate and 
the three PLA NMs, using 0.5 M NaCl aqueous solution. The EEC (Figure 5.4.9e) of the 
bare ITO electrode shows the electrolyte resistance (RS) connected in series with the 
capacitance of the double layer semiconductor/electrolyte interface (Qdl), which is 
consistent with the EEC reported in the literature.60 The quality of the experimental data 
fitting to EECs was evaluated by the estimate percentage error associated with each 
circuit element, being lower than 10% in virtually all cases (Table 5.4.2). The RS 
parameter is not affected by changes occurring on the electrode surface,62 whereas the 
Qdl parameter is often modelled as a constant phase element (CPE) instead of a pure 
capacitance (Cdl) since the phase angle is lower than 90º.62,63 




Figure 5.4.9 Bode (a, b) and Nyquist (c, d) plots of ITO (circle), non-perforated PLA (square), 
nanoperforated PLA (triangle), Omp2a-coated non-perforated PLA (cross) and Omp2a-filled 
nanoperforated PLA (diamond) in NaCl 0.5 M; (d) corresponds to an amplified area from (c), 
for better visualization of high frequency zone. Symbols correspond to experimental data, while 
lines are fitted curves according to EEC. (e) EEC used for fitting the experimental data from EIS 
measurements: RS is the electrolyte resistance; QM and RM are the membrane constant phase 
element and resistance, respectively; Qdl and Rp are the double layer constant phase element and 
the pore resistance, respectively. The depicted surfaces are (left) ITO and (right) non-perforated 






Table 5.4.2 Resistances (R) and constant phase elements (CPE) for each sample, analysed in NaCl 0.5 M solution, from fitting parameters obtained 






n RM (Ω·cm2) CPEdl (Fcm-2·sn-
1) 
n Rp (Ω·cm2) 
Bare ITO 48.5 (0.75) 7.63·10-6 (0.57) 0.97 
(0.13) 
    
Non-perforated PLA 56 (1.15) 3.15·10-6 (4.68) 0.92 (1.2) 5.99·103 
(5.37) 




64.3 (1.62) 5.37·10-5 (12.6) 0.76 (1.5) 2.5·103 (20.2) 3.11·10-5 (6.16) 0. 99 
(1.23) 
18.32·103 (5.3) 





56.1 (1.89) 2.46·10-5 (13.14) 0.96 
(2.95) 
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In addition to the heterogeneity of the electrode surface (i.e. roughness, porosity, 
reactivity), the CPE impedance (ZCPE) is also related to non-uniform diffusion across the 
interface. That is, ZCPE is defined as [Q·(jω)n]-1 and is associated to a pure capacitor for 
n= 1 or a pure resistor for n= 0. For n= 0.5, it accounts for a diffusion process. 
Accordingly, the impedance of ITO layer (Figure 5.4.9a) consists of a frequency-
independent response at high frequencies (RS), while it steadily increases for frequencies 
below 103 Hz (Qdl; n = 0.97). Moreover, as polymer films are porous materials, two 
shoulders appear at log |Z| vs log f plot for systems covered by PLA membrane. Figure 
5.4.9a exhibits a broad shoulder between 10 and 103 Hz, that corresponds to the parallel 
association of the membrane resistance (RM) and the membrane capacitance (QM) 
(Figure 5.4.9e). Furthermore, a second shoulder appears at frequencies below 0 Hz, 
corresponding to the membrane pore resistance (Rp) in parallel with the Qdl of the ITO 
electrolyte/interface. The electrical response is perfectly adjusted to the electrical circuit 
(in series) shown in Figure 5.4.9.e. Both shoulders represent two time constants in the 
Bode plot (Figure 5.4.9b, phase angle). Regarding the Nyquist spectra (Figure 
5.4.9c), all three NMs display curves with two semicircles: the starting point of the curve 
indicates RS, the first semicircle (at high frequencies) corresponds to RM and QM, whereas 
the second (at low frequencies) corresponds to Rp and Qdl. The offset on the high 
frequency impedance zone (Figure 5.4.9d) shows the two semi-circles from 
nanoperforated PLA with adhered Omp2a. 
Table 5.4.2 lists the contribution of each element for the several NMs tested when 
the electrolyte is a 0.5 M NaCl solution. As it can be seen, the RM value of PLA 
membranes drastically decreases when artificial nanopores were induced across the 
polymer film, varying from 5.99 kΩ·cm2 (non-perforated PLA) to 883 Ω·cm2 (perforated 
PLA). The confinement of aggregates (from Omp2a protein) into PLA nanopores further 
reduced the membrane resistance to 317 Ω·cm2, evidencing that the exchange of ions 
between the working electrode (bare ITO) and the electrolyte is favoured compared to 
nanoperforated PLA without protein. However, even though Omp2a adsorbed onto non-
perforated PLA nanomembranes results in a RM value of 2.50 kΩ·cm2, the confinement of 
aggregates (from Omp2a protein) into PLA nanopores further reduces the membrane 




electrode (bare ITO) and the electrolyte is favoured when Omp2a and nanopores are 
combined. Furthermore, the CPE related to the polymer membrane, which accounts for 
the polymer ability to store charge, increases by one order of magnitude after confining 
Omp2a. Moreover, we observe Rp sensible to changes occurring above the electrode, the 
value decreasing as follow: non-perforated PLA > nanoperforated PLA > Omp2a-filled 
nanoperforated PLA, whereas Qdl varies in the opposite order, as expected. Therefore, the 
pore resistance has dropped down to 16.8% of its initial value (nanoperforated PLA), 
indicating a better diffusion of ions across the pore-induced membrane. Diffusion of ions 
is also observed by the reduction of the n exponent in the impedance equation from 0.75 
to 0.48 (Table 5.4.2). Whilst the diffusion of species in a polymer coating is often 
modelled with Warburg impedance (ZW),65 the diffusion processes are controlled by the 
pore resistance in the present study.   
In order to compare the selectivity of the PLA NMs, impedance analyses were 
recorded using three electrolytes: NaCl, KCl, and CaCl2 solutions with various 
concentrations (i.e. 50, 100, 500 and 1000 mM). A complete description of the results is 
provided in the Nyquist plots displayed in Figure 5.4.10, while the contribution of each 
element of the fitted EEC is listed in Tables 5.3-5. Similarly to the above-described 
tendency, non-perforated PLA NMs are characterized by high RM and low QM values that 
vary with the electrolyte concentration but not with the nature of the cation (Figure 
5.4.11a). Whilst the same trend is observed for nanoperforated PLA NMs, RM values 
here decrease by a factor of 8.7 ± 3.5 compared to non-perforated PLA. Thus, the 
presence of nanopores decreases the membrane resistance and increases the membrane 
capacitance, regardless the electrolyte. The RM values for Omp2a-filled nanoperforated 
PLA NMs, which ranged between 150.9 Ω·cm2 (in 1 M NaCl) and 2.2 kΩ·cm2 (in 50 mM 
KCl), not only decrease with increasing ion concentration but they were also nature 
dependent.  
On the other hand, the conductance (Gm= 1/RM) values for Na+ electrolyte at 0.5 M 
NaCl was measured using Omp2a-coated non-perforated PLA NMs.  The resulting Gm 
value, which is 0.30 ± 0.1 mS, is in good agreement with the values obtained for 
uncoated non-perforated PLA nanomembranes (Figure 5.4.11a). This observation is 
consistent with the fact that the fraction of protein adsorbed onto the nanomembrane is 
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not contributing to the ion transport, that role being essentially attributed to the Omp2a 
aggregates confined in the nanopores. 
 
 
Figure 5.4.10 Nyquist plots of (a) non-perforated, (b) nanoperforated and (c) Omp2a-filled 
nanoperforated PLA NMs in NaCl, KCl and CaCl2 aqueous solutions at 50, 100, 500 and 1000 
mM concentrations (black, dark blue, red and light blue profile, respectively). Symbols 
correspond to experimental data, while lines are the fittings to the corresponding electrical 

































































































































































 Figures 5.4.11b and 5.4.11c  depict the ion preferences of nanoperforated PLA 
NMs with and without immobilized Omp2a, respectively, in terms of membrane 
Figure 5.4.11  (a) Comparison of the NM conductance (Gm = 1/RM) values for Na+ (grey), K+ 
(red), and Ca2+ (blue) electrolytes at different concentrations. In most of the cases, values are 
the mean of 3 samples and their standard deviation. Greek letters on the columns refer to 
significant differences (p < 0.05) when the 2way ANOVA and Tukey's multiple comparisons test 
are applied: α vs non-perforated PLA, β vs nanoperforated-PLA and δ vs Omp2a-filled 
nanoperforated PLA. Dependence of the conductivity (σ; Eq. 5.4.1) as a function of the ion 
concentration in solution for (b) Omp2a-filled nanoperforated and (c) nanoperforated PLA 
NMs. Non-perforated PLA membrane conductivities are below the dotted orange line. In 
general the values are the mean of three samples and their standard deviation. 
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conductivity (𝜎) against ion concentration in solution. The membrane conductivity (𝜎) 
was calculated from Eq. 5.4.1:  




   (Eq. 5.4.1) 
     
where σ is the proton conductivity (S/cm), L is the thickness of the membrane (10-5 cm); 
A is the area of the electrode (1 cm2), and RM is the membrane resistance of perforated 
and non-perforated films. As it can be seen, enhanced ion diffusion was achieved for 
higher ionic concentrations, especially in the case of Omp2a-containing NMs. In 
addition, Na+ and Ca2+ ions have a stronger affinity towards the porin channel than K+ 
ions, within the studied concentration range, with the best discriminative sensitivity for 
high concentrations of electrolyte (i.e. 0.5 or 1 M). Furthermore, ion selectivity between 
mono and divalent cations is clearly observed for electrolyte concentrations comprised 
between 100 and 500 mM.  
Finally, changes in RM with the concentration of electrolyte were found to be 
reversible. Indeed, after going from highly diluted solutions to concentrated ones and 
then back to low concentrated solutions, the values for RM were maintained. This is 
illustrated in Figure 5.4.12 for Omp2a-filled nanoperforated PLA NMs, which displays 
the variation of RM with the KCl concentration.   
 
Figure 5.4.12 Variation of the Omp2a-filled nanoperforated membrane resistance (RM) with 


















Table 5.4.3 Resistances and CPEs for each sample from fitting parameters obtained with the EEC displayed in Figure 5.4.9e. For each system 
impedance parameters are displayed according to the NaCl concentrations of 50, 100, 500 and 1000 mM. The percentage errors associated to each 





n RM (Ω·cm2) CPEdl (Fcm-2·sn-
1) 
n Rp (Ω·cm2) 
50 mM        
Non-perforated PLA 127.8 (1.5) 2.91·10-6 (3.6) 0.9 (0.9) 12.3·103 (4.7) 1.22·10-5 (1.2) 0.21 (1.2) 429·103 (2.7) 
Nanoperforated PLA 
99.9 (1.6) 2.95·10-5 (4.1) 0.56 (1.0) 
2.22·103 
(4.8) 
6.14·10-5 (1.1) 0.7 (1.1) 33.7·103 (1.6) 
Omp2a-filled nanoperforated 
PLA 




100 mM        
Non-perforated PLA 
133.2 (1.6) 4.88·10-6 (5.6) 0.85 (1.1) 
6.88·103 
(6.6) 
1.18·10-5 (1.3) 0.85 (1.2) 443·103 (3.2) 
Nanoperforated PLA 





6.14·10-5 (1.3) 0.7 (1.4) 31.6·103 (1.9) 
Omp2a-filled nanoperforated 
PLA 
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500 mM        
Non-perforated PLA 56 (1.1) 3.15·10-6 (4.7) 0.92 (1.2) 5.99·103 (5.4) 1.54·10-5 (1.2) 0.79 (1.2) 135.5·103 (1.9) 
Nanoperforated PLA 






56.1 (1.9) 2.46·10-5 (13.1) 
0.96 
(2.9) 




1000 mM        
Non-perforated PLA 45.7 (1.4) 4.03·10-6 (8.0) 0.95 (1.8) 2.59·103 (7.3) 1.59·10-5 (1.1) 0.77 (1.0) 124.6·103 (1.8) 
Nanoperforated PLA 



















Table 5.4.4 Resistances and CPEs for each sample from fitting parameters obtained with the EEC displayed in Figure 5.4.9e. For each system 
impedance parameters are displayed according to the KCl concentrations of 50, 100, 500 and 1000 mM. The percentage errors associated to each circuit 





n RM (Ω·cm2) CPEdl (Fcm-2·sn-
1) 
n Rp (Ω·cm2) 
50 mM        
Non-perforated PLA 
184.4 (1.9) 5.68·10-6 (6.6) 0.8 (1.3) 
6.16·103 
(6.0) 
1.04·10-5 (1.3) 0.93 (1.0) 492·103 (2.9) 
Nanoperforated PLA 74.4 (2.6) 3·10-5 (8.2) 0.53 (1.8) 1.58·103 (6.8) 5.67·10-5 (1.5) 0.72 (1.5) 37.7·103 (2.6) 
Omp2a-filled nanoperforated 
PLA 
110.5 (2.6) 1.62·10-5 (8.4) 0.83 (2.8) 2.2·103 (7.3) 4.65·10-4 (16.7) 0.51 (4.9) 3.56·103 (8.1) 
100 mM        
Non-perforated PLA 
107.2 (1.5) 4.65·10-6 (4.6) 
0.84 
(0.8) 










79.3 (2.5) 1.68·10-5 (8.9) 0.84 (2.8) 1.87·103 (7.1) 5.21·10-4 (13.9) 0.53 (5.4) 3.67·103 (8.4) 
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500 mM        
Non-perforated PLA 
63.7 (1.0) 4.4·10-6 (2.8) 0.87 (0.5) 
9.39·103 
(3.8) 
1.15·10-5 (1.0) 0.91 (0.9) 255.6·103 (1.6) 
Nanoperforated PLA 






54.6 (2.2) 3.32·10-5 (10.4) 0.79 (3.3) 751 (9.6) 7.07·10-4 (9.0) 0.53 (6.5) 3.71·103 (9.0) 
1000 mM        
Non-perforated PLA 42.8 (1.3) 5.09·10-6 (3.9) 0.87 (0.8) 4.92·103 (5.7) 1.34·10-5 (1.3) 0.87 (1.2) 117·103 (1.7) 
Nanoperforated PLA 

















Table 5.4.5 Resistances and CPEs for each sample from fitting parameters obtained with the EEC displayed in Figure 5.4.9e. For each system 
impedance parameters are displayed according to the CaCl2 concentrations of 50, 100, 500 and 1000 mM. The percentage errors associated to each 





n RM (Ω·cm2) CPEdl (Fcm-2·sn-
1) 
n Rp (Ω·cm2) 
50 mM        
Non-perforated PLA 157 (0.9) 4.3·10-6 (5.2) 0.85 (3.6) 9.24·103 (1.4) 1.13·10-5 (0.9) 0.57 (3.0) 461·103 (4.1) 
Nanoperforated PLA 
112.8 (0.6) 2.947·10-5 (3.6) 0.82 (1.6) 
3.85·103 
(13.1) 
4.14·10-5 (2.9) 0.81 (1.9) 52.6·103 (2.4) 
Omp2a-filled nanoperforated 
PLA 
84.8 (1.4) 1·10-4 (8.4) 0.61 (2.1) 1.01·103 (17.1) 8.2·10-5 (2.2) 0.8 (2.2) 
16.31·103 
(3.0) 
100 mM        
Non-perforated PLA 




Nanoperforated PLA 91 (0.7) 3.67·10-5 (1.0) 0.81 (1.1) 1.15·103 (11.2) 4.06·10-5 (1.0) 0.81 (1.7) 55.5·103 (1.7) 
Omp2a-filled nanoperforated 
PLA 





500 mM        




58.21 (1.0) 3.5·10-6 (2.0) 
0.92 
(0.2) 




Nanoperforated PLA 60.5 (0.9) 7.75·10-5 (13.0) 0.77 (2.8) 326 (15.8) 4.07·10-5 (0.9) 0.81 (0.8) 52.4·103 (1.5) 
Omp2a-filled nanoperforated 
PLA 
41.2 (1.2) 7.73·10-5 (9.7) 0.68 (1.9) 246.2 (6.2) 8.43·10-5 (0.9) 0.81 (0.7) 
18.02·103 
(1.2) 
1000 mM        
Non-perforated PLA 44.8 (3.1) 4.55·10-6 (1.3) 0.9 (0.9) 3.92·103 (5.0) 1.48·10-5 (1.6) 0.79 (1.4) 127·103 (4.2) 
Nanoperforated PLA 53.2 (1.2) 2.33·10 -4 (12.2) 0.61 (2.8) 411 (27.2) 4.29·10-5 (0.9) 0.81 (0.9) 48.6·103 (1.4) 
Omp2a-filled nanoperforated 
PLA 









Through the development of nanotechnology and molecular engineering, biomimetic 
devices based on complex biological structures are now emerging at the nanoscale. 
Within this context, biomimetic artificial channels and pores have been prepared using 
different techniques, as for example lithography66 and ion67 or electron68 beam sculpting. 
Besides, supported OM protein-containing NMs can be prepared by spreading vesicles 
containing the proteins and by chemical or physical immobilization of the OM protein 
(e.g. by incorporating anchor molecules or by promoting hydrophobic protein–substrate 
interactions, respectively) onto the substrate.51,69 In spite of those important advances, 
supported NMs exhibit fundamental drawbacks.  
The first arises from the proximity of the artificial NM and the bare solid surface it is 
deposited onto, which typically is metallic or ceramic. Thus, the NM···substrate distance 
is usually not sufficiently large to avoid direct contact between the incorporated OM 
protein and the solid surface, which usually induces protein denaturation. Different 
strategies have been proposed to reduce and even eliminate this problem. In a seminal 
work, Römer and Steinem,70 inserted gramicidin D into suspended lipidic NMs. More 
specifically, porous alumina substrates with controlled pore diameter were prepared by 
anodizing electropolished aluminium foils in acidic solutions, followed by dissolution of 
the remaining aluminium and alumina at the backside of the pores. After coating one 
side of such porous material with a thin gold layer that was subsequently functionalized 
to achieve a hydrophobic surface, suspended 1,2-diphytanoyl-sn-glycero-3-
phosphocholin NMs were formed, as was proved by EIS measurements.43 However, 
direct contact between the OM protein and the solid surface can be avoided using a much 
simpler approach, which consists on the application of polymeric NMs to reduce the 
frictional coupling with the inorganic support.51,60 For instance, in a recent study, we 
preserved the -barrel structure of the OM protein in PNMPy-Omp2a NMs, which were 
obtained by in situ anodic polymerization introducing Omp2a in the monomer-
containing generation medium.51  
The second, and probably more critical, limitation of supported NMs comes from 
their own lack of self-supported behaviour. As a result, although supported OM protein-
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containing NMs have numerous potential applications such as electrochemical 
biosensing, the applicability of self-supported polymeric NMs is up to now less restricted, 
which makes them attractive not only for biomedical applications (e.g. devices for 
controlled delivery of ions), but also to other technological fields, like nanofluidics.  
In recent years, some studies have been devoted to confine porins into nanopores 
constructed from polymeric membranes. Jovanovic-Talisman et al.71 tethered porins rich 
in Phe-Gly domains in track-etched polycarbonate membranes with cylindrical 
nanopores of 30 nm in diameter and 6 µm in length. For this purpose, a thiol-modified 
tear porin was attached to the gold-layer previously sputtered onto one side of the NM. 
On the other hand, Kowalczyk et al.72 demonstrated selective transport of proteins across 
individual biomimetic nuclear pore complexes at the single-molecule level. This was 
achieved by drilling nanopores into a 20-nm thin free-standing silicon nitride (SiN) 
membrane with a focused transmission electron microscope beam. After this, 
nucleoporin-functionalization of the nanopores was performed in a complex three-step 
chemical process with hetero-bifunctional cross-linkers, which is similar to that 
employed for immobilizing DNA onto silicon surfaces.73  
In this work, nanoperforated PLA FSNMs were fabricated using an approach based 
on the combination of spin-coating with phase segregation using immiscible PLA:PVA 
mixtures, and the subsequent removal of PVA domains via selective solvent etching.56 
The quantitative evaluation of this procedure using different conditions has shown that 
the diameter of the nanopores decreases from 17073 nm to 6532 nm if a 90:10 
PLA:PVA mixture is prepared under vigorous stirring.56 In order to reduce the diameter 
of the nanoperforations (by 20%), the concentration of PVA in the PLA: PVA mixture 
was further decreased in this work. Hence, PLA FSNMs with nanopores of 5122 nm in 
diameter and similar depths (100 nm) were obtained using 99:1 PLA:PVA mixtures.   
The intrinsic conformational flexibility of OM proteins critically governs their 
function as elements for selective transport of ions through cell membranes. Polymeric 
NMs used as domains to accommodate such biomolecules through their immobilization 
either at the surface, inside the matrix, or inserted into nanopores as in this work, must 




(i.e. polymer molecules) facilitate and ultimately determine the functionality of the OM 
protein. These movements largely depend on the flexibility and mechanical properties of 
the whole NM. Within this context, it should be emphasized that PLA FSNMs are flexible 
and, indeed, are softer than bulk PLA. The mechanical properties of non-perforated PLA 
FSNMs prepared using a procedure similar to that employed in this work (i.e. spin-
coating) were carefully examined by Okamura and co-workers8 using a bulging test. 
These authors observed that NMs with a thickness of 235 nm and 6014 nm swelled 
gradually and gave almost semicircular deflection until a pressure of approximately 4 
kPa and 7 kPa, respectively. The elastic moduli of these PLA FSNMs were 1.70.1 GPa 
and 3.10.5 GPa, respectively. On the other hand, the elastic modulus of ultrathin PLA-
mesh systems, which consists of PLA FSNMs collected on stainless steel meshes, was 
found to gradually increase with the thickness.5 That is, the modulus grows from 3.51.3 
GPa to 5.11.0 GPa when the thickness increases from 291 to 2132.4 nm, respectively. 
Interestingly, comparison of the elastic moduli of FSNMs prepared using different 
polymers indicates that those coming from PLA are amongst the softer ones.3 According 
to these reported observations, the elastic modulus of the NMs prepared in this work, 
which exhibited a thickness of 110 nm, are expected to be significantly lower than that 
reported by Eling et al.74 for bulk PLA films (i.e. 7-10 GPa for a film thickness of 7034.4 
nm). 
The OM porin Omp2a was reconstituted into preformed nanoperforated PLA FSNMs 
of moderate electrical resistivity (~12 kΩ). Although this value is considerably smaller 
than the resistance of lipid bilayers (~1 MΩ)75,76 frequently used to incorporate and study 
the functionality of OM proteins and ion transport,75-78 the PLA-Omp2a molecular 
architecture studied in this work has provided direct evidences of the enormous changes 
in the response of artificial nanopores when the protein is confined inside. As a 
consequence of their response, Omp2a-filled nanoporous PLA FSNMs should be 
considered hybrid biological/artificial nanosystems with very promising permeation 
properties for many technological, biomedical, and environmental applications. 
Incubation of nanoperforated PLA NMs in Omp2a solution led not only to the 
immobilization of oval protein aggregates onto the surface, but also to their confinement 
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inside the nanopores. Although the mass of protein at the nanoperforated NMs 
progressively grew with the concentration of Omp2a in the incubation solution, the 
immobilized oval aggregates followed the same random distribution in all cases. This 
behaviour is fully consistent with both the experimental observations and the biophysical 
model of outer membranes growth of Gram-negative bacteria,79 which are composed of 
proteins, phospholipids, lipoproteins, and lipopolysaccharides. Accordingly, patches of 
the new OM material, which include porins, are added in discrete bursts that evolve in 
time following a Stokes flow and organize randomly. 
Comparison of the EIS results obtained for nanoperforated PLA NMs with and 
without Omp2a evidences that the OM protein was properly immobilized, retaining the 
functionality associated to the -barrel structure. Most importantly, the Omp2a protein 
was successfully retained during the overall of the EIS analyses within the membrane, 
and Omp2a-filled nanoperforated PLA NMs exhibit selective transport of ions when the 
electrolyte concentrations are high. Thus, the transport of Ca2+ and Na+ was favoured 
with respect to the transport of K+ for electrolyte concentrations higher than 500 mM, 
this effect increasing with the concentration. This ion affinity becomes less appreciable 
for low electrolyte concentrations (50 mM). Interestingly, the diffusion of Na+ and Ca2+ 
ions are significantly lower for nanoperforated PLA NMs at the highest electrolyte 
concentration (1 M), evidencing the crucial role played by Omp2a in the transport 
process. Although porins are not selective because of their pore dimensions (i.e. they are 
too large to be specific), the pore walls are known to have slight preferences for ion 
permeability.80 In general, the selectivity of large pores, like those of porins, are 
associated with two components:81 i) partitioning, an equilibrium between the exclusion 
and accumulation of ions within the pore; and ii) diffusion, a non-equilibrium measure 
of the intrinsic ion mobility within the pore. The fact that in the present study the best 
discrimination was obtained for very high electrolyte concentrations (> 0.5 M) should be 
attributed to the low transport efficiency of the proteins confined inside the pores, which 
in turn is related with their relative orientations. Thus, the methodology presented in this 
work does not allow control the orientation of confined protein aggregates. In order to 




In a recent work, Balme et. al.61 used commercial polycarbonate membranes, which 
were 5 m thick and exhibited nanopores with diameter of 15 nm, to immobilize 
gramicidin A. The latter is a linear pentadecapeptide that presents an alternating 
sequence of D and L amino acids defining a right handed -helix.82 The head-to-head 
association of gramicidin A molecules gives ion channels that are selectively permeable 
to monovalent cations and impermeable to anions, such as Cl–.83 Polycarbonate 
membranes with gramicidin A confined into the nanopores were permeable to K+ and in 
a minor proportion to Na+ and Ca2+, even though the KCl/NaCl diffusion coefficient ratio 
was comparable to that measured through gramicidin A under biological conditions (i.e. 
lipid bilayers).61 These results were attributed to the fact the -helical conformation was 
kept in the pore centre. Omp2a-filled nanoperforated PLA NMs provide two important 
improvements with respect to polycarbonate membranes. First, the thickness of the 
membrane has been reduced from the micrometric to the nanometric scale preserving 
the free-standing behaviour. Moreover, such a reduction facilitates the movement of the 
polymer molecules enhancing the flexibility of the NM, which affects positively to the ion 
transport across the biomolecule. Second, PLA is not only biocompatible, as is 
polycarbonate, but is also biodegradable. Accordingly, FSNMs made of PLA and Omp2a 
are very promising for biomedical applications that require completely biodegradable 
devices for selective ion transport.  
Chaaya et al.84 reported the confinement of gramicidin A inside nanopores (diameter 
10.6 nm, 5.7 nm and 2 nm) obtained by track-etching and atomic layer deposition on 
flexible poly(ethyleneterephthalate) (PET) films. Amazingly, in that case confined 
gramicidin A exhibited a better permeability to Cl– than to Na+ (i.e. the permeability ratio 
PNa+/PCl– < 1). This behaviour, which is contrary to the selectivity of the channel in 
biological membranes, was explained by the loss of gramicidin head-to-head association. 
In biological membranes the impermeability to Cl– is due to changes in the hydration 
state near the head-to-head connection between associated gramicidin molecules and in 
the -helix structure.85,86 However in PET membranes, the gramicidin aggregation is 
dismantled in the solution used for the immobilization, and is not recovered upon 
confinement inside the nanopore.84 In order to preserve the operative and functional 
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state of the biomolecule when confined inside nanopores, the protein must retain its 
folded and assembled form. In this work, the -barrel structure of the Omp2a porin 
(Figure 5.4.1b) has been saved not only because of the formation of a stable PLA–
Omp2a interface, but also because of the nanometric thickness of PLA FSNMs. Thus, the 
confinement of biomolecules inside polymeric NMs avoids the influence of many effects 
typically associated with bulk polymers. For example, the formation of well-defined 
multiphasic microdomains (i.e. coexisting crystalline and amorphous domains) results in 
different polymer–biomolecule interfaces since the properties of such domains differ. 
Also, with respect to NMs, the flexibility and the elastic modulus of bulk films are lower 
and higher. Accordingly, the formation of stable polymer–biomolecule interfaces is more 
difficult in bulk films because of the reduction of the polymeric molecules motion. It 
should be underlined that the thickness of the PET films reported by Chaaya et al.84 was 
5 m and in this case, the polymer–biomolecule effects should be related to those 
typically found in systems involving bulk polymers. 
 
5.4.3 Conclusions 
We have examined the feasibility of FSNMs for selective ion transport by integrating an 
OM protein, Omp2a, into nanoperforated ultra-thin films of PLA. When oval protein 
aggregates were immobilized inside nanoperforations of diameter 5122 nm, the 
resulting PLA NMs showed much higher ion transport activity than nanoperforated films 
without immobilized Omp2a, especially at high electrolyte concentrations. Hence, the ion 
affinity of Omp2a-filled nanoperforated PLA NMs increases with the concentration. In 
addition, ion diffusion of Ca2+ and Na+ ions through Omp2a-filled nanopores is 
significantly higher than for K+ at concentrations  500 mM. Overall the results suggest 
that the novel Omp2a–PLA platform fulfills not only the nanometric dimensional 
requisite for truly mimicking biological attributes, but also the conditions necessary for 
designing new NMs for biosensing, nanofluidics and ion-rectifying for energy conversion. 
This study demonstrates that the bioinspired combination of nanofeatures supported 
onto polymeric FSNMs with the confinement of OM proteins is a powerful approach that 
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This Chapter tries to review the application of intrinsically conducting polymers (ICPs) for 
drug delivery systems (DDSs).  Drugs administrated to patients do not always reach the targeted 
organ, which may affect other tissues leading to undesired side-effects. To overcome these 
associated problems with drug administration DDSs appeared. Nowadays, it is possible to target the 
administration and, most importantly, to achieve a controlled drug dosage upon external stimuli. In 
this work the attention has been focused on the drug release upon electrically stimuli employing 
ICPs. ICPs are well-known organic polymers with outstanding magnetic, electrical and optical 
properties similar to metals but also retaining some advantageous properties associated with 
polymers, such as mechanical stability and easiness of processing usually. Depending on the redox 
state, ICPs can incorporate or release anionic or cationic molecules on-demand. Besides, the 
releasing rate can be tuned by the type of electrical stimulation applied. Another interesting feature 
is that ICPs are capable to sense redox molecules such as dopamine, serotonin or ascorbic acid 
among others. Therefore, future prospects go towards the design of materials where the releasing 
rate could be self-adjusted in response to changes in the surrounding environment. This 
recompilation of ideas and projects provides an overview of ICP synthesis and properties relevant to 
their use as DDSs. Definitely, ICPs hold great potential in DDSs where the dose can be adjusted by 
the application of an external stimulus, hence optimizing the effect of the drug and diminishing side 
effects.  
 
Publications derived from this work: 
 
Puiggalí-Jou, A.; del Valle, L. J.; and Alemán, C. Drug delivery systems based on intrinsically 
conducting polymers. Draft in progress. 
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6.1 Introduction: drug delivery systems (DDSs) 
The understanding of human and animal diseases and the ability to design and 
synthetize new drugs to overcome them increase year after year. Although such topics 
advance hand in hand, it is unforgettable that the efficiency of the delivery is a main 
factor for reaching the optimal therapy. Moreover, the efficacy of the drugs becomes less 
relevant if they are not directed to the correct target or, what is worse, if the time dosage 
is not appropriate for the stage of the disease or if they are left to interact with unwanted 
targets for a long time, leading to serious side effects. 
Rapid developments are also under way in the field of biomaterials, which have a 
great impact on patient care.1 Although the release and efficacy of a wide range of drugs, 
antibodies, enzymes and vaccines have been improved for the 60 years,2,3 the need of 
DDSs with controlled, localized and efficient drug dosage remains. The principal 
problems of conventional drug administration methods are poor solubility of the drugs, 
possible normal tissue damage, rapid degradation of the drugs, unfavourable 
pharmacokinetics, low biodistribution and lack of selectivity. DDSs can be used to 
improve the drugs solubility by incorporating amphiphilic components, such as lipids or 
specially designed polymers. Furthermore, DDSs provide a carrier for the drug, making 
difficult the accidental extravasation and increasing the protection from early stage 
degradation. Besides, they can slow down the renal clearance, reduce side effects and 
increase drug concentrations in the diseased tissue by enhancing permeability and 
retention (EPR) effects or by ligand-mediated targeting.  
The first steps aimed at the production of DDSs were done in 1950, when drugs were 
incorporated into solid polymers to obtain sustained drug release for agricultural 
purposes. In the next decades, those approaches were extended to biomedicine.4 Since 
then, this field have not stopped burgeoning. The first patent for controlled drug release, 
which consisted on the utilization of coatings onto edible tablets, was deposited by 
Wurster in 1953.5 In 1968 Zaffaroni founded ALZA, the first company dedicated to the 
commercialization of DDSs, which started releasing low molecular weight drugs, like 
pilocarpine, using ethylene vinyl acetatecopolymer (EVA) and 




since the principal inconvenient associated to these materials, which was the 
inflammation and rejection that caused to the body, was solved by introducing the proper 
washing steps.6 Besides, a few years later also high molecular weight molecules were 
retained on polymer pellets and released in a slow fashion manner when exposed to 
aqueous conditions.7 
In the 1960s Alec Bangham studied lipids as units for bilayered structures8 and 
propelled the research of liposomes as potential drug carriers9. Some systems based on 
lipids are nowadays commercially used for cancer therapy, as for example DaunoXome 
(liposomal Daunorubicin), Doxil (liposomal Doxorubicin) and Ara-C liposomal 
(liposomal Citarabine). These systems increase the circulation half-life and tumour 
uptake while the toxicological profile on healthy tissues is reduced.  
Later on, DDSs  extended towards many other inorganic materials (e.g. iron oxide,10,11 
gold,12,13 and silicon14,15) and organic materials.16 Generally, polymeric materials outstand 
from the rest since they can be modelled and processed into a wide range of forms, like 
membranes, fibers, foams, micelles, dendrimers, nanoparticles (NPs) and hydrogels. 
This adjustable feature, along with ease of handling, results in materials able to be 
accommodated for the treatment of a huge number of medical conditions. Some of these 
materials have been translated to the clinical use and are being commercialized for a 
wide range of therapies. For instance, Lupron Depot, which is used to treat advanced 
prostate cancer, consists on poly(lactic-co-glycolic) acid (PLGA) microspheres 
encapsulating the hormone leuprolide.  
Biodegradable polymers, as for example poly(lactic acid) (PLA) and PLGA, are 
suitable materials for sustained long term release in vivo. However, there is no control 
over when the drug wants to be delivered. New-born systems are those called stimuli 
responsive or smart biomaterials. These are designed to exert a response when there is a 
change in the environment (e.g. pressure, pH, enzymes, level of glucose or temperature) 
or, alternatively, they can be remotely trigged by an external stimuli (e.g. near infrared 
(NIR) light, ultrasounds, magnetic fields or electric currents). The former materials 
respond to localized changes on the ambient of pathological abnormalities and promote 
the drug release while the latter ones are stimulated on demand for pulsatile drug 
delivery. Overall, it has been claimed that the global advanced market for DDSs is 
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expected to grow from roughly $178.8 billion in 2015 to nearly $227.3 billion by 
2020.17,18  
 
6.2 Intrinsically conducting polymers  
Among all the DDSs triggerable by external stimuli, herein we focus on recent 
advances in intrinsically conducting polymers (ICPs). In general, ICPs are organic 
materials with characteristics similar to those encountered in metals (i.e. good electrical, 
magnetic and optical properties) and with the outstanding properties of conventional 
polymers (i.e. flexibility in processing, lightness of weight, and easiness in synthesis). 
Within the context of DDSs, ICPs are considered as electrochemically active and 
conducting biomaterials that allow the delivery upon electrochemical and/or electrical 
stimuli. 
The modern era of ICPs began at the end of the 1970s when Shirakawa, Heeger and 
MacDiarmid discovered that the conductivity of doped polyacetylene can increase by 12 
orders of magnitude upon iodine counter ions incorporation.19,20 The basic structural 
characteristic of ICPs is the conjugated π system that extends over a large number of 
monomer units, creating a continuous electron pathway along the polymer backbone.21 
Thus, the conductivity essentially relies on the characteristic electronic structure of 
conjugated bonds consisting of alternating single and double bonds along the polymer 
chain. This conjugation results in an extended -orbital system that allows charge 
delocalization along the polymer backbone and between adjacent chains, endowing the 
polymer semiconductive properties. The doping process facilitates the formation of 
radical cations / anions (polarons) or dications / dianions (bipolarons) in the backbone, 
counter-ions from the solution entering into the polymeric matrix to balance the 






When electrons are removed from the valence band through the named p-doping 
process, positive charged holes are formed in the electronic structure, while negative 
charges are generated when electrons are injected to the conduction band through the 
called n-doping process. In both cases there is the necessity to counter balance the 
electronic charge with opposite charged ions. Obviously, the electrical conductivity of 
ICPs increases (Figure 6.2a) with the extension of the doping process (i.e. doping 
level). Nowadays, there are approximately 25 reported ICPs, which can be synthesized by 
oxidative chemical or electrochemical polymerization. However, polypyrrole (PPy), 
poly(3,4-ethylendioxythiophene) (PEDOT) and polyaniline (PAni), which are displayed 
in Figure 6.2b, are the most employed due to their stability,23 biocompatibility,24 and 
good electrical  and electrochemical properties.25–27  Nevertheless, these polymers also 
present some drawbacks, like brittleness, rigidness, insolubility, lack of biodegradability 
and poor processability. In order to overcome these limitations, many times ICPs are 
combined with biodegradable and / or more flexible polymers, giving place to 















Figure 6.1 Reversible redox activity of poly(3,4-ethylenedioxythiophene) (PEDOT). 




The biocompatibility of ICPs have been studied in a large variety of cell lines, 
including fibroblasts,29 endothelial, bone cells,30 keratinocytes,31 myoblast,32 neural,33 
glial,34 and mesenchymal stem cells.35 After the assessment that ICPs were biocompatible 
with biological systems, their employment in the biomedical field increased remarkably. 
Nonetheless, the removal of unreacted monomers, extra dopant ions or residual solvent 
is critical to obtain non-toxic or, at least, very little toxic ICPs.36,37 Moreover it has been 
claimed that when the materials present nanofeatures could change the toxicity values, 
generating adverse biological effects due to the superficial area increase.38 Thus, it is vital 
a constant toxicity evaluation of the ICPs materials to ensure the safety of these devices 









Figure 6.2 (a) Scale of material’s conductivity, adapted from.28 (b) Chemical structure of the 





6.3 Architecture of ICPs for DDSs 
ICPs can be prepared by chemical (by means of an oxidant agent) or electrochemical 
(using an oxidising potential through electrodes) synthesis. Recurrently, electrochemical 
methodologies are far more employed since offer a better control over the overall charge 
deposition and rate, which are crucial to regulate the final electrochemical and electrical 
properties of the material.  
For their operation, simple ICP films do not provide the most efficient drug loading 
capacity. The use of micro- and nanostructures can offer a greater drug loading capacity 
since the surface area is bigger. Thus, depending on the final application, different 
approaches can be employed for the ICP synthesis with particular structures. Briefly, we 
can divide the methodologies in three strategies: use of hard templates, soft templates or 
template-free.39,40 
The use hard templates, already existing micro- or nano- structures, to direct the 
polymer growth is a simple and controllable approach. The biggest drawback is the later 
removal of the template. Sometimes, this can lead to structure collapse, film ruptures or 
loss of consistency. Besides, the dimension of the template limits the amount of ICP that 
can be produced and may restrict the scale up possibilities.41 Regarding the preparation 
in the case of chemical synthesis the structure is immersed in a solution containing the 
monomer, the dopant and the oxidant. However, when electrochemical synthesis is 
employed, the template needs to be conductive or situated near the electrodes.  
The most common hard template include nanoporous membranes made of track-etch 
polycarbonate (PCTE)42 or porous alumina membranes (Al2O3).43 In one of the first 
examples, Martin et al. 44 prepared nanofibers within the pores (100, 200 and 400 nm in 
diameter) of a PCTE membrane. Strikingly, nanowires as small as 3 nm in diameters can 
also be achieved following this strategy.45 Also, already fabricated nanofibers are 
frequently used. For example, Feng et al. blended the EDOT monomer with PLGA 
polymer and then polymerized by exposure to an oxidative catalyst (FeCl3)46 or colloidal 
particles such as cuprous oxide (Cu2O). 47 
Soft templates are constituted of self-assembled molecules, which interact through 
non-covalent forces (i.e. van der Waals, hydrogen bonds and π-π stacking among 
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others).48 This method is cheap, simple and powerful. Molecules used as soft-templates 
include surfactants, structure-directing molecules and oligomers. Also gas bubbles (H2 or 
O2 from H2O electrolysis) stabilized with surfactants have been used as soft templates, 
which are known as soap bubbles.49,50 Surfactants can self-assemble into micelles, 
determining the polymer nanostructure. For example, core-shell nanomaterials were 
prepared using two different PPys, which were synthesized with different oxidants and 
generated by microemulsion polymerization.51 Also, a mixture of cationic surfactants (i.e. 
octyltrimethylammonium bromide, decyltrimethylammonium bromide, and 
dodecyltrimethylammonium bromide) were used to selectively fabricate PEDOT 
nanocapsules.52 
The template-free approach is based on the ability to control the nanostructures 
during the polymer formation without the use of any template. This can be done 
electrochemically by using high currents, which are reported to form NPs rather than 
films on the electrodes. Liang et al. achieved PAni NPs when current densities of 0.08 
mA cm-2 were used53. The chemical synthesis without any template can be done on the 
interface between air and liquid or when the oxidant and the monomers are dissolved in 
two immiscible liquids.54,55  Nuraje et al.55 reported that the oxidation of aniline and 
pyrrole at the aqueous/organic interface produces nanoneedles. 
  
6.4 Drug loading  
It is well-known that DDSs based on ICPs take profit of the reversible oxidation and 
reduction ability of these polymers to promote the uptake or expulsion of charged 
molecules form the polymer matrix. One of the first DDS prepared with ICPs consisted 
on PPy films doped with ferrycyanide and glutamate.56 A recent review of the literature 
on this topic27 described the mechanisms for drug loading in ICPs and classified them as 
one step loading of anionic drugs, three- step loading of anionic drugs and loading of 
cationic drugs. 
Obviously, the methodology employed for drug loading depends on the chemical and 
physical properties of the drug (e.g. molecular weight, charge, chemical composition…). 




57–59 anti-cancer,60–62 antibiotics,63,64 growth factors,65 peptides,66 and proteins.67,68 
Generally, small anionic drugs can be incorporated as dopants through one-step 
immobilization69,70 process during the monomer oxidation. Nevertheless, depending of 
the molecule, it can strongly interfere on the final properties of the ICP, for example 
diminishing its conductivity, increasing the brittleness and roughness of the material or 
leading to low loading efficiency. 
As an alternative for anionic drug incorporation, a three-step methodology has been 
used. Firstly, the ICP is synthetized with an anionic primary dopant followed by a 
reduction potential to expel this primary dopant while the polymer chain is neutralized. 
Latter, the desired biological molecule is incorporated when the film is oxidised again 
and it acts as secondary dopant. This method represents a ground-breaking alternative to 
the one previously described since the chosen compound does not affect to the formation 
of the polymer structure. The limitation resides on the possible reduction of incorporated 
drug since when the molecule is loaded during the polymerization is more likely to be 
entrapped at the inner parts of the material. 
Similarly, for cationic drugs the polymer is formed with a primary anionic dopant 
and, subsequently, the film is reduced, leading to the incorporation of the cationic 
molecules to counterbalance its charge.71,72. As expected, upon oxidation, the positive 
charge within the polymer backbone increases, causing the repulsion of positively 
charged molecules. Not so common, but some cationic drugs have been reported to be 
incorporated on the ICPs matrix and released under electrical stimuli, including 
neurotrophin growth factor-3,68 dopamine,72,73 chlorpromazine,71, and N-
methylphenothiazine.74  The regulation of the oxidation state in the polymer backbone 
induces changes in the electrostatic forces between the drug and the polymer, enabling a 
controlled release. However, normally only low levels of these cations have been released 
because of their poor integration into the polymer matrix. The drug can be also 
covalently linked to the monomer of the ICP, the release depending on the hydrolysable 
bond rather than on the external triggerable stimuli.75  
Apparently, the entrapment of neutral medical active compounds is more 
complicated, even though the utilization of simple physical principal, as for example, the 
hydrophobic-hydrophilic effect between the drug and the anionic dopant,74 has been 
DDSs BASED ON ICPs  
215 
 
reported. Another approach is the formation of hydrogen bonds between the drug and 
the oxidized polymer chains. These, intermolecular interactions change during the de-
doping of the ICP, making the hydrogen bonds significantly weaker than when the 
polymer is in the oxidized state and facilitating the drug release.62  
 
6.5 Drug release 
Electrostatic forces play a prominent role when it comes to releasing the drug from 
ICP matrices. Moreover, the expansion and contraction (actuation) of ICPs leads to the 
expulsion of the drug by means of mechanical force. Since these properties occur 
simultaneously, it is not possible to separate them to know which is the prominent as 
release driving force.  Drugs incorporated as dopants on an ICP matrix can be delivered 
by cyclic voltammetry (i.e. the potential of the working electrode is ramped over time at 
the desired scan speed and when reaches the wanted potential is reversed to return to the 
initial potential point), chronoamperometry (i.e. a fixed potential is set over a 
determined period of time) or chronopontiometry (i.e. a fixed current is set over a 
determined period of time), hereafter denoted CV, CA and CP, respectively.  
 
6.5.1 Cyclic voltammetry (CV) 
CV favours the exchange of counterions between the polymeric matrix and the 
medium through oxidation and reduction processes, while the kinetics of such exchange 
depends on the scan rate. Furthermore, there is no fixed potential and, therefore, the 
release can be conducted without an intense optimization. Nevertheless, when many 
oxidation-reduction cycles are applied the films fail and crack due to polymer actuation, 
which supposes a limitation for devices thought to have a long life time. Besides, the 
machinery necessary to generate CVs is more complex than for fixed potentials. For 
example, electrodes covered with PPy doped with dexamethasone (Dex) were tested as 
micromachines for recording neural activity by modulating the inflammatory implant-
host tissue reaction. The potential was swept from –0.8 to +1.4 V at a scan rate of 100 
mV/s.58 Nevertheless, after approximately 30 CV cycles the film experienced some 




In another study, PPy deposited onto titanium was doped with antibiotics 
(penicillin/streptomycin, P/S) or an anti-inflammatory drug (Dex). Results showed that 
they were able to release 80% of the loaded drugs with only five CV cycles at a scan rate 
of 100 mV/s.64. Interestingly, the use of CV allows detecting the oxidation/reduction 
peak of the desired molecule and, thus, correlating it with the quantity that remains on 
the film. On the other hand, controlled release of a neurotrophic factor (NT-3) from PPy 
was examined by pulsed potential, CV  and pulsed current.68 . It was found that, 
independently of the film thickness (3.6 or 26 µm), CV is more effective than the other 
two electrochemical methods. However, after 12 min of CV the polymer started to be 
delaminated from the electrode surface.68 Besides Jiang et. al.76 concluded that the scan 
rate regulates the release. More specifically, about 57, 89 and 95% of adenosine 
triphosphate (ATP) loaded into a PPy matrix was released applying scan rates of 50, 100, 
and 200 mV/s, respectively, during 10 hours.76 Nevertheless, it should be mentioned that 
other molecules, as for example oligomers, monomers or salts, could be also released 
during the electrochemical stimuli. Other techniques to quantify the released drugs, as 
for example are ultraviolet absorption spectroscopy,58,77 electrochemical quartz crystal 
microbalance,78,79 enzyme-linked immunosorbent assays,80 and radiometric 
measurements,81 may also lead to the same misinterpretation of the results. Boehler and 
Asplund recommended the use of high performance liquid chromatography, which 
allows to discriminate the signal coming from the monomer or the drug and with a 
detection limit below 5 ng/mL, even though this is not the most straightforward 
methodology.82 In vivo drug release experiments were also conducted using CV. 83 More 
specifically, Dex was released from PEDOT using three CV scans between -0.3 V and 0.45 
Figure 6.3 SEM images of PPy–Dex coated film: (a) as prepared and (b) after 50 CV cycles. 
Adapted from58. 
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V at a scan rate of 0.1 V/s, EDOT leakage and undesired electrochemical reactions being 
avoided under such electrochemical conditions.  
Even though ICPs can be employed for in vivo implantable application they are not 
the optimal materials because they have low or no biodegradability. Therefore, some 
strategies to obtain biodegradable ICPs have been proposed. One approach is the 
preparation of copolymers composed of one conducting block linked to another 
biodegradable. For instance, Hardy et al.84 obtained electroresponsive oligoaniline linked 
to polyethylene glycol (PEG) or polycaprolactone (PCL) via ester bonds and reported 
their ability to deliver an anti-inflammatory drug upon the application of electrochemical 
stimuli. Potential cycling was carried out between 0.7 V and –0.5 V, first sweeping in the 
positive direction of the potential scale at 50 mV s-1. More recently, the same group 
prepared supramolecular polymers based on peptides (oligoalanines) combined with 
ICPs (oligoanilines).85 The resulting polymers were drop-casted to obtain films (blue 
appearance) and doped with camphorsulfonic acid (CSA) and Dex phosphate (green 
appearance). These molecules were released by CV (0.7 and –0.5 V at a scan rate of 50 
mV/s during 62 s).  
 
6.5.2 Chronoamperometry and chronopotenciometry  
Instead of changing the voltage over time it is possible to keep the same voltage or 
current during the desired time, which is the case of CA and CP, respectively. When 
higher voltages or longer times are used, greater is the drug release. However, the 
utilization of the maximum power or time is not always the best option. It is well known 
that, if the potential is too high, the drug can undergoes irreversible damages, losing the 
effectivity. Moreover, if the voltage is higher than 1.229 V hydrolysis can occur. 
Therefore, it is important to check at which voltage the biological molecule is oxidized or 
reduced prior to any use of CA and CP techniques. Generally, large currents are 
considered between 0.5-5 mA and large voltages between 2-25 V during the operation. 
However, the utilization of ICPs allows the employment of lower values since these 
polymers are sensible to lower electrical changes.86 The application of positive or 




release anionic drugs, while the opposite for cationic drugs. However, there are some 
exceptions. For instances, George et al.87 applied 3 V during 150 s to release an anionic 
complex containing the nerve growth factor (NGF). Other interesting studies claimed 
that it is possible to employ very low voltages (e.g. −0.05 V) for drug release when ferric 
chloride is used as the oxidizing agent.88  
Although CA is the most well stablished methodology for drug release, there is still a 
clear need to test whether the delivered drugs are still bioactive. Accordingly, limitations 
in the utilization of prolonged times or high voltages currently restrict the general 
applicability of this strategy. 
 
6.6 Nanostructure matters 
Effectiveness during the design and development of the ICP DDSs is associated with 
drug loading capacity, system stability and biocompatibility. Micro- and nanostructures 
offer important advantages, such increased loading capacity and sensitivity towards the 
electrical stimuli. Nevertheless, there is no straightforward comparison between the 
different materials and structures since reported experimental setups and quantifying 
methods are too divergent. During the last years materials of multiple dimension scales 
and different shapes have been studied, ranging from polymer films, NPs, fibers and 
nanowires, hydrogels and other 3D organizations, incorporating the advantages of 
nanomaterials to enable a highly integrated and sophisticated multi-functional device 
(Figure 6.4). When these structures are made of ICPs, they exhibit unique electrical 
behaviours, which can lead to new frontiers in bioelectronics.  
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6.6.1 Polymer films 
Electrochemically grown thin films is the most easy and common format of ICPs. The 
electrochemical methodology to prepare ICP films of controlled thickness and doped 
with biomedical active compounds is well-stablished. Thus, electrochemically 
synthetized polymer films have been largely employed to release drugs on demand. 
Previous research shown that significantly different drugs such as Dex,58 
methotrexate,60 chlorpromazine,71 sulfosalicylic acid (SSA) and ATP,90 risperidone,91 
heparine92 or NGF,87 can be incorporated to ICP films and released in a controlled 
fashion. Table 6.1 summarizes some remarkable examples reported in literature, which 
included films prepared with PPy, PEDOT, poly(N-methylpyrrole) (PNMPy), 
oligoaniline, oligolaniline-PCL, oligoaniline-PEG and oligoaniline-alanine. 
For example, Krukiewicz et al.93 demonstrated that PEDOT films incorporating 
botulin, a biological active molecule against a variety of tumours, exhibit high 
cytotoxicity against KB and MCF-7 cell lines. Furthermore, the cell killing increases 
significantly when the botulin release is facilitated by applying a potential. Therefore, 
these matrices hold great potential for local chemotherapy applications. In a very recent 
study, the neural activity was recorded by implanting electrodes in the rat hippocampus, 
83 local inflammation being successfully avoided by a weekly drug release triggered by 
CV. Figure 6.5 schematizes how such flexible electrode was implanted. The anti-
inflammatory Dex was stored in the PEDOT film, which was coating an electrode, and 





released in controlled manner. The evaluation lasted 12 weeks and the electrodes 
exposed to active drug release had neurons closer to the electrode sites compared to the 
controls. 
 
Figure 6.5 (a) Micrograph of a polyimide neural probe with 4 PEDOT/Dex coated electrode 
sites. Procedure for probe insertion is shown in (b) with an optical fibre as guiding tool. The 
final placement of the electrodes can be seen in (c). Both the passive probe (control) and the 
active probe (functionalized) were fixated to the skull. The connection of the active probe to the 
recording/stimulation equipment was achieved via a connector placed on the head of the animal 
(d). Reproduced with permission from reference 83. 
 




Table 6.1 Summary of some remarkable examples of polymer films reported in literature with the most important characteristics (i.e. preparation 
method, polymer, drug, dopant and release mechanism) for DDSs made of ICP.  
Polymer Drug Dopant Synthesis Release Ref. 
PPy Dex (0.1 M) Drug One step, CA at 1.8 V until a charge of 25–30 
mC/cm2 is reached. 
CV from -0.8 to 1.4 V. 58 
PPy SA (0.005 M) Drug CA at 0.8 V for 900 s and, subsequently 40 CV from 
-0.1 to 0.8 V. Then, overoxidation in NaCl solution 
by CA at +1.0 V for 10 min. 
-0.7 V for 30 min. 59 
PPy Methotrexate (0.01M) Drug+cetypyridi
nium (0.002 M) 
CA at +0.9 V for 100 s using Cl– as dopant. After this, 
second polymerization by CA at 0.7 V for 2400 s with 
the drug and cetypyridinium. 
Fixed potential (0.3, -0.5, 
-0.7 and -0.9 V) for 2 min. 
60 
PPy Dex phosphate (0.02M) Drug First layer: CA at 0.85 V. Second layer: Steps of 
potential to 0.9 V. Self-doped PAni film casted on the 
top. 
Potential lower than -0.6 




acesulfamate (0. 1M), 1-
butyl-3-
methylimidazolium 
saccharinate (0.1 M), 
choline acesulfamate 
(0.1 M) or choline 
Drug 5 CV from -1 to 1.5V or by CA at +1.5 or +1.2 V for 1 
h. 
Constant potential of 0.6, 





saccharinate (0.1 M) 
PPy SSA (0.2 M) or ATP 
(0.05 M) 
Drug PPy-SSA: CP with SSA at 2.5 mA/cm2 for 800 s.  
PPy-ATP: CA with ATP at 0.85 V until a charge of 1 
mC is reached. 
Constant potential (-0.5, -
0.8, and -1.0 V) for 24 h 
(SSA) or 2 h (ATP). 
90 
PPy Risperidone (0.09 M) p-toluene 
sulfonate (0.1 
M) 
Two layers: CP without or with the drug at 2.5 
mA/cm2 for 90 and 960 s, respectively. 
Constant potential of -0.6 
V or 0.6 V for 120 s 
followed by 500 s. Also 
alternating electrical 
stimulation at ±0.6 V (0.5 
Hz). 
91 





(0.02 M) and 
biotin (0.008 M) 
CP at 2 mA/cm2 . Constant potential of 3 V 
for a maximum of 150 s. 
87 
PPy ATP (0.02 M) Drug CA at 0.5-1.0 V or CP at 0.1-10 mA/cm2 until 
achieving a relation between film thikness and 
charge of 3.3 µm C-1 cm2.  
 
Constant potential of -0.7 
V for 700 s. 
96 
PPy ATP (0.02 M) Drug First layer: PPy with ATP by CA at 0.80 V for 
preparing films of varied thicknesses 150, 300, 750 
nm. Second layer: Poly(N-methylpyrrole) with NaCl 
by CA at 0.9 V for preparing films of varied 
thicknesses 150, 300, 450, 750 nm.  
After 10 min at 0.0 V, first 
layer is fully reduced by 
stepping the potential to -
0.6 V.  
78 
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Assuming that 240 mC/cm2 yields 1 µm layer 
PPy Risperidone (0.09 M) p-toluene 
sulfonate (0.1 
M) and drug 
First layer: CP with p-toluene sulfonate at 2 mA/cm2 
for 90 s. 
Second layer: CP with drug at 2mA/cm2 for 960 s. 
Pulsed potential of ±0.6 V 
at 0.5 Hz. 
97 
PPy Heparin (0.5% (w/v)) Toluene-4-
sulfonic acid 
(0.1M) 
Free-standing PPy film (thickness: 25 µm) 
synthesized at 8 V. Surface functionalization with 
poly(ethylene glycol) monomethacrylate graft 
copolymerization and subsequent oxidation. 
Covalent immobilization of poly(vinyl alcohol)-
heparin hydrogel onto the functionalized surface. 
Pulses of electric current 
ranging from 0 to 3.5 mA.  
92 
PEDOT Betulin (0.005 M) HCl (1 M) 75 CV from –0.5 to 1.4 V with NaCl. Dedoping at –
0.5 V over 10 min. Immobilization of the drug at 
+0.5 V for 10 min.  
Constant potential at  −0.5 
V for 10 min. 
93 
PEDOT Dex (0.01 M) Drug CP at 800 mA/cm2 with a target charge density of 
300 mC/cm2.  
 
In vitro: 45 days with 5 CV 
scans (from –0.3 to 0.45 
V) on day 10, 14, 42 and 
45.  
In vivo: 3 CV scans 
between –0.6 V and 0.15 
V. 
83 
PEDOT Anionic form of 
ibuprofen (0.4 M) 
LiClO4 (0.1 M) 50 CV with LiClO4 from 0.0 to 1.1 V. 10 mM EDOT 
and 0.1 M LiClO4. Reduction at –0.7 V for 10 min. 
Immobilization of the drug at +0.8 V for 10 min. 
Constant potential at 
−0.5 V for 600 s. 
57 




M) M) +1.1 V. 
Three steps: (i) 50 CV with LiClO4 from 0.0 to +1.1 
V; (ii) reduction at –0.7 V for 10 min; (iii) 
Immobilization of the drug at +0.8 V for 10 min. 
−0.5 V for 10min. 
PEDOT Dex (0.01 M) Drug CP at 80 mA/cm2 until a charge of 100 mC/cm2 is 
reached. 
CV from −0.6 to +0.9 V. 
Cathodic sweep (from 
−0.6 to 0.0 V) or anodic 
sweep (from 0.0 to −0.9 








Dex phosphate (doping 
was at mole ratio of 1 : 1 
DMP : aniline 
pentamers)  
CSA (doping was at a 
mole ratio of 3 : 1 CSA : 
aniline pentamers) 
Drugs Polymers dissolved in hexafluoroisopropanol (0.1 
g/mL) were casted onto insoluble substrates. Doping 
was carried out by adding CSA or DMP to the 
solution prior to the casting. 
CV from 0.7 to –0.5 V: 6 
cycles with 14 minutes off. 
Constant potential at 0.6 
V: 3 cycles of 0.5 minutes 








Dex phosphate (at a 
mass ratio of 10:1 
polymer:Dex) 
CSA (at a mass ratio of 
1:10 CSA:MTT) 
Drugs  Polymers dissolved in hexafluoroisopropanol (0.1 
g/mL) were casted onto insoluble substrates. Doping 
was carried out by adding CSA or DMP to the 
solution prior to the casting. 
CV from 0.7 V to –0.5 V: 
first sweeping in the 
positive direction of the 
potential scale (this 
stimulation lasted 62 s). 
85 
PPy N-methylphenothiazine Heptasulphonat CA with heptasulphonated β- cyclodextrin by CA at CV from -1.2 to 0.4 V at 20 74 
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(0.1 M) and N- 
butylsulphonate 




0.4 V until a charge of 0.3 C/cm2 is reached. 
Incorporation of the drugs by dipping in the 
corresponding solutions for 90 min.   
Then thoroughly rinsed in CH3CN, and subsequently 
in aqueous 0.5 M LiClO4 for 45 min. 
mV/s  for at least 7 cycles. 
PPy Quercetin (0.006 M) 
Ciprofloxacin (0.007 M) 
HCl (1 M) 25 CV from −0.8 to +0.8 V with NaCl. Dedoping at 
−0.7 V over 10 min. Immobilization of drugs at 0.6 V 
for 10 min. 
Constant potential at  −0.5 
V for 12 min. 
70 






First layer: CP with p-toluene sulfonic acid sodium 
salt at 2 mA/cm2 for 90 s. Second layer: identical to 
the first layer but adding neurotrophin-3 to the 
solution.  
CV from −0.8 to 1.0 V. 
Pulsed potential of of ±0.6 
V 5 Hz. 
Pulsed current of ±0.5 mA 
at 5 Hz. 
Pulsed current of ±20 mA 
at 5 Hz. 
68 
PPy Chlorpromazine (0.01M) 0.064 g/L  
melanin and 
HCl (0.1 M) 
CA with melanin at 0.6 V until a charge of 765.6 µC 
is reached. Chlorpromazine uptake at -0.8V. 
Release stepwise potential 
changes from -0.8 V to 0.4 
V for 15 min. 
71 
PPy Chlorpromazine (0.01 
M) 
Heparin 1 g/L or 
0.2 g/L 
Pre-electropolymerization with 1 g/L heparin by CA 
at 0.9 V for 100 s. Subsequent polymerization with 
0.2 g/L heparin by CA at 0.7 V for 900s adding 
chlorpromazine to the solution 
0.1 M pyrrole, 0.2 g/L Hep, and 0.01 M CPZ aqueous 
solution, CA at 0.7 V for 900 s. 
Constant potential of 0.4 











First layer: CP with p-toluene sulfonate at 2 mA/cm2 
for 90 s. 
Second layer: identical to the first layer but adding 
brain-derived neurotrophic factor to the solution and 
decreasing the polymerization time to 60 min. 
Biphasic pulses at 250 Hz 
formed by three periods of 
8 h followed by 16 h rest 
periods. 
80 





First layer: CP with p-toluene sulfonate at 2 mA/cm2 
for 90 s. 
Second layer: identical to the first layer but adding 
neurotrophin-3  to the solution and increasing the 
polymerization time to 60 min. 
Charged-balanced 
biphasic current pulses at 
250 Hz were applied for 1 
h. 
81 
PEDOT Acetylcholine chloride ( 
0.055 M) 
PSS (5 mg/mL) CP with PSS at 0.5 mA for 1200 s reaching a charge 
of 0.29 mC/cm2. Immersion in acetylcholine 
chloride of untreated PEDOT/PSS film. 
Constant potential of +1.0 
V and -1.0 V during 25 h. 
99 
PNMPy Dopamine 
hydrobromide (0.1 M) 
PSS (0.03 M) CP with PSS at 4.4 mA/cm2 for 30 s. The film was 
washed and, then, placed in a dopamine 
hydrobromide aqueous solution. The electrode 
potential was stepped to -0.60 V until the cathodic 
current dropped to small values. 
Stepping the potential to 





hydrobromide (0.5 or 1 
mM) 
PSS  CP with PSS at 4.4 mA until 26.2 mC. 
Reduction of the resulting film at -0.5 or -0.6 V in a 
0.5 or 1 mM drug aqueous solution with 0.01 M KC1. 
Stepping the potential to 
0.4, 0.5 or 0.6 V for 20 
min. 
73 
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6.6.2 Polymer nanoparticles 
The development of NPs made of ICPs for electroresponsive drug delivery requires 
chemical synthesis and the use of surfactants to improve their colloidal stability. 
Compared to electrochemically synthetized films, NPs allow easier scalability (i.e. there is 
no limitation due to the substrate dimensions or electrochemical cell size), greater 
processability and improved drug loading (i.e. superficial area is bigger). It has been 
reported drug loadings of 51 wt%, which are much higher than those usually achieved 
with ICP films.88 The main problem related to ICP NPs is how to stimulate the release. 
This question arises from a set up point view: is it necessary to fix the NPs on the 
electrode surface ?, or is it better to have them dispersed on solution ?. In order to 
provide an answer to this question, it is necessary to take into account that the 
oxidation/reduction process of NPs in solution is limited by their diffusion from the bulk 
to the surface of the electrode. Ge et. al100 prepared a gel of PLGA-PEG-PLGA containing 
1 wt% of PPy NPs (Figure 6.6), which was attached to the electrode surface. More 
interestingly, fluorescein was released in vivo upon electrical stimuli by applying an 
electric field of -1.5 V/cm onto the implanted gels for 40 s per each stimulus via two 
needle electrodes.  
In another study, electrodes were coated with PPy NPs and drop-casted 0.05 wt% 
Figure 6.6 (a) Chemical synthesis of PPy NPs. (top) and chemical structures of fluorescein 
(bottom left) and daunorubicin (bottom right). (b) SEM image of fluorescein-encapsulated PPy 
NPs. (c) Photograph showing the solid-gel transition of the injectable conductive hydrogel. (d) 




chitosan in 0.1 M HCl to prevent the NPs detachment during the electrostimulation.88 It 
has also been reported the electrostimulation of the NPs confined in dialysis bags located 
inside the electrochemical cell (i.e. the drug can diffuse across the dialysis bag but the 
NPs cannot).101, Furthermore, it  was also been demonstrated the release of curcumin 
from PEDOT NPs attached onto a glassy carbon surface.62 A summary of the procedures 
employed for the NPs generation and electrostimulation release is presented in Table 
6.2.  
 




Table 6.2 Summary of some remarkable examples of polymer NPs reported in literature with the most important characteristics (i.e. preparation 
method, polymer, drug, dopant and release mechanism) for DDSs made of ICP.  
Polymer Drug Dopant Synthesis Release Ref. 
PPy Fluorescein and 
daunorubicin (0.6 
mg/mL) or ( 0.002 M 








Polymerization in aqueous solution using ferric 
chloride as oxidant agent and adding surfactant and 
the drugs to the reaction medium.  
Fluorescein: Constant 
potential at -0.5 or -1.5 V 
for 10 s and repeated every 
5 min. 
Daunorubicin: Constant 
potential at 0.5 V for 10 s, 
repeated every 5 min. 
100 
PPy Fluorescein sodium salt 
and methotrexate (7.4 
and 0.5 mg/mL) or 




PPy nanoparticles were prepared with three different 
oxidizing agents, hydrogen peroxide, chloroauric 
acid and ferric chloride. Drugs were added to the 
reaction medium before the particle formation. 
5 stimuli at a constant 
potential of −0.5 V for 20 s 
every 3 min. 
88 
PPy Insulin (5 mg/mL) Sodium dodecyl 
sulfate (SDS) 
(0.1 M) 
PPy nanoparticles using hydrogen peroxide as 
oxidizing agent. The encapsulation was conducted by 
adding the insulin to a dispersion of nanoparticles. 
A thin, coiled, Pt wire was 
placed inside the dialysis 
tube as working electrode. 
A constant potential of −1 
V was applied for 20 min.  
101 
PPy Fluorescein, piroxicam 
and insulin (3mg/mL)  
SDS (0.1 M) Chemical polymerization in aqueouous solution 
incorporating the drug to the reaction medium 
Constant current at −50, 
−100, −200 and −300 µA 





Constant potential at −0.5, 
−0.75, −1 and −1.25 V for 3 
min. 
PEDOT Curcumin (0.027 M) SDBS (0.009 M) Chemical polymerization in aqueous solution with 
ammonium persulfate as oxidizing agent and 
incorporating the drug to the reaction medium.  
Constant potential at 0.50, 
−0.50, −1.00, and −1.25 V 
for 3 min. 
62 
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6.6.3 Polymer nanowires, fibers and nanotubes 
In this section all different kinds of tubular nano- and microstructures have been 
grouped. Nanowires consist of elongated and intertwined nanotubes forming a mesh 
made of ICPs. This format has been wide investigated using PPy. Nanowires have been 
prepared following different approaches, such as those based on the utilization of 
functional molecules,103–105 seeding growth,106 and interfacial polymerization.107 
Although the operation of these nanostructures in electronics such as biosensors or as 
energy storage have been considerably explored,108 there is much less information about 
their use for controlled drug release. Ru et al.109 used ATP as both morphology-directing 
agent and model delivery drug. Surprisingly, results showed that the ATP release 
efficiency increases from 53% for conventional PPy morphologies to 90% for PPy 
nanowires after 45 h of electrical stimulation (−0.8 V). It was also visualized by CV that 
PPy nanowires are much more electroactive than conventional PPy formats and by 
electrochemical impedance spectroscopy (EIS) it was corroborated that the material 
resistance was much lower. On the other hand, Lee et al.110 prepared arrays of nanowires 
by electrochemical deposition of a mixture of pyrrole monomers and biotin as a dopant 
in anodic alumina oxide membranes with pore size of 0.2 μm as a sacrificial template 
(Figure 6.7). The length of nanowires ranged from 5 to 25 m depending on the 
polymerization time. Obviously, the number of doxorubicin (DOX) molecules conjugated 
with the biotin dopant (i.e. the encapsulation efficiency) increased with the nanowire 
length. Therefore, stimulated drug delivery assays were conducted using nanowires with 
an approximate length of 25 µm, which was the optimal. Positive stimulation of +0.5 V 
for 1 min did not induce as much as release as negative potential of −1 V. In fact, the 
amount of drug released using positive potentials was similar to that delivered from the 
un-stimulated controls, in which natural diffusion was the only driven force. 
Drugs can also be absorved or encapsulated into PPy nanwires without considering 
specific interactions with the doping agent of the ICP.76 More specifically, Jiang et al. 
used the micro- and nanogaps generated between the nanowires as reservoires for drug 




are not decisive for the loading capacity. Later on, to prevent drug lekeage and to obtain a 
controlled release, the mesh was covered with a protective PPy film making a “sandwich”.  
In their cutting edge paper , Martin and coworkers111 produced conducting nanotubes 
from nanofibers of biodgradable poly(L-lactide) (PLLA) or PLGA as hard templates. 
First, PLLA or PLGA with deaxmentrasone dissolved in chloroform were electrospun 
onto the surface of a probe followed by electrochemical deposition of ICPs around the 
electrospun nanofibers. Then, the drug delivery was achieved by controlled degradation 
of the PLLA/PLGA or by actively acting  on the ICP with an applied electrical field (1 V). 
Similarly, Chen et. al.112 loaded diclofenac into the microfiber core made of bacterial 
cellulose (BC) followed by coating it with a PEDOT shell. During electrical stimulation, 
Figure 6.7 (a) Schematic illustration of DOX-attached PPy nanowires (DOX/PPy). DOX 
molecules were chemically conjugated to the biotin dopants of the PPy nanowires through 1-
Ethyl-3-(3-dimethylaminopropyl)-carbodiimide/N-hydroxysuccinimide EDC/NHS chemistry. 
DOX/ PPy nanowire arrays have synergistic effects in cancer therapy by direct application of an 
electric potential and localized NIR light. (b) SEM images of the fabricated PPy nanowire 
arrays. Different polymerization times were employed to achieve PPy nanowieres with length of 
5 (left), 15 (middle), and 25 μm (right), respectively. Adapted from110. 
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PEDOT contracted and produced a mechanical force that exerted pressure to the BC 
microfiber promoting the drug release. However, the fiber weight loss observed after 
stimulation indicated that some degradation occurred during such process, facilitating 
the drug release. More recently, also combining the actuation of ICPs and fiber 
degradation, we reported electrospun fibrous mats in which i PEDOT NPs were 
incorporated to the curcumine-loaded PLA fibers.  PEDOT NPs exerted some presure on 
the PLA core when a constant potential of 1 V was applied, inducing expansion and 
facilitating the  release of the loaded drug.113 
Esrafilzade et. al.63 prepared a PEDOT:poly(styrenesulfonate) (PSS) fibres by wet-
spinning, which were employed as template to electropolymerize an outer shell layer of 
PPy. Ciprofloxacin hydrochloride (Cipro), which was selected as model drug, was used as 
the dopant agent during PPy synthesis, confirming that the drug release was higher when 
the PPy layer was reduced.  
Overall, this kind of DDSs present outstanding advantages over NPs which suffer 
from huge initial burst release. A summary of the procedures employed for the 
nanowires, nanofibers and nanotubes generation and electrostimulation release is 





Table 6.3 Summary of some remarkable examples of polymer nanowires, nanofibers and nanotubes reported in literature with the most important 
characteristics (i.e. preparation method, polymer, drug, dopant and release mechanism) for DDSs made of ICP.  
Polymer Drug Dopant Synthesis Release Ref. 
PPy ATP (0.20 M) Drug and LiClO4 
(0.07 M) 
First layer: CA with LiClO4 at 1.0 for 150 s.  
Second layer: Nanowires by CP with the drug and  
LiClO4 at 1.0 mA cm2 for 600 s. 
Constant potential at 
−0.80 V for 45 hours. The 
surface was covered with 
a Mg layer to induce self-
powered release. 
109 






Nanowire network by CP with p-toluene sulfonate at 
0.477 mA/cm2 for 1600 s. The drug was loaded by 
dropping an aqueous solution onto the surface of the 
nanowire network. Finally, another PPy layer with p-
toluene sulfonate was deposited. 
CV from −0.9 V to 0.6 V. 76 
PPy DOX (0.0018M) Biotin (1 mM) 
and PSS (0.01 
M) 
Nanowires with biotin and PSS at 1 V for 6, 12, and 
18 min. Then, the carboxyl residue of biotin was 
activated and the system was incubated in a drug 
solution overnight at 4 ºC. 
Constant potential at −1 V 
for 1 min. 
110 
PEDOT Diclofenac - (not 
mentioned) 
FeCl3 (0.154 M) PEDOT core-shell microfiber was obtained by 
immersing diclofenac -loaded bacterial cellulose 
microfiber into a  monomer ethanol solution with 
FeCl3. 
Constant potential at -0.6 
V for 2 and 12h. 
112 
PEDOT Dex (3.75% PBS 1x  Polymerization by CP onto PLGA nanofibers loaded Constant potential at 1 V 111 
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dexamethasone (w/v)) with the drug at 0.9 mA/cm2 for 30 min.  
After electrochemical deposition, the PLGA core was 
dissolved in dichloromethane for 10 min. 
for 10 s.  
PEDOT Cipro (0.05 M) Drug PEDOT:PSS fibers were coated with PPy doped with 
Cipro. The latter was obtained by CP at 0.5 or 2.0 
mA/cm2 for 10 or 20 min.  
Constant potential at 0.3 
V and reduced at −0.26 V.  
63 
PEDOT Curcumin (0.5 mM) DBSA (0.01 M) EDOT NPs (10 mg/mL) and CUR (1.04 mg/mL) 
were and dispersed and dissolved, respectively, in 
0.5 mL of ethanol. Latter, 0.2 mL of PEDOT NPs, 
CUR or PEDOT NPS and CUR solutions were mixed 
with 1.8 mL of PCL solution and loaded in a 5 mL 
syringe for electrospinning. 
1, 3 and 5 pulses of 1.0 V 
(each pulse lasts 60 s) 






6.6.4 Polymer nanoporous films and sponges 
In this section the increase of drug retention and the preparation of prolonged 
stimulable drug release profiles is based on nanoporous films and sponges. The 
preparation of porous surfaces is a good strategy to increase the superficial area of the 
desired format. Although drugs can be loaded during the ICPs polymerization into the 
bulk, some extra drug, not necessarily acting as dopant agent, can be loaded into the 
nanopores inside the polymer film. This pores can be open114 or sealed115 by a thin layer 
of ICP on top. The latter provides an ICP based drug release system with higher loading 
capacity for a wide range of drugs, which should not be limited by the charge nor the size 
of the molecule. In order to attain this porous morphology, hard templates can be used 
(e.g. PSS or poly(methyl methacrylate) (PMMA) beads arrangements), which can be 
latter dissolved with the appropriate solvent.114–118 For example, Figure 6.8, shows the 
procedure reported by Sharma et. al118 for the preparation of sponge like structures. 
First, PMMA beads were distributed as in a colloidal crystal onto a stainless steel 
substrate (i). Then, the electropolymerization of PPy was conducted around the PMMA 
hard template (ii). Afterwards, PMMA particles were dissolved using a 1:3 v/v 
Figure 6.8 Schematic representation of PPy scaffold fabrication and drug loading (a). SEM 
micrographs of: (b) PMMA colloidal crystal template onto the stainless substrate; (c) the PPy 
film obtained by electropolymerization and subsequent PMMA template removal; (d) and (e) 
cross sectional views of the PPy structures following the electropolymerization of the dense PPy 
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toluene:acetone mixture  (iii). Subsequently, a drug solution was added dropwise onto 
the sponge-like PPy films, and then air dried at 20ºC overnight (iv). Finally, a thin layer 
of PPy was electropolymerized above to entrap the drug (v). Corresponding SEM images 
are present in Figure 6.8b-e. The maximum drug release was observed when films were 
reduced with a difference in potential of -0.6 V, which was attributed to an enhancement 
of the drug diffusion rate due to a change in spacing between the nanopores. In another 
interesting work, Jeon et. al.119 used ICPs as actuators to regulate the opening and closing 
of artificial pores (Figure 6.9). They were able to promote the ion diffusion across a 
porous membrane when the pores were open, stopping the diffusion when pores were 
closed. Specifically, the pore size decreased at the reduction state while it increased at the 


















PPy doped dodecyl benzene sulfonate (DBS), hereafter PPy/DBS, was 
electropolymerized onto a porous aluminium oxide membrane covered with a thin layer 
of gold. PPy/DBS was chosen as electrically responsive material because its volume 
Figure 6.9 (a) Scheme of reversible changes in pore size (and the drug release rate) between 
oxidation and reduction states. (b) Drug flux versus time when the pore diameter is 110 nm 
(oxidation-blue open circles) and when the reduction state (magenta closed circles). A data 
point was collected every 10 s. (c,d) In situ AFM height images corresponding to the oxidation 




experiences very large changes (up to 35%) with the electrochemical state. The cause that 
produces such changes is a complex interplay of many factors. In brief, the polymer 
matrix expands when solvated ions enter into it, while the matrix contracts when 
solvated ions escape from it. These compositional changes, which correspond to the 
doping process, alter the length and chemical nature of carbon-carbon bonds the angles 
between adjacent monomer units, affecting polymer···solvent interactions.121,122 
Interestingly, the pulsatile release of the drug was achieved, the on demand response 
taking less than a few seconds.  
A resume of the procedures employed for the nanoporous films and sponges 
generation and electrostimulation release is presented in Table 6.4.  
 
 




Table 6.4 Summary of some remarkable examples of polymer nanoporous films and sponges reported in literature with the most important 
characteristics (i.e. preparation method, polymer, drug, dopant and release mechanism) for DDSs made of ICP.  
Polymer Drug Dopant Synthesis Release Ref. 
PPy Fluorescein (Flu) 
(0.01 M) 
Drug CA at a constant potential of +0.9 V for 200 s 
using glass carbon electrodes coated with PSS 
templates.  
Constant potential 
at -2.0 V for 10 s (6 
times). 
114 
PPy Flu (0.01 M) and Dex 
(0.02 M,) 
 
Drug CV (one cycle) from 0.5 to 1.2 V with the drug 
using PSS templates. 
Constant potential 
at 2 or 0.5 V for 5 s 
followed by 5 s of 0 
V period.  
115 
PPy Dex phosphate (0.05 
M) 
p-Toluene sulfonic acid (0.1 
M) or Drug 
CP at 2 mA/cm2 for 4 min onto PMMA colloidal 




±0.6 V at 0.5 Hz 
during 10 min for 
24, 26, 28 and 30 
h. 
116 
PPy Biotin (0.009 M) Drug and sodium 
dodecylbenzenesulfonate (0.01 
M) 
CA with the drug and the secondary dopant agent 
at 0.7 V for 24 h onto PSS colloidal crystals. The 
PS core was dissolved leaving hollow composites. 
Surfaces were further interacted with 
streptavidin-coated gold NPs. 
Constant potential 
at -2 V for different 
time intervals 
(maximum 60 s). 
117 










for 30~240 sonto porous anodic aluminum oxide.  potential at 0.1 V 
(oxidation) and 
−1.1 V (reduction).  
PEDOT Risperidone (0.1 M) Sodium 
dodecylbenzenesulfonate (0.1 
M) and with p-toluene 
sulfonate (0.1 M) 
First layer: CA with sodium 
dodecylbenzenesulfonate at 2 mAcm−2 for 4 min 
onto stainless steel coated self-assembled PMMA 
particles. Particles were dissolved with a 
toluene:acetone mixture. Drug loading by 
dropwise using a methanol risperidone solution.  
Second layer: CP with p-toluene sulfonate at 2 
mA/cm2 for 2 or 3 min. 
Constant potential 
at +0.6 V 
(oxidation) or -
0.60 V (reduction) 
for 60 min.  
120 
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6.6.5 Polymer hydrogels 
Hydrogels, which absorb and store a huge amount of water molecules due to their 
hydrophilic nature, present a three-dimensional flexible polymeric network with rubbery 
nature.86 These characteristics make them resemble many biological tissues, being 
therefore suitable as implantable DDSs. They can be used for flexible and stretchable 
bioelectronics. Besides, they can be modelled in a variety of shapes and with different 
mechanical strength, depending on the implantation zone. Hydrogels made of 
conventional naturally occurring biopolymers (e.g. hyaluronic acid chondroitin sulphate, 
agarose, and calcium alginate) or synthetic polymers (e.g. polyacrylamide, and 
polydimethylaminoproprylacrylamide among others) require the use of relatively high 
power (i.e. from 2 to 25 V) for their operation.122,123 However, much lower voltages (i.e. 
from 0.1 to 3 V) can be used when ICPs are added to the polymer matrix. ICPs can be 
polymerized onto the hydrogels’ surface, increasing both the surface area of the polymer 
and the amount of entrapped drug. 124  
A representative example of ICP-containing hydrogel was prepared by mixing 
chitosan-graft-PAni copolymer and oxidized dextran (OD) as a cross-linker.125. The 
resulting hydrogel behaved as DDS and application of a variety of voltages (i.e. 0, 1 and 3 
V) revealed that release increases with the voltage.  This system also offered a repeatable 
“on–off” pulse release. Figures 6.10a and b show the aspect of the hydrogel before and 
after crosslinking, respectively.  Figure 6.10c compares the release behaviour achieved 
using different potential, which were repeatedly applied every 10 min. It was observed 
that the cumulative release percentage of amoxicillin was about 34% after 80 min at 0 V, 
while this value increased to 69% and 82% at of 1 V and 3 V, respectively.  
Pourjavadi and Doroudian126 prepared a hydrogel based on hydrolysed-collagen 
modified with PCL. Conductive fibers were incorporated by in situ polymerization of 
aniline for the controlled release of hydrocortisone. In vitro delivery experiments showed 





In a different but interesting approach consisting on the assembly of an ICP film and 
a biohydrogel through a gelatin intermediate layer, the ICPs interface was employed for 
monitoring the dopamine release and the biohydrogel as drug container. Moreover, the 
dopamine release was regulated by electrochemical stimulation, applying potential 
ramps in cyclic phase to the such ICP-biohydrogel assembly.127  
More examples of DDSs based on ICP-containing hydrogels include PPy 
electropolymerized into poly(acrylic acid) hydrogel128 and salicylic acid (SA) doped 
poly(phenylene vinylene)/polyacrylamide (PPV/PAAM) hydrogels.129 Regarding the 
latter, it was noticeable that in absence of electric field the diffusion of SA was delayed in 
the first 3 hours due to the ionic interaction between the anionic drug and the PPV, 
whereas immediate release was observed upon application of an electric field. 
An overview of the procedures employed for the hydrogels generation and 
electrostimulation release is provided in Table 6.5.  
Figure 6.10 Photographs of the ICP-containing solution before crosslinking (a) and after 
crosslinking with OD (b). Graph showing drug release in phosphate buffered saline (PBS) 
solution under different electric potentials (c). Addapted from 125. 




Table 6.5 Summary of some remarkable examples of polymer hydrogels reported in literature with the most important characteristics (i.e. preparation 
method, polymer, drug, dopant and release mechanism) for DDSs made of ICP.  
Polymer Drug Dopant Synthesis Release Ref. 
PAni Amoxicillin (0.004 M) 




Chitosan-g-PAni was dissolved in acetic acid aqueous solution 
and mixed with oxidized dextran dissolved in PBS (pH = 7.4) 
at 37 ºC for 1h. Amoxicillin or ibuprofen was added to the 
mixture before gelation. 
Constat potential at 0 V, 
1 V and 3 V for 3 min. 
Repeated every 30 min 
or 60 min. 
125 
PPV SA (0.0125 M) Drug A PPV solution with SA and H2O2 was stirred for 24 h. SA-
doped PPV particles were filtered and vacuum dried for 24 h. 
Then, a free radical polymerization of acrylamide with SA-
doped PPV was conducted. 
Constant potential at 0, 
0.01, 0.03, 0.05, 0.07, 
0.09, and 0.1 V using 
pH= 5.5 for 48h. 
129 
PPy Safranin (0.01 M) Sodium 
nitrate (1 
M) 
CA with sodium nitrate at +0.6 V was applied until de charge 
achieves a value of 10.5 C. The resulting hydrogel was 
immersed in a safranin solution for 5 h. 
Constant potential at 0.4 
and -0.4 V using pH= 6.4 
or 3.8. 
128 
PAni Hydrocortisone (100 
mg) 
HCl (1 M) Hydrogels were swollen in a HCl solution containing aniline. 
After one day, the hydrogels were washed and then, placed in 
an ammonium persulfate solution. Finally, the dried hydrogel 
was immersed in a PBS solution with hydrocortisone. 
Constant potential at 3 V 





6.6.6 Polymer composites 
An alternative approach to gain superficial area with respect to that of the film format 
is the addition of extra materials into the polymer matrix.  
Nowadays, carbon nanotubes (CNTs) represent a hot topic in many research fields 
related with Materials Science and Engineering.130,131 Although this nanostructured 
compound is frequently used to improve the mechanical and electrical properties of the 
primary materials,132,133  CNTs have been also employed as drug nano-reservoirs for 
controlled release.  
Luo et al.134 proved that Dex-loaded CNTs can release this drug in its bioactive form 
under electrical stimulations. Specifically, the drug was entrapped in the inner cavity of 
CNTs, which were sealed at the ends with PPy films formed by electropolymerization. 
CNTs not only allowed the loading of high amounts of drug but also provided a linear 
and sustainable drug release profile. Figure 6.11 shows a scheme of the synthetic 
process and SEM micrographs presenting the morphology of two types of CNTs: CNTa 
(outer diameter: 100-170 nm; inner diameter: 3-8 nm) and CNTb (outer diameter: 20-30 
nm; inner diameter: 5-10 nm). Drug release was much higher from CNTs sealed with PPy 
than PPy alone. Regarding to the size of the CNTs, CNTb provided the greater release, 
meaning that the loading was much higher. This fact was attributed to the thinner outer 
diameter and wider inner diameter of the CNTb in comparison to CNTa (i.e. the drug 
Figure 6.11 Scheme representing the loading and release process of CNT nanoreservoirs (i). 
SEM images of the PPy/CNTa film (a, b) and the PPy/CNTb film (c, d). CNTa: outer diameter 
110-170 nm; CNTb: outer diameter 20-30 nm (ii). Reproduced with permission from reference 
134. 
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capacity per unit weight was higher for the former than for the latter).  
 Other approaches based on the addition of CNTs have been employed for electrically 
driven drug release65,78,135 and also for dual application such as the combination of 
controlled release and the detection of the neural network activity.136 
A related material is graphene oxide (GO), which consists of a hexagonal ring-based 
carbon 2D “network” (i.e. a sheet) having both sp2- and sp3-hybridised carbon atoms and 
bearing a variety of reactive oxygen functional group (i.e. hydroxyl, carboxyl, carbonyl 
and epoxide)137,138. The preparation of composites containing GO is a burgeoning field 
since this material can improve not only the chemical stability but also  the mechanical 
and electrical properties. Besides, the utilization of GO for DDSs has been widely 
explored since its oxygen-containing functional groups allow the attachment of site 
directed moieties or fluorophores, meanwhile the presence of localized π-electrons at the 
sheet surface enables the formation of intermolecular π-π interactions with facilitating 
the entrapment of aromatic drugs. 
Weaver et al.139 generated PPy matrixes by electropolymerization using GO and an 
anionic drug (Dex) as dopants during the oxidation process. Note that GO nanosheets are 
negatively charged due to carboxylic acid groups formed at their edges. As it was 
expected, the nanocomposite released Dex in response to electrical stimulation with a 
linear release profile and a dosage that can be adjusted by altering the magnitude of 
stimulation. Furthermore, the release persisted over 400 stimulations while there is no 
drug that passively diffused from the non-stimulated composite. 
A different perspective is given from the fact that direct energy sources are not 
necessary for electrostimulated release.140 From this point of view, self-powered devices 
could be a great promise for avoiding the reliance on power sources to operate. Besides, 
this could facilitate their progression from the laboratory to the biomedical marketplace. 
For example, Catt et al.141 covered the surface of magnesium, which is appealing for 
medical implant applications due to its complete in vivo degradation, with 
electropolymerized PEDOT using GO as dopant agent and Dex carrier. Magnesium 
substrates corrosion results in a local release of Mg2+, OH-, and H+, and when the surface 
is coated with by ICPs the corrosion rate slows down. In that work authors took profit of 




corrosion. As it is illustrated in Figure 6.12, Dex releases increases with the uncovered 
area of magnesium due to the electrical current generated from corrosion, whereas there 
is practically no release when PEDOT/GO/Dex is deposited onto a non-corroding gold 
surface. Overall, PEDOT/GO/Dex films, which delivers Dex at the corrosion site to 
minimize the detrimental effects of corrosion by products, can be developed into self-
powered implantable drug delivery devices in which the corrosion is the driving force for 
drug release as well as the energy source. 
A similar effect was observed when PPy· doped with ATP was added on the inner and 
outer part of a cellulose matrix and a thin layer of Mg+ was deposited on one side 
(Figure 6.13).142 Herein, Mg+, ATP-doped PPy film, together with the electrolyte 
solution formed a galvanic cell. The galvanic couple of the PPy film (cathode) to the 
magnesium layer (anode) was the driving force for drug release. In summary, 
magnesium was oxidized and migrated into the solution as an ion while the PPy was 
reduced facilitating the ATP release. 
 More examples of ICPs matrices incorporating other materials, as for example gold 
nanoparticles,143 montmorillonite,144 and palygorskite,145 are available in the literature.  
 
Figure 6.12 Corrosion driven drug release. Dex release from PEDOT/GO/Dex films deposited 
onto a magnesium surface in which the drug delivery is powered by the substrate corrosion. 
Magnesium samples had either long or short exposed area but the same amount of coverage by 
the PEDOT/GO/Dex coating. Reproduced with permission from reference 141. 
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A summary of the different aproaches for the composite generation and 




Figure 6.13 (a) Cross-section of cellulose–PPy composite film; (b) High magnification image 
of a. (c) Energy dispersive X-ray spectrum of cellulose–PPy composite film. (d) Digital photo of 
the DDS with the coating of magnesium layer on the one side of the cellulose–PPy composite 





Table 6.6 Summary of some remarkable examples of polymer composites reported in literature with the most important characteristics (i.e. 
preparation method, polymer, drug, dopant and release mechanism) for DDSs made of ICP.  
Polymer Drug Dopant Synthesis Release Ref. 
PPy P/S mixture (0.007 M 
each) or Dex (0.125 
mM) 
Drug CV with drug from 0 to 1.1 V (10 cycles) of multi-walled 
carbon nanotubes–Ti or AuPd–Ti coated  with monomer. 
CV from −1 to 1 V for up 
to 25 cycles.  
64 
PPy Aspirin (0.017 M) Drug CA with drug and montmorillonite at 0.8 V for 500 s.  Constant potential at -
0.6 V for 230 min. 
144 
PPy Dex (0.051 M) Drug CP with drug-loaded carbon nanotubes at +70 mA for 400 
s. 
A square wave electrical 
stimulation with 50% 
duty cycle; 2.0 V for 5 s 
followed by 0.0 V for 5 s, 
or -0.5 V for 5 s followed 
by 0.5 V for 5 s. 
134 
PPy Dex (0.025 M) Drug CA with drug, graphene oxide nanosheets and Dex 21-
phosphate disodium salt at 0.8 V until the charge density 
reached 400 mC/cm. 
Biphasic voltage pulse at 
-2 V for 5 s, followed by 
0 V for 5 s (1000 cycles) 
or -0.5 V for 5 s, 
followed by 0.5 V for 5 s 
(400 cycles). 
139 
PPy Aspirin (0.017 M) Drug Palygorskite was dispersed in phosphate buffered saline 
solution with aspirin (pH 3.5) and sonicated for 1 h. The 
Constant potential at 
−0.6 V for 160 min. 
145 
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monomer was added to the resulting emulsion. CA at 0.80 
V for 500 s. 
PPy ATP (0.007 M) Ammonium 
persulfate 
(0.050 M) 
A two cell compartment was separated by a cellulose 
nitrate-cellulose acetate film. One of the compartments 
contained the monomer and ATP. The other compartment 
was filled with ammonium persulfate. The cell was kept at 
4 °C for 3.5 h. The ATP-doped PPy film was formed 
gradually on the outer and inner surfaces of the separating 
film. A thin layer of magnesium (or zinc) was magnetron 
sputtered on the one side of the film. 
Self-powered drug 
delivery system driven 
by the oxidation of 
magnesium. 
142 
PEDOT Dex (0.1 M) Drug Carbon nanotubes were tethered to Au electrodes using 
cysteamine was used. This electrode was coated with 
monomer- and Dex-containing solution. CA at 1.1 V. 
CV from -0.8 V to 1.4 V.  77 
PEDOT Dex (0.008 M) Drug CA with previously sonicated single layer graphene oxide 
and Dex at 0.6 V until a total charge of 10 mC. 
Pulsatile stimulation of -
0.25 V for 5s followed by 
0 V for 5s.  
141 
PEDOT 6,7-dinitroquinoxaline-
2,3-dione (0.013 M) 
and Flu (0.017 M) 
Drug  CA with drug-functionalized carbon nanotubes at 0.75-
0.95 V for 15 s. to form the PEDOT/fCNT film.  
Cathodic leading cosine 
waveform (100 ms) with 
an amplitude of 1, 1.5, 
and 2 V.  
136 




M) Na2C2O3 at +0.9 V vs. for 200s onto Pt. Then, Au 
nanoparticles were deposited onto PPy surface by CV from 
−1.0 V to +0.2 V (5 cycles) in a HAuCl4 solution. After this, 
thioglycolic acid was spread onto the electrode surface, 
incubated for 15 min and washed. Finally, the composite 
was immersed in 5 mL sample of aqueous insulin solution 
and a CA at +0.5 V was applied for 900 s. 
0.6 V for 1 h using 
different pHs. 
PPy NT-3 Ferric p-
toluene 
sulfonate  
Aligned multi-walled carbon nanotubes were produced on 
a quartz plate. A thin PPy film was then deposited by a 
vapour-phase polymerisation method using ferric p-
toluenesulfonate as the oxidant. Then, a thin Pt film was 
sputter-coated onto arrays for 10 min at 30 mA. Finally, a 
poly(vinylidene fluoride) layer was then cast onto the 
sample.  
100 µs Biphasic current 
pulses at 250 Hz and at a 
current density of ± 
1mA/cm2. 
135 
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6.6.7 Hybrid 3D-structures 
Hybrid materials containing different size, shape and composition, which were 
engineered to obtain superior properties and multitasking capabilities, have been also 
recently reported. The work Feiner et al.,146  who prepared hybrid patches for enabling 
the recording of cellular electrical activities and the on-demand drug release, is 
particularly noticeable. This hybrid patch was composed of an epoxy named SU-8 and a 
thin layer of gold that was also covered with rough nanoscale layer of titanium nitride. 
PPy was deposited on specified places and, finally, electrospinning was used to deposit 
PCL–gelatin fibres onto the electronics, facilitating cardiac cells attachment (Figure 
6.14). The benefits of the fibers addition were high cell attachment, drug diffusion from 
the ICP and prevention of polymer delamination from the electrode surface. The final 
goal of this material was to collect data from its surroundings and thus ascertain when to 
induce electrical stimulation and/or to release drugs within the 3D microenvironment to 
affect the host tissue. 
 
 
Figure 6.14 Schematics of the microelectronic cardiac patch concept (a). An image of a 
freestanding, flexible device consisting of 32 gold electrodes dispersed within a porous mesh of 
SU-8 (b). Scanning electron micrographs (SEMs) of a 50×50µm2 electrode pad designated for 
recording cellular electrical activities and cell and tissue stimulation (c) and a larger 
150×150µm2 electrode pad, on which electroactive polymer is deposited for controlling the 
release of biomolecules (i. e. growth factors and small molecules) (d). Scale bars, 50µm. Atomic 
force microscopy images of a pristine gold electrode pad (e) and an electrode with a nanoscale 





6.7 Conclusions and outlook 
Currently, ICPs for electrical and/or electrochemical controlled drug release have 
reached a sufficient level of sophistication for on/off triggering and on-demand releasing 
profiles. The fabrication of devices combining the properties of ICPs with biodegradable 
polymers, metals or carbon nanostructures improve the applicability of former ones. Up 
to now, outstand the self-powered devices based on magnesium substrates, which would 
reduce the use of expensive and complicated electronic devices, and the systems able to 
detect real-time changes in the environment and, simultaneously, release drugs.  
Future devices will benefit from features that would extend their mechanical stability 
achieving stretchable electronics, which will allow a proper integration in the human 
body. Besides, systems with additional sensing capabilities such as neuronal recording, 
pH, mechanical stress and heat could be used for, at the same time, deciding the 
optimum amount of drug to be released.  
Future technology that will flourish from the use of ICPs as nano-resevoirs is 
expected to notify physicians of a patient’s health condition followed by the possibility of 
remote drug triggering. Moreover, it is even possible to imagine the ability to integrate a 
feedback loop into the system that would self-regulate and where physician assistance 
may not be required. For example, the optimization of a self-regulated insulin delivery 
remains one of the most demanding technologies to be developed. Instead of multiple 
daily injections of  insulin, millions of diabetes patients could take care of their glucose 
level for months with one injection of self-regulated insulin DDS. Therefore, we expect an 
increase in selectivity, sensitivity and adaptability of drug release profiles depending on 
the patient and allow a better understanding of the body electrophysiology during future 
generations. 
From the material’s perspective, the DDSs need further development in the following 
directions: (1) Better integration of the different components into one unique device; (2) 
More flexibility and biodegradability to improve the implantation of a foreign material 
into the human body; and (3) study the realization of close-looped DDSs through the 
integration of multiple advanced electronic devices, such as a wireless transductor or 
portable batteries.  




1. Boom time for biomaterials. Nat. Mater. 2009, 8, 439. 
2. Yun, Y. H.; Lee, B. K. and Park, K. Controlled Drug Delivery: Historical perspective for the 
next generation. J. Control. Release, 2015, 219, 2–7. 
3. Allen, T. M. and Cullis, P. R. Drug Delivery Systems: Entering the Mainstream. Science (80-. ). 
2004, 303, 1818–1822. 
4. Langer, R. S. and Peppas, N. A. Present and future applications of biomaterials in controlled 
drug delivery systems. Biomaterials 1981, 2, 201–214. 
5. Wurster, D. E. Method of applying coatings to edible tablets or the like. US Pat. 2648609, 
1953. 
6. Folkman, J. How the field of controlled-release technology began, and its central role in the 
development of angiogenesis research. Biomaterials 1990, 11, 615–618. 
7. Langer, R. and Folkman, J. Polymers for the sustained release of proteins and other 
macromolecules. Nature 1976, 263, 797–800. 
8. Bangham, A. D. and Horne, R. W. Negative staining of phospholipids and their structural 
modification by surface-active agents as observed in the electron microscope. J. Mol. Biol. 
1964, 8, IN2–IN10. 
9. Torchilin, V. P. Recent advances with liposomes as pharmaceutical carriers. Nat. Rev. Drug 
Discov. 2005, 4, 145–160. 
10. Chertok, B.; Moffat, B. A.; David, A. E.; Yu, F.; Bergemann, C.; Ross, B. D. and Yang, V. C. Iron 
oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain 
tumors. Biomaterials 2008, 28, 487–496. 
11. Quan, Q.; Xie, J; Gao, H.; Yang, M.; Zhang, F.; Liu, G.; Lin, X.; Wang, A.; Eden, H. S.; Lee, S. 
Zhang, G. and Chen, X. HSA coated iron oxide nanoparticles as drug delivery vehicles for 
cancer therapy. Mol. Pharm. 2011, 8, 1669–1676. 
12. Farooq, M. U.; Novosad, V.; Rozhkova, E. A.; Wali, H.; Ali, A.; Fateh, A. A.; Neogi, P. B.; 
Neogi, A. and Wang Z. Gold nanoparticles-enabled efficient dual delivery of anticancer 
therapeutics to HeLa cells. Sci. Rep. 2018, 8, 1–12. 
13. Dreaden, E. C.; Austin, L. A.; MacKey, M. A. and El-Sayed, M. A. Size matters: Gold 
nanoparticles in targeted cancer drug delivery. Ther. Deliv. 2012, 3, 457–478. 
14. Xia, B.; Zhang, W.; Shi, J. and Xiao, S. A novel strategy to fabricate doxorubicin / bovine 
serum albumin / porous silicon nanocomposites with pH-triggered drug delivery for cancer 
therapy. J. Mater. Chem. B Mater. Biol. Med. 2014, 2, 5280–5286. 
15. Anglin, E. J.; Cheng, L.; Freeman, W. R. and Sailor, M. J. Porous silicon in drug delivery 
devices and materials. Adv. Drug Deliv. Rev. 2008, 60, 1266–1277. 
16. Senapati, S.; Mahanta, A. K.; Kumar, S. and Maiti, P. Controlled drug delivery vehicles for 
cancer treatment and their performance. Signal Transduct. Target. Ther. 2018, 3, 7. 
17. Fenton, O. S., Olafson, K. N., Pillai, P. S., Mitchell, M. J. and Langer, R. Advances in 




18. Global Markets and Technologies for Advanced Drug Delivery Systems. 2016. at 
<https://www.bccresearch.com/market-research/pharmaceuticals/advanced-drug-delivery-
systems-tech-markets-report-phm006k.html> 
19. Shirakawa, H. The discovery of polyacetylene film - The dawning of an era of conducting 
polymers. Angew. Chem. Int. Ed. 2001, 1, 281–286. 
20. Shirakawa, H., Louis, E. J., Macdiarmid, A. G., Chiang, C. K. & Heeger, A. J. Synthesis of 
Electrically conducting organic polymers: halogen derivates of polyacetylene, (CH)x. J.C.S. 
Chem. Comm. 1977, 36, 578–580. 
21. Green, R. and Abidian, M. R. Conducting polymers for neural prosthetic and neural interface 
applications. Adv. Mater. 2015, 27, 7620–7637. 
22. Bredas, J. L. and Street, G. B. Polarons, bipolarons, and solitons in conducting polymers. Acc. 
Chem. Res. 1985, 18, 309–315. 
23. Yi, N. and Abidian, M. R. Conducting polymers and their biomedical applications. 
Biosynthetic Polymers for Medical Applications. 2015, 243-276.  
24. Del Valle, L. J.; Aradilla, D.; Oliver, R.; Sepulcre, F.; Gamez, A.; Armelin, E.; Alemán, C. and 
Estrany, F. Cellular adhesion and proliferation on poly(3,4-ethylenedioxythiophene): Benefits 
in the electroactivity of the conducting polymer. Eur. Polym. J. 2007, 43, 2342–2349. 
25. Balint, R.; Cassidy, N. J. and Cartmell, S. H. Conductive polymers: Towards a smart 
biomaterial for tissue engineering. Acta Biomater. 2014, 10, 2341–2353. 
26. Ateh, D. D.; Navsaria, H. A. and Vadgama, P. Polypyrrole-based conducting polymers and 
interactions with biological tissues. J. R. Soc. Interface 2006, 3, 741–752. 
27. Tandon, B.; Magaz, A.; Balint, R.; Blaker, J. J. and Cartmell, S. H. Electroactive biomaterials: 
Vehicles for controlled delivery of therapeutic agents for drug delivery and tissue 
regeneration. Adv. Drug Deliv. Rev. 2018, 129, 148–168. 
28. Fielding, L. A.; Hillier, J. K.; Burchell, M. J. and Armes, S. P. Space Science Applications for 
Conducting Polymer Particles: Synthetic Mimics for Cosmic Dust and Micrometeorites. Chem. 
Commun. 2015, 51, 16886–16899. 
29. Hardy, J. G.; Li, H.; Chow, J. K.; Geissler, S. A.; McElroy, A. B.; Nguy, L.; Hernandez, D. S. 
and Schmidt, C. E. Conducting polymer-based multilayer films for instructive biomaterial 
coatings. Futur. Sci. 2015, OA 1. 
30. De Giglio, E.; Sabbatini, L. and Zambonin, P. G. Development and analytical characterization 
of cysteine-grafted polypyrrole films electrosynthesized on ptand Ti-substrates as precursors 
of bioactive interfaces. J. Biomater. Sci. Polym. Ed. 1999, 10, 845–858. 
31. Ateh, D. D.; Vadgama, P. and Navsaria, H. A. Culture of human keratinocytes on polypyrrole-
based conducting polymers. Tissue Eng. 2006, 12, 645–655. 
32. Li, M.; Guo, Y.; Wei, Y.; MacDiarmid, A. G. and Lelkes, P. I. Electrospinning polyaniline-
contained gelatin nanofibers for tissue engineering applications. Biomaterials 2006, 27, 
2705–2715. 
DDSs BASED ON ICPs  
255 
 
33. George, P. M.; Lyckman, A. W.; LaVan, D. A.; Hegde, A.; Leung, Y.; Avasare, R.; Testa, C; 
Alexander, P. M.; Langer, R and Sur, M. Fabrication and biocompatibility of polypyrrole 
implants suitable for neural prosthetics. Biomaterials 2005, 26, 3511–3519. 
34. Wang, X.; Gu, X.; Yuan, C.; Chen, S.; Zhang, P.; Zhang, T.; Yao, J.; Chen, F. and Chen, G. 
Evaluation of biocompatibility of polypyrrole in vitro and in vivo. J. Biomed. Mater. Res. - Part 
A 2004, 68, 411–422. 
35. Jang, K.; Kim, L.; Seo, S. J. and Young Lee, J. Facile and controllable electrochemical 
fabrication of cell-adhesive polypyrrole electrodes using pyrrole-RGD peptides. Biofabrication 
2017, 9, 0–23. 
36. Humpolicek, P.; Kasparkova, V.; Saha, P. and Stejskal, J. Biocompatibility of polyaniline. 
Synth. Met. 2012, 162, 722–727. 
37. Green, R. A.; Lovell, N. H.; Wallace, G. G. and Poole-Warren, L. A. Conducting polymers for 
neural interfaces: Challenges in developing an effective long-term implant. Biomaterials 
2008, 29, 3393–3399. 
38. Oh, W. K.; Kwon, O. S. and Jang, J. Conducting polymer nanomaterials for biomedical 
applications: Cellular interfacing and biosensing. Polym. Rev. 2013, 53, 407–442. 
39. Uppalapati, D.; Boyd, B. J.; Garg, S.; Travas-Sejdic, J. and Svirskis, D. Conducting polymers 
with defined micro- or nanostructures for drug delivery. Biomaterials 2016, 111, 149–162. 
40. Ghosh, S.; Maiyalagan, T. and Basu, R. N. Nanostructured conducting polymers for energy 
applications: Towards a sustainable platform. Nanoscale 2016, 8, 6921–6947. 
41. Xia, L.; Wei, Z. and Wan, M. Conducting polymer nanostructures and their application in 
biosensors. J. Colloid Interface Sci. 2010, 341, 1–11. 
42. Schönenberger, C.; van der Zande, B. M. I.; Fokkink, L. G. J.; Henny, M; Schmid, C.; Krüger, 
M.; Bachtold, A.; Huber, R.; Birk, H. and Staufer, U. Template Synthesis of Nanowires in 
Porous Polycarbonate Membranes:  Electrochemistry and Morphology. J. Phys. Chem. B 
1997, 101, 5497–5505. 
43. Han, M. G. and Foulger, S. H. 1-Dimensional structures of poly(3,4-ethylenedioxythiophene) 
(PEDOT): A chemical route to tubes, rods, thimbles, and belts. Chem. Commun. 2005, 1, 
3092–3094. 
44. Martin, C. R.; Parthasarathy, R. and Menon, V. Template synthesis of electronically 
conductive polymers - A new route for achieving higher electronic conductivities. Synth. Met. 
1993, 55, 1165–1170. 
45. Chun-Guey Wu, T. B. Conducting polyaniline filaments in a mesoporosu channel hos. Science 
(80-. ). 1994, 264, 1775–1759. 
46. Wu, J.; Cho, W.; Martin, D. C.; Feng, Z. Q.; Leach, M. K.; Franz, E. W.; Naim, Y. I.; Gu, Z. Z. 
and Corey, J. M. Highly aligned poly(3,4-ethylene dioxythiophene) (PEDOT) nano- and 




47. Zhang, Z.; Sui, J.; Zhang, L.; Wan, M. Wei, Y. and Yu, L. Synthesis of polyaniline with a 
hollow, octahedral morphology by using a cuprous oxide template. Adv. Mater. 2005, 17, 
2854–2857. 
48. Boal, A. K.; Ilhan, F.; DeRouchey, J. E.; Thurn-Albrecht, T.; Russell, T. P. and Rotello, V. M. 
Self-assembly of nanoparticles into structured spherical and network aggregates. Nature 
2000, 404, 746–748. 
49. Qu, L.; Shi, G.; Chen, F. and Zhang, J. Electrochemical growth of polypyrrole microcontainers. 
Macromolecules 2003, 36, 1063–1067. 
50. Bajpai, V.; He, P.; Goettler, L.; Dong, J. H. and Dai, L. Controlled syntheses of conducting 
polymer micro- and nano-structures for potential applications. Synth. Met. 2006, 156, 466–
469. 
51. Jang, J.; Li, X. L. and Oh, J. H. Facile fabrication of polymer and carbon nanocapsules using 
polypyrrole core / shell nanomaterials. Chem. Commun. 2004, 794–795. 
52. Jang, J.; Bae, J. and Park, E. Selective fabrication of poly(3,4-ethylenedioxythiophene) 
nanocapsules and mesocellular foams using surfactant-mediated interfacial polymerization. 
Adv. Mater. 2006, 18, 354–358. 
53. Liang, L.; Liu, J.; Windisch, C. F.; Exarhos, G. J. and Lin, Y. Direct assembly of large arrays of 
oriented conducting polymer nanowires. Angew. Chemie - Int. Ed. 2002, 41, 3665–3668. 
54. Dallas, P. and Georgakilas, V. Interfacial polymerization of conductive polymers: Generation 
of polymeric nanostructures in a 2-D space. Adv. in Colloid and Interfac. 2015, 224, 46-61. 
55. Nuraje, N.; Su, K.; Yang, N. I. and Matsui, H. Liquid/liquid interfacial polymerization to grow 
single crystalline nanoneedles of various conducting polymers. ACS Nano 2008, 2, 502–506. 
56. Zinger, B. and Miller, L. L. Timed Release of Chemicals from Polypyrrole Films. J. Am. Chem. 
Soc. 1984, 106, 6861–6863. 
57. Krukiewicz, K. and Zak, J. K. Conjugated polymers as robust carriers for controlled delivery of 
anti-inflammatory drugs. J. Mater. Sci. 2014, 49, 5738–5745. 
58. Wadhwa, R.; Lagenaur, C. F. and Cui, X. T. Electrochemically controlled release of 
dexamethasone from conducting polymer polypyrrole coated electrode. J. Control. Release 
2006, 110, 531–541. 
59. Shamaeli, E. and Alizadeh, N. Kinetic studies of electrochemically controlled release of 
salicylate from nanostructure conducting molecularly imprinted polymer. Electrochim. Acta 
2013, 114, 409–415. 
60. Alizadeh, N. and Shamaeli, E. Electrochemically controlled release of anticancer drug 
methotrexate using nanostructured polypyrrole modified with cetylpyridinium: Release 
kinetics investigation. Electrochim. Acta 2014, 130, 488–496. 
61. Krukiewicz, K.; Jarosz, T.; Zak, J. K.; Lapkowski, M.; Ruszkowski, P.; Bobkiewicz-Kozlowska, 
T. and Bednarczyk-Cwynar, B. Advancing the delivery of anticancer drugs: Conjugated 
polymer/triterpenoid composite. Acta Biomater. 2015, 19, 158–165. 
DDSs BASED ON ICPs  
257 
 
62. Puiggalí-Jou, A.; Micheletti, P.; Estrany, F.; del Valle, L. J. and Alemán, C. Electrostimulated 
Release of Neutral Drugs from Polythiophene Nanoparticles: Smart Regulation of Drug-
Polymer Interactions. Adv. Healthc. Mater. 2017, 6, 1–11. 
63. Esrafilzadeh, D.; Razal, J. M.; Moulton, S. E.; Stewart, E. M. and Wallace, G. G. 
Multifunctional conducting fibres with electrically controlled release of ciprofloxacin. J. 
Control. Release 2013, 169, 313–320. 
64. Sirivisoot, S.; Pareta, R. and Webster, T. J. Electrically controlled drug release from 
nanostructured polypyrrole coated on titanium. Nanotechnology  2011, 22. 
65. Green, R. A.; Lovell, N. H. and Poole-Warren, L. A. Impact of co-incorporating laminin 
peptide dopants and neurotrophic growth factors on conducting polymer properties. Acta 
Biomater. 2010, 6, 63–71. 
66. Puiggalí-Jou, A.; del Valle, L. J.; Armelin, E. and Alemán, C. Fibrin Association at Hybrid 
Biointerfaces Made of Clot-Binding Peptides and Polythiophene. Macromol. Biosci. 2016, 16, 
1461–1474. 
67. Bax, D. V.; Tipa, R. S.; Kondyurin, A.; Higgins, M. J.; Tsoutas, K.; Gelmi, A.; Wallace, G. G.; 
Mckenzie, D. R.; Weiss, A. S. and Bilek, M. M. Cell patterning via linker-free protein 
functionalization of an organic conducting polymer (polypyrrole) electrode. Acta Biomater. 
2012, 8, 2538–2548. 
68. Thompson, B. C.; Moulton, S. E.; Ding, J.; Richardson, R.; Cameron, A.; O'Leary, S.; Wallace, 
G. G. and Clark, G. M. Optimising the incorporation and release of a neurotrophic factor using 
conducting polypyrrole. J. Control. Release 2006, 116, 285–294. 
69. Krukiewicz, K.; Bednarczyk-Cwynar, B.; Turczyn, R. and Zak, J. K. EQCM verification of the 
concept of drug immobilization and release from conducting polymer matrix. Electrochim. 
Acta 2016, 212, 694–700. 
70. Krukiewicz, K.; Stokfisz, A. and Zak, J. K. Two approaches to the model drug immobilization 
into conjugated polymer matrix. Mater. Sci. Eng. C 2015, 54, 176–181. 
71. Hepel, M. and Mahdavi, F. Application of the electrochemical quartz crystal microbalance for 
electrochemically controlled binding and release of chlorpromazine from conductive polymer 
matrix. Microchem. J. 1997, 56, 54–64. 
72. Miller, L. L. and Zhou, Q. X. Poly(N-methylpyrrolylium) Poly(styrenesulfonate): A 
Conductive, Electrically Switchable Cation Exchanger That Cathodically Binds and Anodically 
Releases Dopamine. Macromolecules 1987, 20, 1594–1597. 
73. Zhou, Q. X.; Miller, L. L. and Valentine, J. R. Electrochemically controlled binding and release 
of protonated dimethyldopamine and other cations from poly( N-methyl-pyrrole)/polyanion 
composite redox polymers. J. Electroanal. Chem. 1989, 261, 147–164. 
74. Bidan, G.; Lopez, C.; Mendes-Viegas, F.; Vieil, E. and Gadelle, A. Incorporation of sulphonated 
cyclodextrins into polypyrrole: an approach for the electro-controlled delivering of neutral 




75. Carli, S. Trapella, C.; Armirotti, A.; Fantinati, A.; Ottonello, G.; Scarpellini, A.; Prato, M.; 
Fadiga, L. and Ricci, D. Biochemically Controlled Release of Dexamethasone Covalently 
Bound to PEDOT. Chem. - A Eur. J. 2018, 24, 10300–10305. 
76. Jiang, S.; Sun, Y.; Cui, X.; Huang, X.; He, Y.; Ji, S.; Shi, W. and Ge, D. Enhanced drug loading 
capacity of polypyrrole nanowire network for controlled drug release. Synth. Met. 2013, 163, 
19–23. 
77. Xiao, Y.; Ye, X.; He, L. and Che, J. New carbon nanotube-conducting polymer composite 
electrodes for drug delivery applications. Polym. Int. 2012, 61, 190–196. 
78. Pyo, M. and Reynolds, J. R. Electrochemically stimulated adenosine 5′-triphosphate (ATP) 
release through redox switching of conducting polypyrrole films and bilayers. Chem. Mater. 
1996, 8, 128–133. 
79. Syritski, V.; Öpik, A. and Forsén, O. Ion transport investigations of polypyrroles doped with 
different anions by EQCM and CER techniques. Electrochim. Acta 2003, 48, 1409–1417. 
80. Evans, A. J.; Thompson, B. C.; Wallace, G. G.; Millard, R.; O'Leary, S. J., Clark, G. M.; 
Shepherd, R. K. and Richardson, R. T. Promoting neurite outgrowth from spiral ganglion 
neuron explants using polypyrrole/BDNF-coated electrodes. J. Biomed. Mater. Res. - Part A 
2009, 91, 241–250. 
81. Richardson, R. T.; Thompson, B.; Moulton, S.; Newbold, C.; Lum, M. G.; Cameron, A.; 
Wallace, G.; Kapsa, R.; Clark, G. and O'Leary, S. The effect of polypyrrole with incorporated 
neurotrophin-3 on the promotion of neurite outgrowth from auditory neurons. Biomaterials 
2007, 28, 513–523. 
82. Boehler, C. and Asplund, M. A detailed insight into drug delivery from PEDOT based on 
analytical methods: Effects and side effects. J. Biomed. Mater. Res. - Part A 2015, 103, 1200–
1207. 
83. Boehler, C. Kleber, C.; Martini, N.; Xie, Y.; Dryg, I.; Stieglitz, T.; Hofmann, U. G. and Asplund, 
M. Actively controlled release of Dexamethasone from neural microelectrodes in a chronic 
in vivo study. Biomaterials 2017, 129, 176–187. 
84. Hardy, J. G.; Mouser, D. J.; Arroyo-Curras, N.; Geissler, S.; Chow, J. K.; Nguy, L.; Kim, J. M. 
and Schmidt, C. E. Biodegradable electroactive polymers for electrochemically-triggered drug 
delivery. J. of Mat. Chem. B 2014¸ 39, 6809–6822.  
85. Hardy, J. G.; Amend, M. N.; Geissler, S.; Lynch, V. M. and Schmidt, C. E. Peptide-directed 
assembly of functional supramolecular polymers for biomedical applications: electroactive 
molecular tongue-twisters (oligoalanine-oligoaniline-oligoalanine) for electrochemically 
enhanced drug delivery. J. Mater. Chem. B 2015, 3, 5005–5009. 
86. Murdan, S. E lectro-responsive drug delivery from hydrogels. J. Control. Release 2003,  92, 
1–17. 
87. George, P. M.; LaVan, D. A.; Burdick, J. A.; Chen, C.-Y.; Liang, E. and Langer, R. Electrically 
controlled drug delivery from biotin-doped conductive polypyrrole. Adv. Mater. 2006, 18, 
577–581. 
DDSs BASED ON ICPs  
259 
 
88. Samanta, D.; Hosseini-Nassab, N.; McCarty, A. D. and Zare, R. N. Ultra-low voltage triggered 
release of an anti-cancer drug from polypyrrole nanoparticles. Nanoscale 2018, 10, 9773–
9779. 
89. Cai, P.; Leow, W. R.; Wang, X.; Wu, Y. L. and Chen, X. Programmable Nano–Bio Interfaces 
for Functional Biointegrated Devices. Adv. Mater. 2017, 29, 1–26. 
90. Ge, D. Tian, X.; Qi, R.; Huang, S.; Mu, J.; Hong, S.; Ye, S.; Zhang, X.; Li, D. and Shi, W. A 
polypyrrole-based microchip for controlled drug release. Electrochim. Acta 2009, 55, 271–
275. 
91. Svirskis, D.; Wright, B. E.; Travas-Sejdic, J.; Rodgers, A. and Garg, S. Development of a 
controlled release system for risperidone using polypyrrole: Mechanistic studies. 
Electroanalysis 2010, 22, 439–444. 
92. Li, Y.; Neoh, K. G. and Kang, E. T. Controlled release of heparin from polypyrrole-poly(vinyl 
alcohol) assembly by electrical stimulation. J. Biomed. Mater. Res. - Part A 2005, 73, 171–181. 
93. Krukiewicz, K.; Cichy, M.; Ruszkowski, P.; Turczyn, R.; Jarosz, T.; Zak, J. K.; Lapkowski, M 
and Bednarczyk-Cwynar, B. Betulin-loaded PEDOT films for regional chemotherapy. Mater. 
Sci. Eng. C 2017, 73, 611–615. 
94. Massoumi, B. and Entezami, A. Electrochemically controlled binding and release of 
dexamethasone from conducting polymer bilayer films. J. Bioact. Compat. Polym. 2002, 17. 
95. Carquigny, S.; Lakard, B.; Lakard, S.; Moutarlier, V.; Hihn, J.-Y. and Viau, L. Investigation of 
pharmaceutically active ionic liquids as electrolyte for the electrosynthesis of polypyrrole and 
active component in controlled drug delivery. Electrochim. Acta 2016, 211, 950–961. 
96. Pernaut, J.-M. andReynolds, J. R. Use of Conducting Electroactive Polymers for Drug Delivery 
and Sensing of Bioactive Molecules. A Redox Chemistry Approach. J. Phys. Chem. B 2000, 
104, 4080–4090. 
97. Svirskis, D.; Wright, B. E.; Travas-Sejdic, J.; Rodgers, A. and Garg, S. Evaluation of physical 
properties and performance over time of an actuating polypyrrole based drug delivery system. 
Sensors Actuators, B Chem. 2010, 151, 97–102. 
98. Shamaeli, E. and Alizadeh, N. Nanostructured biocompatible thermal/electrical stimuli-
responsive biopolymer-doped polypyrrole for controlled release of chlorpromazine: Kinetics 
studies. Int. J. Pharm. 2014, 472, 327–338. 
99. Löffler, S.; Seyock, S.; Nybom, R.; Jacobson, G. B. and Richter-Dahlfors, A. Electrochemically 
triggered release of acetylcholine from CO2 impregnated conductive polymer films evokes 
intracellular Ca2+signaling in neurotypic SH-SY5Y cells. J. Control. Release 2016, 243, 283–
290. 
100. Ge, J.; Neofytou, E.; Cahill, T. J.; Beygui, R. E. and Zare, R. N. Drug release from electric-field-
responsive nanoparticles. ACS Nano 2012, 6, 227–233. 
101. Hosseini-Nassab, N.; Samanta, D.; Abdolazimi, Y.; Annes, J. P. and Zare, R. N. Electrically 




102. Samanta, D.; Hosseini-Nassab, N. and Zare, R. N. Electroresponsive nanoparticles for drug 
delivery on demand. Nanoscale 2016, 8, 9310–9317. 
103. Tran, H. D.; Shin, K.; Hong, W. G.; D'Arcy, J. m.; Kojima, R. W.; Weiller, B. H. and Kaner, R. 
B. A template-free route to polypyrrole nanofibers. Macromol. Rapid Commun. 2007, 28, 
2289–2293. 
104. Shi, W.; Liang, P.; Ge, D.; Wang, J. and Zhang, Q. Starch-assisted synthesis of polypyrrole 
nanowires by a simple electrochemical approach. Chem. Commun. 2007, 23, 2414–2416. 
105. Zhong, W.; Liu, S.; Chen, X.; Wang, Y. and Yang, W. High-yield synthesis of superhydrophilic 
polypyrrole nanowire networks. Macromolecules 2006,  39, 3224–3230. 
106. Zhang, X. and Manohar, S. K. Bulk synthesis of polypyrrole nanofiber by seeding approch. J. 
Ammerican Chem. Soc. 2004, 126, 12714–12715. 
107. Acik, M.; Baristiran, C. and Sonmez, G. Highly surfaced polypyrrole nano-networks and nano-
fibers. J. Mater. Sci. 2006, 41, 4678–4683. 
108. Li, C.; Bai, H. and Shi, G. Conducting polymer nanomaterials: Electrosynthesis and 
applications. Chem. Soc. Rev. 2009, 38, 2397–2409. 
109. Ru, X.; Shi, W.; Huang, X.; Cui, X.; Ren, B. and Ge, D. Synthesis of polypyrrole nanowire 
network with high adenosine triphosphate release efficiency. Electrochim. Acta 2011, 56, 
9887–9892. 
110. Lee, H.; Hong, W.; Jeon, S.; Choi, Y. and Cho, Y. Electroactive polypyrrole nanowire arrays: 
Synergistic effect of cancer treatment by on-demand drug release and photothermal therapy. 
Langmuir 2015, 31, 4264–4269. 
111. Abidian, M. R.; Kim, D. H. and Martin, D. C. Conducting-polymer nanotubes for controlled 
drug release. Adv. Mater. 2006, 18, 405–409. 
112. Chen, C.; Chen, X.; Zhang, H.; Zhang, Q.; Wang, L.; Li, C.; Dai, B.; Yang, J.; Liu, J. and Sun, D. 
Electrically-responsive core-shell hybrid microfibers for controlled drug release and cell 
culture. Acta Biomater. 2017, 55, 434–442. 
113. Puiggalí-Jou, A.; Cejudo, A.; del Valle, L. J. and Alemán, C. Smart drug delivery from 
electrospun fibers through electro-responsive polymeric nanoparticles. ACS Appl. Bio Mater. 
2018, 1, 1594–1605. 
114. Luo, X. and Cui, X. T. Electrochemically controlled release based on nanoporous conducting 
polymers. Electrochem. commun. 2009, 11, 402–404. 
115. Luo, X. and Cui, X. T. Sponge-like nanostructured conducting polymers for electrically 
controlled drug release. Electrochem. commun. 2009, 11, 1956–1959. 
116. Seyfoddin, A.; Chan, A.; Chen, W. T.; Rupenthal, I. D.; Waterhouse, G. I. and Svirskis, D. 
Electro-responsive macroporous polypyrrole scaffolds for triggered dexamethasone delivery. 
Eur. J. Pharm. Biopharm. 2015, 94, 419–426. 
117. Cho, Y. and Borgens, R. B. Biotin-doped porous polypyrrole films for electrically controlled 
nanoparticle release. Langmuir 2011, 27, 6316–6322. 
DDSs BASED ON ICPs  
261 
 
118. Sharma, M.; Waterhouse, G. I. N.; Loader, S. W. C.; Garg, S. and Svirskis, D. High surface area 
polypyrrole scaffolds for tunable drug delivery. Int. J. Pharm. 2013, 443, 163–168. 
119. Jeon, G.; Yang, S. Y.; Byun, J. and Kim, J. K. Electrically actuatable smart nanoporous 
membrane for pulsatile drug release. Nano Lett. 2011, 11, 1284–1288. 
120. Otero, T. F. Reactions drive conformations. Biomimetic properties and devices, theoretical 
description. J. Mater. Chem. B 2013, 1, 3754–3767. 
121. Smela, E. Conjugated Polymer Actuators for Biomedical Applications. Adv. Mater. 2003, 15, 
481–494. 
122. Yuk, S. H.; Cho, S. H. and Lee, H. B. Electric Current-Sensitive Drug Delivery Systems Using 
Sodium Alginate/Polyacrylic Acid Composites. Pharmaceutical Research 1992, 9, 955–957. 
123. Kim, S. Y. and Lee, Y. M. Drug release behavior of electrical responsive poly(vinyl 
alcohol)/poly(acrylic acid) IPN hydrogels under an electric stimulus. J. Appl. Polym. Sci. 
1999, 74, 1752–1761. 
124. Kim, D. H.; Abidian, M. and Martin, D. C. Conducting polymers grown in hydrogel scaffolds 
coated on neural prosthetic devices. J. Biomed. Mater. Res. - Part A 2004, 71, 577–585. 
125. Qu, J.; Zhao, X.; Ma, P. X. and Guo, B. Injectable antibacterial conductive hydrogels with dual 
response to an electric field and pH for localized ‘smart’ drug release. Acta Biomater. 2018, 
72, 55–69. 
126. Pourjavadi, A. and Doroudian, M. Synthesis and characterization of semi-conductive 
nanocomposite based on hydrolyzed collagen and in vitro electrically controlled drug release 
study. Polymer  2015, 76, 287–294. 
127. Fabregat, G.; Giménez, A.; Díaz, A.; Puiggalí, J. and Alemán, C. Dual-Functionalization Device 
for Therapy through Dopamine Release and Monitoring. Macromol. Biosci. 2018, 18, 
1800014. 
128. H. Takahashi, S.; M. Lira, L. and I. Córdoba de Torresi, S. Zero-Order Release Profiles from A 
Multistimuli Responsive Electro-Conductive Hydrogel. J. Biomater. Nanobiotechnol. 2012, 
03, 262–268. 
129. Niamlang, S. and Sirivat, A. Electrically controlled release of salicylic acid from poly(p-
phenylene vinylene)/polyacrylamide hydrogels. Int. J. Pharm. 2009, 371, 126–133. 
130. Lin, H.; Li, L.; Ren, J.; Cai, Z.; Qiu, L.; Yang, Z. and Peng, H. Conducting polymer composite 
film incorporated with aligned carbon nanotubes for transparent, flexible and efficient 
supercapacitor. Sci. Rep. 2013, 3, 1–6. 
131. Wang, J.; Dai, J. and Yarlagadda, T. Carbon nanotube-conducting-polymer composite 
nanowires. Langmuir 2005, 21, 9–12. 
132. Gao, J.; Mikhail, E. I.; Aiping, Y.; Bekyarova, E.; Zhao, B. and Haddon, R. C. et al. Continuous 
spinning of a single-walled carbon nanotube− nylon composite fiber. J. Am. Chem. Soc. 
2005, 127, 3847–3854. 





134. Luo, X.; Matranga, C.; Tan, S.; Alba, N. and Cui, X. T. Carbon nanotube nanoreservior for 
controlled release of anti-inflammatory dexamethasone. Biomaterials 2011, 32, 6316–6323. 
135. Thompson, B. C.; Chen, J.; Moulton, S. E. and Wallace, G. G. Nanostructured aligned CNT 
platforms enhance the controlled release of a neurotrophic protein from polypyrrole. 
Nanoscale 2010, 2, 499–501. 
136. Du, Z. J.; Bi, G.-Q. and Cui, X. T. Electrically Controlled Neurochemical Release from Dual-
Layer Conducting Polymer Films for Precise Modulation of Neural Network Activity in Rat 
Barrel Cortex. Adv. Funct. Mater. 2017, 1703988. 
137. Gao, W. The chemistry of graphene oxide. Graphene Oxide Reduct. Recipes, Spectrosc. Appl. 
2015, 61–95. 
138. Luo, X.; Weaver, C. L.; Tan, S. and Cui, X. T. Pure graphene oxide doped conducting polymer 
nanocomposite for bio-interfacing. J. Mater. Chem. B 2013, 1, 1340–1348. 
139. Weaver, C. L.; Larosa, J. M.; Luo, X. and Cui, X. T. Electrically controlled drug delivery from 
graphene oxide nanocomposite films. ACS Nano 2014, 8, 1834–1843. 
140. Moulton, S. E.; Imisides, M. D.; Shepherd, R. L. and Wallace, G. G. Galvanic coupling 
conducting polymers to biodegradable Mg initiates autonomously powered drug release. J. 
Mater. Chem. 2008, 18, 3608–3613. 
141. Catt, K., Li, H.; Hoang, V.; Beard, R. and Cui, X. T. Self-powered therapeutic release from 
conducting polymer/graphene oxide films on magnesium. Nanomedicine Nanotechnology, 
Biol. Med. 2018, 7, 2495-2503. 
142. Ge, D.; Ru, X.; Hong, S.; Jiang, S.; Tu, J.; Wang, J.; Zhang, A.; Linkov, V.; Ren, B. and Shi, W. 
Coating metals on cellulose-polypyrrole composites: A new route to self-powered drug 
delivery system. Electrochem. commun. 2010, 12, 1367–1370. 
143. Shamaeli, E. and Alizadeh, N. Functionalized gold nanoparticle-polypyrrole 
nanobiocomposite with high effective surface area for electrochemical/pH dual stimuli-
responsive smart release of insulin. Colloids Surfaces B Biointerfaces 2015, 126, 502–509. 
144. Wang, R.; Peng, Y., Zhou, M. and Shou, D. Smart montmorillonite-polypyrrole scaffolds for 
electro-responsive drug release. Appl. Clay Sci. 2016, 134, 50–54. 
145. Kong, Y.; Ge, H.; Xiong, J.; Zuo, S.; Wei, Y.; Yao, C. and Deng, Linhong. Palygorskite 
polypyrrole nanocomposite: A new platform for electrically tunable drug delivery. Appl. Clay 
Sci. 2014, 99, 119–124. 
146. Feiner, R.; Engel, L.; Fleischer, S.; Malki, M.; Gal, I.; Shapira, A.; Shacham-Diamand, Y. and 
Dvir, T. Engineered hybrid cardiac patches with multifunctional electronics for online 

































In this Chapter two different systems for drug delivery have been developed. 
Poly(3,4-ethylenedioxythiophene) (PEDOT) nanoparticles have been loaded with curcumin and 
piperine by in situ emulsion polymerization using dodecyl benzene sulfonic acid (DBSA) as both 
stabilizer and doping agent. The loaded drugs affect the morphology, size and colloidal stability of 
the nanoparticles. Furthermore, kinetics studies of non-stimulated drug release have evidenced that 
polymer···drug interactions are stronger for curcumin than for piperine. This observation suggests 
that drug delivery systems based on combination of the former drug with PEDOT are very 
appropriated to show an externally tailored release profile. This has been demonstrated by 
comparing the release profiles obtained in presence and absence of electrical stimulus. Results 
indicate that controlled and time-programmed release of curcumin is achieved in a physiological 
medium by applying a negative voltage of –1.25 V to loaded PEDOT nanoparticles. 
Furthermore, electrospun poly(caprolactone) (PCL) microfibers loaded with poly(3,4- 
ethylenedioxythiophene) nanoparticles (PEDOT NPs) and curcumin with diameter of 3.9 ± 0.7 µm, 
have been prepared. PEDOT NPs, which are mainly located inside the PCL microfibers, exhibit a 
diameter of 99 ± 21 nm. PEDOT- and curcumin- containing PCL microfibers behave as extracellular 
cell matrices, facilitating cell spreading and enhancing cell proliferation because of their 
heterogeneity and roughness. The release of curcumin from the PCL microfibers by simple diffusion 
is very slow, external electric stimuli being required to boost and regulate the curcumin delivery 
process. PEDOT NPs behave as electro-actuators upon application of well-defined potential pulses, 
increasing their diameter by about 17%. This electro-mechanical actuation mechanism affects the 
structure of the PCL matrix, promoting the release of curcumin that increases with the number of 
pulses. Overall, PCL fibers loaded with electro-responsive PEDOT NPs represent a promising and 
valuable drug delivery system that can be regulated by using pulsatile electrical stimulation. 
 
Publications derived from this work: 
Puiggalí-Jou, A.; Micheletti, P.; Estrany, F.; del Valle, L. J. and Alemán C. Electrostimulated release 
of neutral drugs from polythiophene nanoparticles: smart regulation of drug-polymer interactions. 
Adv Healthc Mater. 2017, 6, 1-11.  
 
Puiggalí-Jou, A.; Cejudo, A.; del Valle, L. J. and Alemán C. Smart drug delivery from electrospun 
fibers through electro-responsive polymeric nanoparticles. ACS Appl Bio Mater. 2018, 1, 1594-1605. 





Intrinsically conducting polymers (ICPs) allow excellent control of the electrical 
stimulus, possess very good electrical and optical properties, have a high 
conductivity/weight ratio and can be biocompatible, biodegradable and porous.1-5 
Furthermore, a great advantage of ICPs is that their properties can be tailored to the 
specific needs of their applications by incorporation of biopolymers, peptides, or other 
bio-related moieties.6-9  
On the other hand, on-demand release of drug molecules from biomedical devices 
enables precise targeted dosing that can be temporally tuned to meet requirements for a 
variety of biomedical applications.10-12 Recent advances have facilitated the use of 
different stimuli, such as light, magnetic and electric fields, ultrasounds and 
electrochemical signals, to trigger drug release from smart material formulations (e.g. 
films, micro- and nanoparticles, and implant devices).12-15 These technologies enable 
greater control over drug delivery compared to traditional systems that cannot be 
modified in response to changing therapeutic needs (e.g. systems based on 
biodegradability of polymers).  
Electro-responsive drug-delivery systems are particularly attractive in this regard 
because electrical signals can be generated relatively easily, be accurately controlled and 
be remotely applied without using large, specialized and complex equipment. Moreover, 
it is possible to develop drug-delivery systems (DDSs) that allow repetitive dosing. In 
particular, recent in vivo assays have proved that ICPs nanoparticles (NPs) are successful 
electro-responsive drug delivery systems.16-18 Thus, the application of a small external 
electric field to these systems, which were subcutaneously localized by syringe injection 
at the place of interest, released the drug from the NPs, allowing its diffusion to the 
surroundings. 
At present time, the existence of multiple methods to incorporate drugs into ICP 
matrices for their subsequent release indicates that these organic materials are potential 
platforms for controlled drug delivery.19 For example, molecules bound in ICPs films20-22 
through doping can be controllably expelled by applying a reducing electrical potential. 




the diffusion of the bound molecules, adding a further reason why ICPs are very suitable 
for drug release applications.23 Nevertheless, formulations based on ICPs thin films, 
which are the most frequent ones, present low drug loading as a major disadvantage.24 
Although more drug can be incorporated by increasing the thickness of the films, the 
majority of the release takes place at the surface while drug molecules at the bulk remain. 
Compared to films, ICP NPs have increased surface-to-volume ratio,25 allowing higher 
drug loading. In spite of their small size, ICP NPs are electrically and electrochemically 
responsive, which is expected to be very advantageous for the design of controllable and 
programmable drug delivery systems. Considering the vast amount of possibilities, ICP 
NPs will undoubtedly play a decisive role in all disciplines of sciences that require 
programmed delivery of chemical compounds, including the biomedical field.  
In some recent but still scarce studies, NPs of polypyrrole (PPy), which is probably 
the most studied non-toxic ICP,26 has been used to trigger sensitive dosage-controlled 
release of drugs.16,27-30 More specifically, the response of PPy NPs embedded in a 
hydrogel against a dual stimulus (temperature and electric field) was demonstrated 
through in vivo experiments.16 Additionally, the on demand release of drugs with 
different polarities and molecular weights from electroresponsive PPy NPs has been 
evaluated.27 The biocompatibility and linear response achieved with a repetitive and 
pulsed release evidenced that such approaches are facile and minimally invasive for 
potential medical applications.16,27 Besides, the pH-sensitive behavior of drug loaded PPy 
NPs has been also reported, 28 reflecting that the release can be controlled through the 
pH, the charge of the drug and/or the addition of charged amphiphiles. 
Among ICPs, poly(3,4-ethylenedioxythiophene) (PEDOT) is probably the most 
employed for the fabrication of biomedical devices because of its outstanding capacitive 
performance, fast doping-undoping process, stable charge-discharge response, and high 
conductivity, biocompatibility and stability in continuous operation.31-40 The structure, 
surface morphology and porosity of PEDOT and the above discussed PPy are completely 
different35,41,42 since the former is exclusively formed by ,-linkages while the latter is 
highly crosslinked. Consequently, both the electrochemical and electrical responses of 
PEDOT are greatly superior to those of PPy. In spite of these advantages, the loading of 
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drugs into PEDOT NPs for release on demand remains practically unstudied. Paradee 
and Sirivat43 examined the electrically-controlled release of benzoic acid loaded on 
PEDOT NPs blended with alginate hydrogels. More recently, Liu et al.44 loaded 2-
phenylethynesulfonamide, which is a heat shock protein 70 inhibitor, into thermo-
responsive poly(N-isopropylacrylamide) shells, incorporating PEDOT NPs as 
photothermal coupling agent.  
 
7.2 Materials and methods 
Materials and Cell line: 3,4-ethylenedioxythiophene (EDOT) monomer, sodium 
dodecylbenzene sulfonate (DBSA), ammonium persulfate (APS), curcumin (CUR), 
piperine (PIP), methyl thiazolyl tetrazolium (MTT), Tween-20 and Hoechst 
(bisBenzimide H 33258) were purchased from Sigma (USA). Cell lines PC3 (epithelial 
cells from human prostate adenocarcinoma) and MCF-7 (epithelial cells from human 
breast adenocarcinoma) were obtained from ECACC (European Collection of Cell 
Culture, UK). Culture media were purchased from BD Gibco: RPMI 1640 (Gibco, USA) 
supplemented with 10% fetal bovine serum (FBS), penicillin G (100 U/mL), and 





Synthesis of PEDOT NPs: A 15 mL a glass tub was filled with 4.5 mL of milli-Q water. 
After this, 0.0163 g DBSA were added and the solution was stirred for 1 hour at 750 rpm 
at room temperature. This was followed by the addition of 23.6 mg of EDOT monomer 
and, again, was allowed to stir for 1 hour at 750 rpm at room temperature. Finally, 91.2 
mg of APS dissolved in 0.5 mL of milli-Q water was added to the mixture. The reaction 
was maintained in agitation at 40 ºC overnight protected from light with aluminium foil. 
In this process, the colour of the reaction mixture changed from light grey to dark blue. 
No sedimentation was observed after the reaction, indicating a good colloidal stability. 
The side products and unreacted chemicals were removed by a sequence of 3 
centrifugations at 11000 rpm for 40 min at 4 ºC.  The resulting supernatants were 




bath (15 min at room temperature). The last pellet was left under vacuum two days, then 
weighted and re-dispersed in the corresponding media at the desired concentration. 
 
Synthesis of drug/PEDOT NPs: 0.0163 g of DBSA was added to a 15 mL tub filled 
with 3.99 mL of milli-Q water and the solution was stirred for 1h at 750 rpm at room 
temperature. After this, 23.6 mg of EDOT and 0.5 mL of drug solution (10 mg/mL in 
ethanol, EtOH) were added and the resulting solution was stirred at 750 rpm and room 
temperature during 1 h. Finally, 91.2 mg of APS dissolved in 0.5 mL of milli-Q water was 
added to the mixture. The reaction was protected from light (aluminium foil) and 
maintained in agitation at 40 ºC overnight. The colour of the reaction mixture changed 
from light grey to dark blue. No sedimentation was observed after the reaction, 
indicating good colloidal stability. The side products, extra drug and unreacted chemicals 
were removed by a sequence of 3 centrifugations at 21000 rpm for 40 min at 4 ºC. The 
resulting supernatants were decanted and the pellet was re-dispersed in deionized water 
by using a vortex and a sonic bath (15 min at room temperature). The last pellet was left 
under vacuum for two days, then weighted and re-dispersed in the corresponding media 
at the desired concentration. 
 
Drug loading: The drug content was determined by re-suspending 5 µL of PEDOT NPs 
in 1 mL of ethanol (EtOH) 70%. The suspension was sonicated and vortexed for 10 min 
since the drug was quickly released in the alcoholic media. Then, the solution was 
centrifuged within a mini-centrifuge for 15 min at 2500 rpm. Finally, 200 µL of the 
supernatant were deposited on flat-bottomed 96 well-plates, where also a standard 
calibration (STC) curve was prepared with the corresponding drug in EtOH 70% and 
read at 425 nm for CUR and 350 nm for PIP. In order to determine the drug released 
during the dialysis or after the electrical stimuli the same procedure was followed, but 
changing the media for the STC to the adequate for each case (PBS with 0.5% Tween 20, 
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      (Eq. 7.2.1) 
where mdrug and mpolymer are the mass of extracted drug and the mass of PEDOT NPs, 
respectively. 
 
7.3 Electrostimulated release of neutral drugs from 
polythiophene nanoparticles: smart regulation of drug-
polymer interactions  
In this work two neutral and hydrophobic drugs have been loaded into PEDOT NPs 
(drug/PEDOT NPs) during their synthesis by emulsion polymerization in water. These 
drugs are CUR, which displays a wide spectrum of medical properties ranging from anti-
bacterial, anti-viral, anti-protozoal, anti-fungal, and anti-inflammatory to anti-cancer 
activity,45-47 and PIP, a piperidine alkaloid with pharmacological properties as anti-
inflammatory, antifertility and stimulator of serotonin synthesis in the central nervous 
system, among others.49-51 The release of the drugs from the ICP NPs has been 
investigated without and with electrostimulation. Results have demonstrated that 
PEDOT NPs loaded with CUR serve as a drug reservoir for electric-field triggered release. 
 
7.3.1 Methods 
Scanning electron microscopy (SEM): SEM micrographs were obtained using a 
Focussed Ion Beam Zeiss Neon 40 scanning electron microscope operating at 10 kV. 
Samples were mounted on a double-side adhesive carbon disc and sputter-coated with a 
thin layer of carbon to prevent sample charging problems.  
 
Atomic force microscopy (AFM): AFM was conducted to obtain topographic images 
of the nanoparticles surface using silicon TAP 150-G probe (Budget Sensors, Bulgaria) 
with a frequency of 150 kHz and a force constant of 5 N/m. Images were obtained with 




ambient conditions in tapping mode. AFM measurements were performed on various 
parts of the samples, which produced reproducible images similar to those displayed in 
this work.  
 
Dynamic light scattering (DLS): DLS studies were performed using NanoBrook 
Omni Zeta Potential Analyzer from Brookheaven Instruments. Measurement consisted of 
3 runs each of 120 s duration, which were averaged to obtain the effective diameter (Deff). 
Samples were analysed at 25 ºC using a scattering angle of 90º. In order to know the Z-
potential particles were re-suspended in 1 mM KCl solution and 30 consecutive 
measurements were taken of each sample. 
 
Fourier transform infrared (FTIR) Spectroscopy: FTIR transmittance spectra 
were recorded on a FTIR Jasco 4100 spectrophotometer. Pellets were deposited on an 
attenuated total reflection accessory (Top-plate) with a diamond crystal (Specac model 
MKII Golden Gate Heated Single Reflection Diamond ATR). For each sample 64 scans 
were performed between 4000 and 600 cm-1 with a resolution of 4 cm-1. 
 
Dialysis: 1 mL of drug/PEDOT NPs (1 mg/mL) or free drug (0.1 mg/mL) were deposited 
into 3.5 KDa MW cut-off bags and immersed in 25 mL of PBS (pH 7.4) with 0.5 % (v/v) 
Tween-20 and kept in a shaker at 37 ºC at 80 rpm. Each day 1 mL of the immersion 
solution was taken out to quantify the released drug and the whole solution was replaced 
by 10 mL of new media. After reaching the plateau of the drug release, the release 
medium was substituted by a PBS solution with 10 % EtOH and, finally, after reach again 
the plateau the medium was replaced by PBS with 70 % EtOH, allowing the complete 
drug release. All the results were normalized by the total amount of drug encapsulated 
within the NPs or used as a free molecule in order compare their kinetics. 
 
Effects of voltage and time on drug release: Washed drug/PEDOT NPs were re-
suspended in PBS at pH 7.4 to have a final concentration of 10 mg/mL. Then, 5 µL of the 
resulting solution were placed on a glassy carbon bar that acted as working electrode (= 
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2 mm) and were dried under vacuum. A three electrodes configuration was used: the 
glassy carbon bar coated with the corresponding NPs as a working electrode (WE), a bar 
of glassy carbon as counter electrode (CE), and AgAgCl as reference electrode (RE). 1 
mL of PBS with 0.5 % (v/v) Tween-20 was used as electrolytic medium. The appropriate 
voltage was applied for a particular period of time. After this, 100 µL of the medium were 
kept to determine the drug concentration and substituted by new PBS 0.5 % (v/v) 
Tween-20. The absorbance was read at the maximum wavelength absorbance of each 
drug. To test the effect of voltage, 0.50 V, −0.50 V, −0.75 V, −1.00 0V and −1.25 V were 
applied for 3 min. The influence of the time was evaluated by applying a voltage of -1.25 
V during 30, 60, 180, 360 and 540 s.  A control experiment was performed in the absence 
of the stimulus to compare the results. All the measures were repeated at least six times. 
 
Cyclic voltammetry: Cyclic voltammetry (CV) studies were conducted with an Autolab 
PGSTAT302N galvanostat equipped with the ECD module (Ecochimie, The 
Netherlands). Measurements were performed on 2.5 or 5 µL of 10 mg/mL NPs solution 
dried on a glassy carbon electrodes (GCE) of diameter = 2 mm or in 0.1 mg/mL of drug 
dissolved in PBS 1 (pH 7.4). 
All electrochemical assays were performed using a three-electrode one compartment 
cell under a nitrogen atmosphere and at room temperature. The cell was filled with 10 
mL of PBS 1x (pH 7.4) as a supporting electrolyte. Covered or bare GCE was used as the 
working electrode, platinum as the counter electrode, while an Ag|AgCl electrode 
containing KCl saturated aqueous solution was the reference electrode (offset potential 
versus the standard hydrogen electrode, E° = 0.222 V at 25 °C). Oxidation-reduction 
cycles were registered within the potential range of −1.5 to +1 V at different scan rates 
(i.e. 10, 20, 40, 60, 80, 100, 200, 300 and 400 mV/s). 
 
Cytotoxicity evaluation: In vitro cytotoxicity evaluation of DBSA, PEDOT NPs, free 
CUR and CUR/PEDOT NPs for PC3 and MCF-7 cell lines was determined by the MTT 
assay. Free CUR was dissolved in ethanol, the final concentration of ethanol in these 




seeded at a density of 2010
4
 cells in 96-well plates and incubated overnight. 
Subsequently, the cells were exposed to a series of increasing DBSA, PEDOT NPs, free 
CUR and CUR/PEDOT NPs concentrations. Cells were incubated with the treatment for 
24 h. Finally, the percentage of viable cells relative to untreated control was determined 
on the basis of the mitochondrial conversion of 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide to formazan. The results were expressed as mean value ± 
standard deviation (SD). All the experiments were performed in triplicate. Statistical 
comparison of values was based on a 2-way ANOVA using Tukey’s test for pair-wise 
comparison with p < 0.05. 
 
Cellular morphology evaluation: Cells morphology and CUR uptake were examined 
by epifluorescence microscopy (BA410 Model, Motic Spain S.L.). Cells were seeded at a 
density of 2010
3
 cells in 24-well plates coated with a round glass and incubated 
overnight. Later, the cells were exposed to a 50 µg/mL of free CUR and CUR/PEDOT 
NPs and the equivalent of PEDOT NPs without CUR. Cells were incubated with the 
treatment for 24 h. Wells were cleaned three times with PBS, then fixed and 
permeabilized with an incubation of 5 min PBS with 70 % EtOH. Again, the wells were 
cleaned three times with PBS, stained with 0.5 µg/mL for 1 h and washed three more 
times. The Hoechst fluorescence and the intrinsic fluorescence of CUR were detected 
with standard fluorescence filters sets: MF31000 filter (Exciter D350/50 and Emitter 
D460/50m) and a MF31001 filter (Exciter D480/30x and Emitter D535/40m), 
respectively. 
 
7.3.2 Results and discussion 
Although different approaches have been proposed to synthesize ICP NPs from their 
corresponding monomers combined with soft-templates,52-54 they have been criticized 
because of the poor control on both size and colloidal stability. Moreover, the difficulty of 
getting rid of the surfactant is added.55 In a recent study, Zhou and coworkers prepared 
PEDOT NPs with a particle size distribution of 17.2±1.6 nm applying a hydrothermal 
approach and using FeCl3·6H2O as oxidant and sodium dodecyl benzene sulfonate as 
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stabilizer.56 In the present study, PEDOT NPs have been obtained in water at 40 ºC using 
DBSA as stabilizer and doping agent simultaneously, and APS as oxidizing agent (Figure 
7.3.1a and b). It is worth noting that the stabilizer is required to avoid the yielding of 
the ECP as an insoluble bulk powder with very limited processability.57 Deff of the 
resulting PEDOT NPs, which are displayed in Figure 7.3.2c, was 356 and 842 nm, as 
determined by SEM and DLS, respectively.  
The two drugs, CUR and PIP (Figure 7.3.1c), considered in this work were loaded in 
situ during the emulsion polymerization. Due to their hydrophobicity, the drugs 
remained into the cores of the surfactant micelles rather than interacting with the 
medium. After polymerization, PEDOT NPs were formed and drugs were successfully 
loaded. The DLR, which was expressed as mass of encapsulated drug with respect to the 
total mass, was 5.91.6% and 8.00.4% for CUR and PIP, respectively, these values being 
similar to those achieved using other polymeric vesicles.58 Moreover, the successful 
loading of the drugs within the PEDOT NPs was further confirmed by FTIR spectroscopy, 




CUR- and PIP-loaded PEDOT NPs, hereafter denoted as CUR/PEDOT and 
PIP/PEDOT NPs, respectively, are spherical and stable in solution (Figure 7.3.2). 
Despite the CUR and PIP are neutral, hydrophobic and of similar size (i.e. 368.4 g/mol 
and 285.3 g/mol, respectively), the average Deff of loaded NPs was found to be 
considerably affected by the drug, as observed by DLS measurements and SEM 
measurements. Table 7.3.1 reflects that the CUR/PEDOT NPs are small and 
monodisperse (i.e. Deff with low standard deviation), whereas PIP/PEDOT NPs are 
relatively large and polydisperse (i.e. Deff with high standard deviations). The yielded NPs 
and their corresponding aggregates successfully remained below 4 µm, which is the 
smallest diameter of human blood capillaries,59 and thus avoiding the blockage of blood 












CURCUMIN (CUR) PIPERINE (PIP)
40 nm
200 nm
Figure 7.3.1 (a) Schematic representation of the chemical synthesis of PEDOT NPs by 
emulsion polymerization. (b) Trasmision electron microscopy (TEM) micrographs of PEDOT 
NPs obtained using the procedure displayed in (a). (c) Chemical structure of CUR and PIP. 
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SEM and DLS observations are corroborated by the AFM images displayed in Figure 
7.3.2d and e, which reflect remarkable differences among PEDOT, CUR/PEDOT and 
PIP/PEDOT NPs. Thus, PEDOT NPs remained stable and very small while CUR/PEDOT 
and, especially, PIP/PEDOT exhibited higher size and tendency to aggregate. 
Figure 7.3.2 SEM images of (a) CUR/PEDOT NPs, (b) PIP/PEDOT NPs, (c) PEDOT NPs 
(Scale bar: 200 nm). Effective diameter histograms derived from SEM measurements and 
average values are also displayed. (d) AFM images (11 µm2) of (top) PEDOT, (middle) 
CUR/PEDOT and (bottom) PIP/PEDOT NPs. The graphs displayed in panels corresponds to 
the profile of the selected particles. (e) AFM images of (top) CUR/PEDOT and (bottom) 
PIP/PEDOT NPs: 3D height images 22 µm2 (right column), 2D height images (left top) and 2D 







The size increment is probably due to the extremely low aqueous solubility of the two 
drugs, which promotes the formation of relatively large molecular cores inside PEDOT 
NPs. The tendency to aggregate is corroborated by the zeta- (-) potential, which varies 
as follows: PEDOT < CUR/PEDOT < PIP/PEDOT (Table 7.3.1). The physical stability of 
an aqueous dispersion is considered to be good when the absolute value of the -
potential is around 30.60-61 Therefore, the colloidal stability of CUR/PEDOT and 
PIP/PEDOT NPs (-potential of -26.5±5.1 and -18.7±3.0 mV, respectively) is lower than 
that of PEDOT NPs (-29.4±3.6 mV). 
FTIR spectroscopy has been used to determine the chemical structure of the 
functional groups on the surface of PEDOT NPs. Figure 7.3.3 displays the FTIR spectra 
recorded for drugs, PEDOT NPs and drug/PEDOT NPs. PEDOT NPs doped with DBSA 
exhibit the main absorption peaks from the thiophene, ether and sulfonate groups: 
stretching modes of C=C in the thiophene ring at 1647 and 1557 cm-1, CH2 stretching 
modes at 1478, 1396 and 750 cm-1, C–O–C vibrations at 1206 and 1057 cm-1, and the S–O 
stretch at 667 cm-1.  
 Deff (nm) SEM Deff (nm) DLS DLR (%) -potential (mV) 
PEDOT  356 842 - -29.4±3.6 
CUR/PEDOT 9616 2073 5.91.6 -26.55.1 
PIP/PEDOT 292132 30417 8.00.4 -18.7±3.0 
Table 7.3.1 Effective diamerter (Deff) determined by SEM and DLS, drug loading ratio (DLR) 
and -potential of unloaded-PEDOT, CUR/PEDOT and PIP/PEDOT NPs. 
 
Figure 7.3.3 FTIR spectra of (a) PEDOT NPs, CUR and CUR/PEDOT NPs; and (b) PEDOT 
NPs, PIP and PIP/PEDOT NPs. 
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The addition of drugs during the polymerization process did not affect the 
localization of PEDOT bands; instead, the bands associated to the individual drugs were 
appreciated proving their incorporation. The two main characteristic C=O stretching 
bands at 1626 and 1535 cm-1 and the enol C–O peak at 1267 cm-1 observed for CUR alone 
are also detected in CUR/PEDOT NPs (Figure 7.3.3a). Similarly, the very broad band at 
3293 cm-1 and the sharp peak at 3508 cm-1 indicate the presence of OH, whereas the 
peaks at 959 and 713 cm-1 have been attributed to the benzoate trans- and cis-CH 
vibrations, respectively. Finally, the FTIR spectrum of free PIP (Figure 7.3.3b) clearly 
shows the characteristic C=O stretching peaks at 1628 and 1545 cm-1, which are 
preserved in PIP/PEDOT NPs.  
Dialysis bags with a molecular weight cut-off of 3500 KDa were used to understand 
the kinetics of the non-stimulated drug release in different media (Figure 7.3.4). In 
order to achieve a complete CUR and PIP release, three different environments with 
increasing affinity for the drug were examined: PBS with 0.5% Tween 20 (which is a 
surfactant that helps the dissolution of the drug), and the same solution mixed with 10% 
EtOH and with 70% EtOH. Comparison of the released amount of drug from 
drug/PEDOT NPs with their respective controls (i.e. drugs alone) allows to visualize a 
different behaviour for CUR and PIP when interact with PEDOT. More specifically, the 
release of CUR from CUR/PEDOT NPs was much slower than that of PIP from 
Figure 7.3.4 Cumulative drug release comparison between drug/PEDOT NPs and free drug 
(control) dispersed in aquous solutions and dyalised against PBS+0.5% Tween 20, the previous 




Figure 7.3.5 (a) Camera image of the three electrodes set-up for the electrochemical 
characterization of unloaded PEDOT and drug/PEDOT NPs. The red arrow points out released 
CUR in experiments with CUR/PEDOT NPs. WE, CE and RE refer to the working electrode, the 
counter electrode and the reference electrode, respectively. Cyclic voltammograms for (b) 
unloaded PEDOT NPs, (c) CUR/PEDOT NPs and (d) and PIP/PEDOT NPs recorded from –1.5 
to 1.0 V at different varying scan rates (10, 20, 40, 60, 80, 100, 200, 300 and 400 mV/s) using 
PBS 1 (pH 7.4) as electrolyte medium. Variation of the current density (jp) at the anodic and 
cathodic peaks (e) of CUR and at the anodic peak (f) of PIP against the square root of the scan 
rate. 
PIP/PEDOT NPs with respect to their corresponding controls. These results reflect a 
relatively strong interaction between CUR and PEDOT, making difficult the release of the 
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drug from the NPs until an environment with a high alcoholic content is used Figure 
7.3.4a). Instead, the release of PIP from the NPs was very similar to that of the control, 
indicating a simple diffusion phenomenon motivated by the poor affinity between the 
drug and the ICP. This feature is confirmed by the almost imperceptible effect of the 
increment of EtOH in the release medium (Figure7.3.4b). The divergent behaviour of 
CUR/PEDOT and PIP/PEDOT should be attributed to the different hydrogen bonding 
abilities of the two drugs. Thus, CUR···PEDOT hydrogen bonds are expected to be 
formed between the hydroxyl groups of CUR (Figure 7.3.1c) and the dioxane rings of 
PEDOT. It should be noted that this kind of specific interactions were found to play a 
crucial role in DNA···PEDOT interactions,62 which are highly dependent on the DNA 
sequence. In contrast, the absence of groups able to act as hydrogen bonding donors in 
PIP precludes the formation of PIP···PEDOT hydrogen bonding interactions. Overall, 
these results suggest that CUR/PEDOT NPs are promising candidates to behave as 
electrically responsive drug delivery systems.  
Before of the electrostimulation studies, the electrochemical response of CUR, PIP, 
and both PEDOT and drug/PEDOT NPs was examined by cyclic voltammetry (CV), 
registering oxidation–reduction cycles within the potential range of -1.5 to +1 V at 
different scan rates. Figure 7.3.5a (left) displays a photograph of the three electrode 
configuration when cyclic voltammetry was recorded from CUR/PEDOT NPs deposited 
on GCE. Interestingly, it was possible to visualize the release of CUR from the NPs when 
low scan rates were employed.  
CVs recorded for CUR and PIP are displayed in Figure 7.3.6a and b, respectively. 
Since CUR molecule contains two hydroxyl groups a conjugation effect can occur from 
the electron cloud deviation. As can be it seen CUR exhibits one well defined anodic peak 
at a potential of  +0.4 V and a less defined cathodic peak at  -0.10 V (Figure 7.3.6a), 
which are similar to that previously observed elsewhere.64,65 These quasi-reversible peaks 
have been attributed to the product of the irreversible oxidation reaction, which can be 
adsorbed onto the electrode surface. The intensity of the peaks increases in absolute 




they correspond to a quasi-reversible redox process.66 Instead, the voltammograms 
recorded for PIP exhibit two irreversible anodic peaks at 0.12 V and 0.92 V.  
CVs of PEDOT, CUR/PEDOT and PIP/PEDOT NPs adsorbed onto glassy carbon 
electrodes are compared in Figure 7.3.5b-d. The current density increases 
proportionally with the scan rate suggesting that the electrochemical process depends on 
the difussion.67 Moreover, detailed inspection of the voltammograms recorded for 
CUR/PEDOT NPs allows identification of the CUR anodic peak at a potential between 
0.4 and 0.5 V, depending on the scan rate. Figure 7.3.5e plots the current density at the 
anodic and cathodic peaks (jp) of CUR against the square root of the scan rate, while 
Figure 7.3.5f represents the same graphic for the irreversible anodic process of PIP at 
0.92 V. A linear behavior is observed in all cases. Moreover, in the case of CUR the slope 
was slightly higher for the anodic process than for the cathodic one. These results 
confirm the dependence of electrode reaction on the diffusion, which is the mass 
transport rate of the electroactive species to the surface of the electrode across a 
concentration gradient.  
Experiments with electrostimulation were performed using a conventional three-
electrode setup, similar to that displayed in Figure 7.3.5a, with glassy carbon coated 
with drug/PEDOT NPs as WE, bare glassy carbon as CE, and AgAgCl as RE. To 
investigate the effect of the voltage on the release of CUR and PIP from drug/PEDOT 
NPs, different voltages (i.e. 0.50 V, −0.50 V, −1.00 V and −1.25 V) were applied during 3 
min. Results have been compared with control experiments, which were performed in 
Figure 7.3.6 CV of (a) CUR and (b) PIP in PBS 1 (pH = 7.4). Initial and final potential: -1.5 V; 
reversal potential: 1.0 V. Scan rates: 10, 20, 40, 60, 80, 100, 200, 300 and 400 mV/s. 
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absence of electric voltage (hereafter denoted 0.00 V). In order to mimic a physiological 
medium, electrically stimulated drug release experiments were performed using PBS 
with 0.5 % (v/v) Tween 20 at pH 7.4 as electrolyte medium.  
Results found for CUR and PIP, which are displayed in Figures 7.3.7a and c, 
respectively, demonstrate completely different behaviours. The percentage of released 
CUR with respect to the amount of encapsulated CUR was lower than 5% when the 
applied voltage was 0.50 V or in absence of stimulus, while increased progressively and 
linearly with the more negative voltage. Thus, the stimulation with −1.25 V for 3 min 
resulted in a CUR delivery of 38%. In the case of PIP/PEDOT NPs, the amount of 
released drug in absence of stimulus is 10%, increasing to 18% and 23% when the applied 
voltage is −0.50 and 0.50 V, respectively. No systematic behaviour was identified in the 
case of PIP (Figures 7.3.7b), indicating that the release of this drug cannot be 
controlled and programmed through electrostimulation. 
Figure 7.3.7  Effect of (a,b) voltage with time constant (3 min) and (c,d) of time with voltage 
constant (-1.25 V) on drug release for drug/PEDOT NPs: (a,c) CUR and (b,d) PIP (n = 6). The 




Figures 7.3.7c and d display the release of CUR and PIP, respectively, from 
drug/PEDOT NPs with time. Results from these experiments, which were performed 
using a fixed voltage of −1.25 V, are consistent with those reported in Figures 7.3.7a 
and b, indicating that controlled release by electrical stimulation can be efficiently 
achieved only for CUR. Thus, although 7% of CUR is released after 30 s only, the amount 
of released drug increases logarithmically with time. In the time interval compressed 
between 3 and 9 min, the release grows from 38% to 60%. Also, complementary assays 
showed that the CUR release stops when the voltage is tuned off, proving that this is a 
regulated process. These results reflect that the controlled CUR release can be achieved 
with both time and applied potential (Figures 7.3.7c and a, respectively). Release 
profiles were reproducible not only with as fresh samples but also with suspensions that 
were stored for even one month before the release assays. The variation of PIP release 
with time is practically null (i.e. 20% after both 3 and 9 min), corroborating that the poor 
interactions between such drug and the ICP preclude the applicability of PIP/PEDOT 
NPs as dosage-controlled drug delivery vehicles.  
Previous studies suggested that the take-up and rate delivery of drugs may depend on 
the structure, composition and oxidation state of the ICP.24 In the particular case of the 
release of charged drugs by electrical stimulation, the main factor is the oxidation state 
since the driving force of this process is the apparition of repulsive drug···ICP 
electrostatic interactions. Thus, the oxidation and reduction of the ICP cause the release 
of cationic and anionic drugs, respectively.24 However, CUR and PIP are neutral drugs at 
pH= 7 and, therefore, their electrically stimulated release is expected to be controlled by 
a more complex mechanism. Unfortunately, designs allowing for the controlled release of 
neutral drugs are very scarce. Langer and co-workers67 used biotin-doped PPy to load 
biotinylated nerve growth factor (NGF) at the biotin binding sites found at the polymer 
surface. Reduction of the PPy film resulted in an electrically triggered NGF release, which 
remained biologically active. On the other hand, N-methylphenpthiazine (NMP) loaded 
into PPy doped with anionic β-cyclodextrins was released when oxidized, which caused 
the formation of positive charges on both the ICP and NMP.69  
The mechanism proposed in this work for the electrically stimulated release of CUR is 
based on the effect of the voltage on the oxidation state of the ICP and, therefore, on 
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PEDOT···CUR interactions. The release of CUR is not stimulated by the application of the 
positive voltage (+0.50 V), which enhances the positive oxidation state of the polymer 
(Figure 7.3.6) while the oxidation of the drug starts at around such potential (Figure 
7.3.6). In contrast, the CUR release becomes electrostimulated upon the application of 
negative voltages, which induce the electrochemical de-doping (reduction) of PEDOT 
NPs. Thus, the fraction of reduced PEDOT sites over the number of total active sites (i.e. 
where electrons are exchanged) increases with the negative voltage, polymer chains 
being expected to be completely, or almost completely, reduced (i.e. de-doped – with 
neutral charge) at the voltage of –1.25 V.67 It was observed that lower voltages caused 
mechanical and electrochemical degradation of the ICP NPs. The de-doping of the ICP 
affects the intermolecular interactions with the drug, hydrogen bonds being significantly 
weaker when PEDOT chains are in the neutral state than in the oxidized state.70 
Accordingly, the mechanism for the electrostimulated CUR release from CUR/PEDOT 
NPs can be summarized by the following Eq.: 
(PEDOT+·DBSA–)···nCUR + e–   
(PEDOT(-)+·(-)DBSA–)···mCUR + DBSA– + (n-m)CUR 
where nCUR refers to the drug molecules hydrogen bonded to the oxidized polymeric 
NPs, mCUR corresponds to the drug molecules that remain hydrogen bonded to the 
polymeric NPs after pump  electrons into the system by electrical stimulation, and + 
and (-)+ are the oxidation states of oxidized and reduced PEDOT, respectively (i.e. 
when PEDOT is completely reduced, =, the charge of the ICP is zero.  
The release mechanism proposed in this work for neutral drugs able to form specific 
interactions with the ICP matrix resembles that typically reported when negatively 
charged drugs act as dopant ions.41,42 Unfortunately, this mechanism does not apply to 
PIP/PEDOT NPs because of the lack of hydrogen bonding donors in the drug. 
Accordingly, PIP molecules are rapidly released by through the walls of the polymeric 
NPs, such diffusion process being independent of the presence or not of external stimuli. 
Thus, although the application of an electric voltage affects the oxidation state of PEDOT 
chains, it does not improve the control in the release that is determined by the 




of the ICP. In order to overcome the limitations associated to the instability in the light, 
poor oral bio-availability in vivo and lack of solubility in aqueous solvents of CUR, the 
use of micro- and nanoparticles made of polymer materials, as for example poly(lactic-
co-glycolic acid), as carriers has been extensively explored.41-73 Although polymeric 
micro- and nanoparticles provided biocompatibility, in some cases also biodegradable, 
platforms for sustained release of CUR with improved bio-availability, several 
disadvantages were detected. The most important one, which is the effective control 
during the release, has been overcome in this work applying a controlled voltage to 
electrodes coated with CUR/PEDOT NPs, achieving a programmed CUR release. The 
biocompatibility and cytotoxicity of such system is an important characteristic to be 
analyzed for further biological applications. PEDOT NPs and the surfactant (DBSA) 
alone were tested in epithelial-like prostate and breast adenocarcinoma cells lines from 
human (PC3 and MCF-7, respectively) using the MTT assay measured after 24 h post-
treatment (Figure 7.3.8a). PEDOT NPs do not exhibit any toxic effect until they are 
used at high concentration. Moreover, it is clearly demonstrated that, after the 3 washing 
steps, the quantity of dopant is lower than 6 µg/mL, when DBSA starts to be toxic. The 
cytotoxicity of free CUR and CUR/PEDOT NPs, which was evaluated at 24 h post-
treatment using the same cell lines, reflects significant concentration dependence 
(Figure 7.3.8b). Significant differences are observed in the behaviour of the two 
systems, free CUR being considerably more toxic than CUR/PEDOT NPs. More 
specifically, for PC3 the half-maximal inhibitory concentration (IC50) of the former and 
the latter is around 20 and 100 µg/mL, respectively, while for MCF-7 both are around 10 
µg/mL. These results, combined with the fact that the drug loaded inside the NPs is only 
partially released in absence of external stimuli, corroborate that PEDOT nanostructures 
formed by emulsion polymerization is a very interesting electroactive vehicle for the 
controlled delivery of neutral drugs having groups able to interact with hydrogen bonds. 
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 In order to explore the mechanisms of cytotoxicity, the cellular uptake of free CUR 
and CUR/PEDOT NPs on PC3 and MCF-7 cells was observed by fluorescence 
microscopy. Figure 7.3.9  shows the images of non-treated cells, PEDOT NPs treated, 
free CUR treated and CUR/PEDOT treated for 24 h. Medium without treatment drug was 
regarded as control, as well as, the PEDOT NPs treated group. Both groups did not 
present any fluorescence at any point and there was not any diminish in cell nucleus 
Figure 7.3.8  (a) Cytotoxicity studies of PEDOT NPs and DBSA on PC3 and MCF-7 cells for 24 
h. Although they are represented in the same graphic, assays with PEDOT NPs and DBSA were 
performed independently. (b) Cytotoxicity evaluation of CUR and CUR/PEDOT NPs on PC3 and 
MCF-7 cells for 24 h. Values are the mean of 3 samples and bars indicate their standard 
deviation. Greek letters on the columns/points refer to significant differences when the 2-way 
ANOVA and Tukey's multiple comparisons test are applied: α, δ, β indicate significant 
differences observed within the specific concentration group with p-values lower than 0.05, 




number. In contrast, an intense fluorescence was observed at the cell cytosol after 24 h 
for free CUR and CUR/PEDOT NPs. In addition, the two groups exhibited lower number 
of cell nuclei than before the treatment had been executed. Besides, different cellular 
morphologies were observed: cells treated with free CUR presented more rounded 
bodies, denoted by high circularity (Figure 7.3.9c), than cells treated with 
CUR/PEDOT. These results suggest that cells were more affected by free CUR than when 
Figure 7.3.9  (a) High magnification fluorescent images of PC3 and MCF-7 cells incubated 
with nothing (control), PEDOT NPs, CUR and CUR/PEDOT NPs for 24 h. Scale bars represent 
40 µm. (b) Low magnification cell images of PC3 and MCF-7 incubated with CUR/PEDOT NPs 
for 24 h. Scale bars represent 100 µm. For each panel, the images from left to right showed cell 
nuclei stained by Hoechst (blue), CUR fluorescence (green) and overlays of both images. (c) Cell 
circularity assessed by ImageJ software. β indicates significant differences with a p-value lower 
than 0.0001 when a t-test is performed. 
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it is encapsulated within the PEDOT NPs, again indicating that the complete effect of the 
drug would not be achieved until it is stimulated. 
Overall, results obtained in this paper indicate that CUR/PEDOT NPs can be 
considered as potential controlled release systems for therapeutic applications based on 
the anti-bacterial, anti-viral, anti-protozoal, anti-inflammatory or anti-cancer activity of 
CUR. This system allows a given dosage at desired periodical time by applying a harmless 
external voltage of only -1.25 V (i.e. from a conventional small battery). Moreover, after 
its optimization to reduce a little bit more the required voltage, one could envision 
advanced biomedical applications of the CUR/PEDOT NPs system using the weak 
electric fields naturally occurring in the body for stimulation (e.g. the intrinsic electric 
fields of cardiovascular and neuronal tissues).  
 
7.3.3 Conclusions 
Encapsulation of CUR and PIP in PEDOT NPs was achieved by in situ emulsion 
polymerization using DBSA as stabilizer and doping agent. The release behaviour of 
these two neutral drugs, which only differ in their capacity to form hydrogen bonding 
interactions with the oxidized polymer chains, was very different in absence and in 
presence of external electrostimulation. The release of CUR is controlled through the 
strength of such specific drug···ICP interactions, which become weaker when polymer 
chains are reduced applying an external negative voltage. Therefore, CUR/PEDOT NPs 
are a promising combination that efficiently controls the release of the drug through 
external stimuli. This methodology, which can be extrapolated to other neutral drugs 
with similar hydrogen bonding abilities, may be a potential strategy for treatments based 
on the programmed dosage of CUR that, among many other medicinal properties, have 
demonstrated efficacy as anticancer agent for many types of malignancies, including 





7.4 Smart drug delivery from electrospun fibers through 
electro-responsive polymeric nanoparticles  
Smart electrosensitive drug delivery systems have attracted much attention in recent 
years because the drug release rate can be easily controlled simply by modulating the 
electric field. Different approaches have been developed to confer response to 
electrostimulation and tune the drug release. For example, biocompatible 
electroconductive hydrogels have been designed to mimic the redox switching and 
electrical properties of intinsically conducting polymers (ICPs), facilitating the drug 
release.4,74-76 Besides, hydrogels made of polyelectrolyte networks have been used in 
combination with electric fields to produce a force on counterions and immobile charged 
groups in the network and attract mobile ions, facilitating drug release through local 
swelling and shrinking of the hydrogel.77,78  
A very different approach is based on the use of electrosensitive nanoparticles (NPs) 
for drug release. Within this context, recent studies have shown that some NPs made of 
ICPs exhibit successful response as electrically controllable drug delivery systems. Ge et 
al.16 controlled the release of therapeutic pharmaceuticals loaded into polypyrrole (PPy) 
NPs through the application of a weak external direct current electric field. Willner and 
coworkers79 introduced imprinted bis-aniline-cross-linked gold NPs as electro-triggered 
sponges for the uptake and release of -acceptor species. In 2017, Hosseini-Nassab et 
al.17 showed that insulin can be released from PPy NPs by electrostimulation. In a very 
recent work80 we used poly(3,4-ethylenedioxythiophene) (PEDOT in Figure 7.4.1a), 
which is a noncytotoxic and biocompatible ICP,34,81 to synthesize NPs loaded with 
curcumin (CUR in Figure 7.4.1a), a drug with antibacterial, antiviral, antifungal and 
anticancer activities,45,46,88,48 by in situ emulsion polymerization. PEDOT exhibits 
important advantages with respect to other ICPs, as for example PPy, because of its great 
environmental stability, electrical conductivity, electrochemical activity, thermoelectric 
behavior and high specific capacitance.32,83,35 Application of a selected voltage to loaded 
PEDOT NPs resulted in an electrically triggered CUR release, evidencing that this system 
is very promising for treatments based on the programmed dosage of CUR.80  
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Although NPs offer important advantages (e.g. facilitate the loading of therapeutic 
agents and increase their stability),84 some limitations that are in detriment of their use 
as nanocarriers are also frequently found. The most important one is related with their 
tendency to aggregate in physiological environment, thus causing loss of basic NP 
characteristics and properties.85 Accumulation by agglomeration often makes difficult 
the release of the drug, even in presence of external stimulus. A strategy to prevent this 
undesired effect could be the dispersion of NPs into electrospun microfibers (MFs). 
Thus, electrospinning has been recognized as a simple and versatile method for the 
fabrication of polymer MF mats, which can act not only supporting the dispersed NPs but 
also enhancing the biocompatibility of the whole system if the appropriated polymer is 
chosen.86-88 Unfortunately, keeping the drug inside already loaded NPs during the 
electrospinning process is a very difficult task, since the operational potential is very high 
and the drug is easily extracted from the NPs during the processing step. Accordingly, the 
drug and the NPs should be loaded separately in electrospun MFs.  
In this work we have designed and prepared by electrospinning a new electrosensitive 
bioplatform that combines CUR, PEDOT NPs and poly(-caprolactone) (PCL in Figure 
7.4.1a). The latter aliphatic polyester has attracted an increasing interest in recent 
decades due to its biodegradability and suitability for tissue engineering applications.89-93 
For biomedical applications, PCL has been approved for use by the USA Food and Drug 
Administration (FDA) since the seventies and can be found in many common sutures 
and suture components. PCL, like other members of this family of polymers, such as 
poly(L-lactide) and poly(lactide-co-glycolide), undergoes auto-catalyzed bulk hydrolysis, 
even though due to its semicrystalline nature the total loss of mass extends over two 
years. On the other hand, ICPs, such as PPy and polythiophene derivatives, behave as 
linear actuators. The actuation principle of ICP films is based on the motion of ions in 
and out of the film during oxidation and reduction, respectively, which cause expansion 
and contraction movements.94,95 Moreover, longitudinal expansion and contraction have 
been identified for ICP MFs in aqueous electrolytic solutions, proving their ability to 
transform electrochemical energy into linear mechanical energy.96,97 The electrosensitive 




mentioned principles. More specifically, the release of CUR from PCL MFs has been 




Materials. 3,4-Ethylenedioxythiophene (EDOT) monomer, sodium dodecylbenzene 
sulfonate (DBSA), ammonium persulfate (APS) and CUR were purchased from Sigma 
(USA).  
Electrospinning: Mixtures of [PCL, PEDOT NPs and CUR], [PCL and PEDOT] and of 
[PCL and CUR] were electrospun, samples being named PCL/PEDOT/CUR, 
PCL/PEDOT and PCL/CUR. Mixtures were prepared as follows. PCL (5.5 g) was 
dissolved in 32 mL of a mixture of chloroform and acetone 2:1 (v/v). The solutions were 
kept in 37 ºC for 24 h under stirring at 100 rpm. PEDOT NPs (10 mg/mL) and CUR (1.04 
mg/mL) were and dispersed and dissolved, respectively, in 0.5 mL of ethanol (EtOH). 
Finally, 0.2 mL of PEDOT NPs, CUR or PEDOT NPS and CUR solutions were mixed with 
1.8 mL of PCL solution and loaded in a 5 mL BD plastic syringe for delivery through an 
18G  1.1/2’’ needle at a mass-flow rate of 10 mL/h using a KDS100 infusion pump. The 
content of PCL, PEDOT NPs and CUR in the optimized electrospinning mixtures, unless 
other conditions are explicitly specified, was: (i) 15.45% (w/v) of PCL, 0.6 wt% of PEDOT 
NPs and 0.06 wt% CUR for PCL/PEDOT/CUR MFs; (ii) 15.45% (w/v) of PCL and 0.6 
wt% of PEDOT for PCL/PEDOT MFs; (iii) and 15.45% (w/v) of PCL and 0.06 wt% of 
CUR for PCL/CUR MFs. As a control, fibers of pure PCL were produced using a 17.18% 
(w/v) concentration of polymer in 2:1 chloroform:acetone. It should be mentioned the 
choice of the processing conditions (i.e. distance between the syringe tip and the 
collector, voltage and the flow rate) were selected on the basis of preliminary 
experiments devoted to optimize the morphology of the MFs. Thus, appropriate selection 
of the processing conditions is required to avoid the formation of droplets and 
electrospun beads. Specifically, electronspun MFs discussed in the work were obtained 
by applying a voltage was 15 kV and using a needle tip-collector distance of 15 cm. 
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Dynamic light scattering (DLS): studies on PEDOT NPs were performed using 
NanoBrook Omni Zeta Potential Analyzer from Brookheaven Instruments. Measurement 
consisted of 3 runs each of 60 s duration, which were averaged to obtain the effective 
diameter. Samples were analyzed at 25 ºC using a scattering angle of 90º.  
Fourier-transform infrared (FTIR): transmittance spectra of PEDOT NPs were 
recorded on a FTIR Jasco 4100 spectrophotometer. Pellets were deposited on an 
attenuated total reflection accessory (Top-plate) with a diamond crystal (Specac model 
MKII Golden Gate Heated Single Reflection Diamond ATR). For each sample 32 scans 
were performed between 4000 and 600 cm-1 with a resolution of 4 cm-1.  
Micro-Raman spectroscopy: using a commercial Renishaw inVia Qontor confocal 
Raman microscope. The Raman setup consisted of a laser (at 785 nm with a nominal 300 
mW output power) directed through a microscope (specially adapted Leica DM2700 M 
microscope) to the sample, after which the scattered light is collected and directed to a 
spectrometer with a 1200 lines·mm−1 grating. The exposure time was 10 s, the laser 
power was adjusted to 0.001-0.05% of its nominal output power depending on the 
sample, and each spectrum was collected with five accumulations.  
UV-vis spectra: were carried out in a UV-vis-NIR Shimadzu 3600 spectrophotometer 
equipped with a tungsten halogen visible source, a deuterium arc UV source, a 
photomultiplier tube UV-vis detector, and an InGaAs photodiode and cooled PbS 
photocell NIR detectors. Spectra were recorded in the absorbance mode using the 
integrating sphere accessory (model ISR-3100), the range wavelength being 250-850 
nm. The interior of the integrating sphere was coated with a highly diffuse BaSO4 
reflectance standard. Measurements, data collection and data evaluation were controlled 
by the computer software UVProbe version 2.31.  
Scanning electron microscopy (SEM): micrographs were obtained using a Focused 
Ion Beam Zeiss Neon 40 scanning electron microscope operating at 5 kV. Samples were 
mounted on a double-side adhesive carbon disc and sputter-coated with a thin layer of 




MFs and of the PEDOT NPs located at the surface of MFs was determined from the SEM 
images using the software SmartTIFF (v1.0.1.2.), and data was fitted to a normal curve 
(OrginPro 8 SR0, v8.0724).  
Atomic force microscopy (AFM): studies were conducted to obtain topographic 
images of the nanoparticles surface using silicon TAP 150-G probe (Budget Sensors, 
Bulgaria) with a frequency of 150 kHz and a force constant of 5 N/m. Images were 
obtained with a Molecular Imaging PicoSPM microscope using a NanoScope IV 
controller under ambient conditions in tapping mode. AFM measurements were 
performed on various parts of the samples, which produced reproducible images similar 
to those displayed in this work.  
Electrochemical response: fiber mats were evaluated by cyclic voltammetry (CV) 
using PGSTAT204 AUTOLAB potentiostat–galvanostat connected to a PC computer 
controlled through the NOVA 1.6 software using a custom made 2 ml cell. Commercial 
polymer-modified ITO substrates with the effective electrode area of 0.23 cm2 were used 
as working electrodes, together with an AgAgCl 3 M KCl reference electrode and a Pt-
wire counter electrode. Electrochemical characterizations were performed in the 
presence of Fe(CN) (10 mM) and KCl (100 mM). Measurements were realized at room 
temperature and the scan rate was set to 100 mV/s. The potential range was chosen as 
between −0.80 V (initial and final potential) and +1.00 V (reversal potential) vs. 
Ag/AgCl.  
Contact angle (CA) measurements: were carried out using the sessile drop method 
at room temperature on an OCA 15EC with SCA20 software (Data-Physics Instruments 
GmbH, Filderstadt, Germany). The solvent used for these experiments was deionized 
water, the contact angle being determined for the first drop. For measurements, the 
sessile drop was gently put on the surface of samples using a micrometric syringe with a 
proper metallic needle (Hamilton 500 μL). The ellipse method was used to fit a 
mathematical function to the measured drop contour. This procedure consists on 
approximate the drop contour to the line of an ellipse, deviations from the true drop 
shape being in the range of a few percent. The ellipse method provides accurate measure 
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of the contact angle and holds the advantage that it is extremely fast. For each sample, no 
less than fifteen drops were examined.  
3D cell culture: MCF-7 cells were used in all experiments. MF mats (1.2 cm in diameter 
and 1 mm in high) were sterilized with an UV lamp for 30 min at both sides and attached 
with non-toxic silicon to the flat bottom of the wells in a 24-well/plate. Cells were seeded 
at a density of 40000 cells/mL in Advanced DMEM (supplemented with 5% FBS, 1% 
penicillin/streptomycin and 4 mM L-glutamine), particularly 500 µL per well and 
incubated overnight at 37 °C and 5% of CO2. After one day, cells were washed gently with 
phosphate buffered saline (PBS) solution and adhesion was evaluated by MTT [3-(4,5- 
dimethylthiazol-2-yl)-2,5-diphe-nyltetra-zolium] which was performed according to 
manufacturer instructions. Cell proliferation was evaluated using same methodology but 
during 7 days. Assays were repeated two times independently and with n=4.  
Cell morphology by confocal microscopy: Cells were fixed and stained for nucleus 
and Factin on days 1 and 7. Particularly, after the desired time, cells were washed with 
PBS 1 and fixed with 2.5 % paraformaldehyde in PBS for 40 min at room temperature. 
After this, samples were washed 3 times 5 min each with PBS 1 and permeabilized with 
0.05% (w/v) triton X-100 in PBS 1 for 20 min under agitation. Subsequently, unspecific 
sites were blocked with a solution containing 1% BSA, 22.52 mg/mL glycine and Tween-
20 0.1 % in S 8 PBS 1 for 30 min. F-actin filaments were stained with phalloidin atto-
488 (Stock solution 10 nmol/500 uL methanol) used with a 1/50 dilution in PBS 1 for 1 
hour at room temperature under agitation. Again, samples were washed 3 times 5 min 
each with PBS 1. Finally cell nucleus was stained with bis-benzimide H33258 (stock 
solution 2 mM) employed at 1/100 dilution in PBS 1 during 30 min under soft constant 
agitation and mounted on the glass slides. Samples were protected from light and kept at 
4ºC before use. Imaging was performed using an Axio Observer Z1 fluorescence 
microscope (Carl Zeiss) confocal laser scanning microscope with a 10 and 40 
objectives. Morphology studies were performed with ImageJ software.  
Release studies: Mats of electrospun MFs (20 mg) were deposited on 40 mL tubes 




saline (PBS, pH 7.4) supplemented with 70 v/v% of ethanol (PBS-EtOH), were added. 
Tubes were maintained at 37º under agitation (100 rpm). At selected time intervals, 1 mL 
of each tube was extracted and deposited into an Eppendorf in order to be quantified 
afterwards. Subsequently, each tube was supplemented with 1 mL of the liberation 
medium, PBSEtOH 70%, to keep the volume. At the end of the studied liberation process, 
matrixes were dried in an oven at 37º overnight and placed in an Eppendorf. 100 µL of 
CHCl3 were added to dissolve the polymer and 1.2 mL of PBS-EtOH 70% was added to 
precipitate the polymer and allow the drug to be retained in the ethanol containing 
phase. Finally, Eppendorf were centrifuged at 10000 rpm during 3 min and the 
supernatant absorbance was read at 450 nm. 1V; 60 s. 
Electrically stimulated drug release: Experiments were performed using steel AISI 
316 sheets covered with the corresponding mats of electrospun MFs. Pulses were applied 
using a three-electrode compartment cell at room temperature. Steel AISI 316 sheets 
were used as working electrodes and platinum as counter electrode. The reference 
electrode was an Ag|AgCl electrode containing a KCl saturated aqueous solution. The cell 
was used with 10 mL of electrolyte media, which consisted in PBS (pH 7.4) supplemented 
with 0.05% Tween 20. After preliminary studies devoted to explore the effect of potential 
and duration of the pulses, the CUR-release was investigated considering 1, 3 and 5 
pulses of 1.0 V (each pulse lasts 60 s) with a time lapse of 5 s in between. After the 
sequence of pulses, 1 mL of the electrolyte solution was withdrawn and replaced for 1mL 
of new electrolyte solution. After recovering the different samples the absorbance was 
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7.4.2 Results and discussion 
Preparation and spectroscopic characterization 
The synthesis of the PEDOT NPs was conducted in water mixed with EtOH (10%) at 
40 ºC using 3,4-ethylenedioxythiophene (EDOT) monomer, sodium dodecylbenzene 
sulfonate (DBSA) as stabilizer and doping agent simultaneously, and ammonium 
persulfate (APS) as oxidizing agent. A schematic representation of the synthetic process 
is provided in Figure 7.4.1.  
Figure 7.4.2a shows a micrograph of the resulting PEDOT NPs, which exhibited an 
effective diameter of 99  21 and 157  1 nm as determined by SEM and DLS (Figure 
7.4.1c), respectively. The FTIR spectrum of PEDOT NPs doped with DBSA is displayed 
in Figure 7.4.1d. The main absorption peaks from the thiophene, ether, and sulfonate 
groups corresponded to: stretching modes of C=C in the thiophene ring at 1647 and 1557 
Figure 7.4.1  (a) Chemical structures of PEDOT, CUR and PCL. (b) Schematic representation 
of the chemical process used to prepare PEDOT NPs. (c) Effective diameter (Deff) of PEDOT NPs 
derived from dynamic light scattering. The graph is expressed in intensity vs diameter. (d) FTIR 
spectra of PEDOT NPs doped with DBSA. The main absorption peaks from the thiophene, ether, 
and sulfonate groups correspond to: stretching modes of C=C in the thiophene ring at 1647 and 
1557 cm-1, CH2 stretching modes at 1478, 1396, and 750 cm-1, C–O–C vibrations at 1206 and 






cm-1, CH2 stretching modes at 1478, 1396, and 750 cm-1, C–O–C vibrations at 1206 and 
1057 cm-1, and the S–O stretch at 667 cm-1.  
Appropriate mixtures of PCL dissolved in 2:1 chloroform:acetone, PEDOT NPs 
dispersed in EtOH and/or CUR dissolved in EtOH were chosen for the electrospinning 
process. PCL/PEDOT/CUR, PCL/PEDOT and PCL/CUR were obtained using 
PCL:PEDOT NPs:CUR, PCL:PEDOT NPs and PCL:CUR mixtures as feeding solutions in 
the electrospinning process, while PCL MFs were directly derived from the polymer 
solution. Because of the characteristics of the electrospinning technique,86-88 the amount 
of CUR and/or PEDOT NPs used in the feeding solution is completely incorporated to 
the PCL-based system. The processing conditions and concentrations, which are 
Figure 7.4.2 (a) SEM micrograph of PEDOT NPs. Inset: effective diameter histogram derived 
from SEM measurements. (b) Optical micrographs of electrospun MFs (scale bar: 50 m). (c) 
Raman and (d) UV-vis spectra of the investigated systems. 
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described in the materials section, were selected to avoid the formation of droplets and 
electrospun beads in the prepared fiber networks. After preparation, they have been 
initially characterized by optical microscopy in order to check the general quality of the 
MFs, and by micro-Raman and UV-vis spectroscopies to confirm the successful 
incorporation of the different components. Subsequently, fiber networks are 
characterized by means of SEM and AFM.  
Figure 7.4.2b displays optical images taken with the Raman confocal microscope of 
PCL/PEDOT/CUR, PCL/PEDOT, PCL/CUR and PCL electrospun MFs obtained using 
optimized processing conditions. In all cases continuous well-defined fibers of 
homogeneous size were apparently achieved, independently of the loading of PEDOT 
NPs and/or CUR. Raman and UV-vis spectra of all MFs, as well as of PEDOT NPs and 
CUR, are compared in Figures 7.4.2c and d, respectively.  
The main vibrational modes of undoped PEDOT are typically located at 1490 cm-1, 
1424 cm-1, 1371 cm-1 and 1261 cm-1,98-100 which correspond to asymmetric Cα=Cβ 
stretching, symmetric Cα=Cβ stretching, Cβ=Cβ stretching and Cα–Cα’ inter-ring stretching 
vibrations, respectively. However, the spectrum displayed in Figure 7.4.2c shows the 
appearance and disappearance of several such bands, indicating that PEDOT NPs are p-
doped.101 Specifically, the most important changes with respect to undoped PEDOT are: 
 The peak that should be centered at 1424 cm-1 experiences a blue shift towards 1444 
cm-1, indicating that the Cα=Cβ stretching vibration mode is sensitive to the p-doping. 
 The band that should appear at 1261 cm-1 splits into two peaks at 1245 and 1268 cm-1 
due the presence of DBSA. This change, which is connected with the conversion from the 
benzoid to the quinoid structure, has been attributed to the variation of C–C’ and 
Cβ=Cβ' to C=C’ and Cβ–Cβ’, respectively. This conversion in the electronic structure is in 
agreement with the interpretation of the changes in the peak at 1424 cm-1. 
 The intensity of the peak at 1490 cm-1 is very low, has been also attributed to a 
reduction of the double bond character in the Cα=Cβ stretching due to the benzoid-to-
quinoid conversion. 
The Raman spectrum of CUR, which is consistent with the keto-enol tautomeric form 




associated with the C–OH, C=C and C=O and C=C stretching vibrations, 
respectively.102,103 According to Kotula et al.,104 the 850 cm.1 to 950 cm-1 region of the PCL 
MFs spectrum corresponds to primarily C–COO stretches, while the one comprised 
between 1030 cm-1 and 1110 cm-1 is assigned to C–C and C–O stretching region. Other 
characteristics peaks of PCL are identified at 1723 cm-1 for the C=O stretching, 1304 cm-1 
for the CH2 twist, and 1441 cm-1 for CH2 bend. Inspection of the spectra recorded for 
PCL/PEDOT/CUR, PCL/PEDOT and PCL/CUR MFs confirm the presence of the 
different components, even though the high intensity of the p-doped PEDOT signals 
mask the PCL and CUR peaks in the corresponding mixtures. 
UV-vis absorption spectrum of PEDOT (Figure 7.4.2d) shows a high dopant 
transition response in the region from 550 nm to 800 nm, which is related with 
bipolaronic states.105, 106 This absorption band is preserved in the UV-vis spectra of 
PCL/PEDOT and PCL/PEDOT/CUR MFs, evidencing that the p-doped state of the CP is 
not altered by the electrospinning process. Besides, UV-vis of CUR shows the absorption 
maximum at wavelength 424 nm, which is clearly identified in PCL/CUR and 
PCL/PEDOT/CUR MFs. This maximum is due to the electronic dipole allowed π – π* 
type excitation of its extended conjugation system, as reported by Kim et al.107  
 
Surface characterization 
Figure 7.4.3 shows representative low (inset) and high magnification SEM 
micrographs, the diameter distribution as determined by SEM, and AFM images of the 
prepared MFs. Unloaded PCL mats consisted of well-defined MFs with a Deff of 3.7±0.8 
µm, even though small beads not detectable by optical microscopy were observed in 
some cases (marked with light blue circles in Figure 7.4.3a). However, the most 
important characteristic of PCL MFs corresponds to their relatively smooth and 
homogeneous surface with a root-mean-square roughness (Rq) of 73±11 nm only. 
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The loading of CUR into PCL MFs caused the complete disappearance of defects 
(Figure 7.4.3b), which suggest the formation of attractive PCL···CUR interactions in the 
feeding solution. Deff and Rq apparently increase when fibers are loaded with PEDOT NPs 
(Figure 7.4.3c). This has been attributed to the lack of attractive PCL···PEDOT 
interactions.  
Figure 7.4.3 Low (inset) and high magnification SEM micrographs (left), effective 
diameter (Deff) histogram derived from SEM measurements (center) and AFM image 
(right) of (a) PCL, (b) PCL/CUR, (c) PCL/PEDOT and (d) PCL/PEDOT/CUR 
electrospun MFs. The average value of Deff, the root mean square roughness (Rq) and 
widow size of the AFM image are also displayed. The presence of small beads in (a) is 
highlighted with light blue circles, while PEDOT NPs at the surface of the fibers in (c) 




This feature is corroborated by the presence of a few spherical PEDOT NPs at the 
surface of the fibers (marked with red circles in Figure 7.4.3c), which reflects the 
complete separation between the PCL matrix and the PEDOT NPs. It is worth noting that 
these NPs cannot be attributed to fracture debris since PCL MFs are very flexible and 
difficult to break and, in addition, NPs are regular in shape and size.  
In order to provide deeper understanding about the disconnected organization of 
PEDOT NPs from the whole PCL matrix, high magnification AFM images of PCL/PEDOT 
MFs are displayed in Figure 7.4.4a. Although both topographic and height images 
support the presence of individual PEDOT NPs distributed at the surface of PCL fibers, 
the colored topographic with the phase image skin confirms unequivocally such feature. 
AFM phase imaging registers phase signal shifts due to changes in the adhesion force 
between the tip and the surface, thus being sensitive to the surface mechanical and 
viscoelastic properties (i.e. stiffness-softness). Accordingly, the information provided by 
this technique is frequently used to examine the organization of the components in 
polymer composites. Hence, Figure 7.4.4a illustrates how the PEDOT NP, which is 
clearly distinguished by the dark purple domain, remains adhered to the surface of the 
PCL fiber. Cross sectional profile of the NPs, also included in Figure 7.4.4a, indicates 
that their diameter is around 125 nm, which is in excellent agreement with DLS 
estimations. PEDOT NPs were expected to be also inside the PCL/PEDOT fibers, SEM 
micrographs over the cross section being performed to corroborate such assumption. 
Unfortunately, the cryo-fracture method was not useful for PCL-based fibers because of 
their high flexibility. Accordingly, the conventional mechanical fracture method, which 
probably caused the detachment of the PEDOT/NPs located inside the PCL matrix 
because of the poor affinity between both polymers, was used to cut the fibers and 
observe the cross sections. Due to these difficulties only a few NPs observed in 
PCL/PEDOT cross sections were ascribed to internal regions (Figure 7.4.4b). In spite 
of this, SEM micrographs achieved after electrostimulation of PCL/PEDOT/CUR MFs 
demonstrated the remarkable accumulation of PEDOT NPs inside the fibers (showed and 
discussed below).  
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Figure 7.4.4 (a) Representative high magnification topographic (left, top), height (right, top) 
and colored phase (left, bottom) AFM images of PCL/PEDOT MFs, supporting the presence of 
individual PEDOT NPs distributed at the surface of PCL fibers. Cross sectional profile of the 
PEDOT NP (right, bottom) at the region marked in the height image. (b) Cross section SEM 
images of PCL/PEDOT. Internally located PEDOT NP is illustrated by the red circle. (c) High 
magnification topographic AFM image of PCL/PEDOT/CUR. Widow size of the AFM images is 
displayed in (a) and (c). (d) CA () of water for polymer-modified ITO bare and coated with 
PCL, PCL/CUR, PCL/PEDOT and PCL/PEDOT/CUR fiber mats. Values correspond to the mean 





PCL/PEDOT/CUR MFs exhibit structural characteristics that are intermediate 
between those of PCL/PEDOT and PEDOT/CUR (Figure 7.4.3d). Specifically, both the 
Deff and Rq values are slightly higher (5% and 8%, respectively) than those PCL fibers, 
compensating the slight reduction and increase caused by the loading of CUR and 
PEDOT NPs, respectively. As it was expected, PCL/PEDOT/CUR MFs show PEDOT NPs 
individually segregated and distributed in the polyester matrix (red circles in SEM 
micrograph displayed in Figure 7.4.3d). Furthermore, representative high 
magnification AFM images, as that displayed in Figure 7.4.4c, evidence a surface 
topography with features that greatly resemble those obtained for PCL/PEDOT MFs 
(Figure 7.4.4a).  
CA () measurements were performed to examine the influence of the loading in the 
fibers wettability (Figure 7.4.4d). The hydrophobicity of PCL MFs decreases slightly 
upon loading of CUR (11º) or PEDOT NPs (7º). However, this reduction is higher when 
both, CUR and PEDOT NPs, are loaded simultaneously, the  being 15º lower for 
PCL/CUR/PEDOT than for PCL. This effect cannot be attributed to a change in the 
roughness, which is similar in both cases, but to synergistic interactions between CUR 
and PEDOT NPs.  
 
Electrochemical response  
The electrochemical ability of the prepared fibers was examined studying by CV the 
oxidation and reduction of K4[Fe(CN)6]. This is a redox inorganic compound that shows 
a reversible redox process on bare commercial polymer-modified ITO electrode (Figure 
7.4.5a), which served as the basic material. As the potential is scanned positively, the 
ferricianide experiences an oxidation process at 0.46 V:  
   Fe(CN)6
4− → Fe(CN)6
3− + e− (Eq. 7.4.1) 
while when the scan direction is switched the reduction is detected at -0.08 V: 
   Fe(CN)6
3− + e− → Fe(CN)6
4− (Eq. 7.4.2) 
Due to the insulating nature of the polyester, which is the main component of the 
fibers, CVs recorded using electrodes coated with PCL, PCL/CUR, PCL/PEDOT and 
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PCL/PEDOT/CUR MFs show a drastic reduction of the oxidation and reduction current 
densities (Figure 7.4.5b). However, the definition and intensity of the oxidation and 
reduction peaks increases as follows: PCL < PCL/CUR << PCL/PEDOT  
PCL/PEDOT/CUR, evidencing that the loading with the ICP considerably improves the 
electrochemical response. This indicates that the conductivity and the surface 
PCL/PEDOT and PCL/PEDOT/CUR are suited to guarantee electrochemical response. It 
Figure 7.4.5 CVs registered within the potential range of –0.80 to +1 V at a scan rate of 100 
mV/s using a K4[Fe(CN)6] solution for (a) commercial polymer-modified ITO electrodes and (b) 
commercial polymer-modified ITO electrodes coated with PCL, PCL/CUR, PCL/PEDOT and 
PCL/PEDOT/CUR fiber mats. (c) Peak separation (Ep, in V) and (d) formal potential (Ef, in V) 
for commercial polymer-modified ITO bare and coated with PCL, PCL/CUR, PCL/PEDOT and 
PCL/PEDOT/CUR fiber mats. In (c) and (d) values correspond to the mean while error bars 















































































































should be noted that the voltammograms of PCL/CUR and PCL/PEDOT/CUR are 
partially masked by CUR, a phenolic compound that also experiences redox behaviour.65 
This explains the apparition of shoulders at both the oxidation and reduction scans (i.e. 
at a potential higher than the oxidation peak of Fe(CN)6
4− and at a potential lower that the 
reduction peak of Fe(CN)6
3−, respectively) of voltammograms recorded for 
PCL/PEDOT/CUR.  
Figure 7.4.5c represents the peak separation (i.e. the difference between the 
oxidation and reduction potentials) for bare and coated electrodes. The peak separation 
is lower for PCL/PEDOT than for the bare ITO electrode, indicating that PEDOT NPs 
promote faster electron transfer. In the case of PCL/PEDOT/CUR this effect is 
compensated by the drug (i.e. CUR has a delaying effect in electron transfer, as is 
reflected by the peak separation of PCL/CUR). Consequently, the peak separation is 
higher for PCL/PEDOT/CUR than for PCL/PEDOT, evidencing the crucial role of 
PEDOT NPs in the reduction of the resistance. Regarding to the formal potential, which 
corresponds to the average of oxidation and reduction potential (Figure 7.4.5d), 
differences are relatively small, even though PCL/PEDOT/CUR provides the closer value 
to bare ITO. Overall, results displayed in Figure 7.4.5a-d allow concluding that 
PCL/PEDOT/CUR networks provide a suitable interface for electrochemical response. 
 
Cell cultures 
PCL is one of the most important biomaterials for the manufacture of longer-term 
degradable platforms for biomedical applications (e.g. tissue regeneration, drug-delivery, 
and wound healing).89 This must be attributed to its non-toxic behaviour, slow 
degradation rate, inexpensive production cost, easiness to be processed and 
manipulated, and USA FDA-approval.89 However, an important drawback of implantable 
PCL-based bioplatforms for drug-delivery is their high hydrophobicity (Figure 7.4.4d), 
which severely affects the release behavior. Thus, after the first burst of drug release, 
which mainly involves the drug loaded on the surface, the release rate decreases very 
rapidly, or even completely, making difficult to reach the therapeutic window after 
implantation.108 Therefore, the fact of containing PEDOT NPs permits a more controlled 
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release like in the previous work where the drug was encapsulated within the PEDOT 
NPs but here is in a supported interface where the NPs are dispersed and there is no 
agglomeration. Clearly, the control and, consequently, the design of cell instructive 
materials (e.g. for smart regulation of drug dosing) are expect to attain much 
applicability in the future fight against cancer. 
Before examining the CUR release without and with electrostimulation, in this 
section we examine how PEDOT NPs affect the cytotoxicity of the PCL matrix and the 
biological function of the drug. MCF-7, a human epithelial breast cancer cell line, was 
used for cell adhesion and proliferation studies, which were conducted on mats of PCL, 
PCL/PEDOT, PCL/CUR and PCL/PEDOT/CUR mats. For this purpose, the cell viability 
was evaluated by the MTT method after 24 h (cell adhesion) and 7 days (cell 
proliferation) of incubation. Collected MFs, which were arranged randomly, resembled 
the topography of the extracellular matrix. Figure 7.4.6a shows that MCF-7 cells 
adhered similarly on the different materials, including the aluminum sheets used as 
control. Instead, after 7 days the cell growth decreased significantly for PCL/CUR MFs 
(Figure 7.4.6b). This observation suggests not only that CUR molecules escape from 
PCL fibers by diffusion but also that the anticancer activity of CUR is still effective after 
the electrospinning process, slowing down cancer cell proliferation. In contrast, the 
presence of PEDOT NPs enhances the cellular proliferation (Figure 7.4.6b), which is 
consistent with the well-known biocompatibility of this ICP.34,81 Indeed, the highest cell 
proliferation was obtained for PCL/PEDOT/CUR, despite the presence of CUR. This 
feature is consistent with the possibility to achieve a control on drug dosage with 
electrical stimuli without having much CUR leaking from such MFs. 
The influence of PCL, CUR and PEDOT NPs on the cell morphology (i.e. cell 
circularity and area) and spreading was quantitatively evaluated after 24 hours and 7 
days. MCF-7 cell nucleus and F-actin were stained with Hoechst and Phalloidin Atto-
488, respectively. Confocal microscopy micrographs displayed in Figure 7.4.6c indicate 
that the amount of cells visualized on the top surface of the 3D scaffolds is lower than on 
the 2D aluminum sheet used as control substrate. This feature was an indicator that cells 
penetrated inside the MFs-containing matrices, as is schematically depicted in Figure 





Figure 7.4.6 MTT evaluation of MCF-7 cultured on 3D MFs scaffolds for (a) 24 hours and (b) 7 
days. Values are the mean and bars indicate their standard deviation (i.e. assays were repeated 
two times independently and with n=4). Greek letter refers to significant differences when one-
way ANOVA and multiple comparison test is applied, p-value is lower than 0.05. (c) Confocal 
microscopy micrographs displaying the morphology of cells adhered (24 hours) and proliferated 
(7 days) onto 3D MFs matrices. Cells were stained for the nucleus in blue (Hoechst) and F-actin 
in green (Phalloidin Atto 488). Scale bar = 100 μm. Different zones magnification remarked in 
red. In all cases (a-c) aluminum sheets were used as control substrate. 
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planes within the intertwined fibers matrices, as is illustrated in Figure 7.4.7b for PCL 
MFs. Cells seeded on PCL/CUR formed clusters after 7 days and adopted a rounded 
morphology. However, the cell area was approximately three times smaller for PCL/CUR 
than the other 3D matrixes (planes within the intertwined fibers matrices, as is 
illustrated in Figure 7.4.7c for PCL MFs), while cell circularity increased by 15-38% 
(planes within the intertwined fibers matrices, as is illustrated in Figure 7.4.7d for PCL 
MFs). This finding reinforces the usefulness of CUR as an anticancer agent. Although 
after 24 hours cells seeded on all 3D-scaffolds showed an elongated appearance in the 
fiber direction, after 7 days mostly in the PCL/PEDOT and PCL/PEDOT/CUR MFs cells 
displayed a higher degree of spreading (i.e. non-aligned with the fiber orientation) and 
cell area was significantly higher. Comparison of the quantitative results displayed in 
planes within the intertwined fibers matrices, as is illustrated in Figures 7.4.7c and d 
Figure 7.4.7 (a) Scheme representing cells seeded on a 3D scaffold. (b) High magnification 
fluorescence microscopy images of MCF-7 cells incubated on PCL MFs for 24 hours. Cells found 
on different planes are marked with red arrows. (c) Cell area quantification (d) and cell 
circularity after 24 hours and 7 days. Values correspond to the mean, while error bars indicate 





for PCL MFs with those shown in Figure 7.4.3 evidences that, more heterogeneity and 
roughness on the fiber surface, more spreading and less circularity and, therefore, more 
similarity with native ECM.  
Overall, these results suggest that PCL-based scaffolds containing PEDOT NPs could 
be of great interest for tissue implantation if electrical stimuli for regulated release are 
possible. Next sections are focused in this objective.  
 
Non-stimulated release  
Quantitative release assays in a simple physiological-like medium were performed 
with PCL/CUR and PCL/PEDOT/CUR (Figure 7.4.8). PBS-EtOH, which consisted in 
phosphate buffer saline (PBS, pH 7.4) supplemented with 70 v/v% of EtOH, was 
considered as release medium. It should be noted that the physical characteristics in a 
place of the body (e.g. pH and hydrophilicity/hydrophobicity ratio) depends on the 
location. The addition of EtOH to PBS is frequently used to increase the hydrophobicity 
of the release medium when hydrophobic drugs are delivered.109,110 Considering that 
CUR is a very hydrophobic drug, the PBS-EtOH medium employed in this work tries to 
mimic the hydrophobicity of lipid-and liposomes-rich environments. Furthermore, the 
addition of EtOH to hydrophilic PBS causes some swelling in polyester matrices,111,112 
which is expected to accelerate the release of hydrophobic drugs, as CUR. Thus, 
preliminary assays using pure water and PBS as release media evidenced that the release 
of hydrophobic CUR is extremely low in hydrophilic media. Therefore, the PBS-EtOH 
medium, which mimics hydrophobic environments, was used to evaluate the release of 
CUR at reasonable time intervals.  
Results displayed in Figure 7.4.8a indicate a relatively slow release for PCL/CUR: 
33% ± 6% of the loaded drug was released after 24 h. This feature proves that CUR is 
mostly embedded into compact PCL fibers, makes difficult its diffusion for fast release to 
the medium. After 96 h the release is higher than 90%, even though a complete release 
was not achieved within such frame. Considering that drug diffusion is the only  
  




Figure 7.4.8 (a) CUR release profiles from PCL/CUR and PCL/PEDOT/CUR MFs in PBS-
EtOH. The release profile obtained from PCL/PEDOT/CUR MFs prepared with half of loaded 
drug is displayed to illustrate the dependence with the CUR concentration. Values correspond 
to the mean while error bars indicate the standard deviations (i.e. assays were repeated four 
times). (b) Scheme representing the diffusion mechanism followed by PCL/CUR and 
PCL/PEDOT/CUR to release CUR in absence of electro-stimulation. (c) CUR release from 
PCL/CUR and PCL/PEDOT/CUR MFs after electro-stimulate by applying 1, 3 and 5 consecutive 
potential pulses (the voltage and time-length of each pulse consisted of 1.00 V and 60 s, 
respectively, consecutive pulses being separated by 5 s). The release obtained from PCL/CUR 
and PCL/PEDOT/CUR MFs prepared reducing the concentration of loaded drug by a half. (d) 
Scheme representing the electro-actuation mechanism followed by PCL/PEDOT/CUR MFs to 
release CUR upon electro-stimulation. (e) SEM micrographs of PCL/PEDOT/CUR fibers after 
electrostimulation. The magnification of the micrographs increases from left to right. Inset at 






mechanism expected in this case (Figure 7.4.8b), the uncomplete release has been 
attributed to the formation of either drug clusters through CUR···CUR hydrogen bonds 
and - stacking interactions or CUR···PCL hydrogen bonds. In any case, the formed 
specific interactions are stable enough to retain such CUR molecules entrapped into the 
PCL matrix.  
Incorporation of the PEDOT NPs does not induce significant changes, the release 
profile obtained for PCL/PEDOT/CUR being very similar to that of PCL/CUR (Figure 
7.4.8a). This feature is consistent with the wettability of both systems (Figure 7.4.4d) 
and suggests that loaded PEDOT NPs do not perturb CUR···CUR and/or CUR···PCL 
interactions. In order to corroborate this hypothesis, PCL/PEDOT/CUR MFs were 
prepared by reducing the concentration of CUR in the feeding medium by a half while the 
concentration of PCL and PEDOT NPs were kept constant. The obtained release profile, 
which has been included in Figure 7.4.8a, reflects a significant slowdown in the release 
of the drug (8.4% ± 0.2% of the loaded drug was released after 24 h), corroborating the 
importance of specific interactions involving CUR in the delivery process. In spite of this, 
the shape of the release profile is identical to that displayed for PCL/CUR, confirming 
that the diffusion of the drug is the main release mechanism (Figure 7.4.8b).   
 
Electrostimulated release  
Experiments with electrostimulations were performed using a conventional three-
electrode setup, with steel AISI (American Iron and Steel Institute) 316 (i.e. a common 
austenitic stainless steel with a face centered cubic structure containing 1.25% Ni and 
0.65-0.80% Cr) sheets coated with PCL/CUR and PCL/PEDOT/CUR fiber mats as 
working electrodes, bare steel as a counter electrode, and AgAgCl as a reference 
electrode. Electrically stimulated CUR release assays were conducted applying controlled 
potential-pulses and using PBS (pH 7.4) with 0.05% (v/v) Tween 20 as electrolyte 
medium, which mimics a physiological environment. It is worth noting that the non-
stimulated diffusion of CUR from PCL/CUR and PCL/PEDOT/CUR MFs to such 
hydrophilic medium was found to be negligible. After examine the influence of different 
operational conditions (i.e. potential, time-length and number of pulses) on the release 
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of CUR, the voltage and time-length of each pulse were fixed at 1.00 V and 60 s, 
respectively. Figure 7.4.8c compares the results obtained after application of 1, 3 and 5 
consecutive pulses, which were separated by 5 s.  
Drug release from PCL/CUR was very small, independently of the number of pulses: 
1.9% ± 0.1%, 3.2% ± 0.4% and 5.8% ± 0.5% after 1, 3 and 5 potential pulses, respectively. 
Moreover, release experiments performed considering PCL/CUR MFs in which the 
concentration of drug was reduced by half, denoted PCL/CUR(half) in Figure 7.4.8c, 
indicates that the release depends on the concentration of CUR inside the fibers (i.e. 
0.9% ± 0.1%, 2.0% ± 0.1% and 2.7% ± 0.1% after 1, 3 and 5 potential pulses, 
respectively). This behavior indicates that the release from PCL/CUR MFs depends on 
small local degradations induced in the PCL matrix by the pulse potentials. Results are 
drastically different for PCL/PEDOT/CUR MFs. In this case, the release increases 
significantly with the number of pulses: reaches 8.1% ± 4.3%, 18.4% ± 7.2% and 30.2% ± 
10.2% after 1, 3 and 5 potential pulses, respectively. This feature is independent of the 
CUR concentration, as is evidenced by the results obtained for PCL/PEDOT/CUR(half) 
MFs (Figure 7.4.8c), in which the CUR concentration was reduced by half in the 
electrospinning medium: 14.9% ± 2.5%, 18.6% ± 5.6% and 28.1% ± 7.8% after 1, 3 and 5 
potential pulses, respectively.  
The release mechanism hypothesized for PCL/PEDOT/CUR MFs is based on the 
voltammetric response of PEDOT NPs, which results in volume variations and structural 
changes. This well-known phenomenon has been extensively used to design and fabricate 
electro-chemo mechanical devices (i.e. actuators and artificial muscles), in which the 
dimensional changes of CP films are converted into mechanical energy through linear or 
angular movements.31,113-115 In addition to PPy and polyaniline,115,116 considerable volume 
change has been also reported for PEDOT.117  
Figure 7.4.8d schematizes the drug release mechanism proposed for electro-
stimulated PCL/PEDOT/CUR MFs. The voltage applied during each pulse causes 
oxidation and/or overoxidation processes in the ICP, electrons are lost from the 
backbone and positive charges are generated along the PEDOT chains. To keep the 
electroneutrality, hydrated counterions (anions) from the electrolytic release medium 




changes induced by repulsive interactions among positive charges. Overall, the events 
produced by applied electric pulses (i.e. conformational movements, electrostatic 
repulsions and compositional variations through the entrance of hydrated anions) induce 
dimensional changes in PEDOT NPs (Figure 7.4.8d). The mechanical energy associated 
to such volume increment is used to alter the structure of PCL MFs, the movement of 
PCL molecules generating macroscopic CUR release. The significant release observed 
upon electro-stimulation indicates that volume changes occur not only at the surface of 
PCL MFs but also inside, encapsulated PEDOT NPs being also reached by the hydrated 
anions that penetrate through PCL chains entanglements. It is worth noting that CP-
based actuators functioning with an electric potential in the range of that used in this 
work (1 V) are known to exert strong mechanical forces ( 1MPa) with volume changes of 
up to 35%.118 
SEM micrographs of PCL/PEDOT/CUR MFs after electrostimulation with a 1.00 V 
potential pulse are displayed in Figure 7.4.8e corroborates our previous hypotheses. As 
it can be seen, the surface of the MFs exhibit multitude of PEDOT NPs, which are 
distributed individually or forming small clusters. The appearance on the surface of these 
NPs, which were not found before electrostimulation (Figure 7.4.3d), confirms that the 
main part of the PEDOT NPs contained in the electrospinning feeding mixture were 
located inside the PCL MFs. Micrographs prove that the application of potential pulses 
causes the migration of the embedded PEDOT NPs to the surface of the MFs. 
Furthermore, the Deff of PEDOT NPs located onto the surface of electrostimulated fibers 
is 116  22 nm (Figure 7.4.8e, inset), which represents an increment of 17% with 
respect to the values obtained before electrostimulation. This nanofeature is consistent 
with the delivery mechanism proposed in Figure 7.4.8d. Thus, the release of CUR 
should be attributed to the effect of migration of enlarged PEDOT NPs to the MFs 









In conclusion, PCL/PEDOT/CUR MFs, which have been successfully prepared by 
electrospinning, exhibit potential advantages to regulate the CUR release by electrical 
stimulation. After characterize the influence of both PEDOT NPs and CUR on the surface 
properties and electrochemical response of PCL MFs, we have demonstrated that the 
topography of mats made of randomly collected PCL/PEDOT/CUR MFs resembles that 
of the extracellular matrix. Besides, in vitro assays have evidenced that CUR maintains 
the anticancer activity after the electrospinning process. Application of potential pulses 
causes changes at the MFs due to the migration of PEDOT NPs from inside to the 
surface. PEDOT NPs experience a volume change with concomitant “on-demand” CUR 
release. Independently of the concentration of CUR initially loaded into the MFs, the 
drug release dose increases with the number of potential pulses, scaling linearly. Overall, 
results indicate that the incorporation of isotropic actuators, as PEDOT NPs, to 
biodegradable electrospun MFs is a promising approach for the development of 
programmable drug delivery devices. 
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CHAPTER 8:  



























CREKA is linear pentapeptide that recognizes clotted plasma proteins and selectively homes to 
tumours, while CR(NMe)EKA was engineer to improve such properties by altering peptide···fibrin 
interactions. The properties as biointerfaces of electroactive conducting polymer-peptide 
biocomposites formed by poly(3,4-ethylenedioxythiophene) (PEDOT) and CREKA or CR(NMe)EKA 
peptide sequences (where Glu has been replaced by N-methyl-Glu in the latter) have been 
compared. Differences between PEDOT-CREKA and PEDOT-CR(NMe)EKA reflect dissemblance in 
the organization of the peptides into the polymeric matrix. Both peptides affect fibrinogen 
thrombin–catalyzed polymerization causing the immediate formation of fibrin, whereas in absence 
of thrombin this phenomenon is only observed for CR(NMe)EKA. Consistently, the fibrin-
adsorption capacity is higher for PEDOT-CR(NMe)EKA than for PEDOT-CREKA, even though in 
both cases adsorbed fibrin exhibits round-like morphologies rather than the characteristic fibrous 
structure. PEDOT-peptide films coated with fibrin are selective in terms of cell adhesion, promoting 
the attachment of metastatic cells with respect to normal cells. Within this context, the second part 
explores the biorecognition event between CR(NMe)EKA, and clotted-plasma proteins (fibrin and 
fibrinogen) by nanomechanical detection. Specifically, the tumor-homing peptide was covalently 
attached via epoxysilane chemistry onto silicon microcantilever chips that acted as sensors during 
dynamic mode experiments. The fibrin(ogen)-binding induced by CR(NMe)EKA was detected by the 
resonance frequency shift of the cantilevers, and a detection limit of 100 ng/mL was achieved with 
both proteins. 
 
Publications derived from this work: 
Puiggalí-Jou, A.; del Valle, L. J.; Armelin, E., Alemán, C. Fibrin association at hybrid biointerfaces 
made of clot-binding peptides and polythiophene. Macromol Biosci. 2016, 16, 1461-1474.  
 
Puiggalí-Jou, A.; del Valle, L. J.; Alemán C. and Pérez-Madrigal, M. M. Weighing biointeractions 









CREKA (Cys-Arg-Glu-Lys-Ala) is a linear pentapeptide that recognizes clotted plasma 
proteins and selectively homes to tumors.1 Thus, this peptide, which was identified using 
in vivo screening of phage-display peptide libraries,2,3 recognizes the interaction of 
fibrin-fibronectin accumulated in walls of tumor vessels and in the interstitial spaces 
within tumors.1 Tumor vessels are less robust and stable than normal vasculature, 
favouring the release of some molecules such as fibrinogen (Fg), which is the fibrin 
precursor.4 Leaked Fg is converted into a fibrin meshwork by the action of thrombin 
(THR), which cleavages and removes fibrinopeptides allowing the self-assembly of fibrin 
monomers into elongated fibers.5 CREKA linked to amino-dextran coated 
superparamagnetic iron oxide nanoparticles not only binds to clotted plasma proteins 
blood and plasma but also induces further localized tumor clotting.1 This amplified 
system enhanced the homing of the nanoparticles in a mouse tumor model and the 
tumor imaging, without causing clotting or other obvious side effects elsewhere in the 
body. CREKA also homes to the surface of atherosclerotic plaques, including bivalirudin 
(i.e. a THR inhibitor that selectively and reversibly binds the active site of free and fibrin 
bound THR) containing micelles, and has been used to deliver and concentrate payloads 
onto atherosclerotic plaques in the ApoE-null mouse model.6,7 
The energy landscape and bioactive conformation of CREKA, which consists in a 
pocket-like shape with the charged groups of Arg, Glu and Lys pointing outwards to 
facilitate the formation of intermolecular interactions, were determined using computer 
assisted modelling tools.8,9 This information was used to engineer variants of CREKA 
peptide to resists proteolysis by targeted replacements.10 More specifically, peptide 
analogues that incorporate the synthetic -methyl and N-methyl derivatives of Arg, Glu 
and Lys were studied. Interestingly, CREKA analogues were more effective in tumor 
homing than the original peptide, results being particularly good for the CREKA 
analogue in which the Glu was replaced by N-methyl-Glu, CR(NMe)EKA.11 Additionally, 
in a very recent study She et al.12 reported that CR(NMe)EKA retains almost completely 




8.2 Fibrin association at hybrid biointerfaces made of 
clot-binding peptides and polythiophene 
Biocomposites derived from the conjugation of synthetic polymers with biomolecules 
(e.g. proteins and peptides) are frequently used in biomedicine because of the synergistic 
effects associated to combination of their individual properties.13-18 In the last few years, 
particular attention has been paid to biocomposites involving intrinsically conducting 
polymers (ICPs), which due to their excellent properties19-21 are used to fabricate 
electrochemically active biointerfaces. Thus, devices based on the combination of ICPs 
and biomolecules have been successfully used applications, as for example bioinspired 
channels for ion-exchange22 electromechanical actuators,23 components of bioelectronics 
devices,24,25 aerogels for nerve regeneration,26 and bioactive platforms for tissue 
regeneration that mimic the growth of biological tissues.27,28 
In a very recent work we reported the conditions required for the preparation of 
bioactive platforms based on the modification of an effective ICP with CREKA.18 The 
polymer selected for such purpose was poly(3,4-ethylenedioxythiophene) (PEDOT), 
which is among the most successful ICPs due to its excellent electrochemical and thermal 
properties, high conductivity, good environmental stability in its doped state, mechanical 
flexibility, relative ease of preparation, biocompatibility, and fast doping-undoping 
process.29-32 PEDOT-CREKA biocomposites prepared by chronoamperometry in basic 
aqueous solution (pH= 10.3) and deposited onto a PEDOT internal layer (i.e. forming a 
bilayered system) were found to entrap one peptide molecule every six polymer repeat 
units. Although the morphology and topography of PEDOT-CREKA were completely 
different to those of the individual ICP, the impact of the entrapped peptide molecules in 
the excellent electrochemical properties of PEDOT was found to be practically negligible.  
Herein, we prepare and characterize a biocomposite based on the combination of PEDOT 
and CR(NMe)EKA, PEDOT-CR(NMe)EKA. This new material has been obtained by 
adapting the strategy previously used for PEDOT-CREKA18 to achieve both (i) a 
reduction of one order of magnitude in the thickness of the films, and (ii) an 
improvement of the electrochemical behavior with respect to pure PEDOT. Results 




biocomposite···fibrin interactions, greatly influencing the properties and response of 
fibrin-coated biocomposites. Moreover, fibrin-coated PEDOT-CR(NMe)EKA exhibits a 
remarkable capacity to adhere tumour cells. Thus, such ICP-peptide-protein 
biocomposite is a very promising material for biomedical applications. 
 
8.2.1 Methods 
Materials: 3,4-ethylenedioxythiophene (EDOT) monomer and dodecylbenzene 
sulfonate (SDBS) were purchased from Aldrich and used as received without further 
purification. CR(NMe)EKA and CREKA peptides with > 98% of HPLC purity was 
purchased from Biomatik (Toronto, ON). Ultrapure milliQ water was used to prepare all 
the aqueous solutions. Fibrinogen from human plasma (50-70% protein;  80% of 
protein is clottable) was purchased from Sigma (F3879). Cell lines MCF-7 (epithelial cells 
from human breast adenocarcinoma), PNT2 (normal prostate epithelium immortalized 
with SV40), and PC-3 (epithelial cells from human prostate adenocarcinoma) were 
obtained from ECACC (European Collection of Cell Culture, UK). Culture media were 
purchased from BD Gibco (Franklin Lakes, NJ, USA). 
 
Synthesis: Anodic polymerization and electrochemical assays were performed with an 
Autolab PGSTAT302N equipped with the ECD module (Ecochimie, the Netherlands) 
using a three-electrode compartment cell under nitrogen atmosphere (99.995% pure) at 
room temperature. Steel AISI 316 sheets of 0.5 and 1 cm2 in area were used as working 
and counter electrode, respectively. The reference electrode was an Ag׀AgCl electrode 
containing a KCl saturated aqueous solution.  
PEDOT-CR(NMe)EKA and PEDOT-CREKA films were prepared by 
chronoamperometry using an aqueous medium pH = 10.3 (adjusted with 1 M NaOH) and 
a constant potential of 1.10 V, which has been identified as the optimum potential for the 
polymerization of EDOT in water. A two-step process was used. First, steel electrode was 
coated with a layer of PEDOT. For this purpose, the anodic compartment of the cell was 
filled with 20 mL of a 20 mM EDOT aqueous solution containing 10 mM SDBS as 




electrolyte solution. The polymerization time used for the electrodeposition of this 
PEDOT coating layer was of τ= 10 s. After this, a second layer of PEDOT-CR(NMe)EKA 
or PEDOT-CREKA was electrodeposited onto the surface of the PEDOT coating layer. 
This was achieved by filling the anodic compartment with a generation solution identical 
to that described above for the internal PEDOT layer but containing 1 mg/mL of 
CR(NMe)EKA or CREKA peptide. The applied potential and the polymerization time 
employed for the preparation of the second layer were 1.10 V and τ = 20 s, respectively. It 
should be remarked that the biocomposite layer was deposited onto the internal PEDOT 
layer immediately after the generation of the latter. This represents an important 
difference with respect to our previous work,18 in which the PEDOT-CREKA layer was 
deposited after dry during several hours the internal PEDOT layer. 
PEDOT films used as control were prepared employing the same experimental 
conditions that for PEDOT-CREKA and PEDOT-CR(NMe)EKA biocomposites but 
without the peptide addition in the second layer (i.e. two PEDOT layers prepared using 
polymerization times of 10 s and 20 s).  
 
Contact profilometry: Film thickness measurements were carried out using a Dektak 
150 stylus profilometer (Veeco, Plainview, NY). Scratches were intentionally provoked on 
the film surface and the average thickness was determined from, at least, nine 
measurements for each condition. Imaging of the films was conducted using the 
following optimized settings: tip radius= 12.5 µm; stylus force= 3 mg; scan length= 2 µm; 
speed= 2 nm/s. 
 
Atomic force microscopy (AFM): AFM was conducted to obtain topographic images 
of the films surface using silicon TAP 150-G probe (Budget Sensors, Bulgaria) with a 
frequency of 150 kHz and a force constant of 5 N/m. Images were obtained with a AFM 
Dimension microscope using a NanoScope IV controller under ambient conditions in 
tapping mode. The row scanning frequency was set between 0.6 and 0.8 Hz. The Root 
Mean Square roughness (Rq), which is the average height deviation taken from the mean 
data plane, was determined using the statistical application of the NanoScope Analysis 




which produced reproducible images similar to those displayed in this work. The scan 
window size was 1010 m2. 
 
X-ray photoelectron spectroscopy (XPS): XPS analyses were performed in a 
SPECS system equipped with a high-intensity twin-anode X-ray source XR50 of Mg/Al 
(1253 eV/1487 eV) operating at 150 W, placed perpendicular to the analyzer axis, and 
using a Phoibos 150 MCD-9 XP detector. The X-ray spot size was 650 mm. The pass 
energy was set to 25 and 0.1 eV for the survey and the narrow scans, respectively. Charge 
compensation was achieved with a combination of electron and argon ion flood guns. 
The energy and emission current of the electrons were 4 eV and 0.35 mA, respectively. 
For the argon gun, the energy and the emission current were 0 eV and 0.1 mA, 
respectively. The spectra were recorded with a pass energy of 25 eV in 0.1 eV steps at a 
pressure below 610-9 mbar. These standard conditions of charge compensation resulted 
in a negative but perfectly uniform static charge. The C 1s peak was used as an internal 
reference with a binding energy of 284.8 eV. High-resolution XPS spectra were acquired 
by Gaussian–Lorentzian curve fitting after S-shape background subtraction. The surface 
composition was determined using the manufacturer's sensitivity factors. 
 
Cyclic voltammetry (CV): CV studies were run to assess the electrochemical behavior 
of the biocomposites. Hence, the ability to exchange charge reversibly (i.e. 
electroactivity) and the electrochemical stability (i.e. electrostability) were determined 
using a 0.1 M phosphate buffer saline solution (PBS; pH= 7.4 adjusted with NaOH). The 
initial and final potentials were -0.40 V, whereas a reversal potential of 0.80 V was 
considered. The scan rate was 50 mV/s in all cases.  
The electroactivity increases with the similarity between the anodic and cathodic 
areas of the first control voltammogram. The electrochemical stability (i.e. loss of 
electroactivity, LEA), which decreases with the oxidation and reduction areas of 







QLEA                                       (Eq. 8.2.1) 
where ΔQ is the difference of voltammetric charge between the second cycle and the last 
cycle and Qi is the voltammetric charge corresponding to the second cycle. In this work 
all values of LEA were referred to five consecutive oxidation-reduction cycles.  
 
Dynamic light scattering (DLS): Real-time monitoring of fibrin polymerization in 
presence and absence of peptide at 37 ºC was conducted by DLS following the increment 
of the particle effective diameter. All buffers and fibrinogen (Fg) samples were filtered 
(0.22 µm centrifugal filter) prior to use. Final concentrations of Fg and thrombin (THR) 
were 0.4 mg/mL and 0.01 U/mL, respectively, in aqueous solution containing 5 mM 
CaCl2 and 76 mM NaCl. Data were collected every minute. Measurements were 
performed using a NanoBrook Omni Zeta Potential Analyzer from Brookheaven 
Instruments Corporation. 
 
Electrochemical impedance spectroscopy (EIS): Impedance spectroscopy was 
performed using a conventional three-electrode cell and AUTOLAB-302N 
potentiostat/galvanostat operating between the frequency range of 100kHz-10 mHz and 
10 mV of amplitude for the sinusoidal voltage. All experiments were performed with 
films electrochemically deposited on stainless steel substrates (AISI 316L with 1cm2 of 
area) and immersed in phosphate buffer saline (PBS, pH 7.4), at room temperature. 
Stainless steel electrodes were used as working and counter-electrodes, whereas Ag|AgCl 
saturated (KCl 3M) was employed as reference electrode. After data collection, EIS 
results were then processed and fitted to an electrical equivalent circuit (EEC). 
 
Protein Adsorption: Analyses to examine the adsorption of proteins onto the surface 
of PEDOT, PEDOT-CREKA and PEDOT-CR(NMe)EKA films were performed using 
fibrin and bovine serum albumin (BSA, Fraction V). BSA, which is a globular plasma 




PEDOT and PEDOT-peptide films were placed on a 24-well plate heated at 37 ºC. 
Meanwhile, fibrin precursors, Fg (0.4 mg/mL) and THR (0.01 U/mL) were heated to the 
same temperature (solutions previously filtered). Fg and THR solutions were deposited 
onto the film surface using a 1:1 ratio. After 60 min with slight agitation (80 rpm) the 
film was rinsed in 0.1 M PBS to remove residues and non-specifically bound fibrin. The 
same procedure was used to adsorb BSA, the only difference being the protein 
concentration in the solution (0.4 mg/mL).  
 
Detection of adsorbed proteins by Bradford assay: Adsorbed fibrin and BSA 
were removed from the films surfaces by adding 0.2 mL of 0.1 M PBS with nonyl 
phenoxypolyethoxyethanol (NP-40) surfactant (0.5% v/v) and orbital shaking at 50 rpm 
during 30 min and 37ºC. In order to avoid interferences between the NP40 surfactant 
and the Bradford reagent, the former was eliminated by precipitating the fibrin with 20 
µL of trichloroacetic acid. Then, the precipitate-containing solution was centrifuged for 
15 min at 12000 rpm. The solid (fibrin or BSA) was washed with cold acetone and 
maintained at 4 ºC for 1 hour. After this, the solid was centrifuged again during 15 min at 
12000 rpm. The protein was dried under vacuum and, finally, dissolved in 0.1 M PBS for 
the Bradford assay.  
Standard curves were carried out using protein dilutions, which were prepared using 
buffer solution with concentrations of protein ranging from 0.05 to 1.00 mg/mL. Next, 5 
µL of protein standards and samples were added to a 96-well plate, blank wells were 
filled with 5µL of buffer. After this, Bradford reagent (250 µL) was added and, 
subsequently, mixed on a shaker for 30 s. Samples were incubated at room temperature 
for 15 min. Finally, the absorbance was measured at 595 nm. 
 
Scanning electron microscopy (SEM): SEM micrographs were obtained using a 
Focussed Ion Beam Zeiss Neon 40 scanning electron microscope operating at 10 kV. 
Samples were mounted on a double-side adhesive carbon disc and sputter-coated with a 
thin layer of carbon to prevent sample charging problems. The projected area and best-fit 




Optical microscopy: To evaluate the THR-catalysed fibrin particles, samples were 
washed three times with milliQ water to avoid unspecific bindings. After this, fibrin 
particles were fixed onto the surface with 300 µL of 2.5% paraformaldehyde in PBS 
during 30 min at 4 ºC. Then, samples were progressively dehydrated using alcohols of 
30º, 40º, 50º, 70º, 95º, and 100º for 15 min each at 4 ºC. Samples were stained with 
eosin for 30 min. Eosin is a fluorescent acidic compound that binds positively charged 
molecules (i.e. the isoelectric point of Fg is 5.5, increases to 6.3 after clipping of polar 
residues in the clotting response by THR).  Finally, samples were washed three times 
again with milliQ water and left on vacuum overnight. 
 
Wettability: Contact angle (CA) measurements were conducted using the water drop 
method. 0.5 µL of milliQ water drops were deposited onto the surface of the films and 
recorded after stabilization with the equipment OCA 15EC (DataPhysics Instruments 
GmbH, Filderstadt). The SCA20 software was used to measure the CA, which is shown 
here as the average of at least 10 measures for each condition. 
 
Cell capture assays: Substrates were placed into a 24-well plate, and 1 mL of cell 
MCF-7 (breast cancer cell line), PNT2 (normal prostate epithelial cell line) or PC-3 
(cancer prostate epithelial cell line) suspension (105 cells/mL) was loaded. After 
incubation for 30 min at 37 ºC, 5% CO2 with slight agitation (80 rpm), the substrates 
were washed with PBS, located in a new 24-well plate and incubated for 24 hours. The 
percentage of cells adhered in the substrate with respect to the amount deposited into the 
well was determined using the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphe- 
nyltetrazolium] method. Cell capture assays were repeated two times with at least 4 
replicas, showing similar results in all cases.  
For the observation of the cell morphology in the SEM, all samples were previously 
coated with a carbon layer of 6−10 nm thickness using a K950X Turbo Evaporator to 
prevent sample charging problems. Before the carbon coating, samples covered with cells 




were dehydrated by washing in an alcohol battery (30°; 50°; 70°; 90°; 95°; and 100°) at 4 
°C for 15 min per wash. Finally, samples were air-dried and sputter-coated with carbon. 
 
8.2.2 Results and discussion 
PEDOT-peptide characterization 
The synthetic approach used in this work to prepare PEDOT (control) and PEDOT-
peptide bilayered films is summarized in Figure 8.2.1. In order to overcome the 
fragility of PEDOT-peptide films, an internal PEDOT layer was electrodeposited between 
the steel and the biocomposite. The average thickness (L) of the internal PEDOT layer 
was L= 15035 nm. Bilayered systems containing an external PEDOT, PEDOT-CREKA or 
PEDOT-CR(NMe)EKA layer deposited onto the internal layer exhibited L values of 
34072, 57357 or 49835 nm, respectively. These L values, which were achieved by 
depositing the external layer immediately after polymerize the internal PEDOT layer, are 
considerably smaller than those reported in for bilayered PEDOT-CREKA (L= 3.81.3 
m).18 Thus, in the latter case the apparition of multiple, prominent, and well-localized 
2) No peptide/ 1mg/ml peptide (a/b) 















1) 20 mM EDOT and 10 mM 
SDBS on aquous solution
E1 = 1.10 V





3)  Fibrin polymerization
2) No peptide / 1 mg/mL peptide 
(a / b) , 20 mM EDOT and 10 mM 
SDBS on aquous solution
E2 = 1.10 V
2 = 20 s
Figure 8.2.1 Scheme displaying the synthetic strategy used to prepare PEDOT (control) and 
PEDOT-peptide bilayered films (a and b, respectively). The strategy involved a two-step 
process: (1) deposition of the internal PEDOT layer onto the AISI steel electrode; and (2) 
deposition of PEDOT (a) or PEDOT-peptide (b) onto the layer prepared in (1). It is worth noting 
that a and b only differ in the absence or presence of peptide in the generation medium used for 
step 2. After this, subsequent surface functionalization with fibrin and application as selective 
bioactive surface are also displayed. RE, WE and CE refer to the reference electrode, working 




folds homogeneously distributed was promoted by drying during several hours the 
internal layer before the deposition of the external layer.18 Accordingly, elimination of the 
drying process induces significant changes not only in L but also on the properties (see 
below) despite the experimental conditions used for the anodic polymerization are 
practically identical.  
Comparison of the Rq determined by AFM for the external layer of PEDOT, PEDOT-
CREKA or PEDOT-CR(NMe)EKA ( Rq= 749, 13323 and 16111 nm, respectively) 
indicates that the peptide affects the surface topography (Figure 8.2.2). PEDOT’s 
surface can be described as a very homogeneous distribution of small molecular 
aggregates, which has been associated with the linear growing of polymer chains.33 
Incorporation of CR(NMe)EKA or CREKA into the polymeric matrix provokes a drastic 
change in the topography that exhibits high and relatively large compact blocks, 
explaining the enhancement of Rq. These blocks, which result from the aggregation of 
small clusters over the polymer surface, are essentially induced by the role of the peptide 
as doping agent. Thus, peptide molecules (individually or forming clusters) embedded 
into the PEDOT matrix alter the growing of polymer chains, which should perpendicular 
to the electrode surface. As PEDOT chains tend to grow forming clusters,34 the tilting 





















































































































































































Figure .2.2 Topographic (3D) and heigh (2D) AFM images of (a) PEDOT, (b) PEDOT-






























































































phenomena are more pronounced for PEDOT-CR(NMe)EKA than for PEDOT-CREKA.  
 PEDOT and PEDOT-peptide composites were characterized by XPS. The atomic 
percent composition (C 1s, N 1s, O 1s and S 2p) of the three systems are compared in 
Table 8.2.1. As it can be seen, nitrogen was detected in the composition of the three 
systems. According to the experimental conditions used in this work, the penetration of 
X-ray radiation is expected to be of 10 nm. Although the thickness of the bilayered films 
prepared in this work ranged from 300 to 600 nm, examination by SEM revealed 
some uncoated regions of the steel substrate. Accordingly, the presence of N 1s in PEDOT 
films has been attributed to the metallic substrate.35,36 It is worth noting that the N 1s 
content increases from 0.47% in PEDOT to 1.20% and 0.92% in PEDOT-CREKA and 
PEDOT-CR(NMe)EKA, respectively, reflecting the successful incorporation of the 
peptides.  
Assuming that the nitrogen coming from the steel substrate is approximately the 
same for the three systems, the number of polymer repeat units per peptide molecule in 
PEDOT-CREKA and PEDOT-CR(NMe)EKA can be roughly estimated using the S/(Np–
Ns) ratio (Table 8.2.1), where S is the total percent composition of sulfur atoms and 
(Np–Ns) refers to the difference between the total percent composition of nitrogen at 








According to this approximation, the content of peptide in PEDOT-CREKA and 
PEDOT-CR(NMe)EKA is relatively high with one peptide molecule every 10 and 15 
polymer repeat units, respectively. The smaller content of immobilized peptide molecules 
in PEDOT-CR(NMe)EKA is due to the increment of the molecular volume provoked by 
# C 1s N 1s O 1s S 2p S / N 
PEDOT 68.64 0.47 23.82 7.07 - 
PEDOT-CREKA 68.57 1.20 23.06 7.17 5.97 
PEDOT-CR(NMe)EKA 69.46 0.92 22.74 6.88 7.48 
Table 8.2.1 Atomic percent composition (C 1s, N 1s, O 1s and S 2p) and S 2p / N 1s ratio 





the N-methylation of the Glu residue, which enhanced peptide–polymer steric 
interactions during the polymerization process. 
 Figure 8.2.3 displays the high-resolution XPS spectra in the N 1s region, which is 
crucial to prove the immobilization of the peptide into the ECP matrix, for PEDOT, 
PEDOT-CREKA and PEDOT-CR(NMe)EKA. The peak centered around 402 eV, which 
was detected in all examined samples including PEDOT ones, is consequence of 
impurities of the AISI 316 steel (see above).35,36 However, the intense peak found at 
400.2 eV for both PEDOT-CREKA and PEDOT-CR(NMe)EKA corresponds to the 
peptides. Thus, this peak is typically explained as a combination of the guanidinium 
(400.1 eV) and the backbone amide (400.5 eV) signals.37 Bhattacharyya and Gleason 
attributed the presence of N 1s characteristic peaks at 399.7 eV (–NH) and 400.4 eV (N–
C=O) to bovine serum albumin attached to the surface of a copolymer of thiophene-3-
acetic acid and EDOT.38 Similarly, the XPS N–H signal of Boc-Val-Gly-Gly-Val-Gly-OEt 


















































































Figure 8.2.3  High-resolution XPS spectra in the N 1s region for (a) PEDOT, (b) PEDOT-








 Electrochemical properties of PEDOT improve upon the incorporation of the 
peptide, independently of the chemical modification at the Glu residue. Figure 8.2.4a 
shows that the electroactivity of both PEDOT-peptide systems is around 15% higher than 
that of PEDOT. These results are consistent with the role of CREKA and CR(NMe)EKA 
molecules as dopant ions, participating in oxidation and reduction processes. This 
achievement, which is in marked contrast previous results,18 is due to the elimination of 
the drying step before the deposition of the external layer.  The presence of the peptide 
also enhances the electrochemical stability of PEDOT, as is reflected by the control 
voltammograms recorded after five consecutive oxidation-reduction cycles in PBS 
(Figure 8.2.4b). After such amount of cycles, the electroactivity of PEDOT is lower than 
that of PEDOT-CREKA and PEDOT-CR(NMe)EKA by 20% and 30%, respectively. 
Analysis of the LEA (Eq. 8.2.1) shows a reduction of 15% and 25% for PEDOT-peptide 










Figure 8.2.4 Initial control voltammogram (a), voltammogram after five consecutive 
oxidation-reduction cycles (b) and variation of the LEA (Eq. 8.2.1) against the number of redox 
cycles (c) in 0.1 M PBS (pH= 7.4) of PEDOT, PEDOT-CREKA and PEDOT-CR(NMe)EKA. Initial 







The reduction of the electroactivity with the number of redox cycles is related with 
the structural degradation of the polymeric matrix that becomes less porous (i.e. more 
compact), making difficult the escape and entrance of dopant ions during the oxidation 
and reduction processes, respectively. In the case of PEDOT-CREKA and PEDOT-
CR(NMe)EKA, the peptides impart protection to the matrix preventing its structural 
degradation. Although determination of such protection mechanism is not an easy task, 
our hypothesis is based on a steric protection due to the formation of nanometric and 
insoluble peptide aggregates inside the polymeric matrix. These could act as structural 
support avoiding the collapse of the polymeric matrix and maintaining the porosity.  
 
Influence of the peptide in fibrinogen polymerization 
The affinity of CR(NMe)EKA towards fibrin has been compared with CREKA. The 
formation of fibrin networks is the central event in vertebrates blood coagulation40,41 and 
is involved in several pathologies like thrombosis and cancer metastasis.41,42 From a 
physiological point of view, it represents the end of the coagulation cascade when THR 
activates the inactive precursor Fg.41-44 Cleavage and removal of fibrinopeptides from Fg 
by THR promote the interaction between neighboring fibrin molecules that self-associate 
to form elongated fibers and fiber networks.5,45  
The effect of the peptides on fibrin THR-catalyzed polymerization was assessed at 37 
ºC by DLS. Figure 8.2.5  represents the temporal evolution of the effective diameter 
(Deff) of Fg particles using conditions optimized to examine the early steps in fibrin 
polymerization46 (i.e. 0.4 mg/mL Fg aqueous solution containing 5 mM CaCl2 and 76 
mM NaCl). In absence of THR, Deff stabilizes at 32 nm (Figure 8.2.5a) indicating 
significant restrictions in association process (i.e. hydrodynamic radius of Fg is 13 
nm47,48). Instead, Deff grows rapidly and progressively over time upon the incorporation 
of THR (Figure 8.2.5a). The value of Deff reaches a plateau after 55 min at 







The influence of CREKA and CR(NMe)KA in fibrin polymerization was studied by 
adding each peptide to Fg aqueous solutions with and without THR (Figure 8.2.5b and 
5c). In absence of enzyme, the increase of Deff reflects that the two peptides promote the 
aggregation of Fg, even though quantitative differences in the aggregation mechanism 
are revealed. CREKA induces a sustained linear increase of Deff, which grows from 45 
nm (t= 1 min) to 191 nm (t= 60 min). In contrast, CR(NMe)EKA provokes a very fast 
aggregation process at the initial stage (Deff 380 nm at t= 1 min), the growing of the 
microparticles remaining practically stopped after this event (Deff 347 nm at t= 60 min). 
Interestingly, incorporation of the peptides to the Fg solution in presence of THR results 









































































Figure 8.2.5 (a) THR-catalyzed polymerization of Fg monitored by DLS. Polymerization was 
initiated by adding THR (0.01 U/mL) to a Fg (0.4 mg/mL) filtered aqueous solution (5 mM 
CaCl2 and 76 mM NaCl). These experimental conditions were taken from reference.46 Polymer 
formation was measured through the the effective diameter (Deff , in nm) as a function of time 
(in min). CREKA (b) and CR(NMe)EKA (c) were added (0.1 mg/mL) to the same Fg solutions 
with and without THR to evaluate the influence of the peptide in the polymerization process. In 





271 and 574 nm for CREKA and CR(NMe)EKA, respectively. After this initial stage, the 
size of particles progressively increased, even though the peptide largely influenced the 
growth rate. In the case of CREKA the growth rate of the particles (6.90.3 nm/min from 
Figure 8.2.5b) decreased considerably with respect to the same solution without 
peptide (50.51.8 nm/min from Figure 8.2.5a). After a liner growth regime, Deff 
stabilized around 712 nm, which represents a reduction of around 72 % with respect to 
the value obtained for the same solution but without CREKA. After a very fast formation 
stage, the growth rate of the particles formed in presence of CR(NMe)EKA progressively 
increases (14.10.3 nm/min from Figure 8.2.4c), stabilizing at Deff 1343 nm after 55 
min. Accordingly, both peptides disturb the THR-induced fibrin polymerization, even 
though such effect is significantly more pronounced for CREKA.  
In an early work, Carr et al.49 proved that positively charged poly(-amino acid)s 
enhance lateral association of fibrin protofibrils during fiber bundling. This phenomenon 
was attributed to the charge and isoelectric point of such polypeptides. High pKa values 
facilitated strong interaction between the protofibrils and the poly(-amino acid), 
independently of the molecular weight, promoting fibrin polymerization, as was 
evidenced by the increase of fibrin fibers diameter.49 In contrast, no effect was observed 
for negatively charged poly(-amino acid)s. Both CREKA and CR(NMe)EKA have an 
isoelectric point of 8.55 and, therefore, they are positively charged at working pH (7.4). 
Accordingly, such peptides could promote the lateral assembly of fibrin protofibrils, 
reducing the elongation capability of fibers, as suggested in Figure 8.2.5.  
 
Adsorption of fibrin onto PEDOT-peptide films 
The selective adsorption of fibrin by PEDOT-peptide biocomposites has been 
examined by comparing with the adsorption of BSA, which is a globular plasma protein. 
Results indicate that the affinity of PEDOT-CREKA and PEDOT-CR(NMe)EKA toward 
fibrin fibers was ~2.5 and ~6 times higher than that of PEDOT (Figure 8.2.6), 
respectively. Thus, 6%, 14% and 37% of the fibrin from the initial solution was 
adsorbed onto PEDOT, PEDOT-CREKA and PEDOT-CR(NMe)EKA, respectively. In 




lower than 2% for PEDOT and PEDOT-CREKA). The selectivity of PEDOT-CR(NMe)EKA 
towards fibrin suggests that the distribution of the charged groups in this biocomposite is 
appropriated for the adsorption of fibrin despite the loss of its fibrous structure (see 
below). However, such distribution is much less suitable for the adsorption of 
globularproteins, like BSA, in which polar groups are expected to be randomly 
distributed.  
The morphology of fibrin adsorbed onto PEDOT-peptide films was studied by SEM 
(Figure 8.2.7). For this purpose, the THR-catalyzed polymerization of Fg was stopped 
after 60 min by the addition of formaldehyde46 (2.5%) and, subsequently, dehydrated 
using 30%, 40%, 70%, 90% and 100% ethanol solutions. Amazingly, the formaldehyde-
fixed fibrin onto PEDOT-peptide surfaces does not exhibit the expected mesh of fibers 
(see below)49,50 but forms agglomerates of micrometric dimensions with very varied 
morphologies 
 Thus, agglomerates of fibrin adsorbed onto PEDOT-CREKA (Figure 8.2.7a) were 
relatively small (1-4 m) and displayed different round-like morphologies, including the 
spherical one. In contrast, fibrin adsorbed onto PEDOT-CR(NMe)EKA presents a larger 
variety of morphologies, including fiber-like, round-like and completely irregular ones 
Figure 8.2.6  Adsorption of fibrin and BSA onto the surface of PEDOT and PEDOT-peptide 





(Figure 8.2.7b). As the elongated fiber-like morphologies were relatively infrequent 
and isolated rather than immersed into a mesh, they have been related with structures 
formed without the participation of the peptide. Furthermore, fibrin aggregates adsorbed 
onto PEDOT-CR(NMe)EKA are typically bigger than those deposited onto PEDOT-
CREKA. Overall, results suggest that the round-like and irregular morphologies of fibrin 
adsorbed onto PEDOT-peptide are controlled by the fast aggregation processes occurring 
at early stages of the polymerization process, which is consistent with the DLS 
observations (Figure 8.2.5). The area and aspect ratio (AR), which is defined by the 
ratio between length and diameter, of the morphologies observed for the 60 min 
formaldehyde-fixed products, were determined with the ImageJ software using SEM 
micrographs. Results indicate that the distribution of both areas and AR (Figure 8.2.8) 
are influenced by the peptide. Thus, 6% of structures formed onto PEDOT-CR(NMe)KA 
shows an area higher than 10 m2, such amount being imperceptible for PEDOT-CREKA. 
4 µm
400 nm 400 nm
400 nm 400 nm
(a)
10 µm 10 µm
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(b)
Figure 8.2.7 Low and high resolution SEM images of fibrin particles adsorbed onto (a) 





Moreover, 8.8% and 20.3% of the structures formed onto PEDOT-CREKA and PEDOT-
CR(NMe)KA, respectively, exhibit an AR > 2.0, reflecting the sporadic formation of 
isolated fibril-like structures in the latter (Figure 8.2.7b).  
In order to further confirm the presence of fibrin onto PEDOT-peptide surfaces, the 
two biocomposites together with steel and PEDOT were stained with eosin. Figure 
8.2.9 compares optical microscopy images of red colored fibrin polymerized with THR 
during 60 min. Although fibrin is apparently able to bind all tested surfaces, differences 
in the amount of adsorbed proteins indicate a certain degree of selectivity. Thus, a typical 
intertwined mesh of long fibers oriented in multiple directions is observed when fibrin is 
deposited onto bare steel (Figure 8.2.9a). PEDOT affects drastically the fibrin 
morphology, inducing the formation of small and rounded-like agglomerates after 60 
min (Figure 8.2.9b). The abundance of these aggregates is very scarce in comparison to 
those adsorbed onto steel, which is fully consistent with Bradford protein assays (Figure 
8.2.6). Thus, the adsorption and morphology of fibrin is largely influenced by the 
roughness and/or chemical nature of the substrate. Dolatshahi-Pirouz et al.50 showed 
that fibrin polymerization and, therefore, fibrillation are slower on flat than on rough 
surfaces. Nevertheless, steel (Rq= 52 nm) is flatter than bilayered PEDOT films (Rq= 
749 nm), evidencing that the chemical nature of the surface is also regulating fibrin 
Figure 8.2.8 Quantitative assessment of the fibrin particles adsorbed onto PEDOT-CREKA 
and PEDOT-CR(NMe)EKA surfaces. Histogram showing the percentage of (a) the area and (b) 






polymerization and morphology. The chemical nature influence is apparently reflected by 
the surface hydrophilicity, which is considerably higher for PEDOT and PEDOT-peptide 
than for steel (Table 8.2.2).  
The hydrophilicity of PEDOT-peptide is similar to that of PEDOT (Table 8.2.2), 
even though the roughness is higher for the formers (Rq= 13323 and 16111 nm for 
PEDOT-CREKA and PEDOT-CR(NMe)EKA, respectively) than for the latter (Rq= 749 
nm). Microscopy images displayed in Figure 8.2.9b-d indicate that the fibrin 
polymerization rate onto PEDOT-containing surfaces increases with the roughness, 
which is in agreement with the findings of Dolatshahi-Pirouz et al.50 Thus, the amount of 
adsorbed fibril increases as follows: PEDOT < PEDOT-CREKA < PEDOT-CR(NMe)EKA.  
Comparison between the CAs for the different surfaces without and with adsorbed 
fibrin reveals differences in the wettability (Table 8.2.2), especially for PEDOT and 
PEDOT-peptide systems. Thus, the highly hydrophilic character of such CP and its two 
biocomposites (CA < 20º) transforms into hydrophobic (CA > 90º) upon the adsorption 
of fibrin particles. This effect is much less pronounced for steel. The transformation of Fg 
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Figure 8.2.9 Optical images of eosin stained fibrin adsorbed on (a) steel, (b) PEDOT, (c) 













Influence of fibrin in PEDOT-peptide electrochemical and electrical 
properties 
CVs of PEDOT and PEDOT-peptide films coated with fibrin are displayed in Figure 
8.2.10. Comparison with those reported in Figure 8.2.4a indicates that the adsorbed 
protein affects negatively the electrochemical response of both the ICP and the 
biocomposites. More specifically, the adsorption of fibrin reduces the electroactivity of 
PEDOT, PEDOT-CREKA and PEDOT-CR(NMe)EKA by 35%, 50% and 51%, respectively. 
The adsorbed protein also affects negatively to the electrochemical stability of the two 
biocomposites. 
 Thus, after only 5 consecutive redox cycles, the LEA is 18%, 22% and 25% for 
PEDOT, PEDOT-CREKA and PEDOT-CR(NMe)EKA, respectively. Accordingly, the 
behavior of the biocomposites relative to the ICP is in terms of electrostability the 
opposite that the one displayed in absence of fibrin (Figure 8.2.4b). These results 
should be attributed to the combination of two related effects: (i) the amount of protein 
at the surface of the biocomposites is considerably higher than at the surface of PEDOT; 
and (ii) protein aggregates are more compact than polymeric and biocomposite matrices. 
Accordingly, the exchange of ions between the matrix and the PBS electrolytic medium 
during redox processes is more difficult at regions covered by the protein, which are 
more abundant at the biocomposites than at PEDOT.  
Surface CA 
Steel 68º±5º 
PEDOT < 20º 
PEDOT-CREKA < 20º 
PEDOT-CR(NMe)EKA < 20º 
Steel / fibrin 94º±4º 
PEDOT / fibrin 112º±1º 
PEDOT-CREKA / fibrin 114º±2º 
PEDOT-CR(NMe)EKA / fibrin 107º±4º 
Table 8.2.2 Contact angle (CA) determined for the surfaces examined in this work before and 




Figure 8.2.10 Control voltammograms in 0.1 M PBS (pH= 7.4) of fibrin-coated PEDOT, 
PEDOT-CREKA and PEDOT-CR(NMe)EKA films. Initial and final potentials: -0.40 V; reversal 
potential: 0.80 V. Scan rate: 50 mV/s. 
A similar behaviour was observed by EIS analyses. The electrode impedance is 
related to the interfacial surface area between the electrode and electrolyte. 
The bare metal only exhibits a low double layer capacitance (CPEdl) and a high 
polarization resistance coming from the interaction between the ions of the electrolytic 
medium (PBS) and the heterogeneous steel surface (Rp) (Figure 8.2.11a). On the other 
hand, the impedance of the electrodes covered with a semiconducting material is more 
complex and other time constants can appear due to several interfaces. More specifically, 
the impedance of PEDOT-coated electrodes decreases three orders of magnitude with 
respect to the bare metal across frequencies between 0.01–10 Hz, which correspond to 
the zone of the coating resistance. This must be attributed, at least partially, to an 
increase in the  ffective surface area, which is provided by the porous PEDOT electrode. 
The coating resistance (Rc), which is identified from the first diameter of the semicircle in 
the Nyquist plots (Figure 8.2.12), describes the resistance for transferring the electrons 
from the PBS ions to the conducting polymer film. The diffusion of ions across the films 
is enhanced upon the incorporation of peptide to PEDOT, leading to lower Rc values 
(Table 8.2.3). The Rc of fibrin-coated PEDOT-peptide films is higher than that of 
biocomposites without fibrin (Table 8.2.3) since the protein aggregates block the pores 
(i.e. barrier effect). This behaviour is more pronounced for PEDOT-CR(NMe)KA, 
















































Figure 8.2.11  (a) Bode plots for all stainless steel electrodes coated with PEDOT-peptide 
without and with fibrin adsorbed at the surface. (b) Electrical equivalent circuits (EEC) for bare 
steel, steel coated with PEDOT, PEDOT-CREKA and PEDOT-CR(NMe)EKA without and with 

































Furthermore, another constant phase element (CPEdif , with n= 0.90) is required to 
model the response of PEDOT-CR(NMe)KA with fibrin (Figure 8.2.12b). This is 
probably due to favourable fibrin···peptide interactions, which cause a slow diffusion of 
ions at very low frequency range. The best-fit values for the adjusted resistances and 




Figure 8.2.12  Nyquist plots for all stainless steel electrodes coated with (a) PEDOT-CREKA 














a) Rs = solution resistance, b) Rc = Coating resistance, c) CPEc = coating capacitance, d) Rp = polarization resistance, e) CPEdl = double layer capacitance f) 
CPEdif = diffusion capacitance, g) Value of resistance for the stainless steel bare (without conducting polymer) is attributed to the polarization resistance 
(Rp) in the electrode/electrolyte interface at low frequency. h) This parameter is better related to the Rdif = ion diffusion resistance across the film (see the 












(F cm−2 sn−1) 
n 
CPEdif f) 
(F cm−2 sn−1) 
n 
Stainless steel (bare) 123 - - - 594kg) 3.85×10-5 0.85 - - 
PEDOT 162 267 4.03×10-5 0.83 - 1.08×10-3 0.76 - - 
PEDOT-CREKA 100 188 1.00×10-4 0.74 - 1.12×10-3 0.93 - - 
PEDOT-CREKA with fibrin 155 209 3.49×10-5 0.73 - 1.23×10-3 0.91 - - 
PEDOT-CR(NMe)EKA 119 128 2.29×10-4 0.54 - 0.82×10-3 1.00 - - 




Cell capture selectivity: tumor versus normal cells  
PEDOT and PEDOT-peptide samples have been used to investigate the effect of fibrin 
adsorption on cell capturing with MCF-7 cells (breast cancer cell line). Results, which are 
displayed in Figure 8.2.13a, clearly indicate that MCF-7 cells are captured more 
efficiently by the biocomposites than by PEDOT. Moreover, the highest cell viability was 
obtained for PEDOT-CR(NMe)EKA coated with fibrin evidencing that such ECP-peptide-
protein biocomposite is a very promising material for biomedical applications. 
Representative SEM micrographs of cells adhered to PEDOT-CR(NMe)EKA without and 
with fibrin are displayed in Figures 8.2.13b-c, respectively.  
On the other hand, the ability of PEDOT-peptide biocomposites to differentiate 
between tumor and normal cells was examined by conducting cell attachment assays 
using normal (PNT2) and metastatic (PC-3) prostate epithelial cell lines. Results 
displayed in Figure 8.2.13d indicate that the amount of normal and tumor attached 
cells is practically the same for the two uncoated biocomposites, no clear preference 
being exhibited. Moreover, the influence of the peptide is practically negligible since the 
cell attachment was practically the same for PEDOT and PEDOT-peptide films. However, 
assays considering biocomposite films coated with fibrin reveal not only an enhancement 
of cell attachment but also of cell identification (Figure 8.2.13d), i.e. normal cells vs 
tumor cells. Thus, both PEDOT-CREKA and PEDOT-CR(NMe)EKA films with adsorbed 
fibrin promoted the adhesion of tumor cells with respect to normal cells by around 12%. 
Moreover, the capture of PNT2 cells is slightly less efficient for biocomposites with 
adsorbed fibrin than without such protein. Overall results suggest that cell capture 
selectivity depends on a balance between different factors, which include surface 
roughness and morphology in addition to chemical structure.  
SEM micrographs of PC3 cells adhered onto non-coated PEDOT films and fibrin-
coated PEDOT-CR(NMe)EKA are displayed in Figures 8.2.13e and 8.2.13f, 
respectively. The former ICP-peptide-protein composite promotes cell attachment, as is 
clearly reflected by both the formation of multiple inter-cell connections and a very 
homogeneous spreading of the adhered cells. These features are less evident in Figure 


























































































































































































Figure 8.2.13 (a) Percentage of MCF-7 cells attached to different surfaces: bare steel, PEDOT, 
biocomposites, and biocomposites coated with fibrin. In all cases data correspond to the average 
of five independent assays  the standard deviation. Asterisk marks (*) and (***) represent 
significant difference among the samples at p < 0.05 and p < 0.001, respectively. SEM 
micrographs of MCF-7 cells onto PEDOT-CR(NMe)EKA films (b) without and (c) with adsorbed 
fibrin at the surface. (d) Comparison of the percentage of normal (PNT2) and metastatic (PC3) 
prostate epithelial cells attached to different surfaces. The description of both the surfaces and 
the marks is identical to that given for (a). SEM micrographs of PC-3 cells onto (e) PEDOT films 







PEDOT-peptide biocomposites have been prepared by chronoamperometry in basic 
aqueous solution. The electrochemical and electrical response of the resulting 
biocomposites is significantly better than that of the ECP in terms of electroactivity, 
electrostability and electrical conductivity. Such improvement suggests that peptide 
molecules play simultaneously two roles acting, on one side, as dopant agents that 
participate actively in oxidation and reduction processes and, on the other side, as 
structural supports that preclude the degradation of the ECP during redox processes. The 
replacement of Glu by NMe-Glu in the peptide alters the surface topology of the 
biocomposite, entrapped CR(NMe)EKA forming bigger aggregates than CREKA. 
Both CREKA and CR(NMe)EKA affect the fibrin THR-catalyzed polymerization 
inducing a very fast aggregation process. However, in absence of catalytic enzyme such 
fast aggregation phenomenon is only promoted by CR(NMe)KA, whereas CREKA 
induces a stepwise linear grow of fibrin particles. This behavior is fully consistent with 
the ability of the different materials to adsorb fibrin at the surface, which grows in the 
following way: PEDOT < PEDOT-CREKA < PEDOT-CR(NMe)EKA. The two PEDOT-
peptide biocomposites, which adsorb selectively fibrin, transform the shape of the 
adsorbed protein from the typical mesh of fibers to agglomerates with different round-
like morphologies. This remarkable change has been attributed to the fact that the 
morphology of fibrin adsorbed onto the biocomposites is kinetically controlled through 
the very rapid aggregation process detected at the early stages of the Fg polymerization.  
Cell adhesion assays have evidenced that PEDOT-peptide-fibrin films promote the 
attachment of metastatic cells with respect to that of normal cells. However, this clearly 
manifested selectivity towards tumor cells is lost in absence of the fibrin coating. The 
overall of the results obtained in this work for PEDOT-CR(NMe)EKA films are currently 
used to develop new biomedical applications based on hollow nano- and microspheres of 






8.3 Weighing biointeractions between fibrin(ogen) and 
clot-binding peptides using microcantilever sensors 
Cancer, which represents the leading cause of morbidity and mortality worldwide (i.e. 
14 million new cases and 8.2 million cancer related deaths in 2012, the latter year in 
which information is available,52 requires detection at an early stage to increase the 
percentage of success of the oncological treatment. Within this context, molecular 
imaging, which is based on tumor-specific molecular ligands with high binding affinity, 
plays a central role in cancer detection in conjugation with conventional anatomic 
clinical imaging techniques (e.g. computed x-ray tomography, magnetic resonance 
imaging, or ultrasound).53 Hence, molecular imaging not only provides molecular and 
physiological information that reveals the presence of cancer in a curable stage, but also 
it is expected to allow for individualized treatment in real time and drug development.53 
As reviewed by Li and Cho, 54 tumor-homing peptides are promising agents to deliver 
drugs and imaging contrast to tumor sites due to their features55: improved tissue 
penetrating ability (i.e. they have a smaller molecular weight - less than 50 amino acids 
in average - than traditional molecular targeting agents, which include antibodies or 
their fragments), low immunogenicity, high affinity to targets, as well as stability in vivo 
and easy of handling during synthetic preparation.56-58 For instance, Arg-Gly-Asp (RGD) 
and Asn-Gly-Arg (NGR), which are two of the most widely used peptides targeting tumor 
vascularity (i.e. formation of new blood vessels - tumor angiogenesis - during tumor 
growth and progression), have also been applied to deliver anticancer drugs (e.g. 
chemotherapeutic drugs, cytokines, toxins, nucleic acids, radioactive isotopes, etc.).59-62 
Recently, other novel peptides targeting tumor neovasculature have been reported and 
tested, such as SVSVGMKPSPRP (SP5-52; several tumor types tested),63 CGKRK and 
CDTRL (HPV16-induced skin carcinoma and breast carcinoma),3 CKAAKNK (KAA) and 
CKGAKAR (KAR) (pancreatic tumors),64 or IFLLWQR (IF7; melanoma and colorectal 
cancer).15 
Among those, Cys-Arg-Glu-Lys-Ala (CREKA), which is a linear pentapeptide 
recognizing clotted plasma proteins in the blood vessels and stroma of tumors,1 was 




the focus of recent studies.6,7 Although the exact site of binding remains unknown, 
evidences strongly suggest that CREKA interacts with fibrin-fibronectin complexes 
present in tumor vessels.6 CREKA has targeted different tumor types (i.e. prostate 
cancer, gliomas, and lung cancer),11,66,67 and it has also induced tumor clotting, thus 
creating further binding sites in a self-amplifying effect.11 However, as stated by Stefanelli 
and Baker,68 CREKA’s specific binding affinity has not been reported yet. 
The excellent electrochemical properties displayed by PEDOT were retained when 
combined with CREKA and even improved when using the N-methyl variant. Moreover, 
the presence of N-methyl-Glu was found to modify the biocomposite-fibrin interactions, 
being fibrin-coated PEDOT-CR(NMe)EKA able to promote the adhesion of tumor cells.69  
During the last years, the application of nanomechanical sensing for biological 
purposes70 has increased considerably, as the review by Calleja et al. clearly evidences71. 
Briefly, this technology is based on the microcantilever mechanical response after 
interacting with a biological analyte, either as a deformation-bending (static mode) or a 
resonance frequency shift (dynamic mode)72. However, despite the fact that this 
biodetection tool is still far from being a practical alternative to other well established 
bioanalytical techniques (e.g. ELISA, microarrays and electrophoresis methods), 
nanomechanical sensors display other advantages (e.g. manageability, easy of synthesis 
and functionalization, and high intrinsic sensitivity)73, that make them suitable for 
specific biomedical purposes: drug detection,74 quantification of biological agents, 75,76 as 
well as understanding biological interactions,77 and detecting bacterial resistance to 
antibiotics.78 Additionally, nanomechanical sensors achieve lower limits of detection 
than those obtained with other commonly used non-labeled techniques, such as surface 
plasmon resonance or quartz crystal microbalance.79 For example, Kosaka et al. detected 
ultralow concentrations (i.e. ranging from 10 ag/mL to 1 pg/mL in undiluted serum) of 
two low-abundant cancer biomarkers using microcantilevers as nanomechanical 
transductors in sandwich bioassays labelled with gold nanoparticles (NPs).75 Similarly, 
highly crystalline TiO2 shells on magnetic cores were applied onto microcantilever 
sensors to detect very low concentrations (0.1 pg/mL) of multiple protein biomarkers in 




suspended mechanical structures when either biological adsorption or interactions take 
place on their surface.80,81 
Within this context, and considering that CREKA-based biocomposites behave as 
excellent candidates to be applied for biomedical purposes, it seems of major importance 
to make an effort in understanding the biological interactions that the tumor-homing 
peptide CR(NMe)EKA establishes. Accordingly, this works aims on detecting 
biomolecular recognition events between CR(NMe)EKA-functionalized microcantilever 
arrays and fibrin (Fb), fibrinogen (Fg), or bovine serum albumin (BSA) by means of 
nanomechanical sensing and, if possibly, quantitatively determine the detection limit. 
The modified pentapeptide has been covalently attached to Si surfaces via epoxysilane 
chemistry. Thus, to ensure an efficient surface immobilization, each step of the 
functionalization process has been characterized by a wide range of techniques. Finally, 
dynamic mode tests have evidenced changes in the resonance frequency of the 
cantilevers according to the adsorbed mass.  
 
8.3.1 Methods 
Materials: single side polished Si wafers (3 in. diam. × 0.5 mm thickness, 100, N-type, 
crystalline with a cubic lattice of a = 5.4037 Å) were purchased from Sigma-Aldrich, 
while Octosensis Microcantilever-Arrays (chips with 8 mono crystalline Si cantilevers, 
500 µm in length) were obtained from Micromotive GmbH (Mainz, Germany). CREKA 
and CR(NMe)EKA peptides with > 98% of HPLC purity were purchased from Biomatik 
(Toronto, ON). The following chemicals were purchased from Sigma-Aldrich and used as 
received without further purification: isopropanol, (3-
glycidyloxypropyl)trimethoxysilane (98%, SigmaAldrich), toluene (99.8%), Nα,Nα-
bis(carboxymethyl)-L-lysine hydrate (NTA-NH2) (97%), 1-[(3-dimethylamino)propyl]-3-
ethylcarbodiimide methiodide (EDC), N-hydroxysuccinimide (NHS), 2-(N-
morpholino)ethanesulfonic acid (MES), 2-amino-2-(hydroxymethyl)-1,3-propanediol 
(Tris base), 3,3’,5,5’-tetramethylbenzidine (TMB) (≥ 99%), carbonate/bicarbonate buffer, 
phosphate buffered saline (PBS, pH 7.4), BSA (lyophilized powder, crystallized, ≥ 




purchased from Panreac (Spain). Finally, the primary (anti-Fib/Fg, mouse monoclonal 
IgM, MFB-HB) and the conjugate antibodies (anti-Mouse IgM secondary ab, HRP 
conjugated, Goat IgG polyclonal) used in ELISA tests were purchased from 
ThermoFisher Scientific. 
 
Silicon functionalization: the functionalization protocol, which was applied to Si 
substrates (either Si pieces or microcantilever chips) was composed of different steps: 
1) Cleaning. Si disks were cut into 0.5  0.5 cm2 pieces. Before being functionalized, Si 
pieces and microcantilevers were activated by UV/ozone treatment. Specifically, 
samples were washed 3 times (5 min each) with isopropanol and placed in a UVO-
Cleaner (model 42-220, Jelight Company, Inc., Irvine, CA, USA) for 30 min. Samples 
were stored under vacuum. 
2) Silanization. Activated samples were silanized with 0.2% solution of (3-
glycidyloxypropyl)trimethoxysilane in dry toluene overnight at room temperature 
under nitrogen atmosphere. Afterwards, samples were washed with toluene and 
milli-Q water. Then, they were incubated into 100 mM NTA-NH2 solution in 50 mM 
carbonate buffer (pH 9.5) overnight at room temperature under gentle agitation. 
Later, Si substrates were washed with 50 mM carbonate buffer pH 9.5 and milli-Q 
water. 
3) Activation. In this step, the carboxyl groups of NTA-NH2 at the Si surface were 
activated for direct reaction with primary amines via amide bond formation with a 
mixture of 100 mM EDC and 150 mM NHS, both dissolved in 10 mM MES (pH 5.5). 
Samples were incubated for 30 minutes at 37 °C under gentle agitation and then 
extensively rinsed with 10 mM MES (pH 5.5). Specifically, EDC couples NHS to 
carboxyls, thus forming a stable NHS ester which allows for an efficient conjugation 
to primary amines. 
4) Immobilization of the pentapeptide. A solution of 100 μg/mL of CREKA or 
CR(NMe)EKA were prepared in 10 mM MES (pH 5.5). The cantilevers/Si pieces 
were incubated for 2 hours at 37 °C. After that, the samples were washed with 10 




2.7 mM KCl, 10 mM Na2HPO4, and 1.8 mM KH2PO4) to desorb those peptide 
fragments not covalently bonded to the surface. The surface of the cantilever/Si 
pieces was subsequently blocked to prevent nonspecific interactions by dipping the 
substrates into a 1 mg/mL BSA solution in 10 mM MES with 0.05% Tween® 20 (pH 
5.5) for 1 hour at room temperature with gentle agitation. Thereafter, samples were 
washed using MES pH 5.5 with 0.05% Tween 20 (pH 5.5). 
5) Protein recognition. The blocked surfaces were incubated in Fg or Fb solutions (PBS 
with 0.05% Tween® 20 at pH 7.4) with varying protein concentration (0, 50, 100, 
500, and 10000 ng/mL). Fibrin, which is an insoluble powder, was firstly dissolved in 
1 N NaOH at 1 mg/mL. Subsequently, this solution was further diluted with PBS 
(0.05% Tween® 20 at pH 7.4) to obtain all the aliquots. After the incubation time (1 
hour, 37 °C), samples were washed with PBS + 0.05% Tween® 20, PBS, and water, 
and were finally dried at room temperature.  
Wettability: Contact angle (CA) measurements were conducted using the water drop 
method. 0.5 µL of milliQ water drops were deposited onto the Si surface and recorded 
after stabilization with the equipment OCA 15EC (DataPhysics Instruments GmbH, 
Filderstadt). The SCA20 software was used to measure the CA, which is shown here as 
the average of at least 30 measures for each condition. 
 
X-ray photoelectron spectroscopy (XPS): XPS was used to analyze the chemical 
composition of Si surfaces. The system (SPECS Surface Nano Analysis GmbH, Berlin, 
Germany) was equipped with a non-monochromatic twin anode X-ray source XR50 of 
Mg/Al (1253 eV/1487 eV). Specifically, the Al anode was operated at 150 W. Detector 
pass energy was set at 25 eV and 0.1 eV for the survey and the narrow scans (high 
resolution spectra), respectively, at a pressure below 7.5 × 10−9 mbar. Casa XPS software 
(Version 2.3.16, Casa Software Ltd., Teignmouth, UK) was used to fit and perform peak 
integration of spectra. The C 1s peak was used as an internal reference (284.8 eV). High 
resolution XPS spectra were acquired by Gaussian–Lorentzian curve fitting after S-shape 





Interferometry: Green light interferometry in vertical scanning interferometry mode 
(Wyko NT9300 Optical Profiler, Veeco Instruments, New York, NY, USA) was used to 
evaluate the roughness of Si pieces after each functionalization step. The mean root 
square roughness (Rq), which is the average height deviation taken from the mean data 
plane, was measured in five randomly chosen areas (25  25 µm2) of three replicates for 
each step.  
 
Atomic force microscopy (AFM): AFM was conducted to obtain topographic images 
of the functionalized surfaces using Si TAP 150-G probes (Budget Sensors, Bulgaria) with 
a frequency of 150 kHz and a force constant of 5 N/m. Images were obtained with an 
AFM Dimension microscope using a NanoScope IV controller under ambient conditions 
in tapping mode. The row scanning frequency was set between 0.6 and 0.8 Hz. The Rq 
was determined using the statistical application of the NanoScope Analysis software 
(1.20, Veeco). 
 
Protein binding affinity (ELISA): Si wafers (0.5  0.5 cm2) were deposited into a 
standard 96 well-plate. The coating protein (BSA, Fg, or Fb) was diluted to a 
concentration of 1 µg/mL within the coating buffer (0.2 M bicarbonate buffer pH 9.4) 
and added (100 L per well) on the plate. The 96-well plate was incubated overnight at 4 
ºC for 1 hour at 37 ºC. Later, the plate was washed 3 times (5 minutes each) with 200 L 
of the washing buffer (25 mM Tris, 0.15 M NaCl, 0.05% Tween 20 pH 7.2). Then, 300 L 
of the blocking buffer (2 % BSA in washing buffer) were added to each well. The plate 
was covered and incubated at room temperature for 1 hour or overnight at 4 C. The 
blocker was removed, and 200 L of the primary antibody (Anti-Fib/Fg, mouse 
monoclonal IgM, MFB-HB) (1:1000) were added to each well. The plate was covered and 
incubated at room temperature for 1 hour. Afterwards, the plate was washed 3 times (5 
minutes each) with the washing buffer (200 L). The conjugated antibody (Anti-Mouse 
IgM secondary ab, HRP conjugated, Goat IgG polyclonal) (1:50000) was added to each 
well (200 L). Again, the plate was covered and incubated at room temperature for 1 




The substrate, TMB, was allowed to equilibrate at room temperature before use and was 
protected from light. Finally, after removing the washing buffer, 100 L of TMB were 
added. The color of the solution slowly developed to 650 nm; after 15 min at 37 ºC the 
plate was read. 
 
Statistical analysis: All the experiments were performed in triplicate. Statistical 
comparison of values was based on a 2-way ANOVA using Tukey’s test for pair-wise 
comparison with p < 0.05. 
 
Nanomechanical biosensing, resonance frequency measurements: 
Monocrystalline Si microcantilever chips containing arrays of 8 cantilevers (Micromotive 
GmbH) were used for the nanomechanical biosensing measurements. Specifically, the 
nominal length, width, and thickness of the cantilevers were 500, 90±2 and 1 µm, 
respectively. The fundamental resonance frequency is 5205.6 ± 161.7 kHz, obtained after 
averaging the response of 65 cantilevers. Resonance frequency measurements were 
conducted less than 24 hours after the protein (BSA, Fg, or Fb) recognition event took 
place onto the cantilever surface in a nitrogen atmosphere at 25 ºC. Figure 8.3.1 
illustrates the experimental setup. Hence, added mass onto the cantilever induces a shift 
in the resonance frequency that can be quantitatively measured by either an 
optomechanical or an electromechanical transduction scheme. In this case, SCALA 
(Scanning Laser Analyzer) is the optical read-out technology used during testing 
(Mecwins S.L., Spain).82,83 This platform is based on the automated two-dimensional 
scanning of a single laser (1 mW) beam by voice-coil actuators perpendicularly located. 
Displacements over a range of several millimeters at speeds up to 10 mm/s and with an 
accuracy of 100 nm are achieved. Once the laser beam is reflected by the cantilever array, 
the exact position and intensity of the reflected spot is collected by a two-dimensional 
linear position detector (PSD). Moreover, TRACKER, which is an algorithm that 






8.3.2 Results and discussion 
CREKA and CR(NMe)EKA, which are the tumor-homing pentapeptides used in this 
work, are displayed in Figure 8.3.2. Both biomolecules bind to clotted plasma proteins 
overexpressed in cancerous tissue (tumor stroma and the walls of vessels).84 Briefly, 
plasma proteins, such as Fg, which is the Fb precursor, and fibronectin, another protein 
crosslinked to Fb during blood clotting, leak from tumor vessels (i.e. they are more 
fragile and irregular than normal vasculature), thus being converted to Fb by 
procoagulant factors, which are commonly found in tumor environments.84 Hence, the 
Fb meshwork localized in the interstitial spaces of tumors acts as CREKA’s binding sites 
for effective tumor imaging or drug delivery. 
 The tumor-homing response of CREKA was enhanced by protecting the pentapeptide 
against proteolytic degradation.11 Specifically, several N- and Cα-methylated amino acids 
were replaced without inducing changes in the peptide conformational profile. Among 
them, CR(NMe)EKA (Glu residue modified, Figure 8.3.2) was reported to be 
significantly more active than CREKA while displaying greater stability. Although both 
pentapeptides accumulate in areas rich in Fb and Fg, CR(NMe)EKA is chosen as the 
tumor-specific molecular ligand in this work for nanomechanical biosensing 
experiments. However, during the optimization and characterization of the 
functionalization protocol, CREKA is used as control to verify any variation provoked by 
































CREKA/CR(NMe)EKA silicon surface functionalization 
Before immobilizing CR(NMe)EKA onto the surface of chips used for 
nanomechanical biosensing, the reliability and efficiency of the functionalization 
protocol was confirmed by using bare Si substrates ( 0.5  0.5 cm2) as control test 
surface. Figure 8.3.3 depicts the functionalization protocol followed to bind 
CR(NMe)EKA onto Si surfaces. The pentapeptide was covalently bonded to the surface 
by following a previously reported silanization process.85 Although this approach 
requires more steps than other procedures (i.e. physical adsorption of the biomolecule 


























As it can be observed in Figure 8.3.3, after generating hydroxyl groups by 
UV/ozone exposure (all physisorbed contamination is removed prior modification), 
silanization was conducted with (3-glycidyloxypropyl)trimethoxysilane. In the next step, 
the epoxy groups were opened by the amino group of NTA-NH2 (basic pH), and thus 
NTA-NH2 enriched the surface with carboxyl groups that were subsequently activated by 
EDC/NHS. Finally, CR(NMe)EKA was covalently attached to the surface by the amide 
bonds created between activated carboxylates and the amino groups from the 
pentapeptide. It should be noted that, as the sulfhydryl group of the single Cys residue is 
not required for binding, this strategy allows for coupling the pentapeptide to other 
moieties, such as anticancer drugs or fluorescent dyes. Accordingly, this procedure can 
add multifunctionality to CREKA-tethered systems if required in a biomedical context. 
As an initial indicator of the satisfactory evolution of the functionalization process, 
Figure 8.3.4a displays the variation in the wettability of the Si surface according to 
each step of the protocol previously described. Hence, –OH groups generated due to the 
UV/ozone treatment notably decrease the CA value of bare Si from 92.7° ± 5.0° to 30.0° 
± 5.0°, indicating the formation of a highly hydrophilic surface. This observation can be  
ascribed to both the removing of hydrophobic substances from the Si surface, as well as 

































Figure 8.3.4 (a) CA values of water and (b) Rq of the silicon square surface in each different 
step of the functionalization process. Greek letters are assigned to statistically significant 
different groups (p-value < 0.05). 




show a CA value of 59.8° ± 2.8°, which decreases to 34.4° ± 3.3° in the next step because 
of –COOH groups provided by NTA-NH2.  
The final step of the functionalization process induces a slight increase in the surface 
hydrophobicity regardless the pentapeptide used, CREKA (51.9° ± 3.9°) or CR(NMe)EKA 









Although CA results are in good agreement with the expected chemical composition 
of each functionalization step, the functionalization protocol was corroborated by XPS. 
Table 8.3.1 summarizes the atomic percentage composition and N/C, N/O, and N/Si 
atomic ratio values of the surfaces throughout each step of the functionalization process. 
As expected, the composition of control Si–OH surfaces accounts for O 1s (47.7%) 
and Si 2p (38.9%), with the percentage of C 1s (13.4%) ascribed to atmospheric 
contamination. In good agreement with CA values, the UV/ozone treatment is 
responsible for the high percentage of O 1s signal (O/Si = 1.19 and O/C = 3.56). In the 
next two functionalization steps, epoxysilane and NTA-NH2 are bonded to Si–OH 
surfaces. Consequently, the O/C ratio decreases to 1.71 and 1.46, respectively. However, 
although the content of N 1s is not altered by the incorporation of NTA-NH2, the CA 





O 1s C 1s Si 2p N 1s N/C O/C N/Si 
Si-OH 47.7 13.4 38.9 - - 3.56 - 
Epoxysilane 40.1 23.5 36.4 - - 1.71 - 
NTA-NH2 36.2 24.8 39.1 - - 1.46 - 
CREKA 32.1 34.8 31.1 2.0 0.06 0.92 0.06 
CR(NMe)EKA 36.7 29.6 31.4 2.3 0.08 1.24 0.07 










Finally, the adequate covalent binding of the two pentapeptides onto the Si substrates 
is detected not only by the increase in the N 1s content to 2% and 2.3% for CREKA and 
CR(NMe)EKA, respectively, but also by the reduction in the atomic percentage of Si 2p as 
well as the increase in C 1s content. The high resolution spectra of N 1s (Figure 8.3.5) 
confirm the peptide attachment since the deconvolution of the signal led to three well-
defined peaks. The central peak, which is located at 400 eV, corresponds to the amide 
bonds of the peptide backbone (N-C=O) as well as uncharged, hydrogen-bonded amines 
(C-NH2), whereas the other two peaks at ~398 eV and ~401 eV are attributed to C=N- 
and free protonated amino groups (NH3+), respectively, present in the side chain groups 
of CREKA and CR(NMe)EKA.86,87  
 
O 1s C 1s Si 2p N 1s N/C O/C N/Si 
CR(NMe)EKA 38.2 32.0 26.0 3.8 0.12 1.19 015 



















Figure 8.3.5 N 1s high-resolution XPS spectra for each silicon surface throughout the 
functionalization protocol. Peaks from deconvolution are also displayed. 
Table 8.3.2 Atomic percentage composition and N/C, N/O and N/Si atomic ratio for 




In order to determine the stability of the peptide binding, CR(NMe)EKA 
functionalized silicon wafers were sonicated at 37 °C in PBS (1x) for 1 hour. Then, both 
the wettability and chemical composition of the samples were examined again by CA and 
XPS measurements, respectively. CA values for CR(NMe)EKA-functionalized surfaces 
were 49.6° ± 2.96° and 57.6° ± 1.3° before and after sonication, respectively, while the 
atomic percentage composition and N/C, N/O, and N/Si atomic ratio values of 
CR(NMe)EKA-surfaces decreased upon sonication but were not completely reduced 
(Table 8.3.2), which confirms the stability of the peptide binding to Si substrates.  
Moreover, the topography of the modified surfaces (scanned areas of 5  5 µm2) was 
observed by AFM to monitor each step of the functionalization process. Figure 8.3.6 
displays height and phase images of Si–OH and CR(NMe)EKA-functionalized surfaces, 
whereas the results for the intermediate steps (i.e. epoxysilane and NTA-NH2) and 
CREKA-functionalized surfaces are included in Figure 8.3.7. Upon coating with the 
pentapeptide (Figure 8.3.4b), the smooth and homogenous features of Si–OH (Rq = 
0.4 nm) evolves towards a rougher surface, even though the Rq values of the modified 
interfaces are still small (in the range between 0.4 nm and 1 nm). Moreover, AFM phase 
images, which register phase signal shifts due to changes in the adhesion force between 
the tip and the surface (i.e. stiffness/softness), allow for the chemical mapping of the 
surface. Specifically, no phase contrast is observed for any step of the functionalization 
process, thus verifying the complete coverage of the Si substrate, which is in good 
agreement with the XPS results.     
Aware that Rq values depend on the analyzed area, interferometric measurements 
were also conducted to determine such parameter but considering bigger scanned areas 
(25  25 µm2). As it is depicted in Figure 8.3.4b, the UV/ozone treatment did not alter 
the topography of the Si surface (i.e. Rq values for Si and Si–OH surfaces are 0.9 ± 0.3 
nm and 1.0 ± 0.4 nm, respectively). As described previously, Rq increases after each step 
of the functionalization process. Thus, with respect to Si–OH, there is an increment in 
roughness of 120%, 239%, 305%, and 312% for epoxysilane (2.3 ± 0.5 nm), NTA-NH2 




Overall, the findings derived from CA measurements, topographical characterization, 
and, most importantly, chemical composition analyses, confirm the proper covalent 
attachment of CREKA and CR(NMe)EKA onto Si surfaces. Hence, the suitability of the 
described functionalization protocol, which is based on a silanization process, has been 
proven, and thus can be applied to microcantilever Si chips for the following 
nanomechanical experiments.  
 
CREKA and CR(NMe)EKA binding affinity 
Before analyzing the interactions between CR(NMe)EKA pentapeptide and Fb or Fg 
by means of nanomechanical characterization, ELISA binding assays were conducted to 
verify such biorecognition event. In this case, we approached the experiment 
qualitatively, our focus being whether CREKA- and CR(NMe)EKA-functionalized Si 
surfaces still recognize clotted plasma.  
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Figure 8.3.6 Topographical characterization (areas of 55 µm2): (top) 2D AFM height and 
(middle) phase micrographs of Si–OH (left) and CR(NMe)EKA (right) surfaces. (bottom) 




Figure 8.3.8 depicts the binding affinity of CREKA and CR(NMe)EKA-
functionalized Si surfaces towards Fb, Fg, or BSA as the absorbance at 650 nm in PBS 
media. Tissue culture polystyrene (TCP) and Si–OH surfaces were used as control 
substrates. As it can be seen, in PBS, the Fb- and Fg-binding capability of CR(NMe)EKA-
functionalized Si surfaces is 118% and 174% higher, respectively, than that displayed by 
CREKA-functionalized substrates. Besides, no BSA interaction occurred, thus further 
confirming the biorecognition of this tumor-homing peptide for Fb and Fg complexes. 
The overall of these results corroborate the role played by NMe-Glu in Fb/Fg 
interaction.11 More specifically, such residue is crucial to promote the protein binding 
mechanism, either by enhancing the activity of the tumor-homing peptide or improving 
its stability. In addition, the binding site of CR(NMe)EKA is not altered by the 
functionalization protocol. Accordingly, on the light of these results and considering our 
previous works,18,69 we selected CR(NMe)EKA as the molecular ligand for 
nanomechanical biosensing tests.  
Epoxysilane
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Figure 8.3.7 Topographical characterization (areas of 5 × 5 µm2): 2D AFM height (top) and 
phase micrographs (bottom) of Epoxysilane (left), NTA-NH2 (middle) and CREKA (right) 























Figure 8.3.8 Protein adhesion assay carried out in PBS. Absorbance values were obtained 
from ab-HRP activity. Greek letters on the columns refer to significant differences (p-value < 
0.05) when the 2-way ANOVA and Tukey's multiple comparisons test are applied: α vs Si-
CR(NMe)EKA BSA absorbance, β vs Fb absorbance on TCP. 
Nanomechanical biosensing: Resonance frequency measurements 
The microcantilever-based biosensing emerging technology has been applied in this 
work to observe and analyze the binding affinity of CR(NMe)EKA towards Fb and Fg 
proteins. Among other features, this platform is characterized by high sensitivity, label-
free detection, and small sample consumption due to the size of the microcantilevers (ca. 
1000 µm2).88 
Specifically, CR(NMe)EKA-functionalized Si chips containing arrays of 8 cantilevers, 
thus using various sensors in parallel, were operated in the dynamic mode combining a 
scanning laser, the beam deflection method, piezoelectrical excitation (an actuator is 
located beneath the chip base) and analysis of the first vibration mode.89 After being 
cleaned (i.e. isopropanol + 30’ UV/ozone exposure), these commercial chips - 500 µm 
long, ~100 µm wide, and 1 µm thick - exhibited a fundamental resonance frequency of 
5205.6 ± 161.7 kHz (n = 65 ) measured in a N2 atmosphere at 25 ºC. The eigenmode 
shape obtained during frequency excitation is plotted for a representative cleaned chip in 
Figure 8.3.9.  
In general, the results take into consideration the response of at least 10 cantilevers at 
each concentration. Besides, data for the Fb-binding event was collected in two 
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microcantilevers incubated in the presence of Fb, Fg, or BSA at a concentration of 10 
µg/mL (i.e. BSA was used as a negative control since no binding is expected for this 
protein). As it is shown, CR(NMe)EKA biointeracts towards the two clotted plasma 
proteins, being the frequency shift values higher for Fb/Fg recognition than for BSA. 
Moreover, provided the molecular weight of Fg and Fb is similar and ca. 340 kDa (Fb, 
which is an insoluble protein, was first dissolved in 1 N NaOH at 1 mg/mL, and then 
highly diluted in PBS), a slightly higher number of binding events occurred for Fg than 
Fb. As a representative example, Figure 8.3.10b depicts the nanomechanical 1st mode 
resonance response of a CR(NMe)EKA-functionalized Si cantilever before and after Fb 
incubation. The same trend was observed when Fg was used (Figure 8.3.11a), whereas 
BSA incubation did not lead to any significant change in the cantilever resonance 
frequency (Figure 8.3.11b).  
Additionally, in an effort to determine the detection limit for CR(NMe)EKA, lower 
protein concentrations were tested in the interval between 50 ng/mL and 10 µg/mL.  
Figure 8.3.10c and d shows the relation between the resonance frequency shift and Fg 
or Fb concentration, respectively. As it can be observed, regardless the protein, the 
resonance frequency shift exhibits a linear dependence with the protein concentration: 
the higher the concentration, the more mass is being recognized by the pentapeptide, 
which induces greater changes in the mechanical vibration of the cantilever. Control 
experiments, which consisted on incubating CR(NMe)EKA-functionalized Si chips in 
solutions with no protein, allow us to establish a noise level produced by non-specific 




is set at 100 ng/mL for both Fb and Fg. Despite the fact that the detection limit obtained 
in these measurements is above the detection range of the technique generally used to 
determine the concentration of Fb and Fg (i.e. ELISA, 0.5 - 6.25 ng/mL and 1.25 – 80 
ng/mL, respectively), this label-free nanomechanical sensing offers simplicity and 
affordability. Furthermore, it has been proven to reach values in the order of magnitude 
of fg/mL by using a different configuration.75,76 Consequently, to improve the detection 
limit of the measurement, different strategies can be applied: (i) use of smaller 
cantilevers; (ii) amplify the signal by means of CREKA-functionalized nanoparticles, 
such as those previously described;1,11 or (iii) optimize the receptor biolayer (i.e. 
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Figure 8.3.10 Nanomechanical response: (a) absolute frequency shift of cantilevers after being 
incubated with 10 µg/mL of BSA, Fg and Fb; (b) mechanical resonance frequency of a Si 
cantilever before and after the Fb recognition event (10 µg/mL in PBS); (c and d) relative 
resonance-frequency shift vs protein concentration of (c) Fg and (d) Fb in PBS. Mean values 
and standard deviations are calculated with the data of a minimum of 10 different cantilevers. 






prevent nonspecific interactions).90 
Finally, it is important to note that the comprehension of protein biorecognition is 
complex and time-demanding. Although the proteins chosen in this work play a major 
role in coagulation events, the study of CR(NMe)EKA binding events towards other 
proteins, such as fibronectin and Fb/fibronectin mixtures, is required to further explore 
the underlying binding mechanism of CREKA-based tumor-homing peptides. Our results 
confirm the promising application of nanomechanical sensing for such purpose. 
Bearing all these considerations, this study establishes a challenging line of research 
focused on CREKA and CR(NMe)EKA tumor-homing peptides and their bioapplication 
that is currently being developed in our laboratory. Moreover, the protein recognition 
event if conducted in a reverse configuration, with Fb/Fg-functionalized cantilevers and 
PEDOT-CREKA/CR(NMe)EKA biocomposite interfaces18,69 designed as nanoparticles91, 
can significantly contribute expand the scope of nanomechanical biosensing.  
 
8.3.3 Conclusions 
In this chapter, we have examined the biorecognition event between clotted plasma 
proteins and a tumor-homing pentapeptide, CR(NMe)EKA, by applying a label-free 
sensing technology based on microcantilevers. For such purpose, CREKA and 
CR(NMe)EKA were covalently linked via an epoxysilane-based protocol to Si substrates 
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Figure 8.3.11 Mechanical resonance frequency of a Si cantilever before and after the 





different characterization techniques performed at each one of the functionalization 
steps confirmed the suitability of the protocol to tether these linear, small pentapeptides 
onto Si surfaces. Moreover, although the presence of the NMe-Glu residue had no impact 
regarding the functionalization result, CR(NMe)EKA-functionalized silicon substrates 
yield the highest Fb adsorption in PBS in comparison to CREKA-functionalized surfaces. 
Hence, after the covalent binding of CR(NMe)EKA onto Si surfaces, NMe-Glu residue 
still promotes Fb-binding. Finally, dynamic mode nanomechanical tests were carried out 
using CR(NMe)EKA-functionalized microcantilever sensors. This simple and 
manageable label-free detection technique provided information regarding the 
interaction between Fb/Fg and the clot-binding peptide, thus establishing a detection 
limit of 100 ng/mL. However, although further improvement is required to lower the 
detection limit and determine the specific binding affinity of CREKA and its analogues, 
the overall of these results reflect the importance of developing emerging technologies 
suitable for specific biomedical purposes. With that goal in mind, extensive investigation 
is being performed in our laboratory to comprehend CREKA and CR(NMe)EKA-
mediated clot-binding and expand their applications in the biotechnological field. 
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CHAPTER 9:  



























This chapter summarizes the main conclusions drawn from this Thesis. 
9.1 General conclusions 
Part A: Biomimetic membranes based on Omp2a transmembrane protein 
First, an ambient resembling to the one encountered in nature is provided to study 
the Omp2a mechanical and morphological properties.  
 The reconstitution of Omp2a into lipid bilayers provides platforms that fulfil 
both the nanometric dimensional requisite for truly mimicking biological 
attributes, and the conditions necessary for exploring their properties. Thus, a 
strategy able to collect the potential individual benefits of lipid bilayers and 
polymer-based nanomembranes into a single platform is expected to provide 
important advantages from a biotechnological point of view. For example, the 
immobilization of Omp2a-based lipid bilayers into the pores of nanoperforated 
polymeric membranes would probably improve the ion affinity detection 
capability since the protein environment would be very close to native 
conditions and, therefore, the negative influence of the polymer in the protein 
structure would be eliminated.  
Subsequently, physicochemical and structural properties of the protein organization 
upon thermal treatment are studied.  
 Thermomechanical measurements at the microscopic level on functionalized 
cantilevers have provided molecular insights that complement the information 
obtained from conventional characterization techniques on ensembles formed 
by a very large number of molecules. A serious limitation of conventional 
techniques is that they provide only a sample average response and are unable 
to give information on specific local features on or within the sample. 
 Soft post-thermal treatments could be very advantageous to improve the 
efficacy of polymeric NMs with porins immobilized onto the surface or confined 
inside synthetic pores. These treatments could regulate the amount of porin 
molecules active for the ion transport, controlling their orientation. 




 Nanoperforated PLA FsNMs have been prepared using a two-step process: (1) 
spin-coating a mixture of immiscible polymers to cause phase segregation and 
formation of appropriated nanofeatures (i.e. phase separation domains with 
dimensions similar to the entire film thickness); and (2) selective solvent 
etching to transform such nanofeatures into nanoperforations. For this purpose, 
PLA has been mixed with PVA and the diameter of the nanopores has been 
controlled through both the PLA:PVA ratio and the processing conditions of the 
mixture. 
 Bioinspired FSNMs for selective ion transport have been tailored by 
immobilizing the Omp2a -barrel membrane protein inside nanoperforations 
created in flexible PLA nanomembranes. The bioinspired combination of 
nanofeatures supported onto polymeric FSNMs with the confinement of OM 
proteins is a powerful approach that synergistically associates the most 
important advantages of each component. Thus, the incorporation of 
nanoperforations enhances the transport of ions across PLA nanomembranes, 
whereas the functionality of immobilized Omp2a is essential to exhibit effects 
similar to those observed in biological nanomembranes. 
Part B: Design of intrinsically controlled polymers for drug delivery systems 
This part is devoted to the preparation of materials made of conducting polymers 
with nano- or microstructures for drug loading and delivery upon electrical stimuli. 
 Hydrophobic drugs have been loaded into PEDOT by in situ emulsion 
polymerization. Polymer···drug interactions have been used to tailor the drug 
release profile by applying an externally electrical stimulus. More specifically, 
controlled and time-programmed release of CUR has been achieved in a 
physiological medium by applying a negative voltage of –1.25 V to loaded 
PEDOT nanoparticles. 
 Electrospun PCL microfibers loaded with PEDOT NPs and CUR have been 
prepared and characterized. The smart release of CUR from the PCL microfibers 
has been achieved by applying well-defined potential pulses, which induce the 
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electro-mechanical response of PEDOT NPs, affecting the structure of the PCL 
matrix and promoting the release of drug.  
Part C: Surface functionalization with CREKA 
This section is thought to optimize platforms for protein recognition based on 
conducting films or silicon microcantilevers functionalized with pentapeptides. 
 Comparison of PEDOT-CREKA and PEDOT-CR(NMe)EKA as biointerfaces 
reflects dissemblance in the organization of the peptides into the polymeric 
matrix. Both peptides affect fibrinogen thrombin–catalyzed polymerization 
causing the immediate formation of fibrin, whereas in absence of thrombin this 
phenomenon is only observed for CR(NMe)EKA. Consistently, the fibrin-
adsorption capacity is higher for PEDOT-CR(NMe)EKA than for PEDOT-
CREKA, even though both PEDOT-peptide films coated with fibrin are selective 
in terms of cell adhesion, promoting the attachment of metastatic cells with 
respect to normal cells. 
 Tumor-homing peptides CREKA and CR(NMe)EKA have been covalently 
attached via epoxysilane chemistry onto silicon microcantilever chips that acted 
as sensors during dynamic nanomechanical experiments. The fibrin(ogen)-
binding induced by CR(NMe)EKA has been detected by the resonance 
frequency shift of the cantilevers, and a detection limit of 100 ng/mL has been 
achieved. Our nanomechanical studies reflect the promising application of 
emerging technologies capable of assisting in the fully comprehension of 
biological interactions and their implications in the biotechnological field.  
 
9.1 Specific conclusions 
Part A: Biomimetic membranes based on Omp2a transmembrane protein 
 The nanomechanical properties of Omp2a reconstituted into bilayers made of 
4:3:1 POPC:POPE:POPG, which have been found to be the most homogenous 
and consistent among those studied in this Thesis, can be summarized as 
follows: average DMT moduli= 10.5±1.7 MPa; adhesion force= 161.9±9 pN; and 




 Nanomechanical properties of reconstituted Omp2a are clearly distinguishable 
from the ones determined for the lipid bilayer and reflect not only the 
satisfactory incorporation of the protein but also its low stiffness and high 
molecular flexibility. This key role played by Omp2a in the nutrition of bacteria.  
 Electrochemical impedance spectroscopy measures of bilayers with different 
lipid-to-protein ratios indicate that the ion affinity increases with the protein 
concentration used in the proteoliposomes reconstitution. More specifically, a 
reduction of 78% being observed between the control and the lowest lipid-to-
protein ratio. 
 The properties Omp2a-based SLBs are less suitable for technological 
applications than those of polymeric FsNMs with Omp2a immobilized in 
nanoperforations. 
 The unique thermomechanical response of Omp2a-functionalized cantilevers, 
which exhibits four well-defined regimes above 40 ºC, suggests practical 
approaches to improve the efficacy of smart biomimetic NMs with porins 
immobilized onto the surface or confined inside synthetic pores.  
 Maximization of favourable interactions among porin molecules has been 
achieved by heating the proteins from their initial assembly state to 
denaturalization and, subsequently, cooling under controlled conditions. This 
thermal treatment enhances the intermolecular -sheets, which requires local 
orientation of the immobilized biomolecules. 
 Nanoperforated PLA FsNMs of thickness 120-130 nm have been successfully 
obtained using spin-coating combined with phase segregation processes in 
immiscible 90:10 PLA:PVA mixtures and the subsequent removal of PVA 
domains via selective solvent etching. 
 The diameter of the nanopores has been controlled through the conditions 
applied to the preparation of the PLA:PVA mixture, the dimensional scale of the 
phase separation domain decreasing when the mixing process is performed 
under vigorous stirring conditions. This procedure led to perforated PLA FsNM 
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with nanopores of = 170±73 nm (prepared without stirring) and = 65±32 nm 
(prepared under vigorous stirring). 
 Cell proliferation assays showed that PLA nanomembranes with nanopores of 
= 170±73 nm interact intensely with cell filopodia, which are protruding 
finger-like structures of = 100-200 nm. Consequently, these nanomembranes 
exhibited cell viabilities significantly higher than those of nanofilms with pores 
of = 65±32 nm and without perforations.  
 The Omp2a porin has been integrated into nanoperforated ultra-thin films of 
PLA by confining oval protein aggregates inside nanoperforations of = 5122 
nm. The resulting device, in which the protein preserves the -barrel structure, 
fulfils the nanometric dimensional requisite for truly mimicking biological 
attributes. 
 Omp2a-containing PLA NMs showed much higher ion transport activity than 
nanoperforated films without immobilized Omp2a, especially at high electrolyte 
concentrations. Hence, the ion affinity of Omp2a-filled nanoperforated PLA 
NMs increases with the concentration.  
 The diffusion of Ca2+ and Na+ ions through Omp2a-filled nanopores is 
significantly higher than for K+ at concentrations  500 mM, suggesting that the 
novel Omp2a–PLA platform fulfils the conditions necessary for designing new 
NMs for biosensing, nanofluidics and ion-rectifying for energy conversion.  
Part B: Design of intrinsically controlled polymers for drug delivery systems 
 Encapsulation of CUR and PIP in PEDOT NPs was achieved by in situ emulsion 
polymerization using DBSA as stabilizer and doping agent. These two neutral 
drugs differ in their capacity to form hydrogen bonding interactions with the 
oxidized polymer chains, regulation of these interactions being used to tailor the 
release profile. 
 The release of CUR is controlled through the strength of drug···PEDOT specific 
interactions, which become weaker when polymer chains are reduced applying 




 CUR/PEDOT NPs are a promising combination that efficiently controls the 
release of the drug through external stimuli. This methodology, which can be 
extrapolated to other neutral drugs with similar hydrogen bonding abilities, 
may be a potential strategy for treatments based on the programmed dosage of 
CUR. 
 PCL/PEDOT/CUR MFs have been successfully prepared by electrospinning. 
PEDOT NPs exhibit a diameter of 99  21 nm and are mainly located inside the 
PCL MFs with diameter of 3.9  0.7 m. 
  The topography of mats made of randomly collected PCL/PEDOT/CUR MFs 
resembles that of the extracellular matrix, facilitating cell spreading and 
enhancing cell proliferation because of their heterogeneity and roughness. 
Furthermore, in vitro assays have evidenced that CUR maintains the biological 
activity after the electrospinning process.  
 PCL/PEDOT/CUR MFs exhibit potential advantages to regulate the CUR 
release by electrical stimulation. Thus, application of potential pulses causes 
changes at the MFs due to the migration of PEDOT NPs from inside to the 
surface. PEDOT NPs experience a volume change with concomitant “on-
demand” CUR release.  
 Independently of the concentration of CUR initially loaded into 
PCL/PEDOT/CUR MFs, the drug release dose increases with the number of 
potential pulses, scaling linearly. This feature proves that the incorporation of 
isotropic actuators, as PEDOT NPs, to biodegradable electrospun MFs is a 
successful approach for the development of programmable drug delivery 
devices. 
Part C: Surface functionalization with CREKA 
 PEDOT-peptide biocomposites have been prepared by chronoamperometry in 
basic aqueous solution. The electrochemical and electrical response of the 
resulting biocomposites is significantly better than that of PEDOT in terms of 
electroactivity, electrostability and electrical conductivity. Such improvement 
suggests that peptide molecules play simultaneously two roles acting, on one 
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side, as dopant agents that participate actively in oxidation and reduction 
processes and, on the other side, as structural supports that preclude the 
degradation of the polymer matrix during redox processes.  
 Both CREKA and CR(NMe)EKA affect the fibrin THR-catalyzed polymerization 
inducing a very fast aggregation process. However, in absence of catalytic 
enzyme such fast aggregation phenomenon is only promoted by CR(NMe)KA, 
whereas CREKA induces a stepwise linear grow of fibrin particles. This 
behaviour is fully consistent with the ability of the different materials to adsorb 
fibrin at the surface, which grows in the following way: PEDOT < PEDOT-
CREKA < PEDOT-CR(NMe)EKA.  
 The two PEDOT-peptide biocomposites, which adsorb selectively fibrin, 
transform the shape of the adsorbed protein from the typical mesh of fibres to 
agglomerates with different round-like morphologies. This remarkable change 
has been attributed to the fact that the morphology of fibrin adsorbed onto the 
biocomposites is kinetically controlled through the very rapid aggregation 
process detected at the early stages of the Fg polymerization.  
 Cell adhesion assays indicated that PEDOT-peptide-fibrin films promote the 
attachment of metastatic cells with respect to that of normal cells. However, this 
clearly manifested selectivity towards tumor cells is lost in absence of the fibrin 
coating.  
 The biorecognition event between clotted plasma proteins and a tumor-homing 
pentapeptide, CR(NMe)EKA has been examined by applying a sensing 
technology based on microcantilevers. For such purpose, CREKA and 
CR(NMe)EKA were covalently linked via an epoxysilane-based protocol to Si 
substrates that efficiently activated by UV/ozone treatment. The results derived 
from the different characterization techniques performed at each one of the 
functionalization steps confirmed the suitability of the protocol to tether these 
linear, small peptides onto Si surfaces.  
 CR(NMe)EKA-functionalized silicon substrates yield the highest Fb adsorption 




covalent binding of CR(NMe)EKA onto Si surfaces, NMe-Glu residue still 
promotes Fb-binding. Dynamic mode nanomechanical tests using 
CR(NMe)EKA-functionalized microcantilever sensors provided information 
regarding the interaction between Fb/Fg and the clot-binding peptide, thus 
establishing a detection limit of 100 ng/mL.  
 Although further improvement is required to lower the detection limit and 
determine the specific binding affinity of CREKA and its analogues, the overall 
of nanomechanical results reflect the importance of developing emerging 
technologies suitable for specific biomedical purposes. With that goal in mind, 
extensive investigation is currently being performed in our laboratory to 
comprehend CREKA and CR(NMe)EKA-mediated clot-binding and expand 
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